id	sid	tid	token	lemma	pos
fnp-2613	1	1	dementia	dementia	NOUN
fnp-2613	1	2	with	with	ADP
fnp-2613	1	3	lewy	lewy	ADJ
fnp-2613	1	4	bodies	body	NOUN
fnp-2613	1	5	–	–	PUNCT
fnp-2613	1	6	a	a	DET
fnp-2613	1	7	clinicopathological	clinicopathological	ADJ
fnp-2613	1	8	update	update	NOUN
fnp-2613	1	9	feel	feel	VERB
fnp-2613	1	10	free	free	ADJ
fnp-2613	1	11	to	to	PART
fnp-2613	1	12	add	add	VERB
fnp-2613	1	13	comments	comment	NOUN
fnp-2613	1	14	by	by	ADP
fnp-2613	1	15	clicking	click	VERB
fnp-2613	1	16	these	these	DET
fnp-2613	1	17	icons	icon	NOUN
fnp-2613	1	18	on	on	ADP
fnp-2613	1	19	the	the	DET
fnp-2613	1	20	sidebar	sidebar	NOUN
fnp-2613	1	21	free	free	ADJ
fnp-2613	1	22	neuropathology	neuropathology	PROPN
fnp-2613	1	23	1:7	1:7	NUM
fnp-2613	1	24	(	(	PUNCT
fnp-2613	1	25	2020	2020	NUM
fnp-2613	1	26	)	)	PUNCT
fnp-2613	1	27	review	review	NOUN
fnp-2613	1	28	dementia	dementia	NOUN
fnp-2613	1	29	with	with	ADP
fnp-2613	1	30	lewy	lewy	ADJ
fnp-2613	1	31	bodies	body	NOUN
fnp-2613	1	32	–	–	PUNCT
fnp-2613	1	33	a	a	DET
fnp-2613	1	34	clinicopathological	clinicopathological	ADJ
fnp-2613	1	35	update	update	NOUN
fnp-2613	1	36	jános	jáno	VERB
fnp-2613	1	37	bencze1,2	bencze1,2	PROPN
fnp-2613	1	38	,	,	PUNCT
fnp-2613	1	39	woosung	woosung	PROPN
fnp-2613	1	40	seo3	seo3	PROPN
fnp-2613	1	41	,	,	PUNCT
fnp-2613	1	42	abdul	abdul	PROPN
fnp-2613	1	43	hye4,5	hye4,5	PROPN
fnp-2613	1	44	,	,	PUNCT
fnp-2613	1	45	dag	dag	PROPN
fnp-2613	1	46	aarsland5,6,7	aarsland5,6,7	PROPN
fnp-2613	1	47	,	,	PUNCT
fnp-2613	1	48	tibor	tibor	PROPN
fnp-2613	1	49	hortobágyi2,6,7,8	hortobágyi2,6,7,8	NOUN
fnp-2613	1	50	1	1	NUM
fnp-2613	1	51	department	department	NOUN
fnp-2613	1	52	of	of	ADP
fnp-2613	1	53	pathology	pathology	PROPN
fnp-2613	1	54	,	,	PUNCT
fnp-2613	1	55	faculty	faculty	NOUN
fnp-2613	1	56	of	of	ADP
fnp-2613	1	57	medicine	medicine	NOUN
fnp-2613	1	58	,	,	PUNCT
fnp-2613	1	59	university	university	NOUN
fnp-2613	1	60	of	of	ADP
fnp-2613	1	61	debrecen	debrecen	PROPN
fnp-2613	1	62	,	,	PUNCT
fnp-2613	1	63	debrecen	debrecen	PROPN
fnp-2613	1	64	,	,	PUNCT
fnp-2613	1	65	hungary	hungary	PROPN
fnp-2613	1	66	2	2	NUM
fnp-2613	1	67	mta	mta	PROPN
fnp-2613	1	68	-	-	PUNCT
fnp-2613	1	69	de	de	X
fnp-2613	1	70	cerebrovascular	cerebrovascular	ADJ
fnp-2613	1	71	and	and	CCONJ
fnp-2613	1	72	neurodegenerative	neurodegenerative	ADJ
fnp-2613	1	73	research	research	NOUN
fnp-2613	1	74	group	group	NOUN
fnp-2613	1	75	,	,	PUNCT
fnp-2613	1	76	department	department	NOUN
fnp-2613	1	77	of	of	ADP
fnp-2613	1	78	neurology	neurology	NOUN
fnp-2613	1	79	,	,	PUNCT
fnp-2613	1	80	university	university	PROPN
fnp-2613	1	81	of	of	ADP
fnp-2613	1	82	debrecen	debrecen	PROPN
fnp-2613	1	83	,	,	PUNCT
fnp-2613	1	84	debrecen	debrecen	PROPN
fnp-2613	1	85	,	,	PUNCT
fnp-2613	1	86	hungary	hungary	PROPN
fnp-2613	1	87	3	3	NUM
fnp-2613	1	88	department	department	NOUN
fnp-2613	1	89	of	of	ADP
fnp-2613	1	90	surgical	surgical	ADJ
fnp-2613	1	91	sciences	science	NOUN
fnp-2613	1	92	,	,	PUNCT
fnp-2613	1	93	radiology	radiology	NOUN
fnp-2613	1	94	,	,	PUNCT
fnp-2613	1	95	uppsala	uppsala	PROPN
fnp-2613	1	96	university	university	PROPN
fnp-2613	1	97	,	,	PUNCT
fnp-2613	1	98	uppsala	uppsala	PROPN
fnp-2613	1	99	,	,	PUNCT
fnp-2613	1	100	sweden	sweden	PROPN
fnp-2613	1	101	4	4	NUM
fnp-2613	1	102	maurice	maurice	NOUN
fnp-2613	1	103	wohl	wohl	VERB
fnp-2613	1	104	clinical	clinical	ADJ
fnp-2613	1	105	neuroscience	neuroscience	PROPN
fnp-2613	1	106	institute	institute	PROPN
fnp-2613	1	107	,	,	PUNCT
fnp-2613	1	108	institute	institute	PROPN
fnp-2613	1	109	of	of	ADP
fnp-2613	1	110	psychiatry	psychiatry	NOUN
fnp-2613	1	111	,	,	PUNCT
fnp-2613	1	112	psychology	psychology	NOUN
fnp-2613	1	113	and	and	CCONJ
fnp-2613	1	114	neuroscience	neuroscience	NOUN
fnp-2613	1	115	,	,	PUNCT
fnp-2613	1	116	king	king	NOUN
fnp-2613	1	117	’s	’s	PART
fnp-2613	1	118	college	college	PROPN
fnp-2613	1	119	london	london	PROPN
fnp-2613	1	120	,	,	PUNCT
fnp-2613	1	121	london	london	PROPN
fnp-2613	1	122	,	,	PUNCT
fnp-2613	1	123	uk	uk	PROPN
fnp-2613	1	124	5	5	NUM
fnp-2613	1	125	nihr	nihr	PROPN
fnp-2613	1	126	biomedical	biomedical	ADJ
fnp-2613	1	127	research	research	NOUN
fnp-2613	1	128	centre	centre	NOUN
fnp-2613	1	129	for	for	ADP
fnp-2613	1	130	mental	mental	ADJ
fnp-2613	1	131	health	health	PROPN
fnp-2613	1	132	&	&	CCONJ
fnp-2613	1	133	biomedical	biomedical	PROPN
fnp-2613	1	134	research	research	NOUN
fnp-2613	1	135	unit	unit	NOUN
fnp-2613	1	136	for	for	ADP
fnp-2613	1	137	dementia	dementia	NOUN
fnp-2613	1	138	at	at	ADP
fnp-2613	1	139	south	south	PROPN
fnp-2613	1	140	london	london	PROPN
fnp-2613	1	141	&	&	CCONJ
fnp-2613	1	142	maudsley	maudsley	PROPN
fnp-2613	1	143	nhs	nhs	PROPN
fnp-2613	1	144	foundation	foundation	PROPN
fnp-2613	1	145	,	,	PUNCT
fnp-2613	1	146	london	london	PROPN
fnp-2613	1	147	,	,	PUNCT
fnp-2613	1	148	uk	uk	PROPN
fnp-2613	1	149	6	6	NUM
fnp-2613	1	150	department	department	NOUN
fnp-2613	1	151	of	of	ADP
fnp-2613	1	152	old	old	ADJ
fnp-2613	1	153	age	age	NOUN
fnp-2613	1	154	psychiatry	psychiatry	NOUN
fnp-2613	1	155	,	,	PUNCT
fnp-2613	1	156	institute	institute	NOUN
fnp-2613	1	157	of	of	ADP
fnp-2613	1	158	psychiatry	psychiatry	NOUN
fnp-2613	1	159	psychology	psychology	NOUN
fnp-2613	1	160	and	and	CCONJ
fnp-2613	1	161	neuroscience	neuroscience	NOUN
fnp-2613	1	162	,	,	PUNCT
fnp-2613	1	163	king	king	NOUN
fnp-2613	1	164	’s	’s	PART
fnp-2613	1	165	college	college	PROPN
fnp-2613	1	166	london	london	PROPN
fnp-2613	1	167	,	,	PUNCT
fnp-2613	1	168	london	london	PROPN
fnp-2613	1	169	,	,	PUNCT
fnp-2613	1	170	uk	uk	PROPN
fnp-2613	1	171	7	7	NUM
fnp-2613	1	172	centre	centre	NOUN
fnp-2613	1	173	for	for	ADP
fnp-2613	1	174	age	age	NOUN
fnp-2613	1	175	-	-	PUNCT
fnp-2613	1	176	related	relate	VERB
fnp-2613	1	177	medicine	medicine	NOUN
fnp-2613	1	178	,	,	PUNCT
fnp-2613	1	179	sesam	sesam	PROPN
fnp-2613	1	180	,	,	PUNCT
fnp-2613	1	181	stavanger	stavanger	PROPN
fnp-2613	1	182	university	university	PROPN
fnp-2613	1	183	hospital	hospital	NOUN
fnp-2613	1	184	,	,	PUNCT
fnp-2613	1	185	stavanger	stavanger	PROPN
fnp-2613	1	186	,	,	PUNCT
fnp-2613	1	187	norway	norway	PROPN
fnp-2613	1	188	8	8	NUM
fnp-2613	1	189	institute	institute	PROPN
fnp-2613	1	190	of	of	ADP
fnp-2613	1	191	pathology	pathology	PROPN
fnp-2613	1	192	,	,	PUNCT
fnp-2613	1	193	faculty	faculty	NOUN
fnp-2613	1	194	of	of	ADP
fnp-2613	1	195	medicine	medicine	NOUN
fnp-2613	1	196	,	,	PUNCT
fnp-2613	1	197	university	university	PROPN
fnp-2613	1	198	of	of	ADP
fnp-2613	1	199	szeged	szeged	PROPN
fnp-2613	1	200	,	,	PUNCT
fnp-2613	1	201	szeged	szeged	PROPN
fnp-2613	1	202	,	,	PUNCT
fnp-2613	1	203	hungary	hungary	PROPN
fnp-2613	1	204	corresponding	corresponding	ADJ
fnp-2613	1	205	author	author	NOUN
fnp-2613	1	206	:	:	PUNCT
fnp-2613	1	207	tibor	tibor	PROPN
fnp-2613	1	208	hortobágyi	hortobágyi	PROPN
fnp-2613	1	209	md	md	PROPN
fnp-2613	1	210	phd	phd	PROPN
fnp-2613	1	211	dsc	dsc	PROPN
fnp-2613	1	212	frcpath	frcpath	PROPN
fnp-2613	1	213	efn	efn	PROPN
fnp-2613	1	214	·	·	PUNCT
fnp-2613	1	215	institute	institute	PROPN
fnp-2613	1	216	of	of	ADP
fnp-2613	1	217	pathology	pathology	PROPN
fnp-2613	1	218	·	·	PUNCT
fnp-2613	1	219	faculty	faculty	NOUN
fnp-2613	1	220	of	of	ADP
fnp-2613	1	221	medicine	medicine	NOUN
fnp-2613	1	222	·	·	PUNCT
fnp-2613	1	223	university	university	NOUN
fnp-2613	1	224	of	of	ADP
fnp-2613	1	225	szeged	szeged	PROPN
fnp-2613	1	226	·	·	PUNCT
fnp-2613	1	227	szeged	szeged	PROPN
fnp-2613	1	228	·	·	PUNCT
fnp-2613	1	229	állomás	állomás	NOUN
fnp-2613	1	230	utca	utca	ADJ
fnp-2613	1	231	1	1	NUM
fnp-2613	1	232	·	·	PUNCT
fnp-2613	1	233	h-6725	h-6725	PROPN
fnp-2613	1	234	·	·	PUNCT
fnp-2613	1	235	hungary	hungary	PROPN
fnp-2613	1	236	hortobagyi.tibor@med.u-szeged.hu	hortobagyi.tibor@med.u-szeged.hu	PROPN
fnp-2613	1	237	submitted	submit	VERB
fnp-2613	1	238	:	:	PUNCT
fnp-2613	1	239	31	31	NUM
fnp-2613	1	240	december	december	PROPN
fnp-2613	1	241	2019	2019	NUM
fnp-2613	1	242	accepted	accept	VERB
fnp-2613	1	243	:	:	PUNCT
fnp-2613	1	244	06	06	NUM
fnp-2613	1	245	february	february	NOUN
fnp-2613	1	246	2020	2020	NUM
fnp-2613	1	247	published	publish	VERB
fnp-2613	1	248	:	:	PUNCT
fnp-2613	1	249	18	18	NUM
fnp-2613	1	250	february	february	PROPN
fnp-2613	1	251	2020	2020	NUM
fnp-2613	1	252	https://doi.org/10.17879/freeneuropathology-2020-2613	https://doi.org/10.17879/freeneuropathology-2020-2613	PROPN
fnp-2613	1	253	keywords	keyword	NOUN
fnp-2613	1	254	:	:	PUNCT
fnp-2613	1	255	α	α	X
fnp-2613	1	256	-	-	PUNCT
fnp-2613	1	257	synuclein	synuclein	NOUN
fnp-2613	1	258	,	,	PUNCT
fnp-2613	1	259	biomarkers	biomarker	NOUN
fnp-2613	1	260	,	,	PUNCT
fnp-2613	1	261	diagnostic	diagnostic	ADJ
fnp-2613	1	262	criteria	criterion	NOUN
fnp-2613	1	263	,	,	PUNCT
fnp-2613	1	264	clinico	clinico	ADJ
fnp-2613	1	265	-	-	PUNCT
fnp-2613	1	266	pathological	pathological	ADJ
fnp-2613	1	267	correlation	correlation	NOUN
fnp-2613	1	268	,	,	PUNCT
fnp-2613	1	269	dementia	dementia	NOUN
fnp-2613	1	270	with	with	ADP
fnp-2613	1	271	lewy	lewy	PROPN
fnp-2613	1	272	bodies	body	NOUN
fnp-2613	1	273	abstract	abstract	ADJ
fnp-2613	1	274	dementia	dementia	NOUN
fnp-2613	1	275	is	be	AUX
fnp-2613	1	276	one	one	NUM
fnp-2613	1	277	of	of	ADP
fnp-2613	1	278	the	the	DET
fnp-2613	1	279	major	major	ADJ
fnp-2613	1	280	burdens	burden	NOUN
fnp-2613	1	281	of	of	ADP
fnp-2613	1	282	our	our	PRON
fnp-2613	1	283	aging	age	VERB
fnp-2613	1	284	society	society	NOUN
fnp-2613	1	285	.	.	PUNCT
fnp-2613	2	1	according	accord	VERB
fnp-2613	2	2	to	to	ADP
fnp-2613	2	3	certain	certain	ADJ
fnp-2613	2	4	predictions	prediction	NOUN
fnp-2613	2	5	,	,	PUNCT
fnp-2613	2	6	the	the	DET
fnp-2613	2	7	number	number	NOUN
fnp-2613	2	8	of	of	ADP
fnp-2613	2	9	patients	patient	NOUN
fnp-2613	2	10	will	will	AUX
fnp-2613	2	11	double	double	VERB
fnp-2613	2	12	every	every	DET
fnp-2613	2	13	20	20	NUM
fnp-2613	2	14	years	year	NOUN
fnp-2613	2	15	.	.	PUNCT
fnp-2613	3	1	although	although	SCONJ
fnp-2613	3	2	alzheimer	alzheimer	PROPN
fnp-2613	3	3	’s	’s	PART
fnp-2613	3	4	disease	disease	NOUN
fnp-2613	3	5	(	(	PUNCT
fnp-2613	3	6	ad	ad	NOUN
fnp-2613	3	7	)	)	PUNCT
fnp-2613	3	8	,	,	PUNCT
fnp-2613	3	9	as	as	SCONJ
fnp-2613	3	10	the	the	DET
fnp-2613	3	11	most	most	ADV
fnp-2613	3	12	frequent	frequent	ADJ
fnp-2613	3	13	neurodegenerative	neurodegenerative	ADJ
fnp-2613	3	14	dementia	dementia	NOUN
fnp-2613	3	15	,	,	PUNCT
fnp-2613	3	16	has	have	AUX
fnp-2613	3	17	been	be	AUX
fnp-2613	3	18	extensively	extensively	ADV
fnp-2613	3	19	analysed	analyse	VERB
fnp-2613	3	20	,	,	PUNCT
fnp-2613	3	21	less	less	ADV
fnp-2613	3	22	is	be	AUX
fnp-2613	3	23	known	know	VERB
fnp-2613	3	24	about	about	ADP
fnp-2613	3	25	dementia	dementia	NOUN
fnp-2613	3	26	with	with	ADP
fnp-2613	3	27	lewy	lewy	ADJ
fnp-2613	3	28	bodies	body	NOUN
fnp-2613	3	29	(	(	PUNCT
fnp-2613	3	30	dlb	dlb	PROPN
fnp-2613	3	31	)	)	PUNCT
fnp-2613	3	32	.	.	PUNCT
fnp-2613	4	1	neuropathological	neuropathological	ADJ
fnp-2613	4	2	hallmarks	hallmark	NOUN
fnp-2613	4	3	of	of	ADP
fnp-2613	4	4	dlb	dlb	NOUN
fnp-2613	4	5	are	be	AUX
fnp-2613	4	6	the	the	DET
fnp-2613	4	7	deposition	deposition	NOUN
fnp-2613	4	8	of	of	ADP
fnp-2613	4	9	intracellular	intracellular	ADJ
fnp-2613	4	10	lewy	lewy	ADJ
fnp-2613	4	11	bodies	body	NOUN
fnp-2613	4	12	(	(	PUNCT
fnp-2613	4	13	lb	lb	NOUN
fnp-2613	4	14	)	)	PUNCT
fnp-2613	4	15	and	and	CCONJ
fnp-2613	4	16	lewy	lewy	PROPN
fnp-2613	4	17	neurites	neurites	PROPN
fnp-2613	4	18	(	(	PUNCT
fnp-2613	4	19	ln	ln	ADJ
fnp-2613	4	20	)	)	PUNCT
fnp-2613	4	21	.	.	PUNCT
fnp-2613	5	1	dlb	dlb	PROPN
fnp-2613	5	2	belongs	belong	VERB
fnp-2613	5	3	to	to	ADP
fnp-2613	5	4	the	the	DET
fnp-2613	5	5	α	α	NOUN
fnp-2613	5	6	-	-	PUNCT
fnp-2613	5	7	synucleinopathies	synucleinopathie	NOUN
fnp-2613	5	8	,	,	PUNCT
fnp-2613	5	9	as	as	SCONJ
fnp-2613	5	10	the	the	DET
fnp-2613	5	11	major	major	ADJ
fnp-2613	5	12	component	component	NOUN
fnp-2613	5	13	of	of	ADP
fnp-2613	5	14	these	these	DET
fnp-2613	5	15	inclusions	inclusion	NOUN
fnp-2613	5	16	is	be	AUX
fnp-2613	5	17	pathologically	pathologically	ADV
fnp-2613	5	18	aggregated	aggregate	VERB
fnp-2613	5	19	α	α	PRON
fnp-2613	5	20	-	-	PUNCT
fnp-2613	5	21	synuclein	synuclein	NOUN
fnp-2613	5	22	.	.	PUNCT
fnp-2613	6	1	depending	depend	VERB
fnp-2613	6	2	on	on	ADP
fnp-2613	6	3	the	the	DET
fnp-2613	6	4	localisation	localisation	NOUN
fnp-2613	6	5	of	of	ADP
fnp-2613	6	6	lbs	lbs	NOUN
fnp-2613	6	7	and	and	CCONJ
fnp-2613	6	8	lns	lns	PROPN
fnp-2613	6	9	in	in	ADP
fnp-2613	6	10	the	the	DET
fnp-2613	6	11	central	central	ADJ
fnp-2613	6	12	nervous	nervous	ADJ
fnp-2613	6	13	system	system	NOUN
fnp-2613	6	14	cognitive	cognitive	ADJ
fnp-2613	6	15	and	and	CCONJ
fnp-2613	6	16	motor	motor	NOUN
fnp-2613	6	17	symptoms	symptom	NOUN
fnp-2613	6	18	can	can	AUX
fnp-2613	6	19	occur	occur	VERB
fnp-2613	6	20	.	.	PUNCT
fnp-2613	7	1	in	in	ADP
fnp-2613	7	2	our	our	PRON
fnp-2613	7	3	work	work	NOUN
fnp-2613	7	4	,	,	PUNCT
fnp-2613	7	5	we	we	PRON
fnp-2613	7	6	will	will	AUX
fnp-2613	7	7	systematically	systematically	ADV
fnp-2613	7	8	review	review	VERB
fnp-2613	7	9	the	the	DET
fnp-2613	7	10	possible	possible	ADJ
fnp-2613	7	11	etiology	etiology	NOUN
fnp-2613	7	12	and	and	CCONJ
fnp-2613	7	13	epidemiology	epidemiology	NOUN
fnp-2613	7	14	,	,	PUNCT
fnp-2613	7	15	pathological	pathological	ADJ
fnp-2613	7	16	(	(	PUNCT
fnp-2613	7	17	both	both	CCONJ
fnp-2613	7	18	macroscopic	macroscopic	ADJ
fnp-2613	7	19	and	and	CCONJ
fnp-2613	7	20	microscopic	microscopic	ADJ
fnp-2613	7	21	)	)	PUNCT
fnp-2613	7	22	features	feature	NOUN
fnp-2613	7	23	,	,	PUNCT
fnp-2613	7	24	structural	structural	ADJ
fnp-2613	7	25	and	and	CCONJ
fnp-2613	7	26	functional	functional	ADJ
fnp-2613	7	27	imaging	imaging	NOUN
fnp-2613	7	28	findings	finding	NOUN
fnp-2613	7	29	,	,	PUNCT
fnp-2613	7	30	with	with	ADP
fnp-2613	7	31	a	a	DET
fnp-2613	7	32	special	special	ADJ
fnp-2613	7	33	emphasis	emphasis	NOUN
fnp-2613	7	34	on	on	ADP
fnp-2613	7	35	the	the	DET
fnp-2613	7	36	clinico	clinico	ADJ
fnp-2613	7	37	-	-	PUNCT
fnp-2613	7	38	pathological	pathological	ADJ
fnp-2613	7	39	correlations	correlation	NOUN
fnp-2613	7	40	.	.	PUNCT
fnp-2613	8	1	finally	finally	ADV
fnp-2613	8	2	,	,	PUNCT
fnp-2613	8	3	we	we	PRON
fnp-2613	8	4	summarize	summarize	VERB
fnp-2613	8	5	the	the	DET
fnp-2613	8	6	latest	late	ADJ
fnp-2613	8	7	clinical	clinical	ADJ
fnp-2613	8	8	symptoms	symptom	NOUN
fnp-2613	8	9	-	-	PUNCT
fnp-2613	8	10	based	base	VERB
fnp-2613	8	11	diagnostic	diagnostic	ADJ
fnp-2613	8	12	criteria	criterion	NOUN
fnp-2613	8	13	and	and	CCONJ
fnp-2613	8	14	the	the	DET
fnp-2613	8	15	novel	novel	ADJ
fnp-2613	8	16	therapeutic	therapeutic	ADJ
fnp-2613	8	17	approaches	approach	NOUN
fnp-2613	8	18	.	.	PUNCT
fnp-2613	9	1	since	since	SCONJ
fnp-2613	9	2	dlb	dlb	PROPN
fnp-2613	9	3	is	be	AUX
fnp-2613	9	4	frequently	frequently	ADV
fnp-2613	9	5	accompanied	accompany	VERB
fnp-2613	9	6	with	with	ADP
fnp-2613	9	7	ad	ad	NOUN
fnp-2613	9	8	pathology	pathology	NOUN
fnp-2613	9	9	,	,	PUNCT
fnp-2613	9	10	highlighting	highlight	VERB
fnp-2613	9	11	possible	possible	ADJ
fnp-2613	9	12	differential	differential	ADJ
fnp-2613	9	13	diagnostic	diagnostic	ADJ
fnp-2613	9	14	approaches	approach	NOUN
fnp-2613	9	15	is	be	AUX
fnp-2613	9	16	an	an	DET
fnp-2613	9	17	integral	integral	ADJ
fnp-2613	9	18	part	part	NOUN
fnp-2613	9	19	of	of	ADP
fnp-2613	9	20	our	our	PRON
fnp-2613	9	21	paper	paper	NOUN
fnp-2613	9	22	.	.	PUNCT
fnp-2613	10	1	although	although	SCONJ
fnp-2613	10	2	our	our	PRON
fnp-2613	10	3	present	present	ADJ
fnp-2613	10	4	knowledge	knowledge	NOUN
fnp-2613	10	5	is	be	AUX
fnp-2613	10	6	insufficient	insufficient	ADJ
fnp-2613	10	7	,	,	PUNCT
fnp-2613	10	8	the	the	DET
fnp-2613	10	9	rapid	rapid	ADJ
fnp-2613	10	10	development	development	NOUN
fnp-2613	10	11	of	of	ADP
fnp-2613	10	12	diagnostic	diagnostic	ADJ
fnp-2613	10	13	and	and	CCONJ
fnp-2613	10	14	research	research	NOUN
fnp-2613	10	15	methods	method	NOUN
fnp-2613	10	16	provide	provide	VERB
fnp-2613	10	17	hope	hope	NOUN
fnp-2613	10	18	for	for	ADP
fnp-2613	10	19	better	well	ADJ
fnp-2613	10	20	diagnosis	diagnosis	NOUN
fnp-2613	10	21	and	and	CCONJ
fnp-2613	10	22	more	more	ADV
fnp-2613	10	23	efficient	efficient	ADJ
fnp-2613	10	24	treatment	treatment	NOUN
fnp-2613	10	25	,	,	PUNCT
fnp-2613	10	26	contributing	contribute	VERB
fnp-2613	10	27	to	to	ADP
fnp-2613	10	28	a	a	DET
fnp-2613	10	29	better	well	ADJ
fnp-2613	10	30	quality	quality	NOUN
fnp-2613	10	31	of	of	ADP
fnp-2613	10	32	life	life	NOUN
fnp-2613	10	33	.	.	PUNCT
fnp-2613	11	1	abbreviations	abbreviation	NOUN
fnp-2613	11	2	aa	aa	PROPN
fnp-2613	11	3	,	,	PUNCT
fnp-2613	11	4	alzheimer	alzheimer	PROPN
fnp-2613	11	5	’s	’s	PART
fnp-2613	11	6	association	association	NOUN
fnp-2613	11	7	;	;	PUNCT
fnp-2613	11	8	ad	ad	NOUN
fnp-2613	11	9	,	,	PUNCT
fnp-2613	11	10	alzheimer	alzheimer	PROPN
fnp-2613	11	11	’s	’s	PART
fnp-2613	11	12	disease	disease	NOUN
fnp-2613	11	13	;	;	PUNCT
fnp-2613	11	14	aβ	aβ	X
fnp-2613	11	15	,	,	PUNCT
fnp-2613	11	16	amyloid	amyloid	NOUN
fnp-2613	11	17	-	-	PUNCT
fnp-2613	11	18	beta	beta	NOUN
fnp-2613	11	19	;	;	PUNCT
fnp-2613	11	20	apoe	apoe	ADV
fnp-2613	11	21	,	,	PUNCT
fnp-2613	11	22	apolipoprotein	apolipoprotein	ADJ
fnp-2613	11	23	e	e	PROPN
fnp-2613	11	24	gene	gene	NOUN
fnp-2613	11	25	;	;	PUNCT
fnp-2613	11	26	bne	bne	PROPN
fnp-2613	11	27	,	,	PUNCT
fnp-2613	11	28	brainnet	brainnet	PROPN
fnp-2613	11	29	europe	europe	PROPN
fnp-2613	11	30	consortium	consortium	PROPN
fnp-2613	11	31	;	;	PUNCT
fnp-2613	11	32	bold	bold	ADJ
fnp-2613	11	33	,	,	PUNCT
fnp-2613	11	34	blood	blood	NOUN
fnp-2613	11	35	oxygen	oxygen	NOUN
fnp-2613	11	36	level	level	NOUN
fnp-2613	11	37	dependent	dependent	ADJ
fnp-2613	11	38	;	;	PUNCT
fnp-2613	11	39	chat	chat	NOUN
fnp-2613	11	40	,	,	PUNCT
fnp-2613	11	41	choline	choline	NOUN
fnp-2613	11	42	-	-	PUNCT
fnp-2613	11	43	acetyltransferase	acetyltransferase	NOUN
fnp-2613	11	44	;	;	PUNCT
fnp-2613	11	45	chat	chat	PROPN
fnp-2613	11	46	-	-	PUNCT
fnp-2613	11	47	i	i	NOUN
fnp-2613	11	48	,	,	PUNCT
fnp-2613	11	49	acetyl	acetyl	NOUN
fnp-2613	11	50	-	-	PUNCT
fnp-2613	11	51	cholinesterase	cholinesterase	NOUN
fnp-2613	11	52	inhibitors	inhibitor	NOUN
fnp-2613	11	53	;	;	PUNCT
fnp-2613	11	54	cr	cr	PROPN
fnp-2613	11	55	,	,	PUNCT
fnp-2613	11	56	creatinine	creatinine	NOUN
fnp-2613	11	57	;	;	PUNCT
fnp-2613	11	58	csf	csf	ADJ
fnp-2613	11	59	,	,	PUNCT
fnp-2613	11	60	cerebrospinal	cerebrospinal	ADJ
fnp-2613	11	61	fluid	fluid	NOUN
fnp-2613	11	62	;	;	PUNCT
fnp-2613	11	63	dlb	dlb	PROPN
fnp-2613	11	64	,	,	PUNCT
fnp-2613	11	65	dementia	dementia	NOUN
fnp-2613	11	66	with	with	ADP
fnp-2613	11	67	lewy	lewy	PROPN
fnp-2613	11	68	bodies	body	NOUN
fnp-2613	11	69	;	;	PUNCT
fnp-2613	11	70	dmn	dmn	NOUN
fnp-2613	11	71	,	,	PUNCT
fnp-2613	11	72	default	default	NOUN
fnp-2613	11	73	mode	mode	NOUN
fnp-2613	11	74	network	network	NOUN
fnp-2613	11	75	;	;	PUNCT
fnp-2613	11	76	dsm	dsm	PROPN
fnp-2613	11	77	,	,	PUNCT
fnp-2613	11	78	diagnostic	diagnostic	ADJ
fnp-2613	11	79	statistical	statistical	ADJ
fnp-2613	11	80	manual	manual	NOUN
fnp-2613	11	81	;	;	PUNCT
fnp-2613	11	82	fmri	fmri	ADJ
fnp-2613	11	83	,	,	PUNCT
fnp-2613	11	84	functional	functional	ADJ
fnp-2613	11	85	mri	mri	NOUN
fnp-2613	11	86	;	;	PUNCT
fnp-2613	11	87	fp	fp	PROPN
fnp-2613	11	88	-	-	PUNCT
fnp-2613	11	89	cit	cit	ADJ
fnp-2613	11	90	,	,	PUNCT
fnp-2613	11	91	[	[	X
fnp-2613	11	92	123i	123i	X
fnp-2613	11	93	]	]	X
fnp-2613	11	94	2ß	2ß	NUM
fnp-2613	11	95	-	-	PUNCT
fnp-2613	11	96	carbomethoxy-3b-(4	carbomethoxy-3b-(4	NUM
fnp-2613	11	97	-	-	PUNCT
fnp-2613	11	98	iodophenyl)-n-(3	iodophenyl)-n-(3	NOUN
fnp-2613	11	99	-	-	PUNCT
fnp-2613	11	100	fluoropropyl	fluoropropyl	ADJ
fnp-2613	11	101	)	)	PUNCT
fnp-2613	11	102	nortropane	nortropane	NOUN
fnp-2613	11	103	;	;	PUNCT
fnp-2613	11	104	gba	gba	NOUN
fnp-2613	11	105	,	,	PUNCT
fnp-2613	11	106	glucosylceramidase	glucosylceramidase	NOUN
fnp-2613	11	107	-	-	PUNCT
fnp-2613	11	108	beta	beta	NOUN
fnp-2613	11	109	gene	gene	NOUN
fnp-2613	11	110	;	;	PUNCT
fnp-2613	11	111	ilbd	ilbd	PROPN
fnp-2613	11	112	,	,	PUNCT
fnp-2613	11	113	incidental	incidental	ADJ
fnp-2613	11	114	lewy	lewy	PROPN
fnp-2613	11	115	body	body	NOUN
fnp-2613	11	116	disease	disease	NOUN
fnp-2613	11	117	;	;	PUNCT
fnp-2613	11	118	lb	lb	X
fnp-2613	11	119	,	,	PUNCT
fnp-2613	11	120	lewy	lewy	ADJ
fnp-2613	11	121	body	body	NOUN
fnp-2613	11	122	;	;	PUNCT
fnp-2613	11	123	lbda	lbda	NOUN
fnp-2613	11	124	,	,	PUNCT
fnp-2613	11	125	lewy	lewy	PROPN
fnp-2613	11	126	body	body	PROPN
fnp-2613	11	127	dementia	dementia	PROPN
fnp-2613	11	128	association	association	PROPN
fnp-2613	11	129	;	;	PUNCT
fnp-2613	11	130	ln	ln	X
fnp-2613	11	131	,	,	PUNCT
fnp-2613	11	132	lewy	lewy	PROPN
fnp-2613	11	133	neurite	neurite	PROPN
fnp-2613	11	134	;	;	PUNCT
fnp-2613	11	135	mapt	mapt	NOUN
fnp-2613	11	136	,	,	PUNCT
fnp-2613	11	137	microtubule	microtubule	NOUN
fnp-2613	11	138	associated	associate	VERB
fnp-2613	11	139	protein	protein	NOUN
fnp-2613	11	140	tau	tau	PROPN
fnp-2613	11	141	gene	gene	NOUN
fnp-2613	11	142	;	;	PUNCT
fnp-2613	11	143	mds	mds	PROPN
fnp-2613	11	144	,	,	PUNCT
fnp-2613	11	145	movement	movement	NOUN
fnp-2613	11	146	disorders	disorder	NOUN
fnp-2613	11	147	society	society	NOUN
fnp-2613	11	148	;	;	PUNCT
fnp-2613	11	149	mri	mri	NOUN
fnp-2613	11	150	,	,	PUNCT
fnp-2613	11	151	magnetic	magnetic	ADJ
fnp-2613	11	152	resonance	resonance	NOUN
fnp-2613	11	153	imaging	imaging	NOUN
fnp-2613	11	154	;	;	PUNCT
fnp-2613	11	155	naa	naa	PROPN
fnp-2613	11	156	,	,	PUNCT
fnp-2613	11	157	n	n	CCONJ
fnp-2613	11	158	-	-	PUNCT
fnp-2613	11	159	acetyl	acetyl	NOUN
fnp-2613	11	160	aspartate	aspartate	NOUN
fnp-2613	11	161	;	;	PUNCT
fnp-2613	11	162	ncd	ncd	X
fnp-2613	11	163	,	,	PUNCT
fnp-2613	11	164	neurocognitive	neurocognitive	ADJ
fnp-2613	11	165	disorder	disorder	NOUN
fnp-2613	11	166	;	;	PUNCT
fnp-2613	11	167	nf	nf	NUM
fnp-2613	11	168	,	,	PUNCT
fnp-2613	11	169	neurofilament	neurofilament	NOUN
fnp-2613	11	170	;	;	PUNCT
fnp-2613	11	171	nia	nia	PROPN
fnp-2613	11	172	,	,	PUNCT
fnp-2613	11	173	national	national	PROPN
fnp-2613	11	174	institute	institute	NOUN
fnp-2613	11	175	on	on	ADP
fnp-2613	11	176	aging	aging	NOUN
fnp-2613	11	177	;	;	PUNCT
fnp-2613	11	178	nmdar	nmdar	ADV
fnp-2613	11	179	,	,	PUNCT
fnp-2613	11	180	n	n	CCONJ
fnp-2613	11	181	-	-	PUNCT
fnp-2613	11	182	methyl	methyl	NOUN
fnp-2613	11	183	-	-	PUNCT
fnp-2613	11	184	d	d	NOUN
fnp-2613	11	185	-	-	PUNCT
fnp-2613	11	186	aspartate	aspartate	ADJ
fnp-2613	11	187	receptor	receptor	NOUN
fnp-2613	11	188	;	;	PUNCT
fnp-2613	11	189	pd	pd	NOUN
fnp-2613	11	190	,	,	PUNCT
fnp-2613	11	191	parkinson	parkinson	NOUN
fnp-2613	11	192	’s	’s	PART
fnp-2613	11	193	disease	disease	NOUN
fnp-2613	11	194	;	;	PUNCT
fnp-2613	11	195	pdd	pdd	NOUN
fnp-2613	11	196	,	,	PUNCT
fnp-2613	11	197	parkinson	parkinson	NOUN
fnp-2613	11	198	’s	’s	PART
fnp-2613	11	199	disease	disease	NOUN
fnp-2613	11	200	dementia	dementia	NOUN
fnp-2613	11	201	;	;	PUNCT
fnp-2613	11	202	pet	pet	NOUN
fnp-2613	11	203	,	,	PUNCT
fnp-2613	11	204	positron	positron	NOUN
fnp-2613	11	205	emission	emission	NOUN
fnp-2613	11	206	tomography	tomography	NOUN
fnp-2613	11	207	;	;	PUNCT
fnp-2613	11	208	psd95	psd95	NOUN
fnp-2613	11	209	,	,	PUNCT
fnp-2613	11	210	density	density	NOUN
fnp-2613	11	211	protein	protein	NOUN
fnp-2613	11	212	95	95	NUM
fnp-2613	11	213	;	;	PUNCT
fnp-2613	11	214	rem	rem	NUM
fnp-2613	11	215	,	,	PUNCT
fnp-2613	11	216	rapid	rapid	ADJ
fnp-2613	11	217	-	-	PUNCT
fnp-2613	11	218	eye	eye	NOUN
fnp-2613	11	219	-	-	PUNCT
fnp-2613	11	220	movement	movement	NOUN
fnp-2613	11	221	;	;	PUNCT
fnp-2613	11	222	scarb2	scarb2	PROPN
fnp-2613	11	223	,	,	PUNCT
fnp-2613	11	224	scavenger	scavenger	NOUN
fnp-2613	11	225	receptor	receptor	NOUN
fnp-2613	11	226	class	class	PROPN
fnp-2613	11	227	b	b	PROPN
fnp-2613	11	228	member	member	NOUN
fnp-2613	11	229	2	2	NUM
fnp-2613	11	230	;	;	PUNCT
fnp-2613	11	231	snare	snare	NOUN
fnp-2613	11	232	,	,	PUNCT
fnp-2613	11	233	snap	snap	ADJ
fnp-2613	11	234	(	(	PUNCT
fnp-2613	11	235	soluble	soluble	ADJ
fnp-2613	11	236	nsf	nsf	NOUN
fnp-2613	11	237	attachment	attachment	NOUN
fnp-2613	11	238	protein	protein	NOUN
fnp-2613	11	239	)	)	PUNCT
fnp-2613	11	240	receptor	receptor	NOUN
fnp-2613	11	241	;	;	PUNCT
fnp-2613	11	242	snca	snca	NOUN
fnp-2613	11	243	,	,	PUNCT
fnp-2613	11	244	α	α	X
fnp-2613	11	245	-	-	PUNCT
fnp-2613	11	246	synuclein	synuclein	NOUN
fnp-2613	11	247	gene	gene	NOUN
fnp-2613	11	248	;	;	PUNCT
fnp-2613	11	249	spect	spect	NOUN
fnp-2613	11	250	,	,	PUNCT
fnp-2613	11	251	single	single	ADJ
fnp-2613	11	252	-	-	PUNCT
fnp-2613	11	253	photon	photon	NOUN
fnp-2613	11	254	emission	emission	NOUN
fnp-2613	11	255	computed	compute	VERB
fnp-2613	11	256	tomography	tomography	NOUN
fnp-2613	11	257	;	;	PUNCT
fnp-2613	11	258	ssri	ssri	PROPN
fnp-2613	11	259	,	,	PUNCT
fnp-2613	11	260	selective	selective	ADJ
fnp-2613	11	261	serotonin	serotonin	NOUN
fnp-2613	11	262	reuptake	reuptake	NOUN
fnp-2613	11	263	inhibitors	inhibitor	NOUN
fnp-2613	11	264	;	;	PUNCT
fnp-2613	11	265	upr	upr	PROPN
fnp-2613	11	266	,	,	PUNCT
fnp-2613	11	267	unfolded	unfold	VERB
fnp-2613	11	268	protein	protein	NOUN
fnp-2613	11	269	response	response	NOUN
fnp-2613	11	270	;	;	PUNCT
fnp-2613	11	271	wml	wml	PROPN
fnp-2613	11	272	,	,	PUNCT
fnp-2613	11	273	white	white	ADJ
fnp-2613	11	274	matter	matter	NOUN
fnp-2613	11	275	lesions	lesion	NOUN
fnp-2613	11	276	;	;	PUNCT
fnp-2613	11	277	znt3	znt3	NOUN
fnp-2613	11	278	,	,	PUNCT
fnp-2613	11	279	zinc	zinc	NOUN
fnp-2613	11	280	transporter	transporter	NOUN
fnp-2613	11	281	3	3	NUM
fnp-2613	11	282	epidemiology	epidemiology	NOUN
fnp-2613	11	283	and	and	CCONJ
fnp-2613	11	284	etiology	etiology	NOUN
fnp-2613	11	285	dementia	dementia	NOUN
fnp-2613	11	286	with	with	ADP
fnp-2613	11	287	lewy	lewy	ADJ
fnp-2613	11	288	bodies	body	NOUN
fnp-2613	11	289	(	(	PUNCT
fnp-2613	11	290	dlb	dlb	PROPN
fnp-2613	11	291	)	)	PUNCT
fnp-2613	11	292	is	be	AUX
fnp-2613	11	293	the	the	DET
fnp-2613	11	294	second	second	ADJ
fnp-2613	11	295	most	most	ADV
fnp-2613	11	296	common	common	ADJ
fnp-2613	11	297	primary	primary	ADJ
fnp-2613	11	298	neurodegenerative	neurodegenerative	ADJ
fnp-2613	11	299	dementia	dementia	NOUN
fnp-2613	11	300	.	.	PUNCT
fnp-2613	12	1	the	the	DET
fnp-2613	12	2	etiology	etiology	NOUN
fnp-2613	12	3	is	be	AUX
fnp-2613	12	4	mainly	mainly	ADV
fnp-2613	12	5	unknown	unknown	ADJ
fnp-2613	12	6	,	,	PUNCT
fnp-2613	12	7	however	however	ADV
fnp-2613	12	8	,	,	PUNCT
fnp-2613	12	9	in	in	ADP
fnp-2613	12	10	certain	certain	ADJ
fnp-2613	12	11	cases	case	NOUN
fnp-2613	12	12	there	there	PRON
fnp-2613	12	13	is	be	VERB
fnp-2613	12	14	strong	strong	ADJ
fnp-2613	12	15	evidence	evidence	NOUN
fnp-2613	12	16	of	of	ADP
fnp-2613	12	17	genetic	genetic	ADJ
fnp-2613	12	18	background	background	NOUN
fnp-2613	12	19	.	.	PUNCT
fnp-2613	13	1	a	a	DET
fnp-2613	13	2	few	few	ADJ
fnp-2613	13	3	papers	paper	NOUN
fnp-2613	13	4	have	have	AUX
fnp-2613	13	5	reported	report	VERB
fnp-2613	13	6	families	family	NOUN
fnp-2613	13	7	with	with	ADP
fnp-2613	13	8	accumulating	accumulate	VERB
fnp-2613	13	9	occurrence	occurrence	NOUN
fnp-2613	13	10	of	of	ADP
fnp-2613	13	11	cognitive	cognitive	ADJ
fnp-2613	13	12	impairment	impairment	NOUN
fnp-2613	13	13	throughout	throughout	ADP
fnp-2613	13	14	generations1	generations1	NOUN
fnp-2613	13	15	.	.	PUNCT
fnp-2613	14	1	the	the	DET
fnp-2613	14	2	vast	vast	ADJ
fnp-2613	14	3	majority	majority	NOUN
fnp-2613	14	4	of	of	ADP
fnp-2613	14	5	the	the	DET
fnp-2613	14	6	familial	familial	ADJ
fnp-2613	14	7	cases	case	NOUN
fnp-2613	14	8	are	be	AUX
fnp-2613	14	9	traced	trace	VERB
fnp-2613	14	10	to	to	ADP
fnp-2613	14	11	α	α	NOUN
fnp-2613	14	12	-	-	PUNCT
fnp-2613	14	13	synuclein	synuclein	NOUN
fnp-2613	14	14	(	(	PUNCT
fnp-2613	14	15	snca	snca	NOUN
fnp-2613	14	16	)	)	PUNCT
fnp-2613	14	17	gene	gene	NOUN
fnp-2613	14	18	alterations	alteration	NOUN
fnp-2613	14	19	,	,	PUNCT
fnp-2613	14	20	particularly	particularly	ADV
fnp-2613	14	21	to	to	ADP
fnp-2613	14	22	e46k	e46k	PROPN
fnp-2613	14	23	mutation2	mutation2	PROPN
fnp-2613	14	24	.	.	PUNCT
fnp-2613	15	1	five	five	NUM
fnp-2613	15	2	candidate	candidate	NOUN
fnp-2613	15	3	genes	gene	NOUN
fnp-2613	15	4	,	,	PUNCT
fnp-2613	15	5	including	include	VERB
fnp-2613	15	6	apoe	apoe	NOUN
fnp-2613	15	7	,	,	PUNCT
fnp-2613	15	8	gba	gba	NOUN
fnp-2613	15	9	,	,	PUNCT
fnp-2613	15	10	mapt	mapt	NOUN
fnp-2613	15	11	,	,	PUNCT
fnp-2613	15	12	snca	snca	NOUN
fnp-2613	15	13	and	and	CCONJ
fnp-2613	15	14	scarb2	scarb2	PROPN
fnp-2613	15	15	,	,	PUNCT
fnp-2613	15	16	are	be	AUX
fnp-2613	15	17	considered	consider	VERB
fnp-2613	15	18	as	as	ADP
fnp-2613	15	19	a	a	DET
fnp-2613	15	20	significant	significant	ADJ
fnp-2613	15	21	risk	risk	NOUN
fnp-2613	15	22	factor	factor	NOUN
fnp-2613	15	23	for	for	ADP
fnp-2613	15	24	dlb	dlb	NOUN
fnp-2613	15	25	,	,	PUNCT
fnp-2613	15	26	nevertheless	nevertheless	ADV
fnp-2613	15	27	,	,	PUNCT
fnp-2613	15	28	further	further	ADJ
fnp-2613	15	29	genetic	genetic	ADJ
fnp-2613	15	30	studies	study	NOUN
fnp-2613	15	31	are	be	AUX
fnp-2613	15	32	needed3	needed3	NOUN
fnp-2613	15	33	.	.	PUNCT
fnp-2613	16	1	although	although	SCONJ
fnp-2613	16	2	it	it	PRON
fnp-2613	16	3	mostly	mostly	ADV
fnp-2613	16	4	appears	appear	VERB
fnp-2613	16	5	in	in	ADP
fnp-2613	16	6	older	old	ADJ
fnp-2613	16	7	age	age	NOUN
fnp-2613	16	8	,	,	PUNCT
fnp-2613	16	9	dementia	dementia	NOUN
fnp-2613	16	10	is	be	AUX
fnp-2613	16	11	not	not	PART
fnp-2613	16	12	strictly	strictly	ADV
fnp-2613	16	13	associated	associate	VERB
fnp-2613	16	14	with	with	ADP
fnp-2613	16	15	aging	aging	NOUN
fnp-2613	16	16	.	.	PUNCT
fnp-2613	17	1	rarely	rarely	ADV
fnp-2613	17	2	it	it	PRON
fnp-2613	17	3	may	may	AUX
fnp-2613	17	4	occur	occur	VERB
fnp-2613	17	5	under	under	ADP
fnp-2613	17	6	the	the	DET
fnp-2613	17	7	age	age	NOUN
fnp-2613	17	8	of	of	ADP
fnp-2613	17	9	65	65	NUM
fnp-2613	17	10	and	and	CCONJ
fnp-2613	17	11	even	even	ADV
fnp-2613	17	12	in	in	ADP
fnp-2613	17	13	young	young	ADJ
fnp-2613	17	14	adulthood	adulthood	NOUN
fnp-2613	17	15	.	.	PUNCT
fnp-2613	18	1	surprisingly	surprisingly	ADV
fnp-2613	18	2	in	in	ADP
fnp-2613	18	3	the	the	DET
fnp-2613	18	4	case	case	NOUN
fnp-2613	18	5	report	report	NOUN
fnp-2613	18	6	of	of	ADP
fnp-2613	18	7	a	a	DET
fnp-2613	18	8	teenager	teenager	NOUN
fnp-2613	18	9	,	,	PUNCT
fnp-2613	18	10	the	the	DET
fnp-2613	18	11	clinical	clinical	ADJ
fnp-2613	18	12	symptoms	symptom	NOUN
fnp-2613	18	13	and	and	CCONJ
fnp-2613	18	14	post	post	ADJ
fnp-2613	18	15	-	-	ADJ
fnp-2613	18	16	mortem	mortem	ADJ
fnp-2613	18	17	pathological	pathological	ADJ
fnp-2613	18	18	findings	finding	NOUN
fnp-2613	18	19	were	be	AUX
fnp-2613	18	20	consistent	consistent	ADJ
fnp-2613	18	21	with	with	ADP
fnp-2613	18	22	those	those	PRON
fnp-2613	18	23	of	of	ADP
fnp-2613	18	24	in	in	ADP
fnp-2613	18	25	dlb4	dlb4	PROPN
fnp-2613	18	26	.	.	PUNCT
fnp-2613	19	1	the	the	DET
fnp-2613	19	2	prevalence	prevalence	NOUN
fnp-2613	19	3	of	of	ADP
fnp-2613	19	4	the	the	DET
fnp-2613	19	5	disease	disease	NOUN
fnp-2613	19	6	is	be	AUX
fnp-2613	19	7	not	not	PART
fnp-2613	19	8	clearly	clearly	ADV
fnp-2613	19	9	established	establish	VERB
fnp-2613	19	10	.	.	PUNCT
fnp-2613	20	1	according	accord	VERB
fnp-2613	20	2	to	to	ADP
fnp-2613	20	3	a	a	DET
fnp-2613	20	4	comprehensive	comprehensive	ADJ
fnp-2613	20	5	analysis	analysis	NOUN
fnp-2613	20	6	of	of	ADP
fnp-2613	20	7	epidemiological	epidemiological	ADJ
fnp-2613	20	8	data	datum	NOUN
fnp-2613	20	9	,	,	PUNCT
fnp-2613	20	10	the	the	DET
fnp-2613	20	11	prevalence	prevalence	NOUN
fnp-2613	20	12	is	be	AUX
fnp-2613	20	13	4.2	4.2	NUM
fnp-2613	20	14	%	%	NOUN
fnp-2613	20	15	in	in	ADP
fnp-2613	20	16	community	community	NOUN
fnp-2613	20	17	based	base	VERB
fnp-2613	20	18	and	and	CCONJ
fnp-2613	20	19	7.5	7.5	NUM
fnp-2613	20	20	%	%	NOUN
fnp-2613	20	21	in	in	ADP
fnp-2613	20	22	clinical	clinical	ADJ
fnp-2613	20	23	studies	study	NOUN
fnp-2613	20	24	,	,	PUNCT
fnp-2613	20	25	while	while	SCONJ
fnp-2613	20	26	the	the	DET
fnp-2613	20	27	incidence	incidence	NOUN
fnp-2613	20	28	is	be	AUX
fnp-2613	20	29	3.8	3.8	NUM
fnp-2613	20	30	%	%	NOUN
fnp-2613	20	31	and	and	CCONJ
fnp-2613	20	32	grows	grow	VERB
fnp-2613	20	33	linearly	linearly	ADV
fnp-2613	20	34	with	with	ADP
fnp-2613	20	35	aging5	aging5	NOUN
fnp-2613	20	36	and	and	CCONJ
fnp-2613	20	37	the	the	DET
fnp-2613	20	38	prevalence	prevalence	NOUN
fnp-2613	20	39	of	of	ADP
fnp-2613	20	40	dlb	dlb	NOUN
fnp-2613	20	41	among	among	ADP
fnp-2613	20	42	patients	patient	NOUN
fnp-2613	20	43	with	with	ADP
fnp-2613	20	44	dementia	dementia	NOUN
fnp-2613	20	45	is	be	AUX
fnp-2613	20	46	probably	probably	ADV
fnp-2613	20	47	around	around	ADV
fnp-2613	20	48	15%6	15%6	NUM
fnp-2613	20	49	.	.	PUNCT
fnp-2613	21	1	pathologic	pathologic	ADJ
fnp-2613	21	2	background	background	NOUN
fnp-2613	21	3	1	1	NUM
fnp-2613	21	4	.	.	PUNCT
fnp-2613	21	5	macroscopic	macroscopic	ADJ
fnp-2613	21	6	observation	observation	NOUN
fnp-2613	21	7	many	many	ADJ
fnp-2613	21	8	of	of	ADP
fnp-2613	21	9	the	the	DET
fnp-2613	21	10	general	general	ADJ
fnp-2613	21	11	pathologic	pathologic	NOUN
fnp-2613	21	12	features	feature	NOUN
fnp-2613	21	13	resemble	resemble	VERB
fnp-2613	21	14	those	those	PRON
fnp-2613	21	15	in	in	ADP
fnp-2613	21	16	parkinson	parkinson	NOUN
fnp-2613	21	17	’s	’s	PART
fnp-2613	21	18	disease	disease	NOUN
fnp-2613	21	19	(	(	PUNCT
fnp-2613	21	20	pd	pd	NOUN
fnp-2613	21	21	)	)	PUNCT
fnp-2613	21	22	.	.	PUNCT
fnp-2613	22	1	the	the	DET
fnp-2613	22	2	brain	brain	NOUN
fnp-2613	22	3	weight	weight	NOUN
fnp-2613	22	4	is	be	AUX
fnp-2613	22	5	often	often	ADV
fnp-2613	22	6	within	within	ADP
fnp-2613	22	7	the	the	DET
fnp-2613	22	8	normal	normal	ADJ
fnp-2613	22	9	limits	limit	NOUN
fnp-2613	22	10	,	,	PUNCT
fnp-2613	22	11	mild	mild	ADJ
fnp-2613	22	12	cortical	cortical	ADJ
fnp-2613	22	13	atrophy	atrophy	NOUN
fnp-2613	22	14	of	of	ADP
fnp-2613	22	15	the	the	DET
fnp-2613	22	16	frontal	frontal	ADJ
fnp-2613	22	17	lobe	lobe	NOUN
fnp-2613	22	18	,	,	PUNCT
fnp-2613	22	19	neuromelanin	neuromelanin	ADJ
fnp-2613	22	20	pigment	pigment	NOUN
fnp-2613	22	21	loss	loss	NOUN
fnp-2613	22	22	in	in	ADP
fnp-2613	22	23	the	the	DET
fnp-2613	22	24	substantia	substantia	NOUN
fnp-2613	22	25	nigra	nigra	NOUN
fnp-2613	22	26	and	and	CCONJ
fnp-2613	22	27	locus	locus	NOUN
fnp-2613	22	28	coeruleus	coeruleus	NOUN
fnp-2613	22	29	are	be	AUX
fnp-2613	22	30	noted	note	VERB
fnp-2613	22	31	.	.	PUNCT
fnp-2613	23	1	in	in	ADP
fnp-2613	23	2	the	the	DET
fnp-2613	23	3	case	case	NOUN
fnp-2613	23	4	of	of	ADP
fnp-2613	23	5	severe	severe	ADJ
fnp-2613	23	6	concomitant	concomitant	ADJ
fnp-2613	23	7	ad	ad	NOUN
fnp-2613	23	8	pathology	pathology	NOUN
fnp-2613	23	9	,	,	PUNCT
fnp-2613	23	10	atrophy	atrophy	NOUN
fnp-2613	23	11	of	of	ADP
fnp-2613	23	12	the	the	DET
fnp-2613	23	13	temporal	temporal	ADJ
fnp-2613	23	14	and	and	CCONJ
fnp-2613	23	15	parietal	parietal	ADJ
fnp-2613	23	16	regions	region	NOUN
fnp-2613	23	17	is	be	AUX
fnp-2613	23	18	more	more	ADV
fnp-2613	23	19	evident	evident	ADJ
fnp-2613	23	20	.	.	PUNCT
fnp-2613	24	1	in	in	ADP
fnp-2613	24	2	contrast	contrast	NOUN
fnp-2613	24	3	to	to	ADP
fnp-2613	24	4	ad	ad	NOUN
fnp-2613	24	5	,	,	PUNCT
fnp-2613	24	6	the	the	DET
fnp-2613	24	7	general	general	ADJ
fnp-2613	24	8	brain	brain	NOUN
fnp-2613	24	9	atrophy	atrophy	NOUN
fnp-2613	24	10	is	be	AUX
fnp-2613	24	11	less	less	ADV
fnp-2613	24	12	prominent	prominent	ADJ
fnp-2613	24	13	in	in	ADP
fnp-2613	24	14	dlb	dlb	NOUN
fnp-2613	24	15	along	along	ADP
fnp-2613	24	16	with	with	ADP
fnp-2613	24	17	the	the	DET
fnp-2613	24	18	relatively	relatively	ADV
fnp-2613	24	19	preserved	preserve	VERB
fnp-2613	24	20	temporal	temporal	ADJ
fnp-2613	24	21	lobe	lobe	NOUN
fnp-2613	24	22	and	and	CCONJ
fnp-2613	24	23	hippocampus7	hippocampus7	PROPN
fnp-2613	24	24	.	.	PUNCT
fnp-2613	25	1	2	2	X
fnp-2613	25	2	.	.	X
fnp-2613	25	3	microscopic	microscopic	ADJ
fnp-2613	25	4	feature	feature	NOUN
fnp-2613	25	5	 	 	SPACE
fnp-2613	25	6	lewy	lewy	PROPN
fnp-2613	25	7	bodies	body	NOUN
fnp-2613	25	8	(	(	PUNCT
fnp-2613	25	9	lbs	lbs	PROPN
fnp-2613	25	10	)	)	PUNCT
fnp-2613	25	11	,	,	PUNCT
fnp-2613	25	12	the	the	DET
fnp-2613	25	13	key	key	ADJ
fnp-2613	25	14	pathological	pathological	ADJ
fnp-2613	25	15	findings	finding	NOUN
fnp-2613	25	16	in	in	ADP
fnp-2613	25	17	dlb	dlb	PROPN
fnp-2613	25	18	,	,	PUNCT
fnp-2613	25	19	were	be	AUX
fnp-2613	25	20	initially	initially	ADV
fnp-2613	25	21	described	describe	VERB
fnp-2613	25	22	by	by	ADP
fnp-2613	25	23	friedrich	friedrich	PROPN
fnp-2613	25	24	lewy	lewy	PROPN
fnp-2613	25	25	in	in	ADP
fnp-2613	25	26	19128	19128	NUM
fnp-2613	25	27	.	.	PUNCT
fnp-2613	26	1	however	however	ADV
fnp-2613	26	2	,	,	PUNCT
fnp-2613	26	3	lbs	lbs	PROPN
fnp-2613	26	4	are	be	AUX
fnp-2613	26	5	characteristic	characteristic	ADJ
fnp-2613	26	6	of	of	ADP
fnp-2613	26	7	other	other	ADJ
fnp-2613	26	8	neurodegenerative	neurodegenerative	ADJ
fnp-2613	26	9	diseases	disease	NOUN
fnp-2613	26	10	including	include	VERB
fnp-2613	26	11	pd	pd	PROPN
fnp-2613	26	12	.	.	PUNCT
fnp-2613	27	1	their	their	PRON
fnp-2613	27	2	typical	typical	ADJ
fnp-2613	27	3	appearance	appearance	NOUN
fnp-2613	27	4	,	,	PUNCT
fnp-2613	27	5	stained	stain	VERB
fnp-2613	27	6	with	with	ADP
fnp-2613	27	7	conventional	conventional	ADJ
fnp-2613	27	8	hematoxylin	hematoxylin	NOUN
fnp-2613	27	9	-	-	PUNCT
fnp-2613	27	10	eosin	eosin	NOUN
fnp-2613	27	11	,	,	PUNCT
fnp-2613	27	12	is	be	AUX
fnp-2613	27	13	a	a	DET
fnp-2613	27	14	central	central	ADJ
fnp-2613	27	15	spherical	spherical	ADJ
fnp-2613	27	16	eosinophilic	eosinophilic	NOUN
fnp-2613	27	17	core	core	NOUN
fnp-2613	27	18	surrounded	surround	VERB
fnp-2613	27	19	by	by	ADP
fnp-2613	27	20	a	a	DET
fnp-2613	27	21	peripheral	peripheral	ADJ
fnp-2613	27	22	halo	halo	NOUN
fnp-2613	27	23	situated	situate	VERB
fnp-2613	27	24	intracellularly	intracellularly	ADV
fnp-2613	27	25	,	,	PUNCT
fnp-2613	27	26	causing	cause	VERB
fnp-2613	27	27	dislocation	dislocation	NOUN
fnp-2613	27	28	of	of	ADP
fnp-2613	27	29	subcellular	subcellular	ADJ
fnp-2613	27	30	organs	organ	NOUN
fnp-2613	27	31	.	.	PUNCT
fnp-2613	28	1	these	these	DET
fnp-2613	28	2	features	feature	NOUN
fnp-2613	28	3	are	be	AUX
fnp-2613	28	4	regularly	regularly	ADV
fnp-2613	28	5	found	find	VERB
fnp-2613	28	6	in	in	ADP
fnp-2613	28	7	brainstem	brainstem	NOUN
fnp-2613	28	8	predominant	predominant	ADJ
fnp-2613	28	9	lb	lb	DET
fnp-2613	28	10	formation	formation	NOUN
fnp-2613	28	11	.	.	PUNCT
fnp-2613	29	1	the	the	DET
fnp-2613	29	2	rest	rest	NOUN
fnp-2613	29	3	of	of	ADP
fnp-2613	29	4	the	the	DET
fnp-2613	29	5	brain	brain	NOUN
fnp-2613	29	6	expresses	express	VERB
fnp-2613	29	7	rather	rather	ADV
fnp-2613	29	8	irregular	irregular	ADJ
fnp-2613	29	9	lbs	lbs	NOUN
fnp-2613	29	10	without	without	ADP
fnp-2613	29	11	the	the	DET
fnp-2613	29	12	typical	typical	ADJ
fnp-2613	29	13	peripheral	peripheral	ADJ
fnp-2613	29	14	halo	halo	NOUN
fnp-2613	29	15	(	(	PUNCT
fnp-2613	29	16	figure	figure	NOUN
fnp-2613	29	17	1	1	NUM
fnp-2613	29	18	)	)	PUNCT
fnp-2613	29	19	.	.	PUNCT
fnp-2613	30	1	figure	figure	VERB
fnp-2613	30	2	1	1	NUM
fnp-2613	30	3	:	:	PUNCT
fnp-2613	30	4	dementia	dementia	NOUN
fnp-2613	30	5	with	with	ADP
fnp-2613	30	6	lewy	lewy	ADJ
fnp-2613	30	7	bodies	body	NOUN
fnp-2613	30	8	(	(	PUNCT
fnp-2613	30	9	dlb	dlb	NOUN
fnp-2613	30	10	)	)	PUNCT
fnp-2613	30	11	specific	specific	ADJ
fnp-2613	30	12	pathological	pathological	ADJ
fnp-2613	30	13	changes	change	NOUN
fnp-2613	30	14	are	be	AUX
fnp-2613	30	15	shown	show	VERB
fnp-2613	30	16	with	with	ADP
fnp-2613	30	17	hematoxylin	hematoxylin	NOUN
fnp-2613	30	18	and	and	CCONJ
fnp-2613	30	19	eosin	eosin	NOUN
fnp-2613	30	20	(	(	PUNCT
fnp-2613	30	21	he	he	PRON
fnp-2613	30	22	)	)	PUNCT
fnp-2613	30	23	staining	stain	VERB
fnp-2613	30	24	(	(	PUNCT
fnp-2613	30	25	panel	panel	NOUN
fnp-2613	30	26	a	a	NOUN
fnp-2613	30	27	)	)	PUNCT
fnp-2613	30	28	and	and	CCONJ
fnp-2613	30	29	α	α	X
fnp-2613	30	30	-	-	PUNCT
fnp-2613	30	31	synuclein	synuclein	NOUN
fnp-2613	30	32	immunohistochemistry	immunohistochemistry	NOUN
fnp-2613	30	33	(	(	PUNCT
fnp-2613	30	34	ich	ich	NOUN
fnp-2613	30	35	)	)	PUNCT
fnp-2613	30	36	(	(	PUNCT
fnp-2613	30	37	panel	panel	NOUN
fnp-2613	30	38	b	b	NOUN
fnp-2613	30	39	)	)	PUNCT
fnp-2613	30	40	.	.	PUNCT
fnp-2613	31	1	cortical	cortical	ADJ
fnp-2613	31	2	-	-	PUNCT
fnp-2613	31	3	type	type	NOUN
fnp-2613	31	4	lewy	lewy	ADJ
fnp-2613	31	5	bodies	body	NOUN
fnp-2613	31	6	(	(	PUNCT
fnp-2613	31	7	lbs	lbs	PROPN
fnp-2613	31	8	)	)	PUNCT
fnp-2613	31	9	are	be	AUX
fnp-2613	31	10	eosinophilic	eosinophilic	ADJ
fnp-2613	31	11	intracellar	intracellar	ADJ
fnp-2613	31	12	neuronal	neuronal	ADJ
fnp-2613	31	13	inclusions	inclusion	NOUN
fnp-2613	31	14	which	which	PRON
fnp-2613	31	15	dislocate	dislocate	VERB
fnp-2613	31	16	the	the	DET
fnp-2613	31	17	nucleus	nucleus	NOUN
fnp-2613	31	18	(	(	PUNCT
fnp-2613	31	19	panel	panel	NOUN
fnp-2613	31	20	a	a	DET
fnp-2613	31	21	,	,	PUNCT
fnp-2613	31	22	black	black	ADJ
fnp-2613	31	23	star	star	NOUN
fnp-2613	31	24	)	)	PUNCT
fnp-2613	31	25	.	.	PUNCT
fnp-2613	32	1	α	α	X
fnp-2613	32	2	-	-	PUNCT
fnp-2613	32	3	synuclein	synuclein	NOUN
fnp-2613	32	4	ihc	ihc	PROPN
fnp-2613	32	5	highlights	highlights	PROPN
fnp-2613	32	6	lbs	lbs	PROPN
fnp-2613	32	7	(	(	PUNCT
fnp-2613	32	8	white	white	PROPN
fnp-2613	32	9	star	star	PROPN
fnp-2613	32	10	,	,	PUNCT
fnp-2613	32	11	panel	panel	NOUN
fnp-2613	32	12	b	b	NOUN
fnp-2613	32	13	)	)	PUNCT
fnp-2613	32	14	and	and	CCONJ
fnp-2613	32	15	lns	lns	PROPN
fnp-2613	32	16	(	(	PUNCT
fnp-2613	32	17	arrowhead	arrowhead	NOUN
fnp-2613	32	18	,	,	PUNCT
fnp-2613	32	19	panel	panel	NOUN
fnp-2613	32	20	b	b	NOUN
fnp-2613	32	21	)	)	PUNCT
fnp-2613	32	22	.	.	PUNCT
fnp-2613	33	1	histopathologically	histopathologically	ADV
fnp-2613	33	2	,	,	PUNCT
fnp-2613	33	3	the	the	DET
fnp-2613	33	4	dominant	dominant	ADJ
fnp-2613	33	5	component	component	NOUN
fnp-2613	33	6	of	of	ADP
fnp-2613	33	7	the	the	DET
fnp-2613	33	8	central	central	ADJ
fnp-2613	33	9	core	core	NOUN
fnp-2613	33	10	is	be	AUX
fnp-2613	33	11	α	α	NOUN
fnp-2613	33	12	-	-	PUNCT
fnp-2613	33	13	synuclein	synuclein	NOUN
fnp-2613	33	14	,	,	PUNCT
fnp-2613	33	15	while	while	SCONJ
fnp-2613	33	16	the	the	DET
fnp-2613	33	17	peripheral	peripheral	ADJ
fnp-2613	33	18	halo	halo	NOUN
fnp-2613	33	19	consists	consist	VERB
fnp-2613	33	20	of	of	ADP
fnp-2613	33	21	several	several	ADJ
fnp-2613	33	22	ubiquitinated	ubiquitinated	ADJ
fnp-2613	33	23	proteins9	proteins9	NOUN
fnp-2613	33	24	.	.	PUNCT
fnp-2613	34	1	lewy	lewy	PROPN
fnp-2613	34	2	neurites	neurites	PROPN
fnp-2613	34	3	(	(	PUNCT
fnp-2613	34	4	lns	lns	PROPN
fnp-2613	34	5	)	)	PUNCT
fnp-2613	34	6	,	,	PUNCT
fnp-2613	34	7	as	as	ADP
fnp-2613	34	8	an	an	DET
fnp-2613	34	9	additional	additional	ADJ
fnp-2613	34	10	hallmark	hallmark	NOUN
fnp-2613	34	11	of	of	ADP
fnp-2613	34	12	α	α	NOUN
fnp-2613	34	13	-	-	PUNCT
fnp-2613	34	14	synucleinopathies	synucleinopathie	NOUN
fnp-2613	34	15	,	,	PUNCT
fnp-2613	34	16	are	be	AUX
fnp-2613	34	17	abnormal	abnormal	ADJ
fnp-2613	34	18	thickened	thicken	VERB
fnp-2613	34	19	neurites	neurite	NOUN
fnp-2613	34	20	containing	contain	VERB
fnp-2613	34	21	filaments	filament	NOUN
fnp-2613	34	22	corresponding	correspond	VERB
fnp-2613	34	23	to	to	ADP
fnp-2613	34	24	those	those	PRON
fnp-2613	34	25	in	in	ADP
fnp-2613	34	26	lbs10	lbs10	NOUN
fnp-2613	34	27	.	.	PUNCT
fnp-2613	35	1	interestingly	interestingly	ADV
fnp-2613	35	2	,	,	PUNCT
fnp-2613	35	3	in	in	ADP
fnp-2613	35	4	experimental	experimental	ADJ
fnp-2613	35	5	mouse	mouse	NOUN
fnp-2613	35	6	models	model	NOUN
fnp-2613	35	7	mutant	mutant	VERB
fnp-2613	35	8	snca	snca	NOUN
fnp-2613	35	9	inoculation	inoculation	NOUN
fnp-2613	35	10	of	of	ADP
fnp-2613	35	11	wild	wild	ADJ
fnp-2613	35	12	type	type	NOUN
fnp-2613	35	13	mouse	mouse	NOUN
fnp-2613	35	14	causes	cause	VERB
fnp-2613	35	15	lb	lb	ADJ
fnp-2613	35	16	/	/	SYM
fnp-2613	35	17	ln	ln	ADJ
fnp-2613	35	18	-	-	PUNCT
fnp-2613	35	19	like	like	ADJ
fnp-2613	35	20	pathology	pathology	NOUN
fnp-2613	35	21	,	,	PUNCT
fnp-2613	35	22	supporting	support	VERB
fnp-2613	35	23	the	the	DET
fnp-2613	35	24	pathognomonic	pathognomonic	ADJ
fnp-2613	35	25	role	role	NOUN
fnp-2613	35	26	of	of	ADP
fnp-2613	35	27	the	the	DET
fnp-2613	35	28	protein11	protein11	NOUN
fnp-2613	35	29	.	.	PUNCT
fnp-2613	36	1	the	the	DET
fnp-2613	36	2	background	background	NOUN
fnp-2613	36	3	of	of	ADP
fnp-2613	36	4	lb	lb	NUM
fnp-2613	36	5	genesis	genesis	NOUN
fnp-2613	36	6	is	be	AUX
fnp-2613	36	7	still	still	ADV
fnp-2613	36	8	undiscovered	undiscovered	ADJ
fnp-2613	36	9	,	,	PUNCT
fnp-2613	36	10	although	although	SCONJ
fnp-2613	36	11	numerous	numerous	ADJ
fnp-2613	36	12	hypotheses	hypothesis	NOUN
fnp-2613	36	13	have	have	AUX
fnp-2613	36	14	been	be	AUX
fnp-2613	36	15	proposed	propose	VERB
fnp-2613	36	16	trying	try	VERB
fnp-2613	36	17	to	to	PART
fnp-2613	36	18	explain	explain	VERB
fnp-2613	36	19	the	the	DET
fnp-2613	36	20	proper	proper	ADJ
fnp-2613	36	21	mechanism	mechanism	NOUN
fnp-2613	36	22	.	.	PUNCT
fnp-2613	37	1	according	accord	VERB
fnp-2613	37	2	to	to	ADP
fnp-2613	37	3	the	the	DET
fnp-2613	37	4	aggresome	aggresome	ADJ
fnp-2613	37	5	hypothesis	hypothesis	NOUN
fnp-2613	37	6	,	,	PUNCT
fnp-2613	37	7	lb	lb	DET
fnp-2613	37	8	formation	formation	NOUN
fnp-2613	37	9	is	be	AUX
fnp-2613	37	10	originally	originally	ADV
fnp-2613	37	11	a	a	DET
fnp-2613	37	12	neuroprotective	neuroprotective	ADJ
fnp-2613	37	13	process	process	NOUN
fnp-2613	37	14	,	,	PUNCT
fnp-2613	37	15	facilitating	facilitate	VERB
fnp-2613	37	16	the	the	DET
fnp-2613	37	17	cells	cell	NOUN
fnp-2613	37	18	to	to	PART
fnp-2613	37	19	remove	remove	VERB
fnp-2613	37	20	harmful	harmful	ADJ
fnp-2613	37	21	proteins12	proteins12	NOUN
fnp-2613	37	22	.	.	PUNCT
fnp-2613	38	1	however	however	ADV
fnp-2613	38	2	,	,	PUNCT
fnp-2613	38	3	failure	failure	NOUN
fnp-2613	38	4	of	of	ADP
fnp-2613	38	5	the	the	DET
fnp-2613	38	6	aggresome	aggresome	ADJ
fnp-2613	38	7	formation	formation	NOUN
fnp-2613	38	8	may	may	AUX
fnp-2613	38	9	occur	occur	VERB
fnp-2613	38	10	,	,	PUNCT
fnp-2613	38	11	leading	lead	VERB
fnp-2613	38	12	to	to	ADP
fnp-2613	38	13	excessive	excessive	ADJ
fnp-2613	38	14	lb	lb	ADP
fnp-2613	38	15	development13	development13	NOUN
fnp-2613	38	16	.	.	PUNCT
fnp-2613	39	1	other	other	ADJ
fnp-2613	39	2	authors	author	NOUN
fnp-2613	39	3	presume	presume	VERB
fnp-2613	39	4	that	that	SCONJ
fnp-2613	39	5	autophagy	autophagy	ADJ
fnp-2613	39	6	dysfunction	dysfunction	NOUN
fnp-2613	39	7	is	be	AUX
fnp-2613	39	8	responsible	responsible	ADJ
fnp-2613	39	9	for	for	ADP
fnp-2613	39	10	the	the	DET
fnp-2613	39	11	neuronal	neuronal	ADJ
fnp-2613	39	12	loss14	loss14	NOUN
fnp-2613	39	13	.	.	PUNCT
fnp-2613	40	1	a	a	DET
fnp-2613	40	2	recent	recent	ADJ
fnp-2613	40	3	study	study	NOUN
fnp-2613	40	4	suggests	suggest	VERB
fnp-2613	40	5	that	that	SCONJ
fnp-2613	40	6	the	the	DET
fnp-2613	40	7	increased	increase	VERB
fnp-2613	40	8	unfolded	unfold	VERB
fnp-2613	40	9	protein	protein	NOUN
fnp-2613	40	10	response	response	NOUN
fnp-2613	40	11	(	(	PUNCT
fnp-2613	40	12	upr	upr	NOUN
fnp-2613	40	13	)	)	PUNCT
fnp-2613	40	14	activation	activation	NOUN
fnp-2613	40	15	has	have	VERB
fnp-2613	40	16	an	an	DET
fnp-2613	40	17	important	important	ADJ
fnp-2613	40	18	role	role	NOUN
fnp-2613	40	19	in	in	ADP
fnp-2613	40	20	the	the	DET
fnp-2613	40	21	lb	lb	NOUN
fnp-2613	40	22	pathology15	pathology15	NOUN
fnp-2613	40	23	.	.	PUNCT
fnp-2613	41	1	nevertheless	nevertheless	ADV
fnp-2613	41	2	,	,	PUNCT
fnp-2613	41	3	according	accord	VERB
fnp-2613	41	4	to	to	ADP
fnp-2613	41	5	tompkins	tompkins	PROPN
fnp-2613	41	6	et	et	PROPN
fnp-2613	41	7	al	al	PROPN
fnp-2613	41	8	.	.	PUNCT
fnp-2613	41	9	neurons	neuron	NOUN
fnp-2613	41	10	burdened	burden	VERB
fnp-2613	41	11	with	with	ADP
fnp-2613	41	12	lbs	lbs	NOUN
fnp-2613	41	13	are	be	AUX
fnp-2613	41	14	less	less	ADJ
fnp-2613	41	15	apoptotic16	apoptotic16	NOUN
fnp-2613	41	16	.	.	PUNCT
fnp-2613	42	1	moreover	moreover	ADV
fnp-2613	42	2	,	,	PUNCT
fnp-2613	42	3	the	the	DET
fnp-2613	42	4	downregulation	downregulation	NOUN
fnp-2613	42	5	of	of	ADP
fnp-2613	42	6	tyrosine	tyrosine	NOUN
fnp-2613	42	7	hydroxylase	hydroxylase	NOUN
fnp-2613	42	8	enzymes	enzyme	NOUN
fnp-2613	42	9	protects	protect	VERB
fnp-2613	42	10	against	against	ADP
fnp-2613	42	11	toxic	toxic	ADJ
fnp-2613	42	12	products	product	NOUN
fnp-2613	42	13	of	of	ADP
fnp-2613	42	14	dopamine	dopamine	NOUN
fnp-2613	42	15	oxidation17	oxidation17	NOUN
fnp-2613	42	16	.	.	PUNCT
fnp-2613	43	1	these	these	DET
fnp-2613	43	2	findings	finding	NOUN
fnp-2613	43	3	confirm	confirm	VERB
fnp-2613	43	4	the	the	DET
fnp-2613	43	5	theory	theory	NOUN
fnp-2613	43	6	that	that	SCONJ
fnp-2613	43	7	α	α	NOUN
fnp-2613	43	8	-	-	PUNCT
fnp-2613	43	9	synuclein	synuclein	NOUN
fnp-2613	43	10	is	be	AUX
fnp-2613	43	11	physiologically	physiologically	ADV
fnp-2613	43	12	involved	involve	VERB
fnp-2613	43	13	in	in	ADP
fnp-2613	43	14	the	the	DET
fnp-2613	43	15	maintenance	maintenance	NOUN
fnp-2613	43	16	of	of	ADP
fnp-2613	43	17	cell	cell	NOUN
fnp-2613	43	18	homeostasis	homeostasis	NOUN
fnp-2613	43	19	.	.	PUNCT
fnp-2613	44	1	the	the	DET
fnp-2613	44	2	first	first	ADJ
fnp-2613	44	3	standardized	standardized	ADJ
fnp-2613	44	4	criterion	criterion	NOUN
fnp-2613	44	5	assessing	assess	VERB
fnp-2613	44	6	the	the	DET
fnp-2613	44	7	connections	connection	NOUN
fnp-2613	44	8	between	between	ADP
fnp-2613	44	9	pathological	pathological	ADJ
fnp-2613	44	10	findings	finding	NOUN
fnp-2613	44	11	and	and	CCONJ
fnp-2613	44	12	dlb	dlb	NOUN
fnp-2613	44	13	was	be	AUX
fnp-2613	44	14	made	make	VERB
fnp-2613	44	15	by	by	ADP
fnp-2613	44	16	kosaka	kosaka	PROPN
fnp-2613	44	17	et	et	PROPN
fnp-2613	44	18	al	al	PROPN
fnp-2613	44	19	.	.	PROPN
fnp-2613	45	1	in	in	ADP
fnp-2613	45	2	1984	1984	NUM
fnp-2613	45	3	.	.	PUNCT
fnp-2613	46	1	based	base	VERB
fnp-2613	46	2	on	on	ADP
fnp-2613	46	3	the	the	DET
fnp-2613	46	4	anatomical	anatomical	ADJ
fnp-2613	46	5	distribution	distribution	NOUN
fnp-2613	46	6	of	of	ADP
fnp-2613	46	7	pathology	pathology	NOUN
fnp-2613	46	8	they	they	PRON
fnp-2613	46	9	determined	determine	VERB
fnp-2613	46	10	three	three	NUM
fnp-2613	46	11	different	different	ADJ
fnp-2613	46	12	subtypes	subtype	NOUN
fnp-2613	46	13	:	:	PUNCT
fnp-2613	46	14	i	i	NOUN
fnp-2613	46	15	)	)	PUNCT
fnp-2613	46	16	brainstem	brainstem	NOUN
fnp-2613	46	17	predominant	predominant	ADJ
fnp-2613	46	18	lbs	lbs	NOUN
fnp-2613	46	19	(	(	PUNCT
fnp-2613	46	20	commonly	commonly	ADV
fnp-2613	46	21	in	in	ADP
fnp-2613	46	22	pd	pd	PROPN
fnp-2613	46	23	)	)	PUNCT
fnp-2613	46	24	ii	ii	PROPN
fnp-2613	46	25	)	)	PUNCT
fnp-2613	46	26	limbic	limbic	NOUN
fnp-2613	46	27	(	(	PUNCT
fnp-2613	46	28	transitional	transitional	ADJ
fnp-2613	46	29	)	)	PUNCT
fnp-2613	46	30	lbs	lbs	NOUN
fnp-2613	46	31	and	and	CCONJ
fnp-2613	46	32	iii	iii	X
fnp-2613	46	33	)	)	PUNCT
fnp-2613	46	34	diffuse	diffuse	VERB
fnp-2613	46	35	cortical	cortical	ADJ
fnp-2613	46	36	lbs18	lbs18	NOUN
fnp-2613	46	37	.	.	PUNCT
fnp-2613	47	1	later	later	ADV
fnp-2613	47	2	the	the	DET
fnp-2613	47	3	consortium	consortium	NOUN
fnp-2613	47	4	on	on	ADP
fnp-2613	47	5	dlb	dlb	PROPN
fnp-2613	47	6	international	international	ADJ
fnp-2613	47	7	workshop	workshop	NOUN
fnp-2613	47	8	has	have	AUX
fnp-2613	47	9	improved	improve	VERB
fnp-2613	47	10	the	the	DET
fnp-2613	47	11	original	original	ADJ
fnp-2613	47	12	assignment	assignment	NOUN
fnp-2613	47	13	and	and	CCONJ
fnp-2613	47	14	published	publish	VERB
fnp-2613	47	15	a	a	DET
fnp-2613	47	16	more	more	ADV
fnp-2613	47	17	detailed	detailed	ADJ
fnp-2613	47	18	instruction	instruction	NOUN
fnp-2613	47	19	emphasizing	emphasize	VERB
fnp-2613	47	20	the	the	DET
fnp-2613	47	21	importance	importance	NOUN
fnp-2613	47	22	of	of	ADP
fnp-2613	47	23	the	the	DET
fnp-2613	47	24	diagnostic	diagnostic	ADJ
fnp-2613	47	25	procedure	procedure	NOUN
fnp-2613	47	26	.	.	PUNCT
fnp-2613	48	1	the	the	DET
fnp-2613	48	2	widely	widely	ADV
fnp-2613	48	3	used	use	VERB
fnp-2613	48	4	immunohistochemical	immunohistochemical	ADJ
fnp-2613	48	5	markers	marker	NOUN
fnp-2613	48	6	,	,	PUNCT
fnp-2613	48	7	α	α	NOUN
fnp-2613	48	8	-	-	PUNCT
fnp-2613	48	9	synuclein	synuclein	NOUN
fnp-2613	48	10	(	(	PUNCT
fnp-2613	48	11	the	the	DET
fnp-2613	48	12	most	most	ADV
fnp-2613	48	13	specific	specific	ADJ
fnp-2613	48	14	)	)	PUNCT
fnp-2613	48	15	and	and	CCONJ
fnp-2613	48	16	p62	p62	NOUN
fnp-2613	48	17	serve	serve	VERB
fnp-2613	48	18	the	the	DET
fnp-2613	48	19	accurate	accurate	ADJ
fnp-2613	48	20	pathological	pathological	ADJ
fnp-2613	48	21	diagnosis19	diagnosis19	NOUN
fnp-2613	48	22	.	.	PUNCT
fnp-2613	49	1	the	the	DET
fnp-2613	49	2	latest	late	ADJ
fnp-2613	49	3	mckeith	mckeith	NOUN
fnp-2613	49	4	diagnostic	diagnostic	ADJ
fnp-2613	49	5	consensus	consensus	NOUN
fnp-2613	49	6	criteria	criterion	NOUN
fnp-2613	49	7	recommends	recommend	VERB
fnp-2613	49	8	a	a	DET
fnp-2613	49	9	semiquantitative	semiquantitative	ADJ
fnp-2613	49	10	grading	grading	NOUN
fnp-2613	49	11	of	of	ADP
fnp-2613	49	12	10	10	NUM
fnp-2613	49	13	different	different	ADJ
fnp-2613	49	14	brain	brain	NOUN
fnp-2613	49	15	regions	region	NOUN
fnp-2613	49	16	(	(	PUNCT
fnp-2613	49	17	dorsal	dorsal	NOUN
fnp-2613	49	18	motor	motor	NOUN
fnp-2613	49	19	nucleus	nucleus	PROPN
fnp-2613	49	20	of	of	ADP
fnp-2613	49	21	vagus	vagus	NOUN
fnp-2613	49	22	,	,	PUNCT
fnp-2613	49	23	locus	locus	NOUN
fnp-2613	49	24	coeruleus	coeruleus	NOUN
fnp-2613	49	25	,	,	PUNCT
fnp-2613	49	26	substantia	substantia	NOUN
fnp-2613	49	27	nigra	nigra	NOUN
fnp-2613	49	28	,	,	PUNCT
fnp-2613	49	29	nucleus	nucleus	NOUN
fnp-2613	49	30	basalis	basali	NOUN
fnp-2613	49	31	of	of	ADP
fnp-2613	49	32	meynert	meynert	NOUN
fnp-2613	49	33	,	,	PUNCT
fnp-2613	49	34	amygdala	amygdala	NOUN
fnp-2613	49	35	,	,	PUNCT
fnp-2613	49	36	transentorhinal	transentorhinal	ADJ
fnp-2613	49	37	and	and	CCONJ
fnp-2613	49	38	cingulate	cingulate	PROPN
fnp-2613	49	39	gyri	gyri	PROPN
fnp-2613	49	40	,	,	PUNCT
fnp-2613	49	41	temporal-	temporal-	PRON
fnp-2613	49	42	,	,	PUNCT
fnp-2613	49	43	frontaland	frontaland	ADJ
fnp-2613	49	44	parietal	parietal	ADJ
fnp-2613	49	45	lobes	lobe	NOUN
fnp-2613	49	46	)	)	PUNCT
fnp-2613	49	47	based	base	VERB
fnp-2613	49	48	on	on	ADP
fnp-2613	49	49	the	the	DET
fnp-2613	49	50	lesion	lesion	NOUN
fnp-2613	49	51	density	density	NOUN
fnp-2613	49	52	instead	instead	ADV
fnp-2613	49	53	of	of	ADP
fnp-2613	49	54	the	the	DET
fnp-2613	49	55	previously	previously	ADV
fnp-2613	49	56	used	use	VERB
fnp-2613	49	57	lb	lb	PRON
fnp-2613	49	58	counting	counting	NOUN
fnp-2613	49	59	method	method	NOUN
fnp-2613	49	60	.	.	PUNCT
fnp-2613	50	1	moreover	moreover	ADV
fnp-2613	50	2	,	,	PUNCT
fnp-2613	50	3	it	it	PRON
fnp-2613	50	4	suggests	suggest	VERB
fnp-2613	50	5	two	two	NUM
fnp-2613	50	6	additional	additional	ADJ
fnp-2613	50	7	categories	category	NOUN
fnp-2613	50	8	,	,	PUNCT
fnp-2613	50	9	the	the	DET
fnp-2613	50	10	amygdala	amygdala	NOUN
fnp-2613	50	11	-	-	PUNCT
fnp-2613	50	12	predominant	predominant	NOUN
fnp-2613	50	13	and	and	CCONJ
fnp-2613	50	14	the	the	DET
fnp-2613	50	15	olfactory	olfactory	NOUN
fnp-2613	50	16	bulb	bulb	VERB
fnp-2613	50	17	only	only	ADV
fnp-2613	50	18	dlb	dlb	PROPN
fnp-2613	50	19	.	.	PUNCT
fnp-2613	51	1	according	accord	VERB
fnp-2613	51	2	to	to	ADP
fnp-2613	51	3	the	the	DET
fnp-2613	51	4	distribution	distribution	NOUN
fnp-2613	51	5	of	of	ADP
fnp-2613	51	6	lb	lb	DET
fnp-2613	51	7	pathology	pathology	NOUN
fnp-2613	51	8	on	on	ADP
fnp-2613	51	9	α	α	PROPN
fnp-2613	51	10	-	-	PUNCT
fnp-2613	51	11	synuclein	synuclein	NOUN
fnp-2613	51	12	immunostained	immunostaine	VERB
fnp-2613	51	13	slides	slide	NOUN
fnp-2613	51	14	,	,	PUNCT
fnp-2613	51	15	the	the	DET
fnp-2613	51	16	scoring	scoring	NOUN
fnp-2613	51	17	system	system	NOUN
fnp-2613	51	18	distinguishes	distinguish	VERB
fnp-2613	51	19	four	four	NUM
fnp-2613	51	20	stages	stage	NOUN
fnp-2613	51	21	:	:	PUNCT
fnp-2613	51	22	1	1	NUM
fnp-2613	51	23	–	–	PUNCT
fnp-2613	51	24	mild	mild	ADJ
fnp-2613	51	25	(	(	PUNCT
fnp-2613	51	26	sparse	sparse	ADJ
fnp-2613	51	27	lbs	lbs	NOUN
fnp-2613	51	28	or	or	CCONJ
fnp-2613	51	29	lns	lns	PROPN
fnp-2613	51	30	)	)	PUNCT
fnp-2613	51	31	;	;	PUNCT
fnp-2613	51	32	2	2	NUM
fnp-2613	51	33	–	–	PUNCT
fnp-2613	51	34	moderate	moderate	ADJ
fnp-2613	51	35	(	(	PUNCT
fnp-2613	51	36	1	1	NUM
fnp-2613	51	37	<	<	X
fnp-2613	51	38	lbs	lbs	NOUN
fnp-2613	51	39	in	in	ADP
fnp-2613	51	40	a	a	DET
fnp-2613	51	41	low	low	ADJ
fnp-2613	51	42	power	power	NOUN
fnp-2613	51	43	field	field	NOUN
fnp-2613	51	44	and	and	CCONJ
fnp-2613	51	45	sparse	sparse	VERB
fnp-2613	51	46	lns	lns	PROPN
fnp-2613	51	47	)	)	PUNCT
fnp-2613	51	48	;	;	PUNCT
fnp-2613	51	49	3	3	NUM
fnp-2613	51	50	severe	severe	ADJ
fnp-2613	51	51	(	(	PUNCT
fnp-2613	51	52	4≤	4≤	NUM
fnp-2613	51	53	lbs	lbs	NOUN
fnp-2613	51	54	and	and	CCONJ
fnp-2613	51	55	scattered	scatter	VERB
fnp-2613	51	56	lns	lns	NOUN
fnp-2613	51	57	in	in	ADP
fnp-2613	51	58	a	a	DET
fnp-2613	51	59	low	low	ADJ
fnp-2613	51	60	power	power	NOUN
fnp-2613	51	61	field	field	NOUN
fnp-2613	51	62	)	)	PUNCT
fnp-2613	51	63	;	;	PUNCT
fnp-2613	51	64	4	4	NUM
fnp-2613	51	65	–	–	PUNCT
fnp-2613	51	66	very	very	ADV
fnp-2613	51	67	severe	severe	ADJ
fnp-2613	51	68	(	(	PUNCT
fnp-2613	51	69	numerous	numerous	ADJ
fnp-2613	51	70	lbs	lb	NOUN
fnp-2613	51	71	and	and	CCONJ
fnp-2613	51	72	numerous	numerous	ADJ
fnp-2613	51	73	lns	lns	PROPN
fnp-2613	51	74	)	)	PUNCT
fnp-2613	51	75	.	.	PUNCT
fnp-2613	52	1	finally	finally	ADV
fnp-2613	52	2	,	,	PUNCT
fnp-2613	52	3	as	as	ADP
fnp-2613	52	4	a	a	DET
fnp-2613	52	5	synthesis	synthesis	NOUN
fnp-2613	52	6	of	of	ADP
fnp-2613	52	7	score	score	NOUN
fnp-2613	52	8	and	and	CCONJ
fnp-2613	52	9	localization	localization	NOUN
fnp-2613	52	10	it	it	PRON
fnp-2613	52	11	ranks	rank	VERB
fnp-2613	52	12	the	the	DET
fnp-2613	52	13	seen	see	VERB
fnp-2613	52	14	pathology	pathology	NOUN
fnp-2613	52	15	into	into	ADP
fnp-2613	52	16	one	one	NUM
fnp-2613	52	17	out	out	ADP
fnp-2613	52	18	of	of	ADP
fnp-2613	52	19	the	the	DET
fnp-2613	52	20	three	three	NUM
fnp-2613	52	21	previously	previously	ADV
fnp-2613	52	22	mentioned	mention	VERB
fnp-2613	52	23	subtypes20	subtypes20	NOUN
fnp-2613	52	24	.	.	PUNCT
fnp-2613	53	1	besides	besides	SCONJ
fnp-2613	53	2	the	the	DET
fnp-2613	53	3	mckeith	mckeith	NOUN
fnp-2613	53	4	staging	staging	NOUN
fnp-2613	53	5	and	and	CCONJ
fnp-2613	53	6	subtyping	subtype	VERB
fnp-2613	53	7	,	,	PUNCT
fnp-2613	53	8	the	the	DET
fnp-2613	53	9	other	other	ADJ
fnp-2613	53	10	widely	widely	ADV
fnp-2613	53	11	used	use	VERB
fnp-2613	53	12	evaluating	evaluating	NOUN
fnp-2613	53	13	technique	technique	NOUN
fnp-2613	53	14	is	be	AUX
fnp-2613	53	15	the	the	DET
fnp-2613	53	16	braak	braak	PROPN
fnp-2613	53	17	staging21	staging21	NOUN
fnp-2613	53	18	.	.	PUNCT
fnp-2613	54	1	the	the	DET
fnp-2613	54	2	authors	author	NOUN
fnp-2613	54	3	proposed	propose	VERB
fnp-2613	54	4	to	to	PART
fnp-2613	54	5	assess	assess	VERB
fnp-2613	54	6	the	the	DET
fnp-2613	54	7	severity	severity	NOUN
fnp-2613	54	8	of	of	ADP
fnp-2613	54	9	lewy	lewy	ADJ
fnp-2613	54	10	-	-	PUNCT
fnp-2613	54	11	type	type	NOUN
fnp-2613	54	12	pathology	pathology	NOUN
fnp-2613	54	13	labelled	label	VERB
fnp-2613	54	14	by	by	ADP
fnp-2613	54	15	α	α	PROPN
fnp-2613	54	16	-	-	PUNCT
fnp-2613	54	17	synuclein	synuclein	NOUN
fnp-2613	54	18	immunostaining	immunostaine	VERB
fnp-2613	54	19	in	in	ADP
fnp-2613	54	20	13	13	NUM
fnp-2613	54	21	different	different	ADJ
fnp-2613	54	22	brain	brain	NOUN
fnp-2613	54	23	areas	area	NOUN
fnp-2613	54	24	(	(	PUNCT
fnp-2613	54	25	dorsal	dorsal	NOUN
fnp-2613	54	26	motor	motor	NOUN
fnp-2613	54	27	nucleus	nucleus	PROPN
fnp-2613	54	28	of	of	ADP
fnp-2613	54	29	vagus	vagus	NOUN
fnp-2613	54	30	,	,	PUNCT
fnp-2613	54	31	locus	locus	NOUN
fnp-2613	54	32	coeruleus	coeruleus	NOUN
fnp-2613	54	33	,	,	PUNCT
fnp-2613	54	34	raphe	raphe	NOUN
fnp-2613	54	35	,	,	PUNCT
fnp-2613	54	36	substantia	substantia	NOUN
fnp-2613	54	37	nigra	nigra	NOUN
fnp-2613	54	38	,	,	PUNCT
fnp-2613	54	39	ca2	ca2	PROPN
fnp-2613	54	40	region	region	NOUN
fnp-2613	54	41	of	of	ADP
fnp-2613	54	42	hippocampus	hippocampus	PROPN
fnp-2613	54	43	,	,	PUNCT
fnp-2613	54	44	nucleus	nucleus	ADJ
fnp-2613	54	45	basalis	basali	NOUN
fnp-2613	54	46	of	of	ADP
fnp-2613	54	47	meynert	meynert	PROPN
fnp-2613	54	48	,	,	PUNCT
fnp-2613	54	49	transentorhinal-	transentorhinal-	INTJ
fnp-2613	54	50	,	,	PUNCT
fnp-2613	54	51	cingulateand	cingulateand	NOUN
fnp-2613	54	52	insular	insular	ADJ
fnp-2613	54	53	gyri	gyri	PROPN
fnp-2613	54	54	,	,	PUNCT
fnp-2613	54	55	temporo	temporo	X
fnp-2613	54	56	-	-	PUNCT
fnp-2613	54	57	occipital-	occipital-	NOUN
fnp-2613	54	58	,	,	PUNCT
fnp-2613	54	59	temporal-	temporal-	X
fnp-2613	54	60	,	,	PUNCT
fnp-2613	54	61	frontaland	frontaland	ADJ
fnp-2613	54	62	parietal	parietal	ADJ
fnp-2613	54	63	lobes	lobe	NOUN
fnp-2613	54	64	)	)	PUNCT
fnp-2613	54	65	.	.	PUNCT
fnp-2613	55	1	considering	consider	VERB
fnp-2613	55	2	that	that	SCONJ
fnp-2613	55	3	neither	neither	CCONJ
fnp-2613	55	4	mckeith	mckeith	NOUN
fnp-2613	55	5	nor	nor	CCONJ
fnp-2613	55	6	braak	braak	PROPN
fnp-2613	55	7	protocol	protocol	NOUN
fnp-2613	55	8	could	could	AUX
fnp-2613	55	9	reach	reach	VERB
fnp-2613	55	10	more	more	ADJ
fnp-2613	55	11	than	than	ADP
fnp-2613	55	12	80	80	NUM
fnp-2613	55	13	%	%	NOUN
fnp-2613	55	14	inter	inter	ADJ
fnp-2613	55	15	-	-	ADJ
fnp-2613	55	16	observer	observer	ADJ
fnp-2613	55	17	agreement	agreement	NOUN
fnp-2613	55	18	;	;	PUNCT
fnp-2613	55	19	the	the	DET
fnp-2613	55	20	original	original	ADJ
fnp-2613	55	21	methods	method	NOUN
fnp-2613	55	22	have	have	AUX
fnp-2613	55	23	been	be	AUX
fnp-2613	55	24	modified	modify	VERB
fnp-2613	55	25	by	by	ADP
fnp-2613	55	26	leverenz	leverenz	PROPN
fnp-2613	55	27	et	et	PROPN
fnp-2613	55	28	al.22	al.22	PROPN
fnp-2613	55	29	and	and	CCONJ
fnp-2613	55	30	müller	müller	PROPN
fnp-2613	55	31	et	et	PROPN
fnp-2613	55	32	al.23	al.23	PROPN
fnp-2613	55	33	,	,	PUNCT
fnp-2613	55	34	respectively	respectively	ADV
fnp-2613	55	35	.	.	PUNCT
fnp-2613	56	1	however	however	ADV
fnp-2613	56	2	,	,	PUNCT
fnp-2613	56	3	their	their	PRON
fnp-2613	56	4	results	result	NOUN
fnp-2613	56	5	did	do	AUX
fnp-2613	56	6	not	not	PART
fnp-2613	56	7	lead	lead	VERB
fnp-2613	56	8	to	to	ADP
fnp-2613	56	9	a	a	DET
fnp-2613	56	10	significant	significant	ADJ
fnp-2613	56	11	improvement	improvement	NOUN
fnp-2613	56	12	in	in	ADP
fnp-2613	56	13	the	the	DET
fnp-2613	56	14	scoring	scoring	NOUN
fnp-2613	56	15	systems	system	NOUN
fnp-2613	56	16	.	.	PUNCT
fnp-2613	57	1	thus	thus	ADV
fnp-2613	57	2	,	,	PUNCT
fnp-2613	57	3	in	in	ADP
fnp-2613	57	4	2009	2009	NUM
fnp-2613	57	5	the	the	DET
fnp-2613	57	6	brainnet	brainnet	PROPN
fnp-2613	57	7	europe	europe	PROPN
fnp-2613	57	8	consortium	consortium	PROPN
fnp-2613	57	9	(	(	PUNCT
fnp-2613	57	10	bne	bne	PROPN
fnp-2613	57	11	)	)	PUNCT
fnp-2613	57	12	revised	revise	VERB
fnp-2613	57	13	their	their	PRON
fnp-2613	57	14	former	former	ADJ
fnp-2613	57	15	assignments	assignment	NOUN
fnp-2613	57	16	and	and	CCONJ
fnp-2613	57	17	suggested	suggest	VERB
fnp-2613	57	18	modifications	modification	NOUN
fnp-2613	57	19	,	,	PUNCT
fnp-2613	57	20	to	to	PART
fnp-2613	57	21	reach	reach	VERB
fnp-2613	57	22	a	a	DET
fnp-2613	57	23	better	well	ADJ
fnp-2613	57	24	inter	inter	ADJ
fnp-2613	57	25	-	-	ADJ
fnp-2613	57	26	observer	observer	ADJ
fnp-2613	57	27	agreement	agreement	NOUN
fnp-2613	57	28	.	.	PUNCT
fnp-2613	58	1	using	use	VERB
fnp-2613	58	2	the	the	DET
fnp-2613	58	3	original	original	ADJ
fnp-2613	58	4	mckeith	mckeith	NOUN
fnp-2613	58	5	and	and	CCONJ
fnp-2613	58	6	braak	braak	PROPN
fnp-2613	58	7	staging	staging	NOUN
fnp-2613	58	8	,	,	PUNCT
fnp-2613	58	9	but	but	CCONJ
fnp-2613	58	10	eliminating	eliminate	VERB
fnp-2613	58	11	their	their	PRON
fnp-2613	58	12	major	major	ADJ
fnp-2613	58	13	pitfalls	pitfall	NOUN
fnp-2613	58	14	and	and	CCONJ
fnp-2613	58	15	obstacles	obstacle	NOUN
fnp-2613	58	16	as	as	ADV
fnp-2613	58	17	well	well	ADV
fnp-2613	58	18	as	as	ADP
fnp-2613	58	19	introducing	introduce	VERB
fnp-2613	58	20	the	the	DET
fnp-2613	58	21	amygdala	amygdala	NOUN
fnp-2613	58	22	predominant	predominant	ADJ
fnp-2613	58	23	category	category	NOUN
fnp-2613	58	24	,	,	PUNCT
fnp-2613	58	25	bne	bne	PROPN
fnp-2613	58	26	’s	’s	PART
fnp-2613	58	27	novel	novel	ADJ
fnp-2613	58	28	strategy	strategy	NOUN
fnp-2613	58	29	resulted	result	VERB
fnp-2613	58	30	in	in	ADP
fnp-2613	58	31	above	above	ADP
fnp-2613	58	32	80	80	NUM
fnp-2613	58	33	%	%	NOUN
fnp-2613	58	34	agreement	agreement	NOUN
fnp-2613	58	35	in	in	ADP
fnp-2613	58	36	both	both	DET
fnp-2613	58	37	typing	type	VERB
fnp-2613	58	38	and	and	CCONJ
fnp-2613	58	39	staging	staging	NOUN
fnp-2613	58	40	of	of	ADP
fnp-2613	58	41	α	α	NOUN
fnp-2613	58	42	-	-	PUNCT
fnp-2613	58	43	synuclein	synuclein	NOUN
fnp-2613	58	44	pathology24	pathology24	NOUN
fnp-2613	58	45	.	.	PUNCT
fnp-2613	59	1	beach	beach	PROPN
fnp-2613	59	2	et	et	PROPN
fnp-2613	59	3	al	al	PROPN
fnp-2613	59	4	.	.	PROPN
fnp-2613	59	5	also	also	ADV
fnp-2613	59	6	published	publish	VERB
fnp-2613	59	7	their	their	PRON
fnp-2613	59	8	unified	unified	ADJ
fnp-2613	59	9	staging	staging	NOUN
fnp-2613	59	10	system	system	NOUN
fnp-2613	59	11	with	with	ADP
fnp-2613	59	12	the	the	DET
fnp-2613	59	13	aim	aim	NOUN
fnp-2613	59	14	of	of	ADP
fnp-2613	59	15	dividing	divide	VERB
fnp-2613	59	16	every	every	DET
fnp-2613	59	17	subject	subject	NOUN
fnp-2613	59	18	with	with	ADP
fnp-2613	59	19	lewy	lewy	ADJ
fnp-2613	59	20	-	-	PUNCT
fnp-2613	59	21	type	type	NOUN
fnp-2613	59	22	α	α	NOUN
fnp-2613	59	23	-	-	PUNCT
fnp-2613	59	24	synuclein	synuclein	NOUN
fnp-2613	59	25	pathology	pathology	NOUN
fnp-2613	59	26	into	into	ADP
fnp-2613	59	27	a	a	DET
fnp-2613	59	28	well	well	ADV
fnp-2613	59	29	-	-	PUNCT
fnp-2613	59	30	defined	define	VERB
fnp-2613	59	31	neuropathological	neuropathological	ADJ
fnp-2613	59	32	group25	group25	NOUN
fnp-2613	59	33	.	.	PUNCT
fnp-2613	60	1	in	in	ADP
fnp-2613	60	2	2009	2009	NUM
fnp-2613	60	3	they	they	PRON
fnp-2613	60	4	used	use	VERB
fnp-2613	60	5	mckeith26	mckeith26	NOUN
fnp-2613	60	6	and	and	CCONJ
fnp-2613	60	7	braak21	braak21	NOUN
fnp-2613	60	8	staging	stage	VERB
fnp-2613	60	9	systems	system	NOUN
fnp-2613	60	10	and	and	CCONJ
fnp-2613	60	11	failed	fail	VERB
fnp-2613	60	12	to	to	PART
fnp-2613	60	13	categorize	categorize	VERB
fnp-2613	60	14	individuals	individual	NOUN
fnp-2613	60	15	with	with	ADP
fnp-2613	60	16	olfactory	olfactory	ADJ
fnp-2613	60	17	bulb	bulb	NOUN
fnp-2613	60	18	or	or	CCONJ
fnp-2613	60	19	limbic	limbic	ADJ
fnp-2613	60	20	-	-	PUNCT
fnp-2613	60	21	predominant	predominant	NOUN
fnp-2613	60	22	lb	lb	DET
fnp-2613	60	23	pathology	pathology	NOUN
fnp-2613	60	24	.	.	PUNCT
fnp-2613	61	1	investigating	investigate	VERB
fnp-2613	61	2	10	10	NUM
fnp-2613	61	3	standard	standard	ADJ
fnp-2613	61	4	brain	brain	NOUN
fnp-2613	61	5	regions	region	NOUN
fnp-2613	61	6	they	they	PRON
fnp-2613	61	7	could	could	AUX
fnp-2613	61	8	classify	classify	VERB
fnp-2613	61	9	all	all	DET
fnp-2613	61	10	patients	patient	NOUN
fnp-2613	61	11	with	with	ADP
fnp-2613	61	12	pd	pd	PROPN
fnp-2613	61	13	,	,	PUNCT
fnp-2613	61	14	dlb	dlb	PROPN
fnp-2613	61	15	,	,	PUNCT
fnp-2613	61	16	incidental	incidental	ADJ
fnp-2613	61	17	lewy	lewy	PROPN
fnp-2613	61	18	body	body	NOUN
fnp-2613	61	19	disease	disease	NOUN
fnp-2613	61	20	(	(	PUNCT
fnp-2613	61	21	ilbd	ilbd	PROPN
fnp-2613	61	22	)	)	PUNCT
fnp-2613	61	23	and	and	CCONJ
fnp-2613	61	24	ad	ad	NOUN
fnp-2613	61	25	with	with	ADP
fnp-2613	61	26	concomitant	concomitant	ADJ
fnp-2613	61	27	lb	lb	DET
fnp-2613	61	28	pathology	pathology	NOUN
fnp-2613	61	29	into	into	ADP
fnp-2613	61	30	one	one	NUM
fnp-2613	61	31	of	of	ADP
fnp-2613	61	32	the	the	DET
fnp-2613	61	33	following	following	ADJ
fnp-2613	61	34	stages	stage	NOUN
fnp-2613	61	35	:	:	PUNCT
fnp-2613	61	36	i	i	PRON
fnp-2613	61	37	olfactory	olfactory	NOUN
fnp-2613	61	38	bulb	bulb	VERB
fnp-2613	61	39	only	only	ADV
fnp-2613	61	40	;	;	PUNCT
fnp-2613	61	41	iia	iia	VERB
fnp-2613	61	42	brainstem	brainstem	NOUN
fnp-2613	61	43	-	-	PUNCT
fnp-2613	61	44	predominant	predominant	ADJ
fnp-2613	61	45	;	;	PUNCT
fnp-2613	61	46	iib	iib	PROPN
fnp-2613	61	47	limbic	limbic	NOUN
fnp-2613	61	48	-	-	PUNCT
fnp-2613	61	49	predominant	predominant	ADJ
fnp-2613	61	50	;	;	PUNCT
fnp-2613	61	51	iii	iii	X
fnp-2613	61	52	brainstem	brainstem	NOUN
fnp-2613	61	53	and	and	CCONJ
fnp-2613	61	54	limbic	limbic	NOUN
fnp-2613	61	55	;	;	PUNCT
fnp-2613	61	56	iv	iv	NUM
fnp-2613	61	57	neocortical	neocortical	NOUN
fnp-2613	61	58	.	.	PUNCT
fnp-2613	62	1	moreover	moreover	ADV
fnp-2613	62	2	,	,	PUNCT
fnp-2613	62	3	they	they	PRON
fnp-2613	62	4	found	find	VERB
fnp-2613	62	5	strong	strong	ADJ
fnp-2613	62	6	correlation	correlation	NOUN
fnp-2613	62	7	between	between	ADP
fnp-2613	62	8	the	the	DET
fnp-2613	62	9	progression	progression	NOUN
fnp-2613	62	10	through	through	ADP
fnp-2613	62	11	these	these	DET
fnp-2613	62	12	stages	stage	NOUN
fnp-2613	62	13	and	and	CCONJ
fnp-2613	62	14	the	the	DET
fnp-2613	62	15	severity	severity	NOUN
fnp-2613	62	16	of	of	ADP
fnp-2613	62	17	nigrostriatal	nigrostriatal	ADJ
fnp-2613	62	18	degeneration	degeneration	NOUN
fnp-2613	62	19	,	,	PUNCT
fnp-2613	62	20	cognitive	cognitive	ADJ
fnp-2613	62	21	impairment	impairment	NOUN
fnp-2613	62	22	and	and	CCONJ
fnp-2613	62	23	motor	motor	NOUN
fnp-2613	62	24	dysfunction	dysfunction	NOUN
fnp-2613	62	25	.	.	PUNCT
fnp-2613	63	1	it	it	PRON
fnp-2613	63	2	should	should	AUX
fnp-2613	63	3	be	be	AUX
fnp-2613	63	4	noted	note	VERB
fnp-2613	63	5	that	that	SCONJ
fnp-2613	63	6	olfactory	olfactory	NOUN
fnp-2613	63	7	bulb	bulb	NOUN
fnp-2613	63	8	only	only	ADV
fnp-2613	63	9	and	and	CCONJ
fnp-2613	63	10	amygdala	amygdala	NOUN
fnp-2613	63	11	-	-	PUNCT
fnp-2613	63	12	predominant	predominant	ADJ
fnp-2613	63	13	subtypes	subtype	NOUN
fnp-2613	63	14	are	be	AUX
fnp-2613	63	15	also	also	ADV
fnp-2613	63	16	included	include	VERB
fnp-2613	63	17	in	in	ADP
fnp-2613	63	18	the	the	DET
fnp-2613	63	19	current	current	ADJ
fnp-2613	63	20	mckeith	mckeith	PROPN
fnp-2613	63	21	criteria20	criteria20	NOUN
fnp-2613	63	22	.	.	PUNCT
fnp-2613	64	1	as	as	SCONJ
fnp-2613	64	2	mentioned	mention	VERB
fnp-2613	64	3	above	above	ADV
fnp-2613	64	4	,	,	PUNCT
fnp-2613	64	5	ad	ad	NOUN
fnp-2613	64	6	pathology	pathology	NOUN
fnp-2613	64	7	is	be	AUX
fnp-2613	64	8	frequently	frequently	ADV
fnp-2613	64	9	encountered	encounter	VERB
fnp-2613	64	10	in	in	ADP
fnp-2613	64	11	dlb	dlb	PROPN
fnp-2613	64	12	.	.	PUNCT
fnp-2613	65	1	approximately	approximately	ADV
fnp-2613	65	2	80	80	NUM
fnp-2613	65	3	%	%	NOUN
fnp-2613	65	4	of	of	ADP
fnp-2613	65	5	patients	patient	NOUN
fnp-2613	65	6	have	have	VERB
fnp-2613	65	7	diffuse	diffuse	ADJ
fnp-2613	65	8	amyloid	amyloid	NOUN
fnp-2613	65	9	-	-	PUNCT
fnp-2613	65	10	beta	beta	NOUN
fnp-2613	65	11	(	(	PUNCT
fnp-2613	65	12	aβ	aβ	NOUN
fnp-2613	65	13	)	)	PUNCT
fnp-2613	65	14	plaques	plaque	NOUN
fnp-2613	65	15	and	and	CCONJ
fnp-2613	65	16	60	60	NUM
fnp-2613	65	17	%	%	NOUN
fnp-2613	65	18	have	have	VERB
fnp-2613	65	19	neurofibrillary	neurofibrillary	ADJ
fnp-2613	65	20	tangles	tangle	NOUN
fnp-2613	65	21	with	with	ADP
fnp-2613	65	22	varying	vary	VERB
fnp-2613	65	23	severity	severity	NOUN
fnp-2613	65	24	in	in	ADP
fnp-2613	65	25	the	the	DET
fnp-2613	65	26	entorhinal	entorhinal	ADJ
fnp-2613	65	27	cortex	cortex	NOUN
fnp-2613	65	28	and	and	CCONJ
fnp-2613	65	29	rarely	rarely	ADV
fnp-2613	65	30	in	in	ADP
fnp-2613	65	31	the	the	DET
fnp-2613	65	32	neocortex	neocortex	NOUN
fnp-2613	65	33	.	.	PUNCT
fnp-2613	66	1	some	some	PRON
fnp-2613	66	2	of	of	ADP
fnp-2613	66	3	these	these	DET
fnp-2613	66	4	cases	case	NOUN
fnp-2613	66	5	meet	meet	VERB
fnp-2613	66	6	the	the	DET
fnp-2613	66	7	pathological	pathological	ADJ
fnp-2613	66	8	criteria	criterion	NOUN
fnp-2613	66	9	of	of	ADP
fnp-2613	66	10	ad27	ad27	PROPN
fnp-2613	66	11	.	.	PUNCT
fnp-2613	67	1	in	in	ADP
fnp-2613	67	2	contrast	contrast	NOUN
fnp-2613	67	3	,	,	PUNCT
fnp-2613	67	4	“	"	PUNCT
fnp-2613	67	5	pure	pure	ADJ
fnp-2613	67	6	”	"	PUNCT
fnp-2613	67	7	neuropathological	neuropathological	ADJ
fnp-2613	67	8	form	form	NOUN
fnp-2613	67	9	of	of	ADP
fnp-2613	67	10	dlb	dlb	NOUN
fnp-2613	67	11	is	be	AUX
fnp-2613	67	12	less	less	ADV
fnp-2613	67	13	common	common	ADJ
fnp-2613	67	14	.	.	PUNCT
fnp-2613	68	1	autopsy	autopsy	ADJ
fnp-2613	68	2	series	series	PROPN
fnp-2613	68	3	suggest	suggest	VERB
fnp-2613	68	4	that	that	SCONJ
fnp-2613	68	5	the	the	DET
fnp-2613	68	6	frequency	frequency	NOUN
fnp-2613	68	7	of	of	ADP
fnp-2613	68	8	this	this	DET
fnp-2613	68	9	entity	entity	NOUN
fnp-2613	68	10	is	be	AUX
fnp-2613	68	11	approximately	approximately	ADV
fnp-2613	68	12	25	25	NUM
fnp-2613	68	13	%	%	NOUN
fnp-2613	68	14	of	of	ADP
fnp-2613	68	15	all	all	DET
fnp-2613	68	16	dlb	dlb	PROPN
fnp-2613	68	17	cases28,29	cases28,29	PROPN
fnp-2613	68	18	.	.	PUNCT
fnp-2613	69	1	theoretically	theoretically	ADV
fnp-2613	69	2	,	,	PUNCT
fnp-2613	69	3	the	the	DET
fnp-2613	69	4	likelihood	likelihood	NOUN
fnp-2613	69	5	to	to	PART
fnp-2613	69	6	manifest	manifest	VERB
fnp-2613	69	7	dlb	dlb	PROPN
fnp-2613	69	8	clinical	clinical	ADJ
fnp-2613	69	9	syndrome	syndrome	NOUN
fnp-2613	69	10	is	be	AUX
fnp-2613	69	11	directly	directly	ADV
fnp-2613	69	12	proportional	proportional	ADJ
fnp-2613	69	13	to	to	ADP
fnp-2613	69	14	the	the	DET
fnp-2613	69	15	severity	severity	NOUN
fnp-2613	69	16	of	of	ADP
fnp-2613	69	17	lb	lb	DET
fnp-2613	69	18	pathology	pathology	NOUN
fnp-2613	69	19	and	and	CCONJ
fnp-2613	69	20	inversely	inversely	ADV
fnp-2613	69	21	proportional	proportional	ADJ
fnp-2613	69	22	to	to	ADP
fnp-2613	69	23	the	the	DET
fnp-2613	69	24	severity	severity	NOUN
fnp-2613	69	25	of	of	ADP
fnp-2613	69	26	ad	ad	NOUN
fnp-2613	69	27	pathology	pathology	NOUN
fnp-2613	69	28	.	.	PUNCT
fnp-2613	70	1	the	the	DET
fnp-2613	70	2	mckeith	mckeith	PROPN
fnp-2613	70	3	classification	classification	NOUN
fnp-2613	70	4	integrates	integrate	VERB
fnp-2613	70	5	the	the	DET
fnp-2613	70	6	assessment	assessment	NOUN
fnp-2613	70	7	of	of	ADP
fnp-2613	70	8	concomitant	concomitant	ADJ
fnp-2613	70	9	ad	ad	NOUN
fnp-2613	70	10	pathology	pathology	NOUN
fnp-2613	70	11	by	by	ADP
fnp-2613	70	12	national	national	PROPN
fnp-2613	70	13	institute	institute	PROPN
fnp-2613	70	14	on	on	ADP
fnp-2613	70	15	aging	aging	NOUN
fnp-2613	70	16	and	and	CCONJ
fnp-2613	70	17	alzheimer	alzheimer	PROPN
fnp-2613	70	18	’s	’s	PROPN
fnp-2613	70	19	association	association	PROPN
fnp-2613	70	20	(	(	PUNCT
fnp-2613	70	21	nia	nia	PROPN
fnp-2613	70	22	-	-	PUNCT
fnp-2613	70	23	aa)30	aa)30	NOUN
fnp-2613	70	24	,	,	PUNCT
fnp-2613	70	25	the	the	DET
fnp-2613	70	26	braak	braak	NOUN
fnp-2613	70	27	criteria	criterion	NOUN
fnp-2613	70	28	and	and	CCONJ
fnp-2613	70	29	the	the	DET
fnp-2613	70	30	type	type	NOUN
fnp-2613	70	31	of	of	ADP
fnp-2613	70	32	lb	lb	DET
fnp-2613	70	33	pathology20	pathology20	NOUN
fnp-2613	70	34	.	.	PUNCT
fnp-2613	71	1	table	table	NOUN
fnp-2613	71	2	1	1	NUM
fnp-2613	71	3	shows	show	VERB
fnp-2613	71	4	the	the	DET
fnp-2613	71	5	probability	probability	NOUN
fnp-2613	71	6	of	of	ADP
fnp-2613	71	7	pathological	pathological	ADJ
fnp-2613	71	8	findings	finding	NOUN
fnp-2613	71	9	in	in	ADP
fnp-2613	71	10	relation	relation	NOUN
fnp-2613	71	11	to	to	ADP
fnp-2613	71	12	dlb	dlb	VERB
fnp-2613	71	13	clinical	clinical	ADJ
fnp-2613	71	14	syndrome	syndrome	NOUN
fnp-2613	71	15	.	.	PUNCT
fnp-2613	72	1	it	it	PRON
fnp-2613	72	2	is	be	AUX
fnp-2613	72	3	likely	likely	ADJ
fnp-2613	72	4	that	that	SCONJ
fnp-2613	72	5	not	not	PART
fnp-2613	72	6	only	only	ADV
fnp-2613	72	7	the	the	DET
fnp-2613	72	8	α	α	PROPN
fnp-2613	72	9	-	-	PUNCT
fnp-2613	72	10	synuclein	synuclein	NOUN
fnp-2613	72	11	pathology	pathology	NOUN
fnp-2613	72	12	is	be	AUX
fnp-2613	72	13	responsible	responsible	ADJ
fnp-2613	72	14	for	for	ADP
fnp-2613	72	15	the	the	DET
fnp-2613	72	16	cognitive	cognitive	ADJ
fnp-2613	72	17	decline	decline	NOUN
fnp-2613	72	18	,	,	PUNCT
fnp-2613	72	19	but	but	CCONJ
fnp-2613	72	20	plaques	plaque	NOUN
fnp-2613	72	21	and	and	CCONJ
fnp-2613	72	22	phosphorylated	phosphorylate	VERB
fnp-2613	72	23	tau	tau	PROPN
fnp-2613	72	24	proteins	protein	NOUN
fnp-2613	72	25	also	also	ADV
fnp-2613	72	26	contribute	contribute	VERB
fnp-2613	72	27	to	to	ADP
fnp-2613	72	28	the	the	DET
fnp-2613	72	29	overall	overall	ADJ
fnp-2613	72	30	deficit31	deficit31	NOUN
fnp-2613	72	31	.	.	PUNCT
fnp-2613	73	1	table	table	NOUN
fnp-2613	73	2	1	1	NUM
fnp-2613	73	3	:	:	PUNCT
fnp-2613	73	4	likelihood	likelihood	NOUN
fnp-2613	73	5	of	of	ADP
fnp-2613	73	6	dementia	dementia	NOUN
fnp-2613	73	7	with	with	ADP
fnp-2613	73	8	lewy	lewy	ADJ
fnp-2613	73	9	bodies	body	NOUN
fnp-2613	73	10	(	(	PUNCT
fnp-2613	73	11	dlb	dlb	NOUN
fnp-2613	73	12	)	)	PUNCT
fnp-2613	73	13	clinical	clinical	ADJ
fnp-2613	73	14	syndrome	syndrome	NOUN
fnp-2613	73	15	resulting	result	VERB
fnp-2613	73	16	from	from	ADP
fnp-2613	73	17	the	the	DET
fnp-2613	73	18	assessment	assessment	NOUN
fnp-2613	73	19	of	of	ADP
fnp-2613	73	20	alzheimer's	alzheimer's	NOUN
fnp-2613	73	21	-	-	PUNCT
fnp-2613	73	22	type	type	NOUN
fnp-2613	73	23	and	and	CCONJ
fnp-2613	73	24	lewy	lewy	ADJ
fnp-2613	73	25	body	body	NOUN
fnp-2613	73	26	pathology	pathology	NOUN
fnp-2613	73	27	(	(	PUNCT
fnp-2613	73	28	lb=	lb=	PROPN
fnp-2613	73	29	lewy	lewy	PROPN
fnp-2613	73	30	body	body	NOUN
fnp-2613	73	31	;	;	PUNCT
fnp-2613	73	32	dlb	dlb	NOUN
fnp-2613	73	33	=	=	NOUN
fnp-2613	73	34	dementia	dementia	NOUN
fnp-2613	73	35	with	with	ADP
fnp-2613	73	36	lewy	lewy	PROPN
fnp-2613	73	37	bodies	body	NOUN
fnp-2613	73	38	;	;	PUNCT
fnp-2613	73	39	nia	nia	PROPN
fnp-2613	73	40	-	-	PUNCT
fnp-2613	73	41	aa	aa	NOUN
fnp-2613	73	42	=	=	SYM
fnp-2613	73	43	national	national	PROPN
fnp-2613	73	44	institute	institute	NOUN
fnp-2613	73	45	on	on	ADP
fnp-2613	73	46	aging	age	VERB
fnp-2613	73	47	–	–	PUNCT
fnp-2613	73	48	alzheimer	alzheimer	PROPN
fnp-2613	73	49	’s	’s	PART
fnp-2613	73	50	association	association	NOUN
fnp-2613	73	51	)	)	PUNCT
fnp-2613	74	1	[	[	X
fnp-2613	74	2	modified	modify	VERB
fnp-2613	74	3	from	from	ADP
fnp-2613	74	4	mckeith	mckeith	PROPN
fnp-2613	74	5	et	et	PROPN
fnp-2613	74	6	al.20	al.20	PROPN
fnp-2613	74	7	]	]	PUNCT
fnp-2613	74	8	cognitive	cognitive	ADJ
fnp-2613	74	9	impairment	impairment	NOUN
fnp-2613	74	10	is	be	AUX
fnp-2613	74	11	also	also	ADV
fnp-2613	74	12	a	a	DET
fnp-2613	74	13	common	common	ADJ
fnp-2613	74	14	hallmark	hallmark	NOUN
fnp-2613	74	15	of	of	ADP
fnp-2613	74	16	dlb	dlb	NOUN
fnp-2613	74	17	and	and	CCONJ
fnp-2613	74	18	parkinson	parkinson	NOUN
fnp-2613	74	19	’s	’s	PART
fnp-2613	74	20	disease	disease	NOUN
fnp-2613	74	21	dementia	dementia	NOUN
fnp-2613	74	22	(	(	PUNCT
fnp-2613	74	23	pdd	pdd	NOUN
fnp-2613	74	24	)	)	PUNCT
fnp-2613	74	25	.	.	PUNCT
fnp-2613	75	1	these	these	DET
fnp-2613	75	2	two	two	NUM
fnp-2613	75	3	neurocognitive	neurocognitive	ADJ
fnp-2613	75	4	disorders	disorder	NOUN
fnp-2613	75	5	share	share	VERB
fnp-2613	75	6	several	several	ADJ
fnp-2613	75	7	clinical	clinical	ADJ
fnp-2613	75	8	and	and	CCONJ
fnp-2613	75	9	neuropathological	neuropathological	ADJ
fnp-2613	75	10	features	feature	NOUN
fnp-2613	75	11	,	,	PUNCT
fnp-2613	75	12	i.e.	i.e.	X
fnp-2613	75	13	they	they	PRON
fnp-2613	75	14	are	be	AUX
fnp-2613	75	15	both	both	PRON
fnp-2613	75	16	characterized	characterize	VERB
fnp-2613	75	17	by	by	ADP
fnp-2613	75	18	cortical	cortical	ADJ
fnp-2613	75	19	and	and	CCONJ
fnp-2613	75	20	subcortical	subcortical	ADJ
fnp-2613	75	21	α	α	NOUN
fnp-2613	75	22	-	-	PUNCT
fnp-2613	75	23	synuclein	synuclein	NOUN
fnp-2613	75	24	/	/	SYM
fnp-2613	75	25	lb	lb	NOUN
fnp-2613	75	26	,	,	PUNCT
fnp-2613	75	27	β	β	NOUN
fnp-2613	75	28	-	-	NOUN
fnp-2613	75	29	amyloid	amyloid	NOUN
fnp-2613	75	30	and	and	CCONJ
fnp-2613	75	31	tau	tau	PROPN
fnp-2613	75	32	pathologies32	pathologies32	X
fnp-2613	75	33	.	.	PUNCT
fnp-2613	76	1	according	accord	VERB
fnp-2613	76	2	to	to	ADP
fnp-2613	76	3	jellinger	jellinger	PROPN
fnp-2613	76	4	et	et	PROPN
fnp-2613	76	5	al	al	PROPN
fnp-2613	76	6	.	.	PROPN
fnp-2613	76	7	,	,	PUNCT
fnp-2613	76	8	a	a	DET
fnp-2613	76	9	common	common	ADJ
fnp-2613	76	10	pathophysiology	pathophysiology	NOUN
fnp-2613	76	11	in	in	ADP
fnp-2613	76	12	dlb	dlb	NOUN
fnp-2613	76	13	and	and	CCONJ
fnp-2613	76	14	pdd	pdd	NOUN
fnp-2613	76	15	is	be	AUX
fnp-2613	76	16	synaptic	synaptic	ADJ
fnp-2613	76	17	dysfunction	dysfunction	NOUN
fnp-2613	76	18	due	due	ADP
fnp-2613	76	19	to	to	ADP
fnp-2613	76	20	aggregation	aggregation	NOUN
fnp-2613	76	21	of	of	ADP
fnp-2613	76	22	α	α	NOUN
fnp-2613	76	23	-	-	PUNCT
fnp-2613	76	24	synuclein	synuclein	NOUN
fnp-2613	76	25	in	in	ADP
fnp-2613	76	26	the	the	DET
fnp-2613	76	27	presynapses	presynapse	NOUN
fnp-2613	76	28	.	.	PUNCT
fnp-2613	77	1	this	this	DET
fnp-2613	77	2	results	result	VERB
fnp-2613	77	3	in	in	ADP
fnp-2613	77	4	disruption	disruption	NOUN
fnp-2613	77	5	of	of	ADP
fnp-2613	77	6	axonal	axonal	ADJ
fnp-2613	77	7	transport	transport	NOUN
fnp-2613	77	8	and	and	CCONJ
fnp-2613	77	9	neurotransmitter	neurotransmitter	NOUN
fnp-2613	77	10	deprivation	deprivation	NOUN
fnp-2613	77	11	leading	lead	VERB
fnp-2613	77	12	to	to	ADP
fnp-2613	77	13	neurodegeneration32	neurodegeneration32	NOUN
fnp-2613	77	14	.	.	PUNCT
fnp-2613	78	1	interestingly	interestingly	ADV
fnp-2613	78	2	,	,	PUNCT
fnp-2613	78	3	there	there	PRON
fnp-2613	78	4	are	be	VERB
fnp-2613	78	5	some	some	DET
fnp-2613	78	6	morphologic	morphologic	ADJ
fnp-2613	78	7	differences	difference	NOUN
fnp-2613	78	8	as	as	ADV
fnp-2613	78	9	well	well	ADV
fnp-2613	78	10	.	.	PUNCT
fnp-2613	79	1	dlb	dlb	PROPN
fnp-2613	79	2	seems	seem	VERB
fnp-2613	79	3	to	to	PART
fnp-2613	79	4	show	show	VERB
fnp-2613	79	5	higher	high	ADJ
fnp-2613	79	6	load	load	NOUN
fnp-2613	79	7	of	of	ADP
fnp-2613	79	8	β	β	NOUN
fnp-2613	79	9	-	-	NOUN
fnp-2613	79	10	amyloid	amyloid	NOUN
fnp-2613	79	11	and	and	CCONJ
fnp-2613	79	12	tau	tau	PROPN
fnp-2613	79	13	in	in	ADP
fnp-2613	79	14	several	several	ADJ
fnp-2613	79	15	brain	brain	NOUN
fnp-2613	79	16	regions	region	NOUN
fnp-2613	79	17	primarily	primarily	ADV
fnp-2613	79	18	in	in	ADP
fnp-2613	79	19	striatum	striatum	NOUN
fnp-2613	79	20	,	,	PUNCT
fnp-2613	79	21	cortex	cortex	NOUN
fnp-2613	79	22	,	,	PUNCT
fnp-2613	79	23	claustrum	claustrum	NOUN
fnp-2613	79	24	,	,	PUNCT
fnp-2613	79	25	amygdala	amygdala	NOUN
fnp-2613	79	26	and	and	CCONJ
fnp-2613	79	27	putamen	putaman	NOUN
fnp-2613	79	28	compared	compare	VERB
fnp-2613	79	29	to	to	ADP
fnp-2613	79	30	pdd32	pdd32	PROPN
fnp-2613	79	31	.	.	PUNCT
fnp-2613	80	1	jellinger	jellinger	PROPN
fnp-2613	80	2	et	et	PROPN
fnp-2613	80	3	al	al	PROPN
fnp-2613	80	4	.	.	PROPN
fnp-2613	80	5	also	also	ADV
fnp-2613	80	6	describes	describe	VERB
fnp-2613	80	7	that	that	SCONJ
fnp-2613	80	8	α	α	X
fnp-2613	80	9	-	-	PUNCT
fnp-2613	80	10	synuclein	synuclein	NOUN
fnp-2613	80	11	distribution	distribution	NOUN
fnp-2613	80	12	is	be	AUX
fnp-2613	80	13	different	different	ADJ
fnp-2613	80	14	in	in	ADP
fnp-2613	80	15	dlb	dlb	NOUN
fnp-2613	80	16	and	and	CCONJ
fnp-2613	80	17	pdd	pdd	NOUN
fnp-2613	80	18	where	where	SCONJ
fnp-2613	80	19	α	α	NOUN
fnp-2613	80	20	-	-	PUNCT
fnp-2613	80	21	synuclein	synuclein	NOUN
fnp-2613	80	22	load	load	NOUN
fnp-2613	80	23	was	be	AUX
fnp-2613	80	24	highest	high	ADJ
fnp-2613	80	25	in	in	ADP
fnp-2613	80	26	hippocampal	hippocampal	ADJ
fnp-2613	80	27	subarea	subarea	PROPN
fnp-2613	80	28	ca2	ca2	PROPN
fnp-2613	80	29	and	and	CCONJ
fnp-2613	80	30	in	in	ADP
fnp-2613	80	31	amygdala	amygdala	NOUN
fnp-2613	80	32	in	in	ADP
fnp-2613	80	33	dlb	dlb	PROPN
fnp-2613	80	34	,	,	PUNCT
fnp-2613	80	35	whereas	whereas	SCONJ
fnp-2613	80	36	in	in	ADP
fnp-2613	80	37	pd	pd	PROPN
fnp-2613	80	38	it	it	PRON
fnp-2613	80	39	is	be	AUX
fnp-2613	80	40	highest	high	ADJ
fnp-2613	80	41	in	in	ADP
fnp-2613	80	42	the	the	DET
fnp-2613	80	43	cingulate	cingulate	NOUN
fnp-2613	80	44	cortex	cortex	NOUN
fnp-2613	80	45	.	.	PUNCT
fnp-2613	81	1	moreover	moreover	ADV
fnp-2613	81	2	,	,	PUNCT
fnp-2613	81	3	nigral	nigral	ADJ
fnp-2613	81	4	neuronal	neuronal	ADJ
fnp-2613	81	5	loss	loss	NOUN
fnp-2613	81	6	is	be	AUX
fnp-2613	81	7	more	more	ADV
fnp-2613	81	8	marked	mark	VERB
fnp-2613	81	9	in	in	ADP
fnp-2613	81	10	pdd	pdd	NOUN
fnp-2613	81	11	which	which	PRON
fnp-2613	81	12	ultimately	ultimately	ADV
fnp-2613	81	13	results	result	VERB
fnp-2613	81	14	in	in	ADP
fnp-2613	81	15	dopaminergic	dopaminergic	ADJ
fnp-2613	81	16	upregulation32	upregulation32	NOUN
fnp-2613	81	17	.	.	PUNCT
fnp-2613	82	1	a	a	DET
fnp-2613	82	2	simple	simple	ADJ
fnp-2613	82	3	interpretation	interpretation	NOUN
fnp-2613	82	4	of	of	ADP
fnp-2613	82	5	above	above	ADJ
fnp-2613	82	6	findings	finding	NOUN
fnp-2613	82	7	could	could	AUX
fnp-2613	82	8	support	support	VERB
fnp-2613	82	9	the	the	DET
fnp-2613	82	10	current	current	ADJ
fnp-2613	82	11	diagnostic	diagnostic	ADJ
fnp-2613	82	12	criteria	criterion	NOUN
fnp-2613	82	13	where	where	SCONJ
fnp-2613	82	14	dlb	dlb	NOUN
fnp-2613	82	15	is	be	AUX
fnp-2613	82	16	associated	associate	VERB
fnp-2613	82	17	with	with	ADP
fnp-2613	82	18	early	early	ADJ
fnp-2613	82	19	cognitive	cognitive	ADJ
fnp-2613	82	20	impairment	impairment	NOUN
fnp-2613	82	21	including	include	VERB
fnp-2613	82	22	memory	memory	NOUN
fnp-2613	82	23	problems	problem	NOUN
fnp-2613	82	24	,	,	PUNCT
fnp-2613	82	25	which	which	PRON
fnp-2613	82	26	differs	differ	VERB
fnp-2613	82	27	from	from	ADP
fnp-2613	82	28	pdd	pdd	NOUN
fnp-2613	82	29	with	with	ADP
fnp-2613	82	30	mainly	mainly	ADV
fnp-2613	82	31	motor	motor	NOUN
fnp-2613	82	32	impairment	impairment	NOUN
fnp-2613	82	33	in	in	ADP
fnp-2613	82	34	the	the	DET
fnp-2613	82	35	early	early	ADJ
fnp-2613	82	36	phase	phase	NOUN
fnp-2613	82	37	.	.	PUNCT
fnp-2613	83	1	in	in	ADP
fnp-2613	83	2	reality	reality	NOUN
fnp-2613	83	3	,	,	PUNCT
fnp-2613	83	4	it	it	PRON
fnp-2613	83	5	is	be	AUX
fnp-2613	83	6	not	not	PART
fnp-2613	83	7	easy	easy	ADJ
fnp-2613	83	8	to	to	PART
fnp-2613	83	9	define	define	VERB
fnp-2613	83	10	dlb	dlb	NOUN
fnp-2613	83	11	based	base	VERB
fnp-2613	83	12	upon	upon	SCONJ
fnp-2613	83	13	only	only	ADV
fnp-2613	83	14	the	the	DET
fnp-2613	83	15	histological	histological	ADJ
fnp-2613	83	16	findings	finding	NOUN
fnp-2613	83	17	,	,	PUNCT
fnp-2613	83	18	thus	thus	ADV
fnp-2613	83	19	in	in	ADP
fnp-2613	83	20	uncertain	uncertain	ADJ
fnp-2613	83	21	cases	case	NOUN
fnp-2613	83	22	,	,	PUNCT
fnp-2613	83	23	anamnestic	anamnestic	ADJ
fnp-2613	83	24	clinical	clinical	ADJ
fnp-2613	83	25	data	datum	NOUN
fnp-2613	83	26	has	have	VERB
fnp-2613	83	27	invaluable	invaluable	ADJ
fnp-2613	83	28	support	support	NOUN
fnp-2613	83	29	for	for	ADP
fnp-2613	83	30	the	the	DET
fnp-2613	83	31	diagnostics	diagnostic	NOUN
fnp-2613	83	32	.	.	PUNCT
fnp-2613	84	1	it	it	PRON
fnp-2613	84	2	is	be	AUX
fnp-2613	84	3	important	important	ADJ
fnp-2613	84	4	to	to	PART
fnp-2613	84	5	highlight	highlight	VERB
fnp-2613	84	6	that	that	SCONJ
fnp-2613	84	7	the	the	DET
fnp-2613	84	8	listed	list	VERB
fnp-2613	84	9	strategies	strategy	NOUN
fnp-2613	84	10	are	be	AUX
fnp-2613	84	11	not	not	PART
fnp-2613	84	12	absolute	absolute	ADJ
fnp-2613	84	13	or	or	CCONJ
fnp-2613	84	14	perfect	perfect	ADJ
fnp-2613	84	15	diagnostic	diagnostic	ADJ
fnp-2613	84	16	criteria	criterion	NOUN
fnp-2613	84	17	,	,	PUNCT
fnp-2613	84	18	but	but	CCONJ
fnp-2613	84	19	rather	rather	ADV
fnp-2613	84	20	useful	useful	ADJ
fnp-2613	84	21	schemes	scheme	NOUN
fnp-2613	84	22	to	to	PART
fnp-2613	84	23	predict	predict	VERB
fnp-2613	84	24	the	the	DET
fnp-2613	84	25	clinical	clinical	ADJ
fnp-2613	84	26	syndrome	syndrome	NOUN
fnp-2613	84	27	of	of	ADP
fnp-2613	84	28	dlb	dlb	NOUN
fnp-2613	84	29	based	base	VERB
fnp-2613	84	30	on	on	ADP
fnp-2613	84	31	the	the	DET
fnp-2613	84	32	observed	observed	ADJ
fnp-2613	84	33	pathological	pathological	ADJ
fnp-2613	84	34	findings	finding	NOUN
fnp-2613	84	35	.	.	PUNCT
fnp-2613	85	1	as	as	SCONJ
fnp-2613	85	2	mentioned	mention	VERB
fnp-2613	85	3	above	above	ADV
fnp-2613	85	4	,	,	PUNCT
fnp-2613	85	5	a	a	DET
fnp-2613	85	6	major	major	ADJ
fnp-2613	85	7	weakness	weakness	NOUN
fnp-2613	85	8	of	of	ADP
fnp-2613	85	9	current	current	ADJ
fnp-2613	85	10	guidelines	guideline	NOUN
fnp-2613	85	11	is	be	AUX
fnp-2613	85	12	the	the	DET
fnp-2613	85	13	low	low	ADJ
fnp-2613	85	14	inter	inter	ADJ
fnp-2613	85	15	-	-	ADJ
fnp-2613	85	16	observer	observer	ADJ
fnp-2613	85	17	agreement	agreement	NOUN
fnp-2613	85	18	;	;	PUNCT
fnp-2613	85	19	therefore	therefore	ADV
fnp-2613	85	20	further	further	ADJ
fnp-2613	85	21	research	research	NOUN
fnp-2613	85	22	is	be	AUX
fnp-2613	85	23	needed	need	VERB
fnp-2613	85	24	to	to	PART
fnp-2613	85	25	assess	assess	VERB
fnp-2613	85	26	the	the	DET
fnp-2613	85	27	accuracy	accuracy	NOUN
fnp-2613	85	28	of	of	ADP
fnp-2613	85	29	the	the	DET
fnp-2613	85	30	current	current	ADJ
fnp-2613	85	31	clinical	clinical	ADJ
fnp-2613	85	32	diagnostic	diagnostic	ADJ
fnp-2613	85	33	criteria	criterion	NOUN
fnp-2613	85	34	versus	versus	ADP
fnp-2613	85	35	neuropathology	neuropathology	NOUN
fnp-2613	85	36	similar	similar	ADJ
fnp-2613	85	37	to	to	ADP
fnp-2613	85	38	studies	study	NOUN
fnp-2613	85	39	assessing	assess	VERB
fnp-2613	85	40	the	the	DET
fnp-2613	85	41	2005	2005	NUM
fnp-2613	85	42	criteria	criterion	NOUN
fnp-2613	85	43	in	in	ADP
fnp-2613	85	44	this	this	DET
fnp-2613	85	45	respect33	respect33	NOUN
fnp-2613	85	46	.	.	PUNCT
fnp-2613	86	1	3	3	X
fnp-2613	86	2	.	.	X
fnp-2613	86	3	synaptic	synaptic	ADJ
fnp-2613	86	4	alterations	alteration	NOUN
fnp-2613	86	5	in	in	ADP
fnp-2613	86	6	connection	connection	NOUN
fnp-2613	86	7	with	with	ADP
fnp-2613	86	8	the	the	DET
fnp-2613	86	9	dopaminergic	dopaminergic	ADJ
fnp-2613	86	10	neuronal	neuronal	ADJ
fnp-2613	86	11	loss	loss	NOUN
fnp-2613	86	12	of	of	ADP
fnp-2613	86	13	substantia	substantia	NOUN
fnp-2613	86	14	nigra	nigra	NOUN
fnp-2613	86	15	,	,	PUNCT
fnp-2613	86	16	dopamine	dopamine	NOUN
fnp-2613	86	17	transporter	transporter	NOUN
fnp-2613	86	18	level	level	NOUN
fnp-2613	86	19	is	be	AUX
fnp-2613	86	20	decreased	decrease	VERB
fnp-2613	86	21	in	in	ADP
fnp-2613	86	22	the	the	DET
fnp-2613	86	23	striatum	striatum	NOUN
fnp-2613	86	24	in	in	ADP
fnp-2613	86	25	dlb	dlb	PROPN
fnp-2613	86	26	,	,	PUNCT
fnp-2613	86	27	although	although	SCONJ
fnp-2613	86	28	not	not	PART
fnp-2613	86	29	to	to	ADP
fnp-2613	86	30	the	the	DET
fnp-2613	86	31	same	same	ADJ
fnp-2613	86	32	extent	extent	NOUN
fnp-2613	86	33	observed	observe	VERB
fnp-2613	86	34	in	in	ADP
fnp-2613	86	35	pd34	pd34	PROPN
fnp-2613	86	36	.	.	PUNCT
fnp-2613	87	1	the	the	DET
fnp-2613	87	2	choline	choline	NOUN
fnp-2613	87	3	-	-	PUNCT
fnp-2613	87	4	acetyltransferase	acetyltransferase	NOUN
fnp-2613	87	5	(	(	PUNCT
fnp-2613	87	6	chat	chat	NOUN
fnp-2613	87	7	)	)	PUNCT
fnp-2613	87	8	levels	level	NOUN
fnp-2613	87	9	are	be	AUX
fnp-2613	87	10	lower	low	ADJ
fnp-2613	87	11	than	than	ADP
fnp-2613	87	12	in	in	ADP
fnp-2613	87	13	patients	patient	NOUN
fnp-2613	87	14	with	with	ADP
fnp-2613	87	15	ad	ad	NOUN
fnp-2613	87	16	,	,	PUNCT
fnp-2613	87	17	who	who	PRON
fnp-2613	87	18	suffer	suffer	VERB
fnp-2613	87	19	from	from	ADP
fnp-2613	87	20	similarly	similarly	ADV
fnp-2613	87	21	severe	severe	ADJ
fnp-2613	87	22	dementia35,36	dementia35,36	NOUN
fnp-2613	87	23	.	.	PUNCT
fnp-2613	88	1	interestingly	interestingly	ADV
fnp-2613	88	2	,	,	PUNCT
fnp-2613	88	3	dynamin-1	dynamin-1	PROPN
fnp-2613	88	4	,	,	PUNCT
fnp-2613	88	5	which	which	PRON
fnp-2613	88	6	takes	take	VERB
fnp-2613	88	7	part	part	NOUN
fnp-2613	88	8	in	in	ADP
fnp-2613	88	9	the	the	DET
fnp-2613	88	10	regulation	regulation	NOUN
fnp-2613	88	11	of	of	ADP
fnp-2613	88	12	synaptic	synaptic	ADJ
fnp-2613	88	13	transmission	transmission	NOUN
fnp-2613	88	14	,	,	PUNCT
fnp-2613	88	15	shows	show	VERB
fnp-2613	88	16	significantly	significantly	ADV
fnp-2613	88	17	decreased	decrease	VERB
fnp-2613	88	18	levels	level	NOUN
fnp-2613	88	19	in	in	ADP
fnp-2613	88	20	the	the	DET
fnp-2613	88	21	prefrontal	prefrontal	ADJ
fnp-2613	88	22	cortex	cortex	NOUN
fnp-2613	88	23	in	in	ADP
fnp-2613	88	24	parallel	parallel	NOUN
fnp-2613	88	25	with	with	ADP
fnp-2613	88	26	the	the	DET
fnp-2613	88	27	severity	severity	NOUN
fnp-2613	88	28	of	of	ADP
fnp-2613	88	29	cognitive	cognitive	ADJ
fnp-2613	88	30	decline37	decline37	NOUN
fnp-2613	88	31	.	.	PUNCT
fnp-2613	89	1	in	in	ADP
fnp-2613	89	2	addition	addition	NOUN
fnp-2613	89	3	,	,	PUNCT
fnp-2613	89	4	the	the	DET
fnp-2613	89	5	amount	amount	NOUN
fnp-2613	89	6	of	of	ADP
fnp-2613	89	7	zinc	zinc	NOUN
fnp-2613	89	8	transporter	transporter	NOUN
fnp-2613	89	9	3	3	NUM
fnp-2613	89	10	(	(	PUNCT
fnp-2613	89	11	znt3	znt3	NOUN
fnp-2613	89	12	)	)	PUNCT
fnp-2613	89	13	and	and	CCONJ
fnp-2613	89	14	postsynaptic	postsynaptic	ADJ
fnp-2613	89	15	density	density	NOUN
fnp-2613	89	16	protein	protein	NOUN
fnp-2613	89	17	95	95	NUM
fnp-2613	89	18	(	(	PUNCT
fnp-2613	89	19	psd95	psd95	NOUN
fnp-2613	89	20	)	)	PUNCT
fnp-2613	89	21	,	,	PUNCT
fnp-2613	89	22	are	be	AUX
fnp-2613	89	23	significantly	significantly	ADV
fnp-2613	89	24	reduced	reduce	VERB
fnp-2613	89	25	in	in	ADP
fnp-2613	89	26	dlb	dlb	NOUN
fnp-2613	89	27	compared	compare	VERB
fnp-2613	89	28	to	to	ADP
fnp-2613	89	29	aged	aged	ADJ
fnp-2613	89	30	-	-	PUNCT
fnp-2613	89	31	controls	control	NOUN
fnp-2613	89	32	and	and	CCONJ
fnp-2613	89	33	patients	patient	NOUN
fnp-2613	89	34	with	with	ADP
fnp-2613	89	35	ad38,39	ad38,39	NOUN
fnp-2613	89	36	.	.	PUNCT
fnp-2613	90	1	it	it	PRON
fnp-2613	90	2	should	should	AUX
fnp-2613	90	3	be	be	AUX
fnp-2613	90	4	noted	note	VERB
fnp-2613	90	5	that	that	SCONJ
fnp-2613	90	6	at	at	ADP
fnp-2613	90	7	the	the	DET
fnp-2613	90	8	beginning	beginning	NOUN
fnp-2613	90	9	of	of	ADP
fnp-2613	90	10	the	the	DET
fnp-2613	90	11	disease	disease	NOUN
fnp-2613	90	12	,	,	PUNCT
fnp-2613	90	13	an	an	DET
fnp-2613	90	14	upregulation	upregulation	NOUN
fnp-2613	90	15	of	of	ADP
fnp-2613	90	16	soluble	soluble	ADJ
fnp-2613	90	17	nsf	nsf	NOUN
fnp-2613	90	18	attachment	attachment	NOUN
fnp-2613	90	19	protein	protein	NOUN
fnp-2613	90	20	receptors	receptor	NOUN
fnp-2613	90	21	(	(	PUNCT
fnp-2613	90	22	snare	snare	NOUN
fnp-2613	90	23	)	)	PUNCT
fnp-2613	90	24	complex	complex	NOUN
fnp-2613	90	25	is	be	AUX
fnp-2613	90	26	observed	observe	VERB
fnp-2613	90	27	,	,	PUNCT
fnp-2613	90	28	probably	probably	ADV
fnp-2613	90	29	as	as	ADP
fnp-2613	90	30	a	a	DET
fnp-2613	90	31	compensatory	compensatory	ADJ
fnp-2613	90	32	response	response	NOUN
fnp-2613	90	33	to	to	ADP
fnp-2613	90	34	the	the	DET
fnp-2613	90	35	synaptic	synaptic	ADJ
fnp-2613	90	36	loss	loss	NOUN
fnp-2613	90	37	.	.	PUNCT
fnp-2613	91	1	however	however	ADV
fnp-2613	91	2	,	,	PUNCT
fnp-2613	91	3	during	during	ADP
fnp-2613	91	4	the	the	DET
fnp-2613	91	5	progression	progression	NOUN
fnp-2613	91	6	of	of	ADP
fnp-2613	91	7	dlb	dlb	PROPN
fnp-2613	91	8	synaptotagmin	synaptotagmin	NOUN
fnp-2613	91	9	,	,	PUNCT
fnp-2613	91	10	synapsin	synapsin	NOUN
fnp-2613	91	11	and	and	CCONJ
fnp-2613	91	12	synaptophysin	synaptophysin	NOUN
fnp-2613	91	13	,	,	PUNCT
fnp-2613	91	14	proteins	protein	NOUN
fnp-2613	91	15	involved	involve	VERB
fnp-2613	91	16	in	in	ADP
fnp-2613	91	17	the	the	DET
fnp-2613	91	18	snare	snare	NOUN
fnp-2613	91	19	complex	complex	NOUN
fnp-2613	91	20	steadily	steadily	ADV
fnp-2613	91	21	disintegrate	disintegrate	VERB
fnp-2613	91	22	,	,	PUNCT
fnp-2613	91	23	contributing	contribute	VERB
fnp-2613	91	24	further	far	ADV
fnp-2613	91	25	to	to	ADP
fnp-2613	91	26	synaptic	synaptic	ADJ
fnp-2613	91	27	dysfunction40,41	dysfunction40,41	NOUN
fnp-2613	91	28	.	.	PUNCT
fnp-2613	92	1	recent	recent	ADJ
fnp-2613	92	2	studies	study	NOUN
fnp-2613	92	3	have	have	AUX
fnp-2613	92	4	revealed	reveal	VERB
fnp-2613	92	5	that	that	SCONJ
fnp-2613	92	6	more	more	ADJ
fnp-2613	92	7	than	than	ADP
fnp-2613	92	8	90	90	NUM
fnp-2613	92	9	%	%	NOUN
fnp-2613	92	10	of	of	ADP
fnp-2613	92	11	α	α	NOUN
fnp-2613	92	12	-	-	PUNCT
fnp-2613	92	13	synuclein	synuclein	NOUN
fnp-2613	92	14	aggregates	aggregate	NOUN
fnp-2613	92	15	are	be	AUX
fnp-2613	92	16	located	locate	VERB
fnp-2613	92	17	at	at	ADP
fnp-2613	92	18	the	the	DET
fnp-2613	92	19	presynapses	presynapse	NOUN
fnp-2613	92	20	leading	lead	VERB
fnp-2613	92	21	to	to	ADP
fnp-2613	92	22	neurotransmitter	neurotransmitter	NOUN
fnp-2613	92	23	deficits42,43	deficits42,43	ADJ
fnp-2613	92	24	.	.	PUNCT
fnp-2613	93	1	these	these	DET
fnp-2613	93	2	findings	finding	NOUN
fnp-2613	93	3	suggest	suggest	VERB
fnp-2613	93	4	that	that	SCONJ
fnp-2613	93	5	degeneration	degeneration	NOUN
fnp-2613	93	6	of	of	ADP
fnp-2613	93	7	postsynaptic	postsynaptic	ADJ
fnp-2613	93	8	neurons	neuron	NOUN
fnp-2613	93	9	may	may	AUX
fnp-2613	93	10	result	result	VERB
fnp-2613	93	11	from	from	ADP
fnp-2613	93	12	the	the	DET
fnp-2613	93	13	loss	loss	NOUN
fnp-2613	93	14	of	of	ADP
fnp-2613	93	15	their	their	PRON
fnp-2613	93	16	inputs	input	NOUN
fnp-2613	93	17	.	.	PUNCT
fnp-2613	94	1	this	this	DET
fnp-2613	94	2	theory	theory	NOUN
fnp-2613	94	3	serves	serve	VERB
fnp-2613	94	4	as	as	ADP
fnp-2613	94	5	a	a	DET
fnp-2613	94	6	potential	potential	ADJ
fnp-2613	94	7	explanation	explanation	NOUN
fnp-2613	94	8	for	for	ADP
fnp-2613	94	9	the	the	DET
fnp-2613	94	10	dlb	dlb	NOUN
fnp-2613	94	11	-	-	PUNCT
fnp-2613	94	12	specific	specific	ADJ
fnp-2613	94	13	clinical	clinical	ADJ
fnp-2613	94	14	symptoms	symptom	NOUN
fnp-2613	94	15	as	as	ADV
fnp-2613	94	16	well	well	ADV
fnp-2613	94	17	as	as	ADP
fnp-2613	94	18	raises	raise	VERB
fnp-2613	94	19	the	the	DET
fnp-2613	94	20	possibility	possibility	NOUN
fnp-2613	94	21	of	of	ADP
fnp-2613	94	22	future	future	ADJ
fnp-2613	94	23	curative	curative	ADJ
fnp-2613	94	24	treatments	treatment	NOUN
fnp-2613	94	25	by	by	ADP
fnp-2613	94	26	pharmaceutical	pharmaceutical	ADJ
fnp-2613	94	27	modification	modification	NOUN
fnp-2613	94	28	of	of	ADP
fnp-2613	94	29	neurotransmission	neurotransmission	NOUN
fnp-2613	94	30	.	.	PUNCT
fnp-2613	95	1	4	4	X
fnp-2613	95	2	.	.	X
fnp-2613	95	3	incidental	incidental	ADJ
fnp-2613	95	4	lewy	lewy	ADJ
fnp-2613	95	5	-	-	PUNCT
fnp-2613	95	6	body	body	NOUN
fnp-2613	95	7	disease	disease	NOUN
fnp-2613	95	8	(	(	PUNCT
fnp-2613	95	9	ilbd	ilbd	PROPN
fnp-2613	95	10	)	)	PUNCT
fnp-2613	95	11	in	in	ADP
fnp-2613	95	12	ilbd	ilbd	PROPN
fnp-2613	95	13	,	,	PUNCT
fnp-2613	95	14	patients	patient	NOUN
fnp-2613	95	15	have	have	VERB
fnp-2613	95	16	histologically	histologically	ADV
fnp-2613	95	17	detectable	detectable	ADJ
fnp-2613	95	18	α	α	NOUN
fnp-2613	95	19	-	-	PUNCT
fnp-2613	95	20	synuclein	synuclein	ADJ
fnp-2613	95	21	deposits	deposit	NOUN
fnp-2613	95	22	in	in	ADP
fnp-2613	95	23	their	their	PRON
fnp-2613	95	24	brain	brain	NOUN
fnp-2613	95	25	,	,	PUNCT
fnp-2613	95	26	without	without	ADP
fnp-2613	95	27	presenting	present	VERB
fnp-2613	95	28	any	any	DET
fnp-2613	95	29	clinical	clinical	ADJ
fnp-2613	95	30	symptoms	symptom	NOUN
fnp-2613	95	31	.	.	PUNCT
fnp-2613	96	1	researchers	researcher	NOUN
fnp-2613	96	2	accept	accept	VERB
fnp-2613	96	3	that	that	SCONJ
fnp-2613	96	4	ilbd	ilbd	PROPN
fnp-2613	96	5	,	,	PUNCT
fnp-2613	96	6	which	which	PRON
fnp-2613	96	7	appears	appear	VERB
fnp-2613	96	8	in	in	ADP
fnp-2613	96	9	approximately	approximately	ADV
fnp-2613	96	10	8	8	NUM
fnp-2613	96	11	-	-	SYM
fnp-2613	96	12	17	17	NUM
fnp-2613	96	13	%	%	NOUN
fnp-2613	96	14	of	of	ADP
fnp-2613	96	15	the	the	DET
fnp-2613	96	16	clinically	clinically	ADV
fnp-2613	96	17	normal	normal	ADJ
fnp-2613	96	18	60	60	NUM
fnp-2613	96	19	+	+	NUM
fnp-2613	96	20	years	year	NOUN
fnp-2613	96	21	old	old	ADJ
fnp-2613	96	22	patients	patient	NOUN
fnp-2613	96	23	,	,	PUNCT
fnp-2613	96	24	is	be	AUX
fnp-2613	96	25	the	the	DET
fnp-2613	96	26	early	early	ADJ
fnp-2613	96	27	stage	stage	NOUN
fnp-2613	96	28	of	of	ADP
fnp-2613	96	29	pd	pd	PROPN
fnp-2613	96	30	or	or	CCONJ
fnp-2613	96	31	dlb44,45	dlb44,45	PROPN
fnp-2613	96	32	.	.	PUNCT
fnp-2613	97	1	confirming	confirm	VERB
fnp-2613	97	2	this	this	DET
fnp-2613	97	3	hypothesis	hypothesis	NOUN
fnp-2613	97	4	,	,	PUNCT
fnp-2613	97	5	it	it	PRON
fnp-2613	97	6	is	be	AUX
fnp-2613	97	7	frequently	frequently	ADV
fnp-2613	97	8	observed	observe	VERB
fnp-2613	97	9	in	in	ADP
fnp-2613	97	10	patients	patient	NOUN
fnp-2613	97	11	who	who	PRON
fnp-2613	97	12	represent	represent	VERB
fnp-2613	97	13	the	the	DET
fnp-2613	97	14	prodromes	prodrome	NOUN
fnp-2613	97	15	of	of	ADP
fnp-2613	97	16	pd	pd	PROPN
fnp-2613	97	17	,	,	PUNCT
fnp-2613	97	18	including	include	VERB
fnp-2613	97	19	olfactory	olfactory	ADJ
fnp-2613	97	20	dysfunction	dysfunction	NOUN
fnp-2613	97	21	or	or	CCONJ
fnp-2613	97	22	bowel	bowel	NOUN
fnp-2613	97	23	frequency46,47	frequency46,47	NOUN
fnp-2613	97	24	.	.	PUNCT
fnp-2613	98	1	the	the	DET
fnp-2613	98	2	presence	presence	NOUN
fnp-2613	98	3	of	of	ADP
fnp-2613	98	4	neuronal	neuronal	ADJ
fnp-2613	98	5	loss	loss	NOUN
fnp-2613	98	6	is	be	AUX
fnp-2613	98	7	usually	usually	ADV
fnp-2613	98	8	minimal	minimal	ADJ
fnp-2613	98	9	in	in	ADP
fnp-2613	98	10	these	these	DET
fnp-2613	98	11	cases	case	NOUN
fnp-2613	98	12	contrary	contrary	ADJ
fnp-2613	98	13	to	to	ADP
fnp-2613	98	14	pd	pd	PROPN
fnp-2613	98	15	or	or	CCONJ
fnp-2613	98	16	dlb48	dlb48	PROPN
fnp-2613	98	17	.	.	PUNCT
fnp-2613	99	1	distribution	distribution	NOUN
fnp-2613	99	2	of	of	ADP
fnp-2613	99	3	α	α	NOUN
fnp-2613	99	4	-	-	PUNCT
fnp-2613	99	5	synuclein	synuclein	NOUN
fnp-2613	99	6	pathology	pathology	NOUN
fnp-2613	99	7	in	in	ADP
fnp-2613	99	8	ilbd	ilbd	PROPN
fnp-2613	99	9	is	be	AUX
fnp-2613	99	10	particularly	particularly	ADV
fnp-2613	99	11	predictive	predictive	ADJ
fnp-2613	99	12	,	,	PUNCT
fnp-2613	99	13	i.e.	i.e.	X
fnp-2613	99	14	the	the	DET
fnp-2613	99	15	brainstem	brainstem	NOUN
fnp-2613	99	16	predominant	predominant	ADJ
fnp-2613	99	17	subtype	subtype	NOUN
fnp-2613	99	18	frequently	frequently	ADV
fnp-2613	99	19	results	result	VERB
fnp-2613	99	20	in	in	ADP
fnp-2613	99	21	pd	pd	PROPN
fnp-2613	99	22	,	,	PUNCT
fnp-2613	99	23	while	while	SCONJ
fnp-2613	99	24	the	the	DET
fnp-2613	99	25	cortical	cortical	ADJ
fnp-2613	99	26	predominant	predominant	ADJ
fnp-2613	99	27	subtype	subtype	NOUN
fnp-2613	99	28	often	often	ADV
fnp-2613	99	29	leads	lead	VERB
fnp-2613	99	30	to	to	ADP
fnp-2613	99	31	dlb44	dlb44	NOUN
fnp-2613	99	32	.	.	PUNCT
fnp-2613	100	1	clinical	clinical	ADJ
fnp-2613	100	2	symptoms	symptom	NOUN
fnp-2613	100	3	the	the	DET
fnp-2613	100	4	new	new	ADJ
fnp-2613	100	5	diagnostic	diagnostic	ADJ
fnp-2613	100	6	statistical	statistical	ADJ
fnp-2613	100	7	manual	manual	NOUN
fnp-2613	100	8	(	(	PUNCT
fnp-2613	100	9	dsm-5	dsm-5	NOUN
fnp-2613	100	10	)	)	PUNCT
fnp-2613	100	11	(	(	PUNCT
fnp-2613	100	12	published	publish	VERB
fnp-2613	100	13	in	in	ADP
fnp-2613	100	14	2013	2013	NUM
fnp-2613	100	15	)	)	PUNCT
fnp-2613	100	16	created	create	VERB
fnp-2613	100	17	a	a	DET
fnp-2613	100	18	new	new	ADJ
fnp-2613	100	19	neurocognitive	neurocognitive	ADJ
fnp-2613	100	20	disorder	disorder	NOUN
fnp-2613	100	21	(	(	PUNCT
fnp-2613	100	22	ncd	ncd	PROPN
fnp-2613	100	23	)	)	PUNCT
fnp-2613	100	24	group	group	NOUN
fnp-2613	100	25	,	,	PUNCT
fnp-2613	100	26	replacing	replace	VERB
fnp-2613	100	27	the	the	DET
fnp-2613	100	28	former	former	ADJ
fnp-2613	100	29	‘	'	PUNCT
fnp-2613	100	30	dementia	dementia	NOUN
fnp-2613	100	31	,	,	PUNCT
fnp-2613	100	32	delirium	delirium	NOUN
fnp-2613	100	33	,	,	PUNCT
fnp-2613	100	34	amnestic	amnestic	ADJ
fnp-2613	100	35	and	and	CCONJ
fnp-2613	100	36	other	other	ADJ
fnp-2613	100	37	cognitive	cognitive	ADJ
fnp-2613	100	38	disorders	disorder	NOUN
fnp-2613	100	39	’	'	PUNCT
fnp-2613	100	40	category	category	NOUN
fnp-2613	100	41	,	,	PUNCT
fnp-2613	100	42	that	that	PRON
fnp-2613	100	43	were	be	AUX
fnp-2613	100	44	used	use	VERB
fnp-2613	100	45	in	in	ADP
fnp-2613	100	46	the	the	DET
fnp-2613	100	47	previous	previous	ADJ
fnp-2613	100	48	dsm	dsm	PROPN
fnp-2613	100	49	-	-	PUNCT
fnp-2613	100	50	iv	iv	NUM
fnp-2613	100	51	handbook	handbook	NOUN
fnp-2613	100	52	.	.	PUNCT
fnp-2613	101	1	the	the	DET
fnp-2613	101	2	definition	definition	NOUN
fnp-2613	101	3	emphasizes	emphasize	VERB
fnp-2613	101	4	that	that	SCONJ
fnp-2613	101	5	ncd	ncd	PROPN
fnp-2613	101	6	is	be	AUX
fnp-2613	101	7	a	a	DET
fnp-2613	101	8	progressive	progressive	ADJ
fnp-2613	101	9	,	,	PUNCT
fnp-2613	101	10	acquired	acquire	VERB
fnp-2613	101	11	decline	decline	NOUN
fnp-2613	101	12	;	;	PUNCT
fnp-2613	101	13	which	which	PRON
fnp-2613	101	14	implies	imply	VERB
fnp-2613	101	15	that	that	SCONJ
fnp-2613	101	16	disorders	disorder	NOUN
fnp-2613	101	17	occurring	occur	VERB
fnp-2613	101	18	at	at	ADP
fnp-2613	101	19	birth	birth	NOUN
fnp-2613	101	20	or	or	CCONJ
fnp-2613	101	21	at	at	ADP
fnp-2613	101	22	the	the	DET
fnp-2613	101	23	early	early	ADJ
fnp-2613	101	24	stage	stage	NOUN
fnp-2613	101	25	of	of	ADP
fnp-2613	101	26	cognitive	cognitive	ADJ
fnp-2613	101	27	development	development	NOUN
fnp-2613	101	28	are	be	AUX
fnp-2613	101	29	excluded	exclude	VERB
fnp-2613	101	30	from	from	ADP
fnp-2613	101	31	this	this	DET
fnp-2613	101	32	category	category	NOUN
fnp-2613	101	33	.	.	PUNCT
fnp-2613	102	1	as	as	ADP
fnp-2613	102	2	an	an	DET
fnp-2613	102	3	advantage	advantage	NOUN
fnp-2613	102	4	,	,	PUNCT
fnp-2613	102	5	the	the	DET
fnp-2613	102	6	new	new	ADJ
fnp-2613	102	7	handbook	handbook	NOUN
fnp-2613	102	8	removed	remove	VERB
fnp-2613	102	9	the	the	DET
fnp-2613	102	10	stigmatizing	stigmatize	VERB
fnp-2613	102	11	debilitating	debilitating	ADJ
fnp-2613	102	12	term	term	NOUN
fnp-2613	102	13	,	,	PUNCT
fnp-2613	102	14	dementia	dementia	NOUN
fnp-2613	102	15	.	.	PUNCT
fnp-2613	103	1	within	within	ADP
fnp-2613	103	2	the	the	DET
fnp-2613	103	3	ncd	ncd	NOUN
fnp-2613	103	4	there	there	PRON
fnp-2613	103	5	are	be	VERB
fnp-2613	103	6	two	two	NUM
fnp-2613	103	7	subcategories	subcategorie	NOUN
fnp-2613	103	8	:	:	PUNCT
fnp-2613	103	9	major	major	ADJ
fnp-2613	103	10	and	and	CCONJ
fnp-2613	103	11	mild	mild	ADJ
fnp-2613	103	12	neurocognitive	neurocognitive	ADJ
fnp-2613	103	13	disorders	disorder	NOUN
fnp-2613	103	14	based	base	VERB
fnp-2613	103	15	upon	upon	SCONJ
fnp-2613	103	16	the	the	DET
fnp-2613	103	17	severity	severity	NOUN
fnp-2613	103	18	of	of	ADP
fnp-2613	103	19	decline	decline	NOUN
fnp-2613	103	20	.	.	PUNCT
fnp-2613	104	1	for	for	ADP
fnp-2613	104	2	the	the	DET
fnp-2613	104	3	diagnosis	diagnosis	NOUN
fnp-2613	104	4	,	,	PUNCT
fnp-2613	104	5	six	six	NUM
fnp-2613	104	6	main	main	ADJ
fnp-2613	104	7	fields	field	NOUN
fnp-2613	104	8	are	be	AUX
fnp-2613	104	9	examined	examine	VERB
fnp-2613	104	10	by	by	ADP
fnp-2613	104	11	dsm-5	dsm-5	NOUN
fnp-2613	104	12	:	:	PUNCT
fnp-2613	104	13	complex	complex	ADJ
fnp-2613	104	14	attention	attention	NOUN
fnp-2613	104	15	,	,	PUNCT
fnp-2613	104	16	executive	executive	ADJ
fnp-2613	104	17	function	function	NOUN
fnp-2613	104	18	,	,	PUNCT
fnp-2613	104	19	learning	learning	NOUN
fnp-2613	104	20	and	and	CCONJ
fnp-2613	104	21	memory	memory	NOUN
fnp-2613	104	22	,	,	PUNCT
fnp-2613	104	23	language	language	NOUN
fnp-2613	104	24	,	,	PUNCT
fnp-2613	104	25	perceptual	perceptual	ADJ
fnp-2613	104	26	motor	motor	NOUN
fnp-2613	104	27	or	or	CCONJ
fnp-2613	104	28	social	social	ADJ
fnp-2613	104	29	cognition49	cognition49	NOUN
fnp-2613	104	30	.	.	PUNCT
fnp-2613	105	1	in	in	ADP
fnp-2613	105	2	the	the	DET
fnp-2613	105	3	case	case	NOUN
fnp-2613	105	4	of	of	ADP
fnp-2613	105	5	dlb	dlb	NOUN
fnp-2613	105	6	,	,	PUNCT
fnp-2613	105	7	patients	patient	NOUN
fnp-2613	105	8	show	show	VERB
fnp-2613	105	9	both	both	CCONJ
fnp-2613	105	10	cortical	cortical	ADJ
fnp-2613	105	11	and	and	CCONJ
fnp-2613	105	12	subcortical	subcortical	ADJ
fnp-2613	105	13	progressive	progressive	ADJ
fnp-2613	105	14	dementia	dementia	NOUN
fnp-2613	105	15	symptoms	symptom	NOUN
fnp-2613	105	16	.	.	PUNCT
fnp-2613	106	1	characteristic	characteristic	ADJ
fnp-2613	106	2	features	feature	NOUN
fnp-2613	106	3	comprise	comprise	VERB
fnp-2613	106	4	of	of	ADP
fnp-2613	106	5	attention	attention	NOUN
fnp-2613	106	6	and	and	CCONJ
fnp-2613	106	7	spatial	spatial	ADJ
fnp-2613	106	8	perception	perception	NOUN
fnp-2613	106	9	disorder	disorder	NOUN
fnp-2613	106	10	,	,	PUNCT
fnp-2613	106	11	dysexecutive	dysexecutive	ADJ
fnp-2613	106	12	syndrome	syndrome	NOUN
fnp-2613	106	13	,	,	PUNCT
fnp-2613	106	14	fluctuating	fluctuate	VERB
fnp-2613	106	15	cognitive	cognitive	ADJ
fnp-2613	106	16	performance	performance	NOUN
fnp-2613	106	17	lasting	last	VERB
fnp-2613	106	18	from	from	ADP
fnp-2613	106	19	minutes	minute	NOUN
fnp-2613	106	20	to	to	ADP
fnp-2613	106	21	days	day	NOUN
fnp-2613	106	22	.	.	PUNCT
fnp-2613	107	1	among	among	ADP
fnp-2613	107	2	the	the	DET
fnp-2613	107	3	psychiatric	psychiatric	ADJ
fnp-2613	107	4	alteration	alteration	NOUN
fnp-2613	107	5	the	the	DET
fnp-2613	107	6	most	most	ADV
fnp-2613	107	7	frequent	frequent	ADJ
fnp-2613	107	8	is	be	AUX
fnp-2613	107	9	the	the	DET
fnp-2613	107	10	visual	visual	ADJ
fnp-2613	107	11	hallucination	hallucination	NOUN
fnp-2613	107	12	,	,	PUNCT
fnp-2613	107	13	although	although	SCONJ
fnp-2613	107	14	anxiety	anxiety	NOUN
fnp-2613	107	15	,	,	PUNCT
fnp-2613	107	16	apathy	apathy	NOUN
fnp-2613	107	17	or	or	CCONJ
fnp-2613	107	18	organised	organise	VERB
fnp-2613	107	19	delusions	delusion	NOUN
fnp-2613	107	20	could	could	AUX
fnp-2613	107	21	also	also	ADV
fnp-2613	107	22	be	be	AUX
fnp-2613	107	23	detected50,51	detected50,51	PROPN
fnp-2613	107	24	.	.	PUNCT
fnp-2613	108	1	interestingly	interestingly	ADV
fnp-2613	108	2	,	,	PUNCT
fnp-2613	108	3	advanced	advanced	ADJ
fnp-2613	108	4	cerebral	cerebral	ADJ
fnp-2613	108	5	amyloid	amyloid	NOUN
fnp-2613	108	6	angiopathy	angiopathy	ADJ
fnp-2613	108	7	and	and	CCONJ
fnp-2613	108	8	small	small	ADJ
fnp-2613	108	9	vessel	vessel	NOUN
fnp-2613	108	10	disease	disease	NOUN
fnp-2613	108	11	are	be	AUX
fnp-2613	108	12	associated	associate	VERB
fnp-2613	108	13	with	with	ADP
fnp-2613	108	14	psychosis	psychosis	NOUN
fnp-2613	108	15	in	in	ADP
fnp-2613	108	16	ad	ad	NOUN
fnp-2613	108	17	and	and	CCONJ
fnp-2613	108	18	not	not	PART
fnp-2613	108	19	in	in	ADP
fnp-2613	108	20	dlb52	dlb52	PROPN
fnp-2613	108	21	.	.	PUNCT
fnp-2613	109	1	depression	depression	NOUN
fnp-2613	109	2	is	be	AUX
fnp-2613	109	3	more	more	ADV
fnp-2613	109	4	common	common	ADJ
fnp-2613	109	5	in	in	ADP
fnp-2613	109	6	patients	patient	NOUN
fnp-2613	109	7	with	with	ADP
fnp-2613	109	8	dlb	dlb	NOUN
fnp-2613	109	9	than	than	ADP
fnp-2613	109	10	in	in	ADP
fnp-2613	109	11	patients	patient	NOUN
fnp-2613	109	12	with	with	ADP
fnp-2613	109	13	ad	ad	NOUN
fnp-2613	109	14	.	.	PUNCT
fnp-2613	110	1	it	it	PRON
fnp-2613	110	2	may	may	AUX
fnp-2613	110	3	accompany	accompany	VERB
fnp-2613	110	4	with	with	ADP
fnp-2613	110	5	mild	mild	ADJ
fnp-2613	110	6	dementia	dementia	NOUN
fnp-2613	110	7	,	,	PUNCT
fnp-2613	110	8	although	although	SCONJ
fnp-2613	110	9	more	more	ADV
fnp-2613	110	10	frequent	frequent	ADJ
fnp-2613	110	11	in	in	ADP
fnp-2613	110	12	cases	case	NOUN
fnp-2613	110	13	of	of	ADP
fnp-2613	110	14	advanced	advanced	ADJ
fnp-2613	110	15	dlb53,54	dlb53,54	NOUN
fnp-2613	110	16	.	.	PUNCT
fnp-2613	111	1	the	the	DET
fnp-2613	111	2	vast	vast	ADJ
fnp-2613	111	3	majority	majority	NOUN
fnp-2613	111	4	of	of	ADP
fnp-2613	111	5	the	the	DET
fnp-2613	111	6	patients	patient	NOUN
fnp-2613	111	7	,	,	PUNCT
fnp-2613	111	8	from	from	ADP
fnp-2613	111	9	the	the	DET
fnp-2613	111	10	beginning	beginning	NOUN
fnp-2613	111	11	or	or	CCONJ
fnp-2613	111	12	during	during	ADP
fnp-2613	111	13	the	the	DET
fnp-2613	111	14	progression	progression	NOUN
fnp-2613	111	15	,	,	PUNCT
fnp-2613	111	16	show	show	VERB
fnp-2613	111	17	extrapyramidal	extrapyramidal	ADJ
fnp-2613	111	18	signs	sign	NOUN
fnp-2613	111	19	,	,	PUNCT
fnp-2613	111	20	such	such	ADJ
fnp-2613	111	21	as	as	ADP
fnp-2613	111	22	action	action	NOUN
fnp-2613	111	23	tremor	tremor	NOUN
fnp-2613	111	24	,	,	PUNCT
fnp-2613	111	25	gait	gait	ADJ
fnp-2613	111	26	disturbances	disturbance	NOUN
fnp-2613	111	27	,	,	PUNCT
fnp-2613	111	28	rigidity	rigidity	NOUN
fnp-2613	111	29	or	or	CCONJ
fnp-2613	111	30	changes	change	NOUN
fnp-2613	111	31	in	in	ADP
fnp-2613	111	32	facial	facial	ADJ
fnp-2613	111	33	expressions55	expressions55	NOUN
fnp-2613	111	34	.	.	PUNCT
fnp-2613	112	1	rapid	rapid	ADJ
fnp-2613	112	2	-	-	PUNCT
fnp-2613	112	3	eye	eye	NOUN
fnp-2613	112	4	-	-	PUNCT
fnp-2613	112	5	movement	movement	NOUN
fnp-2613	112	6	(	(	PUNCT
fnp-2613	112	7	rem	rem	NOUN
fnp-2613	112	8	)	)	PUNCT
fnp-2613	112	9	parasomnia	parasomnia	NOUN
fnp-2613	112	10	is	be	AUX
fnp-2613	112	11	frequently	frequently	ADV
fnp-2613	112	12	diagnosed	diagnose	VERB
fnp-2613	112	13	in	in	ADP
fnp-2613	112	14	dlb	dlb	NOUN
fnp-2613	112	15	,	,	PUNCT
fnp-2613	112	16	characterised	characterise	VERB
fnp-2613	112	17	by	by	ADP
fnp-2613	112	18	vivid	vivid	ADJ
fnp-2613	112	19	,	,	PUNCT
fnp-2613	112	20	often	often	ADV
fnp-2613	112	21	frightening	frightening	ADJ
fnp-2613	112	22	dreams	dream	NOUN
fnp-2613	112	23	and	and	CCONJ
fnp-2613	112	24	complex	complex	ADJ
fnp-2613	112	25	purposeful	purposeful	ADJ
fnp-2613	112	26	motor	motor	NOUN
fnp-2613	112	27	activity	activity	NOUN
fnp-2613	112	28	.	.	PUNCT
fnp-2613	113	1	since	since	SCONJ
fnp-2613	113	2	it	it	PRON
fnp-2613	113	3	often	often	ADV
fnp-2613	113	4	appears	appear	VERB
fnp-2613	113	5	in	in	ADP
fnp-2613	113	6	different	different	ADJ
fnp-2613	113	7	neurodegenerative	neurodegenerative	ADJ
fnp-2613	113	8	disorders	disorder	NOUN
fnp-2613	113	9	,	,	PUNCT
fnp-2613	113	10	rem	rem	X
fnp-2613	113	11	parasomnia	parasomnia	NOUN
fnp-2613	113	12	might	might	AUX
fnp-2613	113	13	be	be	AUX
fnp-2613	113	14	an	an	DET
fnp-2613	113	15	early	early	ADJ
fnp-2613	113	16	herald	herald	NOUN
fnp-2613	113	17	of	of	ADP
fnp-2613	113	18	these	these	DET
fnp-2613	113	19	diseases56	diseases56	NOUN
fnp-2613	113	20	.	.	PUNCT
fnp-2613	114	1	in	in	ADP
fnp-2613	114	2	dlb	dlb	PROPN
fnp-2613	114	3	the	the	DET
fnp-2613	114	4	autonomic	autonomic	ADJ
fnp-2613	114	5	nervous	nervous	ADJ
fnp-2613	114	6	system	system	NOUN
fnp-2613	114	7	dysfunction	dysfunction	NOUN
fnp-2613	114	8	is	be	AUX
fnp-2613	114	9	more	more	ADV
fnp-2613	114	10	severe	severe	ADJ
fnp-2613	114	11	than	than	ADP
fnp-2613	114	12	in	in	ADP
fnp-2613	114	13	ad	ad	NOUN
fnp-2613	114	14	.	.	PUNCT
fnp-2613	115	1	patients	patient	NOUN
fnp-2613	115	2	usually	usually	ADV
fnp-2613	115	3	complain	complain	VERB
fnp-2613	115	4	of	of	ADP
fnp-2613	115	5	dizziness	dizziness	NOUN
fnp-2613	115	6	,	,	PUNCT
fnp-2613	115	7	falls	fall	VERB
fnp-2613	115	8	or	or	CCONJ
fnp-2613	115	9	loss	loss	NOUN
fnp-2613	115	10	of	of	ADP
fnp-2613	115	11	consciousness	consciousness	NOUN
fnp-2613	115	12	.	.	PUNCT
fnp-2613	116	1	orthostatic	orthostatic	ADJ
fnp-2613	116	2	hypotension	hypotension	NOUN
fnp-2613	116	3	,	,	PUNCT
fnp-2613	116	4	cardioinhibitory	cardioinhibitory	ADJ
fnp-2613	116	5	carotid	carotid	NOUN
fnp-2613	116	6	sinushypersensitivity	sinushypersensitivity	NOUN
fnp-2613	116	7	and	and	CCONJ
fnp-2613	116	8	urinary	urinary	ADJ
fnp-2613	116	9	incontinency	incontinency	NOUN
fnp-2613	116	10	often	often	ADV
fnp-2613	116	11	accompany	accompany	VERB
fnp-2613	116	12	with	with	ADP
fnp-2613	116	13	dlb57	dlb57	NOUN
fnp-2613	116	14	.	.	PUNCT
fnp-2613	117	1	pathognomonic	pathognomonic	ADJ
fnp-2613	117	2	feature	feature	NOUN
fnp-2613	117	3	is	be	AUX
fnp-2613	117	4	the	the	DET
fnp-2613	117	5	neuroleptic	neuroleptic	ADJ
fnp-2613	117	6	hypersensitivity	hypersensitivity	NOUN
fnp-2613	117	7	,	,	PUNCT
fnp-2613	117	8	triggered	trigger	VERB
fnp-2613	117	9	by	by	ADP
fnp-2613	117	10	even	even	ADV
fnp-2613	117	11	a	a	DET
fnp-2613	117	12	small	small	ADJ
fnp-2613	117	13	dose	dose	NOUN
fnp-2613	117	14	of	of	ADP
fnp-2613	117	15	drug	drug	NOUN
fnp-2613	117	16	,	,	PUNCT
fnp-2613	117	17	leading	lead	VERB
fnp-2613	117	18	to	to	ADP
fnp-2613	117	19	severe	severe	ADJ
fnp-2613	117	20	parkinsonism20	parkinsonism20	NOUN
fnp-2613	117	21	.	.	PUNCT
fnp-2613	118	1	a	a	DET
fnp-2613	118	2	5	5	NUM
fnp-2613	118	3	-	-	PUNCT
fnp-2613	118	4	year	year	NOUN
fnp-2613	118	5	prospective	prospective	ADJ
fnp-2613	118	6	cohort	cohort	NOUN
fnp-2613	118	7	study	study	NOUN
fnp-2613	118	8	published	publish	VERB
fnp-2613	118	9	by	by	ADP
fnp-2613	118	10	rongve	rongve	PROPN
fnp-2613	118	11	et	et	PROPN
fnp-2613	118	12	al	al	PROPN
fnp-2613	118	13	.	.	PROPN
fnp-2613	118	14	has	have	AUX
fnp-2613	118	15	reported	report	VERB
fnp-2613	118	16	that	that	SCONJ
fnp-2613	118	17	the	the	DET
fnp-2613	118	18	progression	progression	NOUN
fnp-2613	118	19	of	of	ADP
fnp-2613	118	20	cognitive	cognitive	ADJ
fnp-2613	118	21	decline	decline	NOUN
fnp-2613	118	22	from	from	ADP
fnp-2613	118	23	mild	mild	ADJ
fnp-2613	118	24	to	to	ADP
fnp-2613	118	25	severe	severe	ADJ
fnp-2613	118	26	stage	stage	NOUN
fnp-2613	118	27	is	be	AUX
fnp-2613	118	28	more	more	ADV
fnp-2613	118	29	rapid	rapid	ADJ
fnp-2613	118	30	in	in	ADP
fnp-2613	118	31	patients	patient	NOUN
fnp-2613	118	32	with	with	ADP
fnp-2613	118	33	dlb	dlb	NOUN
fnp-2613	118	34	than	than	ADP
fnp-2613	118	35	in	in	ADP
fnp-2613	118	36	patients	patient	NOUN
fnp-2613	118	37	with	with	ADP
fnp-2613	118	38	ad58	ad58	PROPN
fnp-2613	118	39	.	.	PUNCT
fnp-2613	119	1	many	many	ADJ
fnp-2613	119	2	clinical	clinical	ADJ
fnp-2613	119	3	symptoms	symptom	NOUN
fnp-2613	119	4	of	of	ADP
fnp-2613	119	5	dlb	dlb	NOUN
fnp-2613	119	6	can	can	AUX
fnp-2613	119	7	not	not	PART
fnp-2613	119	8	be	be	AUX
fnp-2613	119	9	explained	explain	VERB
fnp-2613	119	10	only	only	ADV
fnp-2613	119	11	by	by	ADP
fnp-2613	119	12	the	the	DET
fnp-2613	119	13	intracerebral	intracerebral	ADJ
fnp-2613	119	14	localization	localization	NOUN
fnp-2613	119	15	of	of	ADP
fnp-2613	119	16	lbs	lbs	NOUN
fnp-2613	119	17	and	and	CCONJ
fnp-2613	119	18	lns33	lns33	PROPN
fnp-2613	119	19	.	.	PUNCT
fnp-2613	120	1	neurotransmitter	neurotransmitter	NOUN
fnp-2613	120	2	depletion	depletion	NOUN
fnp-2613	120	3	,	,	PUNCT
fnp-2613	120	4	synaptic	synaptic	ADJ
fnp-2613	120	5	alterations	alteration	NOUN
fnp-2613	120	6	,	,	PUNCT
fnp-2613	120	7	concomitant	concomitant	ADJ
fnp-2613	120	8	ad	ad	NOUN
fnp-2613	120	9	-	-	PUNCT
fnp-2613	120	10	type	type	NOUN
fnp-2613	120	11	pathology	pathology	NOUN
fnp-2613	120	12	and	and	CCONJ
fnp-2613	120	13	metabolic	metabolic	NOUN
fnp-2613	120	14	changes	change	NOUN
fnp-2613	120	15	highly	highly	ADV
fnp-2613	120	16	influence	influence	VERB
fnp-2613	120	17	the	the	DET
fnp-2613	120	18	clinical	clinical	ADJ
fnp-2613	120	19	presentation	presentation	NOUN
fnp-2613	120	20	of	of	ADP
fnp-2613	120	21	dlb	dlb	NOUN
fnp-2613	120	22	,	,	PUNCT
fnp-2613	120	23	and	and	CCONJ
fnp-2613	120	24	correlate	correlate	VERB
fnp-2613	120	25	with	with	ADP
fnp-2613	120	26	the	the	DET
fnp-2613	120	27	severity	severity	NOUN
fnp-2613	120	28	of	of	ADP
fnp-2613	120	29	cognitive	cognitive	ADJ
fnp-2613	120	30	decline6,42,59,60	decline6,42,59,60	NOUN
fnp-2613	120	31	.	.	PUNCT
fnp-2613	121	1	moreover	moreover	ADV
fnp-2613	121	2	,	,	PUNCT
fnp-2613	121	3	a	a	DET
fnp-2613	121	4	recent	recent	ADJ
fnp-2613	121	5	paper	paper	NOUN
fnp-2613	121	6	has	have	AUX
fnp-2613	121	7	reported	report	VERB
fnp-2613	121	8	association	association	NOUN
fnp-2613	121	9	of	of	ADP
fnp-2613	121	10	serum	serum	NOUN
fnp-2613	121	11	potassium	potassium	NOUN
fnp-2613	121	12	levels	level	NOUN
fnp-2613	121	13	with	with	ADP
fnp-2613	121	14	cognitive	cognitive	ADJ
fnp-2613	121	15	decline	decline	NOUN
fnp-2613	121	16	in	in	ADP
fnp-2613	121	17	dlb	dlb	NOUN
fnp-2613	121	18	,	,	PUNCT
fnp-2613	121	19	specifically	specifically	ADV
fnp-2613	121	20	in	in	ADP
fnp-2613	121	21	patients	patient	NOUN
fnp-2613	121	22	not	not	PART
fnp-2613	121	23	using	use	VERB
fnp-2613	121	24	any	any	DET
fnp-2613	121	25	medications	medication	NOUN
fnp-2613	121	26	that	that	PRON
fnp-2613	121	27	affect	affect	VERB
fnp-2613	121	28	serum	serum	NOUN
fnp-2613	121	29	k+	k+	PROPN
fnp-2613	121	30	levels61	levels61	PROPN
fnp-2613	121	31	.	.	PUNCT
fnp-2613	122	1	reduced	reduce	VERB
fnp-2613	122	2	perfusion	perfusion	NOUN
fnp-2613	122	3	and	and	CCONJ
fnp-2613	122	4	dysconnectivity	dysconnectivity	NOUN
fnp-2613	122	5	of	of	ADP
fnp-2613	122	6	the	the	DET
fnp-2613	122	7	occipital	occipital	NOUN
fnp-2613	122	8	lobe	lobe	NOUN
fnp-2613	122	9	may	may	AUX
fnp-2613	122	10	contribute	contribute	VERB
fnp-2613	122	11	to	to	ADP
fnp-2613	122	12	visual	visual	ADJ
fnp-2613	122	13	hallucinations	hallucination	NOUN
fnp-2613	122	14	and	and	CCONJ
fnp-2613	122	15	disturbance	disturbance	NOUN
fnp-2613	122	16	of	of	ADP
fnp-2613	122	17	visuospatial	visuospatial	ADJ
fnp-2613	122	18	orientation62,63	orientation62,63	PROPN
fnp-2613	122	19	.	.	PUNCT
fnp-2613	123	1	rem	rem	VERB
fnp-2613	123	2	sleep	sleep	NOUN
fnp-2613	123	3	behavior	behavior	NOUN
fnp-2613	123	4	disorder	disorder	NOUN
fnp-2613	123	5	rbd	rbd	PROPN
fnp-2613	123	6	associates	associate	NOUN
fnp-2613	123	7	with	with	ADP
fnp-2613	123	8	striatal	striatal	ADJ
fnp-2613	123	9	dopamine	dopamine	NOUN
fnp-2613	123	10	depletion64	depletion64	NOUN
fnp-2613	123	11	.	.	PUNCT
fnp-2613	124	1	vegetative	vegetative	ADJ
fnp-2613	124	2	dysfunctions	dysfunction	NOUN
fnp-2613	124	3	(	(	PUNCT
fnp-2613	124	4	i.e.	i.e.	X
fnp-2613	124	5	orthostatic	orthostatic	ADJ
fnp-2613	124	6	hypotension	hypotension	NOUN
fnp-2613	124	7	)	)	PUNCT
fnp-2613	124	8	may	may	AUX
fnp-2613	124	9	result	result	VERB
fnp-2613	124	10	from	from	ADP
fnp-2613	124	11	the	the	DET
fnp-2613	124	12	deposition	deposition	NOUN
fnp-2613	124	13	of	of	ADP
fnp-2613	124	14	lbs	lbs	NOUN
fnp-2613	124	15	in	in	ADP
fnp-2613	124	16	the	the	DET
fnp-2613	124	17	autonomic	autonomic	ADJ
fnp-2613	124	18	ganglia65	ganglia65	NOUN
fnp-2613	124	19	.	.	PUNCT
fnp-2613	125	1	decreased	decrease	VERB
fnp-2613	125	2	znt3	znt3	PROPN
fnp-2613	125	3	levels	level	NOUN
fnp-2613	125	4	were	be	AUX
fnp-2613	125	5	also	also	ADV
fnp-2613	125	6	identified	identify	VERB
fnp-2613	125	7	in	in	ADP
fnp-2613	125	8	patients	patient	NOUN
fnp-2613	125	9	with	with	ADP
fnp-2613	125	10	depression	depression	NOUN
fnp-2613	125	11	,	,	PUNCT
fnp-2613	125	12	providing	provide	VERB
fnp-2613	125	13	a	a	DET
fnp-2613	125	14	novel	novel	NOUN
fnp-2613	125	15	therapeutic	therapeutic	ADJ
fnp-2613	125	16	target38,66	target38,66	NOUN
fnp-2613	125	17	.	.	PUNCT
fnp-2613	126	1	interestingly	interestingly	ADV
fnp-2613	126	2	,	,	PUNCT
fnp-2613	126	3	several	several	ADJ
fnp-2613	126	4	clinical	clinical	ADJ
fnp-2613	126	5	symptoms	symptom	NOUN
fnp-2613	126	6	of	of	ADP
fnp-2613	126	7	dlb	dlb	NOUN
fnp-2613	126	8	are	be	AUX
fnp-2613	126	9	transient	transient	ADJ
fnp-2613	126	10	in	in	ADP
fnp-2613	126	11	nature	nature	NOUN
fnp-2613	126	12	,	,	PUNCT
fnp-2613	126	13	however	however	ADV
fnp-2613	126	14	lbs	lbs	PROPN
fnp-2613	126	15	and	and	CCONJ
fnp-2613	126	16	lns	lns	PROPN
fnp-2613	126	17	permanently	permanently	ADV
fnp-2613	126	18	occur	occur	VERB
fnp-2613	126	19	in	in	ADP
fnp-2613	126	20	the	the	DET
fnp-2613	126	21	brain	brain	NOUN
fnp-2613	126	22	.	.	PUNCT
fnp-2613	127	1	probably	probably	ADV
fnp-2613	127	2	,	,	PUNCT
fnp-2613	127	3	metabolic	metabolic	NOUN
fnp-2613	127	4	disturbances67	disturbances67	NOUN
fnp-2613	127	5	,	,	PUNCT
fnp-2613	127	6	hormonal	hormonal	ADJ
fnp-2613	127	7	alterations68	alterations68	NOUN
fnp-2613	127	8	,	,	PUNCT
fnp-2613	127	9	circadian	circadian	ADJ
fnp-2613	127	10	rhythm69	rhythm69	NOUN
fnp-2613	127	11	and	and	CCONJ
fnp-2613	127	12	comorbidities	comorbiditie	NOUN
fnp-2613	127	13	such	such	ADJ
fnp-2613	127	14	as	as	ADP
fnp-2613	127	15	high	high	ADJ
fnp-2613	127	16	blood	blood	NOUN
fnp-2613	127	17	pressure70	pressure70	NOUN
fnp-2613	127	18	can	can	AUX
fnp-2613	127	19	affect	affect	VERB
fnp-2613	127	20	the	the	DET
fnp-2613	127	21	clinical	clinical	ADJ
fnp-2613	127	22	appearance	appearance	NOUN
fnp-2613	127	23	of	of	ADP
fnp-2613	127	24	dlb	dlb	PROPN
fnp-2613	127	25	.	.	PUNCT
fnp-2613	128	1	radiologic	radiologic	ADJ
fnp-2613	128	2	feature	feature	NOUN
fnp-2613	128	3	besides	besides	SCONJ
fnp-2613	128	4	the	the	DET
fnp-2613	128	5	clinical	clinical	ADJ
fnp-2613	128	6	symptoms	symptom	NOUN
fnp-2613	128	7	,	,	PUNCT
fnp-2613	128	8	the	the	DET
fnp-2613	128	9	most	most	ADV
fnp-2613	128	10	significant	significant	ADJ
fnp-2613	128	11	diagnostic	diagnostic	ADJ
fnp-2613	128	12	tool	tool	NOUN
fnp-2613	128	13	in	in	ADP
fnp-2613	128	14	the	the	DET
fnp-2613	128	15	identification	identification	NOUN
fnp-2613	128	16	of	of	ADP
fnp-2613	128	17	dlb	dlb	NOUN
fnp-2613	128	18	is	be	AUX
fnp-2613	128	19	the	the	DET
fnp-2613	128	20	rapidly	rapidly	ADV
fnp-2613	128	21	developing	develop	VERB
fnp-2613	128	22	imaging	imaging	NOUN
fnp-2613	128	23	techniques	technique	NOUN
fnp-2613	128	24	.	.	PUNCT
fnp-2613	129	1	the	the	DET
fnp-2613	129	2	numerous	numerous	ADJ
fnp-2613	129	3	reachable	reachable	ADJ
fnp-2613	129	4	modalities	modality	NOUN
fnp-2613	129	5	allow	allow	VERB
fnp-2613	129	6	both	both	DET
fnp-2613	129	7	structural	structural	ADJ
fnp-2613	129	8	and	and	CCONJ
fnp-2613	129	9	functional	functional	ADJ
fnp-2613	129	10	examination	examination	NOUN
fnp-2613	129	11	.	.	PUNCT
fnp-2613	130	1	magnetic	magnetic	ADJ
fnp-2613	130	2	resonance	resonance	NOUN
fnp-2613	130	3	imaging	imaging	NOUN
fnp-2613	130	4	(	(	PUNCT
fnp-2613	130	5	mri	mri	NOUN
fnp-2613	130	6	)	)	PUNCT
fnp-2613	130	7	examination	examination	NOUN
fnp-2613	130	8	regarding	regard	VERB
fnp-2613	130	9	the	the	DET
fnp-2613	130	10	structural	structural	ADJ
fnp-2613	130	11	changes	change	NOUN
fnp-2613	130	12	,	,	PUNCT
fnp-2613	130	13	the	the	DET
fnp-2613	130	14	literature	literature	NOUN
fnp-2613	130	15	is	be	AUX
fnp-2613	130	16	not	not	PART
fnp-2613	130	17	consistent	consistent	ADJ
fnp-2613	130	18	:	:	PUNCT
fnp-2613	130	19	some	some	DET
fnp-2613	130	20	studies	study	NOUN
fnp-2613	130	21	have	have	AUX
fnp-2613	130	22	noted	note	VERB
fnp-2613	130	23	significant	significant	ADJ
fnp-2613	130	24	atrophy	atrophy	NOUN
fnp-2613	130	25	of	of	ADP
fnp-2613	130	26	the	the	DET
fnp-2613	130	27	insular	insular	ADJ
fnp-2613	130	28	,	,	PUNCT
fnp-2613	130	29	frontal	frontal	ADJ
fnp-2613	130	30	,	,	PUNCT
fnp-2613	130	31	inferior	inferior	ADJ
fnp-2613	130	32	parietal	parietal	ADJ
fnp-2613	130	33	,	,	PUNCT
fnp-2613	130	34	temporal	temporal	ADJ
fnp-2613	130	35	or	or	CCONJ
fnp-2613	130	36	occipital	occipital	ADJ
fnp-2613	130	37	cortex71	cortex71	NOUN
fnp-2613	130	38	,	,	PUNCT
fnp-2613	130	39	whereas	whereas	SCONJ
fnp-2613	130	40	others	other	NOUN
fnp-2613	130	41	have	have	AUX
fnp-2613	130	42	found	find	VERB
fnp-2613	130	43	only	only	ADV
fnp-2613	130	44	a	a	DET
fnp-2613	130	45	minimal	minimal	ADJ
fnp-2613	130	46	volumetric	volumetric	NOUN
fnp-2613	130	47	decrease	decrease	NOUN
fnp-2613	130	48	in	in	ADP
fnp-2613	130	49	the	the	DET
fnp-2613	130	50	frontal	frontal	ADJ
fnp-2613	130	51	and	and	CCONJ
fnp-2613	130	52	parietal	parietal	ADJ
fnp-2613	130	53	lobe	lobe	NOUN
fnp-2613	130	54	,	,	PUNCT
fnp-2613	130	55	or	or	CCONJ
fnp-2613	130	56	in	in	ADP
fnp-2613	130	57	the	the	DET
fnp-2613	130	58	territory	territory	NOUN
fnp-2613	130	59	of	of	ADP
fnp-2613	130	60	hypothalamus	hypothalamus	PROPN
fnp-2613	130	61	,	,	PUNCT
fnp-2613	130	62	basal	basal	ADJ
fnp-2613	130	63	forebrain	forebrain	NOUN
fnp-2613	130	64	and	and	CCONJ
fnp-2613	130	65	midbrain72	midbrain72	NOUN
fnp-2613	130	66	.	.	PUNCT
fnp-2613	131	1	however	however	ADV
fnp-2613	131	2	,	,	PUNCT
fnp-2613	131	3	these	these	DET
fnp-2613	131	4	alterations	alteration	NOUN
fnp-2613	131	5	are	be	AUX
fnp-2613	131	6	not	not	PART
fnp-2613	131	7	specific	specific	ADJ
fnp-2613	131	8	to	to	ADP
fnp-2613	131	9	dlb	dlb	VERB
fnp-2613	131	10	and	and	CCONJ
fnp-2613	131	11	might	might	AUX
fnp-2613	131	12	appear	appear	VERB
fnp-2613	131	13	in	in	ADP
fnp-2613	131	14	ad	ad	NOUN
fnp-2613	131	15	.	.	PUNCT
fnp-2613	132	1	although	although	SCONJ
fnp-2613	132	2	differentiation	differentiation	NOUN
fnp-2613	132	3	from	from	ADP
fnp-2613	132	4	ad	ad	NOUN
fnp-2613	132	5	is	be	AUX
fnp-2613	132	6	usually	usually	ADV
fnp-2613	132	7	based	base	VERB
fnp-2613	132	8	on	on	ADP
fnp-2613	132	9	the	the	DET
fnp-2613	132	10	absence	absence	NOUN
fnp-2613	132	11	of	of	ADP
fnp-2613	132	12	medial	medial	ADJ
fnp-2613	132	13	temporal	temporal	ADJ
fnp-2613	132	14	atrophy	atrophy	NOUN
fnp-2613	132	15	,	,	PUNCT
fnp-2613	132	16	its	its	PRON
fnp-2613	132	17	presence	presence	NOUN
fnp-2613	132	18	can	can	AUX
fnp-2613	132	19	not	not	PART
fnp-2613	132	20	rule	rule	VERB
fnp-2613	132	21	out	out	ADP
fnp-2613	132	22	the	the	DET
fnp-2613	132	23	diagnosis	diagnosis	NOUN
fnp-2613	132	24	of	of	ADP
fnp-2613	132	25	dlb73	dlb73	PROPN
fnp-2613	132	26	.	.	PUNCT
fnp-2613	133	1	sabattoli	sabattoli	PROPN
fnp-2613	133	2	et	et	PROPN
fnp-2613	133	3	al	al	PROPN
fnp-2613	133	4	.	.	PROPN
fnp-2613	133	5	have	have	AUX
fnp-2613	133	6	found	find	VERB
fnp-2613	133	7	atrophic	atrophic	ADJ
fnp-2613	133	8	changes	change	NOUN
fnp-2613	133	9	in	in	ADP
fnp-2613	133	10	the	the	DET
fnp-2613	133	11	anterior	anterior	ADJ
fnp-2613	133	12	ca1	ca1	PROPN
fnp-2613	133	13	,	,	PUNCT
fnp-2613	133	14	ca2/3	ca2/3	ADJ
fnp-2613	133	15	hippocampus	hippocampus	NOUN
fnp-2613	133	16	,	,	PUNCT
fnp-2613	133	17	subiculum	subiculum	NOUN
fnp-2613	133	18	and	and	CCONJ
fnp-2613	133	19	presubiculum	presubiculum	NOUN
fnp-2613	133	20	in	in	ADP
fnp-2613	133	21	dlb	dlb	PROPN
fnp-2613	133	22	.	.	PUNCT
fnp-2613	134	1	this	this	DET
fnp-2613	134	2	pattern	pattern	NOUN
fnp-2613	134	3	differs	differ	VERB
fnp-2613	134	4	significantly	significantly	ADV
fnp-2613	134	5	from	from	ADP
fnp-2613	134	6	those	those	PRON
fnp-2613	134	7	in	in	ADP
fnp-2613	134	8	ad74	ad74	PROPN
fnp-2613	134	9	.	.	PUNCT
fnp-2613	135	1	according	accord	VERB
fnp-2613	135	2	to	to	ADP
fnp-2613	135	3	an	an	DET
fnp-2613	135	4	mri	mri	NOUN
fnp-2613	135	5	study	study	NOUN
fnp-2613	135	6	,	,	PUNCT
fnp-2613	135	7	the	the	DET
fnp-2613	135	8	annual	annual	ADJ
fnp-2613	135	9	progression	progression	NOUN
fnp-2613	135	10	rate	rate	NOUN
fnp-2613	135	11	of	of	ADP
fnp-2613	135	12	cortical	cortical	ADJ
fnp-2613	135	13	atrophy	atrophy	NOUN
fnp-2613	135	14	is	be	AUX
fnp-2613	135	15	approximately	approximately	ADV
fnp-2613	135	16	2x	2x	NUM
fnp-2613	135	17	higher	high	ADJ
fnp-2613	135	18	in	in	ADP
fnp-2613	135	19	patients	patient	NOUN
fnp-2613	135	20	with	with	ADP
fnp-2613	135	21	ad72	ad72	PROPN
fnp-2613	135	22	.	.	PUNCT
fnp-2613	136	1	the	the	DET
fnp-2613	136	2	role	role	NOUN
fnp-2613	136	3	of	of	ADP
fnp-2613	136	4	white	white	ADJ
fnp-2613	136	5	matter	matter	NOUN
fnp-2613	136	6	lesions	lesion	NOUN
fnp-2613	136	7	(	(	PUNCT
fnp-2613	136	8	wml	wml	PROPN
fnp-2613	136	9	)	)	PUNCT
fnp-2613	136	10	in	in	ADP
fnp-2613	136	11	dlb	dlb	NOUN
fnp-2613	136	12	,	,	PUNCT
fnp-2613	136	13	including	include	VERB
fnp-2613	136	14	loss	loss	NOUN
fnp-2613	136	15	of	of	ADP
fnp-2613	136	16	myelin	myelin	NOUN
fnp-2613	136	17	,	,	PUNCT
fnp-2613	136	18	axonal	axonal	ADJ
fnp-2613	136	19	damage	damage	NOUN
fnp-2613	136	20	and	and	CCONJ
fnp-2613	136	21	gliosis	gliosis	NOUN
fnp-2613	136	22	is	be	AUX
fnp-2613	136	23	not	not	PART
fnp-2613	136	24	consistent	consistent	ADJ
fnp-2613	136	25	.	.	PUNCT
fnp-2613	137	1	presumably	presumably	ADV
fnp-2613	137	2	,	,	PUNCT
fnp-2613	137	3	wmls	wmls	NOUN
fnp-2613	137	4	are	be	AUX
fnp-2613	137	5	implicated	implicate	VERB
fnp-2613	137	6	in	in	ADP
fnp-2613	137	7	vascular	vascular	ADJ
fnp-2613	137	8	dementia	dementia	NOUN
fnp-2613	137	9	rather	rather	ADV
fnp-2613	137	10	than	than	ADP
fnp-2613	137	11	being	be	AUX
fnp-2613	137	12	specific	specific	ADJ
fnp-2613	137	13	feature	feature	NOUN
fnp-2613	137	14	of	of	ADP
fnp-2613	137	15	neurodegenerative	neurodegenerative	ADJ
fnp-2613	137	16	disorders75	disorders75	NOUN
fnp-2613	137	17	.	.	PUNCT
fnp-2613	138	1	mri	mri	NOUN
fnp-2613	138	2	spectroscopy	spectroscopy	NOUN
fnp-2613	138	3	provides	provide	VERB
fnp-2613	138	4	a	a	DET
fnp-2613	138	5	chance	chance	NOUN
fnp-2613	138	6	to	to	PART
fnp-2613	138	7	indirectly	indirectly	ADV
fnp-2613	138	8	assess	assess	VERB
fnp-2613	138	9	the	the	DET
fnp-2613	138	10	neuronal	neuronal	ADJ
fnp-2613	138	11	and	and	CCONJ
fnp-2613	138	12	glial	glial	ADJ
fnp-2613	138	13	function	function	NOUN
fnp-2613	138	14	by	by	ADP
fnp-2613	138	15	measuring	measure	VERB
fnp-2613	138	16	the	the	DET
fnp-2613	138	17	key	key	ADJ
fnp-2613	138	18	metabolites	metabolite	NOUN
fnp-2613	138	19	.	.	PUNCT
fnp-2613	139	1	n	n	X
fnp-2613	139	2	-	-	PUNCT
fnp-2613	139	3	acetyl	acetyl	NOUN
fnp-2613	139	4	aspartate	aspartate	NOUN
fnp-2613	139	5	(	(	PUNCT
fnp-2613	139	6	naa	naa	NOUN
fnp-2613	139	7	)	)	PUNCT
fnp-2613	139	8	and	and	CCONJ
fnp-2613	139	9	creatinine	creatinine	NOUN
fnp-2613	139	10	(	(	PUNCT
fnp-2613	139	11	cr	cr	NOUN
fnp-2613	139	12	)	)	PUNCT
fnp-2613	139	13	are	be	AUX
fnp-2613	139	14	two	two	NUM
fnp-2613	139	15	widely	widely	ADV
fnp-2613	139	16	used	use	VERB
fnp-2613	139	17	markers	marker	NOUN
fnp-2613	139	18	in	in	ADP
fnp-2613	139	19	the	the	DET
fnp-2613	139	20	characterization	characterization	NOUN
fnp-2613	139	21	of	of	ADP
fnp-2613	139	22	central	central	ADJ
fnp-2613	139	23	nervous	nervous	ADJ
fnp-2613	139	24	system	system	NOUN
fnp-2613	139	25	metabolism	metabolism	NOUN
fnp-2613	139	26	.	.	PUNCT
fnp-2613	140	1	watson	watson	PROPN
fnp-2613	140	2	et	et	PROPN
fnp-2613	140	3	al	al	PROPN
fnp-2613	140	4	.	.	PROPN
fnp-2613	140	5	have	have	AUX
fnp-2613	140	6	found	find	VERB
fnp-2613	140	7	that	that	SCONJ
fnp-2613	140	8	the	the	DET
fnp-2613	140	9	naa	naa	PROPN
fnp-2613	140	10	/	/	SYM
fnp-2613	140	11	cr	cr	PROPN
fnp-2613	140	12	ratio	ratio	NOUN
fnp-2613	140	13	is	be	AUX
fnp-2613	140	14	relatively	relatively	ADV
fnp-2613	140	15	preserved	preserve	VERB
fnp-2613	140	16	in	in	ADP
fnp-2613	140	17	dlb	dlb	NOUN
fnp-2613	140	18	in	in	ADP
fnp-2613	140	19	comparison	comparison	NOUN
fnp-2613	140	20	to	to	ADP
fnp-2613	140	21	in	in	ADP
fnp-2613	140	22	ad76	ad76	PROPN
fnp-2613	140	23	.	.	PUNCT
fnp-2613	141	1	functional	functional	ADJ
fnp-2613	141	2	imaging	imaging	NOUN
fnp-2613	141	3	although	although	SCONJ
fnp-2613	141	4	,	,	PUNCT
fnp-2613	141	5	task	task	NOUN
fnp-2613	141	6	-	-	PUNCT
fnp-2613	141	7	related	relate	VERB
fnp-2613	141	8	functional	functional	ADJ
fnp-2613	141	9	mri	mri	NOUN
fnp-2613	141	10	(	(	PUNCT
fnp-2613	141	11	fmri	fmri	PROPN
fnp-2613	141	12	)	)	PUNCT
fnp-2613	141	13	has	have	AUX
fnp-2613	141	14	been	be	AUX
fnp-2613	141	15	performed	perform	VERB
fnp-2613	141	16	in	in	ADP
fnp-2613	141	17	very	very	ADV
fnp-2613	141	18	few	few	ADJ
fnp-2613	141	19	cases	case	NOUN
fnp-2613	141	20	of	of	ADP
fnp-2613	141	21	dlb	dlb	NOUN
fnp-2613	141	22	,	,	PUNCT
fnp-2613	141	23	a	a	DET
fnp-2613	141	24	paper	paper	NOUN
fnp-2613	141	25	has	have	AUX
fnp-2613	141	26	reported	report	VERB
fnp-2613	141	27	reduced	reduced	ADJ
fnp-2613	141	28	activity	activity	NOUN
fnp-2613	141	29	in	in	ADP
fnp-2613	141	30	response	response	NOUN
fnp-2613	141	31	to	to	ADP
fnp-2613	141	32	movement	movement	NOUN
fnp-2613	141	33	activity	activity	NOUN
fnp-2613	141	34	compared	compare	VERB
fnp-2613	141	35	with	with	ADP
fnp-2613	141	36	aged	aged	ADJ
fnp-2613	141	37	controls	control	NOUN
fnp-2613	141	38	and	and	CCONJ
fnp-2613	141	39	patients	patient	NOUN
fnp-2613	141	40	with	with	ADP
fnp-2613	141	41	ad77	ad77	PROPN
fnp-2613	141	42	.	.	PUNCT
fnp-2613	142	1	alternatively	alternatively	ADV
fnp-2613	142	2	,	,	PUNCT
fnp-2613	142	3	researchers	researcher	NOUN
fnp-2613	142	4	have	have	AUX
fnp-2613	142	5	examined	examine	VERB
fnp-2613	142	6	the	the	DET
fnp-2613	142	7	functional	functional	ADJ
fnp-2613	142	8	activity	activity	NOUN
fnp-2613	142	9	during	during	ADP
fnp-2613	142	10	rest	rest	NOUN
fnp-2613	142	11	.	.	PUNCT
fnp-2613	143	1	the	the	DET
fnp-2613	143	2	resting	rest	VERB
fnp-2613	143	3	-	-	PUNCT
fnp-2613	143	4	state	state	NOUN
fnp-2613	143	5	network	network	NOUN
fnp-2613	143	6	shows	show	VERB
fnp-2613	143	7	increased	increase	VERB
fnp-2613	143	8	activity	activity	NOUN
fnp-2613	143	9	during	during	ADP
fnp-2613	143	10	rest	rest	NOUN
fnp-2613	143	11	and	and	CCONJ
fnp-2613	143	12	decreased	decrease	VERB
fnp-2613	143	13	activity	activity	NOUN
fnp-2613	143	14	during	during	ADP
fnp-2613	143	15	cognitive	cognitive	ADJ
fnp-2613	143	16	tasks	task	NOUN
fnp-2613	143	17	.	.	PUNCT
fnp-2613	144	1	the	the	DET
fnp-2613	144	2	most	most	ADV
fnp-2613	144	3	investigated	investigated	ADJ
fnp-2613	144	4	resting	rest	VERB
fnp-2613	144	5	-	-	PUNCT
fnp-2613	144	6	state	state	NOUN
fnp-2613	144	7	network	network	NOUN
fnp-2613	144	8	to	to	ADP
fnp-2613	144	9	date	date	NOUN
fnp-2613	144	10	is	be	AUX
fnp-2613	144	11	the	the	DET
fnp-2613	144	12	default	default	NOUN
fnp-2613	144	13	mode	mode	NOUN
fnp-2613	144	14	network	network	NOUN
fnp-2613	144	15	(	(	PUNCT
fnp-2613	144	16	dmn	dmn	PROPN
fnp-2613	144	17	)	)	PUNCT
fnp-2613	144	18	,	,	PUNCT
fnp-2613	144	19	including	include	VERB
fnp-2613	144	20	prefrontal	prefrontal	ADJ
fnp-2613	144	21	cortex	cortex	NOUN
fnp-2613	144	22	,	,	PUNCT
fnp-2613	144	23	posterior	posterior	ADJ
fnp-2613	144	24	cingulate	cingulate	NOUN
fnp-2613	144	25	gyrus	gyru	NOUN
fnp-2613	144	26	,	,	PUNCT
fnp-2613	144	27	medial	medial	ADJ
fnp-2613	144	28	temporal	temporal	ADJ
fnp-2613	144	29	lobe	lobe	NOUN
fnp-2613	144	30	and	and	CCONJ
fnp-2613	144	31	precuneus	precuneus	NOUN
fnp-2613	144	32	.	.	PUNCT
fnp-2613	145	1	in	in	ADP
fnp-2613	145	2	these	these	DET
fnp-2613	145	3	areas	area	NOUN
fnp-2613	145	4	the	the	DET
fnp-2613	145	5	task	task	NOUN
fnp-2613	145	6	-	-	PUNCT
fnp-2613	145	7	related	relate	VERB
fnp-2613	145	8	deactivation	deactivation	NOUN
fnp-2613	145	9	during	during	ADP
fnp-2613	145	10	the	the	DET
fnp-2613	145	11	colour	colour	NOUN
fnp-2613	145	12	and	and	CCONJ
fnp-2613	145	13	motion	motion	NOUN
fnp-2613	145	14	tasks	task	NOUN
fnp-2613	145	15	were	be	AUX
fnp-2613	145	16	decreased	decrease	VERB
fnp-2613	145	17	in	in	ADP
fnp-2613	145	18	dlb	dlb	NOUN
fnp-2613	145	19	,	,	PUNCT
fnp-2613	145	20	but	but	CCONJ
fnp-2613	145	21	it	it	PRON
fnp-2613	145	22	was	be	AUX
fnp-2613	145	23	not	not	PART
fnp-2613	145	24	significantly	significantly	ADV
fnp-2613	145	25	different	different	ADJ
fnp-2613	145	26	from	from	ADP
fnp-2613	145	27	ad78	ad78	PROPN
fnp-2613	145	28	.	.	PUNCT
fnp-2613	146	1	a	a	DET
fnp-2613	146	2	technique	technique	NOUN
fnp-2613	146	3	for	for	ADP
fnp-2613	146	4	evaluation	evaluation	NOUN
fnp-2613	146	5	of	of	ADP
fnp-2613	146	6	functional	functional	ADJ
fnp-2613	146	7	resting	rest	VERB
fnp-2613	146	8	state	state	NOUN
fnp-2613	146	9	connectivity	connectivity	NOUN
fnp-2613	146	10	is	be	AUX
fnp-2613	146	11	based	base	VERB
fnp-2613	146	12	on	on	ADP
fnp-2613	146	13	the	the	DET
fnp-2613	146	14	functional	functional	ADJ
fnp-2613	146	15	alterations	alteration	NOUN
fnp-2613	146	16	in	in	ADP
fnp-2613	146	17	blood	blood	NOUN
fnp-2613	146	18	oxygen	oxygen	NOUN
fnp-2613	146	19	level	level	NOUN
fnp-2613	146	20	dependent	dependent	ADJ
fnp-2613	146	21	(	(	PUNCT
fnp-2613	146	22	bold	bold	ADJ
fnp-2613	146	23	)	)	PUNCT
fnp-2613	146	24	activity	activity	NOUN
fnp-2613	146	25	.	.	PUNCT
fnp-2613	147	1	galvin	galvin	PROPN
fnp-2613	147	2	et	et	PROPN
fnp-2613	147	3	al	al	PROPN
fnp-2613	147	4	.	.	PROPN
fnp-2613	147	5	have	have	AUX
fnp-2613	147	6	noted	note	VERB
fnp-2613	147	7	increased	increase	VERB
fnp-2613	147	8	resting	rest	VERB
fnp-2613	147	9	state	state	NOUN
fnp-2613	147	10	connectivity	connectivity	NOUN
fnp-2613	147	11	between	between	ADP
fnp-2613	147	12	precuneus	precuneus	NOUN
fnp-2613	147	13	seeding	seed	VERB
fnp-2613	147	14	regions	region	NOUN
fnp-2613	147	15	,	,	PUNCT
fnp-2613	147	16	inferior	inferior	ADJ
fnp-2613	147	17	parietal	parietal	ADJ
fnp-2613	147	18	cortex	cortex	NOUN
fnp-2613	147	19	and	and	CCONJ
fnp-2613	147	20	putamen	putaman	NOUN
fnp-2613	147	21	,	,	PUNCT
fnp-2613	147	22	with	with	ADP
fnp-2613	147	23	decreased	decrease	VERB
fnp-2613	147	24	connectivity	connectivity	NOUN
fnp-2613	147	25	between	between	ADP
fnp-2613	147	26	medial	medial	ADJ
fnp-2613	147	27	prefrontal	prefrontal	ADJ
fnp-2613	147	28	,	,	PUNCT
fnp-2613	147	29	frontoparietal	frontoparietal	ADJ
fnp-2613	147	30	operculum	operculum	NOUN
fnp-2613	147	31	and	and	CCONJ
fnp-2613	147	32	visual	visual	ADJ
fnp-2613	147	33	cortex79	cortex79	NOUN
fnp-2613	147	34	.	.	PUNCT
fnp-2613	148	1	taking	take	VERB
fnp-2613	148	2	into	into	ADP
fnp-2613	148	3	account	account	NOUN
fnp-2613	148	4	that	that	SCONJ
fnp-2613	148	5	the	the	DET
fnp-2613	148	6	results	result	NOUN
fnp-2613	148	7	in	in	ADP
fnp-2613	148	8	dlb	dlb	PROPN
fnp-2613	148	9	significantly	significantly	ADV
fnp-2613	148	10	differed	differ	VERB
fnp-2613	148	11	from	from	ADP
fnp-2613	148	12	those	those	PRON
fnp-2613	148	13	of	of	ADP
fnp-2613	148	14	in	in	ADP
fnp-2613	148	15	ad	ad	NOUN
fnp-2613	148	16	,	,	PUNCT
fnp-2613	148	17	the	the	DET
fnp-2613	148	18	method	method	NOUN
fnp-2613	148	19	can	can	AUX
fnp-2613	148	20	be	be	AUX
fnp-2613	148	21	considered	consider	VERB
fnp-2613	148	22	in	in	ADP
fnp-2613	148	23	the	the	DET
fnp-2613	148	24	in	in	ADP
fnp-2613	148	25	vivo	vivo	ADJ
fnp-2613	148	26	differential	differential	ADJ
fnp-2613	148	27	diagnosis	diagnosis	NOUN
fnp-2613	148	28	.	.	PUNCT
fnp-2613	149	1	the	the	DET
fnp-2613	149	2	real	real	ADJ
fnp-2613	149	3	value	value	NOUN
fnp-2613	149	4	of	of	ADP
fnp-2613	149	5	perfusion	perfusion	NOUN
fnp-2613	149	6	imaging	imaging	NOUN
fnp-2613	149	7	techniques	technique	NOUN
fnp-2613	149	8	in	in	ADP
fnp-2613	149	9	the	the	DET
fnp-2613	149	10	identification	identification	NOUN
fnp-2613	149	11	of	of	ADP
fnp-2613	149	12	dlb	dlb	NOUN
fnp-2613	149	13	is	be	AUX
fnp-2613	149	14	not	not	PART
fnp-2613	149	15	fully	fully	ADV
fnp-2613	149	16	consistent	consistent	ADJ
fnp-2613	149	17	.	.	PUNCT
fnp-2613	150	1	the	the	DET
fnp-2613	150	2	vast	vast	ADJ
fnp-2613	150	3	majority	majority	NOUN
fnp-2613	150	4	of	of	ADP
fnp-2613	150	5	the	the	DET
fnp-2613	150	6	authors	author	NOUN
fnp-2613	150	7	described	describe	VERB
fnp-2613	150	8	occipital	occipital	NOUN
fnp-2613	150	9	hypoperfusion	hypoperfusion	NOUN
fnp-2613	150	10	as	as	ADP
fnp-2613	150	11	a	a	DET
fnp-2613	150	12	hallmark	hallmark	NOUN
fnp-2613	150	13	of	of	ADP
fnp-2613	150	14	the	the	DET
fnp-2613	150	15	disease	disease	NOUN
fnp-2613	150	16	on	on	ADP
fnp-2613	150	17	single	single	ADJ
fnp-2613	150	18	-	-	PUNCT
fnp-2613	150	19	photon	photon	NOUN
fnp-2613	150	20	emission	emission	NOUN
fnp-2613	150	21	computed	compute	VERB
fnp-2613	150	22	tomography	tomography	NOUN
fnp-2613	150	23	(	(	PUNCT
fnp-2613	150	24	spect	spect	NOUN
fnp-2613	150	25	)	)	PUNCT
fnp-2613	150	26	images	image	NOUN
fnp-2613	150	27	,	,	PUNCT
fnp-2613	150	28	whereas	whereas	SCONJ
fnp-2613	150	29	the	the	DET
fnp-2613	150	30	specificity	specificity	NOUN
fnp-2613	150	31	of	of	ADP
fnp-2613	150	32	the	the	DET
fnp-2613	150	33	method	method	NOUN
fnp-2613	150	34	is	be	AUX
fnp-2613	150	35	variable	variable	ADJ
fnp-2613	150	36	depending	depend	VERB
fnp-2613	150	37	on	on	ADP
fnp-2613	150	38	the	the	DET
fnp-2613	150	39	study80	study80	NOUN
fnp-2613	150	40	.	.	PUNCT
fnp-2613	151	1	[	[	X
fnp-2613	151	2	123i	123i	X
fnp-2613	151	3	]	]	X
fnp-2613	151	4	2ß	2ß	NUM
fnp-2613	151	5	-	-	PUNCT
fnp-2613	151	6	carbomethoxy-3b-(4	carbomethoxy-3b-(4	NUM
fnp-2613	151	7	-	-	PUNCT
fnp-2613	151	8	iodophenyl)-n-(3	iodophenyl)-n-(3	NOUN
fnp-2613	151	9	-	-	PUNCT
fnp-2613	151	10	fluoropropyl	fluoropropyl	ADJ
fnp-2613	151	11	)	)	PUNCT
fnp-2613	151	12	nortropane	nortropane	NOUN
fnp-2613	151	13	(	(	PUNCT
fnp-2613	151	14	fp	fp	ADJ
fnp-2613	151	15	-	-	PUNCT
fnp-2613	151	16	cit	cit	NOUN
fnp-2613	151	17	)	)	PUNCT
fnp-2613	151	18	could	could	AUX
fnp-2613	151	19	be	be	AUX
fnp-2613	151	20	useful	useful	ADJ
fnp-2613	151	21	to	to	PART
fnp-2613	151	22	discover	discover	VERB
fnp-2613	151	23	dlb	dlb	NOUN
fnp-2613	151	24	in	in	ADP
fnp-2613	151	25	early	early	ADJ
fnp-2613	151	26	stages	stage	NOUN
fnp-2613	151	27	before	before	SCONJ
fnp-2613	151	28	the	the	DET
fnp-2613	151	29	full	full	ADJ
fnp-2613	151	30	spectrum	spectrum	NOUN
fnp-2613	151	31	of	of	ADP
fnp-2613	151	32	clinical	clinical	ADJ
fnp-2613	151	33	symptoms	symptom	NOUN
fnp-2613	151	34	evolve	evolve	VERB
fnp-2613	151	35	,	,	PUNCT
fnp-2613	151	36	moreover	moreover	ADV
fnp-2613	151	37	it	it	PRON
fnp-2613	151	38	reliably	reliably	ADV
fnp-2613	151	39	identifies	identify	VERB
fnp-2613	151	40	neurobiological	neurobiological	ADJ
fnp-2613	151	41	changes	change	NOUN
fnp-2613	151	42	in	in	ADP
fnp-2613	151	43	the	the	DET
fnp-2613	151	44	dopaminergic	dopaminergic	ADJ
fnp-2613	151	45	system81	system81	NOUN
fnp-2613	151	46	.	.	PUNCT
fnp-2613	152	1	in	in	ADP
fnp-2613	152	2	dlb	dlb	NOUN
fnp-2613	152	3	there	there	PRON
fnp-2613	152	4	is	be	VERB
fnp-2613	152	5	markedly	markedly	ADV
fnp-2613	152	6	reduced	reduce	VERB
fnp-2613	152	7	tracer	tracer	NOUN
fnp-2613	152	8	uptake	uptake	ADJ
fnp-2613	152	9	in	in	ADP
fnp-2613	152	10	the	the	DET
fnp-2613	152	11	regions	region	NOUN
fnp-2613	152	12	of	of	ADP
fnp-2613	152	13	caudate	caudate	NOUN
fnp-2613	152	14	and	and	CCONJ
fnp-2613	152	15	putamen	putaman	NOUN
fnp-2613	152	16	reflecting	reflect	VERB
fnp-2613	152	17	the	the	DET
fnp-2613	152	18	severely	severely	ADV
fnp-2613	152	19	affected	affect	VERB
fnp-2613	152	20	dopaminergic	dopaminergic	ADJ
fnp-2613	152	21	system	system	NOUN
fnp-2613	152	22	.	.	PUNCT
fnp-2613	153	1	strong	strong	ADJ
fnp-2613	153	2	connection	connection	NOUN
fnp-2613	153	3	has	have	AUX
fnp-2613	153	4	been	be	AUX
fnp-2613	153	5	found	find	VERB
fnp-2613	153	6	between	between	ADP
fnp-2613	153	7	striatal	striatal	ADJ
fnp-2613	153	8	fp	fp	PROPN
fnp-2613	153	9	-	-	PUNCT
fnp-2613	153	10	cit	cit	ADJ
fnp-2613	153	11	uptake	uptake	NOUN
fnp-2613	153	12	and	and	CCONJ
fnp-2613	153	13	certain	certain	ADJ
fnp-2613	153	14	clinical	clinical	ADJ
fnp-2613	153	15	symptoms	symptom	NOUN
fnp-2613	153	16	,	,	PUNCT
fnp-2613	153	17	such	such	ADJ
fnp-2613	153	18	as	as	ADP
fnp-2613	153	19	depression	depression	NOUN
fnp-2613	153	20	,	,	PUNCT
fnp-2613	153	21	anxiety	anxiety	NOUN
fnp-2613	153	22	,	,	PUNCT
fnp-2613	153	23	apathy	apathy	NOUN
fnp-2613	153	24	and	and	CCONJ
fnp-2613	153	25	daytime	daytime	NOUN
fnp-2613	153	26	somnolence82	somnolence82	NOUN
fnp-2613	153	27	.	.	PUNCT
fnp-2613	154	1	positron	positron	NOUN
fnp-2613	154	2	emission	emission	NOUN
fnp-2613	154	3	tomography	tomography	NOUN
fnp-2613	154	4	(	(	PUNCT
fnp-2613	154	5	pet	pet	NOUN
fnp-2613	154	6	)	)	PUNCT
fnp-2613	154	7	is	be	AUX
fnp-2613	154	8	probably	probably	ADV
fnp-2613	154	9	a	a	DET
fnp-2613	154	10	more	more	ADV
fnp-2613	154	11	sensitive	sensitive	ADJ
fnp-2613	154	12	functional	functional	ADJ
fnp-2613	154	13	imaging	imaging	NOUN
fnp-2613	154	14	technique	technique	NOUN
fnp-2613	154	15	than	than	ADP
fnp-2613	154	16	spect	spect	NOUN
fnp-2613	154	17	in	in	ADP
fnp-2613	154	18	different	different	ADJ
fnp-2613	154	19	dementias	dementia	NOUN
fnp-2613	154	20	.	.	PUNCT
fnp-2613	155	1	ishii	ishii	PROPN
fnp-2613	155	2	et	et	PROPN
fnp-2613	155	3	al	al	PROPN
fnp-2613	155	4	.	.	PROPN
fnp-2613	155	5	have	have	AUX
fnp-2613	155	6	compared	compare	VERB
fnp-2613	155	7	the	the	DET
fnp-2613	155	8	two	two	NUM
fnp-2613	155	9	methods	method	NOUN
fnp-2613	155	10	and	and	CCONJ
fnp-2613	155	11	found	find	VERB
fnp-2613	155	12	that	that	SCONJ
fnp-2613	155	13	pet	pet	NOUN
fnp-2613	155	14	is	be	AUX
fnp-2613	155	15	more	more	ADV
fnp-2613	155	16	reliable	reliable	ADJ
fnp-2613	155	17	in	in	ADP
fnp-2613	155	18	the	the	DET
fnp-2613	155	19	detection	detection	NOUN
fnp-2613	155	20	of	of	ADP
fnp-2613	155	21	occipital	occipital	ADJ
fnp-2613	155	22	and	and	CCONJ
fnp-2613	155	23	parietal	parietal	ADJ
fnp-2613	155	24	lobe	lobe	ADJ
fnp-2613	155	25	hypometabolism83	hypometabolism83	NOUN
fnp-2613	155	26	.	.	PUNCT
fnp-2613	156	1	besides	besides	SCONJ
fnp-2613	156	2	the	the	DET
fnp-2613	156	3	dopaminergic	dopaminergic	ADJ
fnp-2613	156	4	system	system	NOUN
fnp-2613	156	5	,	,	PUNCT
fnp-2613	156	6	cholinergic	cholinergic	ADJ
fnp-2613	156	7	transmission	transmission	NOUN
fnp-2613	156	8	also	also	ADV
fnp-2613	156	9	has	have	VERB
fnp-2613	156	10	a	a	DET
fnp-2613	156	11	crucial	crucial	ADJ
fnp-2613	156	12	role	role	NOUN
fnp-2613	156	13	in	in	ADP
fnp-2613	156	14	the	the	DET
fnp-2613	156	15	pathomechanism	pathomechanism	NOUN
fnp-2613	156	16	of	of	ADP
fnp-2613	156	17	dlb	dlb	NOUN
fnp-2613	156	18	,	,	PUNCT
fnp-2613	156	19	for	for	ADP
fnp-2613	156	20	instance	instance	NOUN
fnp-2613	156	21	in	in	ADP
fnp-2613	156	22	the	the	DET
fnp-2613	156	23	alteration	alteration	NOUN
fnp-2613	156	24	of	of	ADP
fnp-2613	156	25	memory	memory	NOUN
fnp-2613	156	26	,	,	PUNCT
fnp-2613	156	27	attention	attention	NOUN
fnp-2613	156	28	or	or	CCONJ
fnp-2613	156	29	arousal	arousal	NOUN
fnp-2613	156	30	.	.	PUNCT
fnp-2613	157	1	significant	significant	ADJ
fnp-2613	157	2	cholinergic	cholinergic	ADJ
fnp-2613	157	3	neuronal	neuronal	ADJ
fnp-2613	157	4	loss	loss	NOUN
fnp-2613	157	5	and	and	CCONJ
fnp-2613	157	6	reduced	reduce	VERB
fnp-2613	157	7	chat	chat	NOUN
fnp-2613	157	8	activity	activity	NOUN
fnp-2613	157	9	are	be	AUX
fnp-2613	157	10	noted	note	VERB
fnp-2613	157	11	extensively	extensively	ADV
fnp-2613	157	12	in	in	ADP
fnp-2613	157	13	the	the	DET
fnp-2613	157	14	cortical	cortical	ADJ
fnp-2613	157	15	and	and	CCONJ
fnp-2613	157	16	subcortical	subcortical	ADJ
fnp-2613	157	17	regions	region	NOUN
fnp-2613	157	18	,	,	PUNCT
fnp-2613	157	19	including	include	VERB
fnp-2613	157	20	both	both	CCONJ
fnp-2613	157	21	nicotinergic	nicotinergic	ADJ
fnp-2613	157	22	and	and	CCONJ
fnp-2613	157	23	muscarinergic	muscarinergic	ADJ
fnp-2613	157	24	systems	system	NOUN
fnp-2613	157	25	,	,	PUNCT
fnp-2613	157	26	compared	compare	VERB
fnp-2613	157	27	to	to	ADP
fnp-2613	157	28	ad36	ad36	PROPN
fnp-2613	157	29	.	.	PUNCT
fnp-2613	158	1	shimada	shimada	PROPN
fnp-2613	158	2	et	et	PROPN
fnp-2613	158	3	al	al	PROPN
fnp-2613	158	4	.	.	PROPN
fnp-2613	158	5	have	have	AUX
fnp-2613	158	6	shown	show	VERB
fnp-2613	158	7	reduced	reduce	VERB
fnp-2613	158	8	chat	chat	VERB
fnp-2613	158	9	enzymatic	enzymatic	ADJ
fnp-2613	158	10	activity	activity	NOUN
fnp-2613	158	11	in	in	ADP
fnp-2613	158	12	the	the	DET
fnp-2613	158	13	medial	medial	ADJ
fnp-2613	158	14	occipital	occipital	NOUN
fnp-2613	158	15	cortex	cortex	NOUN
fnp-2613	158	16	with	with	ADP
fnp-2613	158	17	relatively	relatively	ADV
fnp-2613	158	18	preserved	preserve	VERB
fnp-2613	158	19	temporal	temporal	ADJ
fnp-2613	158	20	activity	activity	NOUN
fnp-2613	158	21	in	in	ADP
fnp-2613	158	22	dlb	dlb	NOUN
fnp-2613	158	23	,	,	PUNCT
fnp-2613	158	24	in	in	ADP
fnp-2613	158	25	contrast	contrast	NOUN
fnp-2613	158	26	to	to	ADP
fnp-2613	158	27	ad84	ad84	PROPN
fnp-2613	158	28	.	.	PUNCT
fnp-2613	159	1	the	the	DET
fnp-2613	159	2	fact	fact	NOUN
fnp-2613	159	3	that	that	SCONJ
fnp-2613	159	4	eeg	eeg	NOUN
fnp-2613	159	5	is	be	AUX
fnp-2613	159	6	involved	involve	VERB
fnp-2613	159	7	in	in	ADP
fnp-2613	159	8	the	the	DET
fnp-2613	159	9	mckeith	mckeith	NOUN
fnp-2613	159	10	criterion	criterion	NOUN
fnp-2613	159	11	further	far	ADV
fnp-2613	159	12	justifies	justify	VERB
fnp-2613	159	13	its	its	PRON
fnp-2613	159	14	diagnostic	diagnostic	ADJ
fnp-2613	159	15	relevance	relevance	NOUN
fnp-2613	159	16	.	.	PUNCT
fnp-2613	160	1	compared	compare	VERB
fnp-2613	160	2	to	to	ADP
fnp-2613	160	3	ad	ad	NOUN
fnp-2613	160	4	the	the	DET
fnp-2613	160	5	detectable	detectable	ADJ
fnp-2613	160	6	slower	slow	ADJ
fnp-2613	160	7	background	background	NOUN
fnp-2613	160	8	activity	activity	NOUN
fnp-2613	160	9	and	and	CCONJ
fnp-2613	160	10	more	more	ADJ
fnp-2613	160	11	diffuse	diffuse	ADJ
fnp-2613	160	12	slow	slow	ADJ
fnp-2613	160	13	-	-	PUNCT
fnp-2613	160	14	wave	wave	NOUN
fnp-2613	160	15	activity	activity	NOUN
fnp-2613	160	16	probably	probably	ADV
fnp-2613	160	17	reflect	reflect	VERB
fnp-2613	160	18	the	the	DET
fnp-2613	160	19	severe	severe	ADJ
fnp-2613	160	20	cholinergic	cholinergic	ADJ
fnp-2613	160	21	deficit	deficit	NOUN
fnp-2613	160	22	in	in	ADP
fnp-2613	160	23	dlb85	dlb85	NOUN
fnp-2613	160	24	.	.	PUNCT
fnp-2613	161	1	biomarkers	biomarker	NOUN
fnp-2613	161	2	it	it	PRON
fnp-2613	161	3	is	be	AUX
fnp-2613	161	4	difficult	difficult	ADJ
fnp-2613	161	5	to	to	PART
fnp-2613	161	6	find	find	VERB
fnp-2613	161	7	specific	specific	ADJ
fnp-2613	161	8	biomarkers	biomarker	NOUN
fnp-2613	161	9	of	of	ADP
fnp-2613	161	10	dlb	dlb	NOUN
fnp-2613	161	11	that	that	PRON
fnp-2613	161	12	would	would	AUX
fnp-2613	161	13	allow	allow	VERB
fnp-2613	161	14	us	we	PRON
fnp-2613	161	15	to	to	PART
fnp-2613	161	16	discriminate	discriminate	VERB
fnp-2613	161	17	neuropathologically	neuropathologically	ADV
fnp-2613	161	18	‘	'	PUNCT
fnp-2613	161	19	pure	pure	ADJ
fnp-2613	161	20	’	'	PUNCT
fnp-2613	161	21	forms	form	NOUN
fnp-2613	161	22	of	of	ADP
fnp-2613	161	23	the	the	DET
fnp-2613	161	24	disease	disease	NOUN
fnp-2613	161	25	from	from	ADP
fnp-2613	161	26	cases	case	NOUN
fnp-2613	161	27	with	with	ADP
fnp-2613	161	28	concomitant	concomitant	ADJ
fnp-2613	161	29	ad	ad	NOUN
fnp-2613	161	30	pathology86	pathology86	NOUN
fnp-2613	161	31	,	,	PUNCT
fnp-2613	161	32	as	as	SCONJ
fnp-2613	161	33	that	that	DET
fnp-2613	161	34	majority	majority	NOUN
fnp-2613	161	35	of	of	ADP
fnp-2613	161	36	dlb	dlb	NOUN
fnp-2613	161	37	cases	case	NOUN
fnp-2613	161	38	show	show	VERB
fnp-2613	161	39	a	a	DET
fnp-2613	161	40	combination	combination	NOUN
fnp-2613	161	41	of	of	ADP
fnp-2613	161	42	α	α	NOUN
fnp-2613	161	43	-	-	PUNCT
fnp-2613	161	44	synuclein	synuclein	NOUN
fnp-2613	161	45	,	,	PUNCT
fnp-2613	161	46	tau	tau	PROPN
fnp-2613	161	47	and	and	CCONJ
fnp-2613	161	48	β	β	NOUN
fnp-2613	161	49	-	-	NOUN
fnp-2613	161	50	amyloid	amyloid	ADJ
fnp-2613	161	51	pathologies87,88	pathologies87,88	NOUN
fnp-2613	161	52	.	.	PUNCT
fnp-2613	162	1	however	however	ADV
fnp-2613	162	2	,	,	PUNCT
fnp-2613	162	3	novel	novel	ADJ
fnp-2613	162	4	biomarkers	biomarker	NOUN
fnp-2613	162	5	such	such	ADJ
fnp-2613	162	6	as	as	ADP
fnp-2613	162	7	reduced	reduce	VERB
fnp-2613	162	8	electroencephalography	electroencephalography	NOUN
fnp-2613	162	9	activity89	activity89	NOUN
fnp-2613	162	10	and	and	CCONJ
fnp-2613	162	11	the	the	DET
fnp-2613	162	12	detection	detection	NOUN
fnp-2613	162	13	of	of	ADP
fnp-2613	162	14	rbd90	rbd90	PROPN
fnp-2613	162	15	also	also	ADV
fnp-2613	162	16	have	have	VERB
fnp-2613	162	17	some	some	DET
fnp-2613	162	18	value	value	NOUN
fnp-2613	162	19	.	.	PUNCT
fnp-2613	163	1	recent	recent	ADJ
fnp-2613	163	2	dlb	dlb	PROPN
fnp-2613	163	3	biomarker	biomarker	NOUN
fnp-2613	163	4	research	research	NOUN
fnp-2613	163	5	has	have	AUX
fnp-2613	163	6	focused	focus	VERB
fnp-2613	163	7	on	on	ADP
fnp-2613	163	8	targets	target	NOUN
fnp-2613	163	9	that	that	PRON
fnp-2613	163	10	are	be	AUX
fnp-2613	163	11	primarily	primarily	ADV
fnp-2613	163	12	related	relate	VERB
fnp-2613	163	13	to	to	ADP
fnp-2613	163	14	ad	ad	NOUN
fnp-2613	163	15	.	.	PUNCT
fnp-2613	164	1	as	as	ADP
fnp-2613	164	2	in	in	ADP
fnp-2613	164	3	ad	ad	NOUN
fnp-2613	164	4	,	,	PUNCT
fnp-2613	164	5	csf	csf	ADJ
fnp-2613	164	6	levels	level	NOUN
fnp-2613	164	7	of	of	ADP
fnp-2613	164	8	aβ1	aβ1	NOUN
fnp-2613	164	9	-	-	PUNCT
fnp-2613	164	10	42	42	NUM
fnp-2613	164	11	are	be	AUX
fnp-2613	164	12	decreased	decrease	VERB
fnp-2613	164	13	in	in	ADP
fnp-2613	164	14	dlb91	dlb91	PROPN
fnp-2613	164	15	,	,	PUNCT
fnp-2613	164	16	although	although	SCONJ
fnp-2613	164	17	tau	tau	PROPN
fnp-2613	164	18	seems	seem	VERB
fnp-2613	164	19	to	to	PART
fnp-2613	164	20	show	show	VERB
fnp-2613	164	21	an	an	DET
fnp-2613	164	22	opposite	opposite	ADJ
fnp-2613	164	23	relationship	relationship	NOUN
fnp-2613	164	24	from	from	ADP
fnp-2613	164	25	ad92	ad92	PROPN
fnp-2613	164	26	.	.	PUNCT
fnp-2613	165	1	that	that	PRON
fnp-2613	165	2	said	say	VERB
fnp-2613	165	3	tau	tau	PROPN
fnp-2613	165	4	has	have	AUX
fnp-2613	165	5	been	be	AUX
fnp-2613	165	6	shown	show	VERB
fnp-2613	165	7	to	to	PART
fnp-2613	165	8	be	be	AUX
fnp-2613	165	9	higher	high	ADJ
fnp-2613	165	10	in	in	ADP
fnp-2613	165	11	dlb	dlb	NOUN
fnp-2613	165	12	when	when	SCONJ
fnp-2613	165	13	compared	compare	VERB
fnp-2613	165	14	to	to	ADP
fnp-2613	165	15	pd	pd	PROPN
fnp-2613	165	16	and	and	CCONJ
fnp-2613	165	17	pdd87,93,94	pdd87,93,94	PROPN
fnp-2613	165	18	.	.	PUNCT
fnp-2613	166	1	dlb	dlb	PROPN
fnp-2613	166	2	is	be	AUX
fnp-2613	166	3	considered	consider	VERB
fnp-2613	166	4	α	α	NOUN
fnp-2613	166	5	-	-	NOUN
fnp-2613	166	6	synucleinopathy	synucleinopathy	NOUN
fnp-2613	166	7	alongside	alongside	ADP
fnp-2613	166	8	with	with	ADP
fnp-2613	166	9	pd	pd	PROPN
fnp-2613	166	10	and	and	CCONJ
fnp-2613	166	11	pdd	pdd	NOUN
fnp-2613	166	12	.	.	PUNCT
fnp-2613	167	1	when	when	SCONJ
fnp-2613	167	2	α	α	X
fnp-2613	167	3	-	-	PUNCT
fnp-2613	167	4	synuclein	synuclein	NOUN
fnp-2613	167	5	was	be	AUX
fnp-2613	167	6	discovered	discover	VERB
fnp-2613	167	7	as	as	ADP
fnp-2613	167	8	a	a	DET
fnp-2613	167	9	major	major	ADJ
fnp-2613	167	10	component	component	NOUN
fnp-2613	167	11	of	of	ADP
fnp-2613	167	12	lb	lb	NOUN
fnp-2613	167	13	this	this	PRON
fnp-2613	167	14	initiated	initiate	VERB
fnp-2613	167	15	a	a	DET
fnp-2613	167	16	string	string	NOUN
fnp-2613	167	17	of	of	ADP
fnp-2613	167	18	studies	study	NOUN
fnp-2613	167	19	investigating	investigate	VERB
fnp-2613	167	20	α	α	NOUN
fnp-2613	167	21	-	-	PUNCT
fnp-2613	167	22	synuclein	synuclein	NOUN
fnp-2613	167	23	as	as	ADP
fnp-2613	167	24	a	a	DET
fnp-2613	167	25	biomarker	biomarker	NOUN
fnp-2613	167	26	in	in	ADP
fnp-2613	167	27	csf95,96	csf95,96	NOUN
fnp-2613	167	28	.	.	PUNCT
fnp-2613	168	1	in	in	ADP
fnp-2613	168	2	general	general	ADJ
fnp-2613	168	3	,	,	PUNCT
fnp-2613	168	4	some	some	DET
fnp-2613	168	5	groups	group	NOUN
fnp-2613	168	6	have	have	AUX
fnp-2613	168	7	reported	report	VERB
fnp-2613	168	8	reduced	reduce	VERB
fnp-2613	168	9	α	α	NOUN
fnp-2613	168	10	-	-	PUNCT
fnp-2613	168	11	synuclein97,98	synuclein97,98	NOUN
fnp-2613	168	12	while	while	SCONJ
fnp-2613	168	13	others	other	NOUN
fnp-2613	168	14	have	have	AUX
fnp-2613	168	15	shown	show	VERB
fnp-2613	168	16	contradictory	contradictory	ADJ
fnp-2613	168	17	results99,100	results99,100	NOUN
fnp-2613	168	18	.	.	PUNCT
fnp-2613	169	1	these	these	DET
fnp-2613	169	2	discrepancies	discrepancy	NOUN
fnp-2613	169	3	may	may	AUX
fnp-2613	169	4	arise	arise	VERB
fnp-2613	169	5	from	from	ADP
fnp-2613	169	6	the	the	DET
fnp-2613	169	7	nature	nature	NOUN
fnp-2613	169	8	of	of	ADP
fnp-2613	169	9	α	α	NOUN
fnp-2613	169	10	-	-	PUNCT
fnp-2613	169	11	synuclein	synuclein	NOUN
fnp-2613	169	12	expression	expression	NOUN
fnp-2613	169	13	.	.	PUNCT
fnp-2613	170	1	α	α	X
fnp-2613	170	2	-	-	PUNCT
fnp-2613	170	3	synuclein	synuclein	NOUN
fnp-2613	170	4	appears	appear	VERB
fnp-2613	170	5	in	in	ADP
fnp-2613	170	6	four	four	NUM
fnp-2613	170	7	isoforms	isoform	NOUN
fnp-2613	170	8	,	,	PUNCT
fnp-2613	170	9	(	(	PUNCT
fnp-2613	170	10	α	α	NOUN
fnp-2613	170	11	-	-	PUNCT
fnp-2613	170	12	syn98	syn98	ADJ
fnp-2613	170	13	,	,	PUNCT
fnp-2613	170	14	α	α	NOUN
fnp-2613	170	15	-	-	PUNCT
fnp-2613	170	16	syn112	syn112	PROPN
fnp-2613	170	17	,	,	PUNCT
fnp-2613	170	18	α	α	NOUN
fnp-2613	170	19	-	-	NOUN
fnp-2613	170	20	syn126	syn126	NOUN
fnp-2613	170	21	and	and	CCONJ
fnp-2613	170	22	α	α	NOUN
fnp-2613	170	23	-	-	PUNCT
fnp-2613	170	24	syn140	syn140	NOUN
fnp-2613	170	25	)	)	PUNCT
fnp-2613	170	26	,	,	PUNCT
fnp-2613	170	27	based	base	VERB
fnp-2613	170	28	on	on	ADP
fnp-2613	170	29	alternative	alternative	ADJ
fnp-2613	170	30	splicing	splicing	NOUN
fnp-2613	170	31	of	of	ADP
fnp-2613	170	32	exon	exon	PROPN
fnp-2613	170	33	3	3	NUM
fnp-2613	170	34	and	and	CCONJ
fnp-2613	170	35	5	5	NUM
fnp-2613	170	36	,	,	PUNCT
fnp-2613	170	37	and	and	CCONJ
fnp-2613	170	38	the	the	DET
fnp-2613	170	39	largest	large	ADJ
fnp-2613	170	40	isoform	isoform	NOUN
fnp-2613	170	41	,	,	PUNCT
fnp-2613	170	42	α	α	NOUN
fnp-2613	170	43	-	-	PUNCT
fnp-2613	170	44	syn140	syn140	PROPN
fnp-2613	170	45	,	,	PUNCT
fnp-2613	170	46	is	be	AUX
fnp-2613	170	47	the	the	DET
fnp-2613	170	48	most	most	ADV
fnp-2613	170	49	abundant	abundant	ADJ
fnp-2613	170	50	isoform	isoform	NOUN
fnp-2613	170	51	in	in	ADP
fnp-2613	170	52	the	the	DET
fnp-2613	170	53	brain101,102	brain101,102	NOUN
fnp-2613	170	54	.	.	PUNCT
fnp-2613	171	1	nonetheless	nonetheless	ADV
fnp-2613	171	2	,	,	PUNCT
fnp-2613	171	3	to	to	PART
fnp-2613	171	4	overcome	overcome	VERB
fnp-2613	171	5	this	this	DET
fnp-2613	171	6	issue	issue	NOUN
fnp-2613	171	7	several	several	ADJ
fnp-2613	171	8	groups	group	NOUN
fnp-2613	171	9	have	have	AUX
fnp-2613	171	10	tried	try	VERB
fnp-2613	171	11	using	use	VERB
fnp-2613	171	12	a	a	DET
fnp-2613	171	13	combination	combination	NOUN
fnp-2613	171	14	of	of	ADP
fnp-2613	171	15	antibodies	antibody	NOUN
fnp-2613	171	16	to	to	PART
fnp-2613	171	17	quantify	quantify	VERB
fnp-2613	171	18	‘	'	PUNCT
fnp-2613	171	19	total	total	ADJ
fnp-2613	171	20	’	'	PUNCT
fnp-2613	171	21	α	α	PROPN
fnp-2613	171	22	-	-	PUNCT
fnp-2613	171	23	synuclein103	synuclein103	PROPN
fnp-2613	171	24	.	.	PUNCT
fnp-2613	172	1	in	in	ADP
fnp-2613	172	2	addition	addition	NOUN
fnp-2613	172	3	to	to	ADP
fnp-2613	172	4	this	this	DET
fnp-2613	172	5	many	many	ADJ
fnp-2613	172	6	are	be	AUX
fnp-2613	172	7	convinced	convince	VERB
fnp-2613	172	8	that	that	SCONJ
fnp-2613	172	9	oligomeric	oligomeric	ADJ
fnp-2613	172	10	α	α	NOUN
fnp-2613	172	11	-	-	PUNCT
fnp-2613	172	12	synuclein	synuclein	NOUN
fnp-2613	172	13	is	be	AUX
fnp-2613	172	14	potentially	potentially	ADV
fnp-2613	172	15	a	a	DET
fnp-2613	172	16	more	more	ADV
fnp-2613	172	17	pathogenic	pathogenic	ADJ
fnp-2613	172	18	form104	form104	PROPN
fnp-2613	172	19	and	and	CCONJ
fnp-2613	172	20	efforts	effort	NOUN
fnp-2613	172	21	have	have	AUX
fnp-2613	172	22	been	be	AUX
fnp-2613	172	23	made	make	VERB
fnp-2613	172	24	to	to	PART
fnp-2613	172	25	measure	measure	VERB
fnp-2613	172	26	this	this	PRON
fnp-2613	172	27	in	in	ADP
fnp-2613	172	28	both	both	CCONJ
fnp-2613	172	29	csf	csf	ADJ
fnp-2613	172	30	and	and	CCONJ
fnp-2613	172	31	in	in	ADP
fnp-2613	172	32	plasma105–107	plasma105–107	NOUN
fnp-2613	172	33	.	.	PUNCT
fnp-2613	173	1	in	in	ADP
fnp-2613	173	2	addition	addition	NOUN
fnp-2613	173	3	to	to	ADP
fnp-2613	173	4	α	α	NOUN
fnp-2613	173	5	-	-	PUNCT
fnp-2613	173	6	synuclein	synuclein	NOUN
fnp-2613	173	7	and	and	CCONJ
fnp-2613	173	8	ad	ad	NOUN
fnp-2613	173	9	biomarkers	biomarker	NOUN
fnp-2613	173	10	,	,	PUNCT
fnp-2613	173	11	other	other	ADJ
fnp-2613	173	12	potential	potential	ADJ
fnp-2613	173	13	biomarkers	biomarker	NOUN
fnp-2613	173	14	such	such	ADJ
fnp-2613	173	15	as	as	ADP
fnp-2613	173	16	neurofilaments	neurofilament	NOUN
fnp-2613	173	17	(	(	PUNCT
fnp-2613	173	18	nf	nf	INTJ
fnp-2613	173	19	)	)	PUNCT
fnp-2613	173	20	have	have	AUX
fnp-2613	173	21	been	be	AUX
fnp-2613	173	22	investigated108	investigated108	PROPN
fnp-2613	173	23	.	.	PROPN
fnp-2613	173	24	nfs	nfs	PROPN
fnp-2613	173	25	are	be	AUX
fnp-2613	173	26	components	component	NOUN
fnp-2613	173	27	within	within	ADP
fnp-2613	173	28	a	a	DET
fnp-2613	173	29	cell	cell	NOUN
fnp-2613	173	30	that	that	PRON
fnp-2613	173	31	assists	assist	VERB
fnp-2613	173	32	in	in	ADP
fnp-2613	173	33	maintaining	maintain	VERB
fnp-2613	173	34	the	the	DET
fnp-2613	173	35	structural	structural	ADJ
fnp-2613	173	36	integrity	integrity	NOUN
fnp-2613	173	37	.	.	PUNCT
fnp-2613	174	1	it	it	PRON
fnp-2613	174	2	has	have	AUX
fnp-2613	174	3	been	be	AUX
fnp-2613	174	4	shown	show	VERB
fnp-2613	174	5	that	that	SCONJ
fnp-2613	174	6	nfs	nfs	NOUN
fnp-2613	174	7	are	be	AUX
fnp-2613	174	8	associated	associate	VERB
fnp-2613	174	9	with	with	ADP
fnp-2613	174	10	ad	ad	NOUN
fnp-2613	174	11	and	and	CCONJ
fnp-2613	174	12	other	other	ADJ
fnp-2613	174	13	degenerative	degenerative	ADJ
fnp-2613	174	14	disorders109–111	disorders109–111	PROPN
fnp-2613	174	15	,	,	PUNCT
fnp-2613	174	16	however	however	ADV
fnp-2613	174	17	that	that	PRON
fnp-2613	174	18	is	be	AUX
fnp-2613	174	19	not	not	PART
fnp-2613	174	20	the	the	DET
fnp-2613	174	21	case	case	NOUN
fnp-2613	174	22	with	with	ADP
fnp-2613	174	23	dlb	dlb	PROPN
fnp-2613	174	24	.	.	PUNCT
fnp-2613	175	1	nfs	nfs	PROPN
fnp-2613	175	2	seem	seem	VERB
fnp-2613	175	3	to	to	PART
fnp-2613	175	4	provide	provide	VERB
fnp-2613	175	5	only	only	ADV
fnp-2613	175	6	a	a	DET
fnp-2613	175	7	general	general	ADJ
fnp-2613	175	8	hint	hint	NOUN
fnp-2613	175	9	of	of	ADP
fnp-2613	175	10	neuronal	neuronal	ADJ
fnp-2613	175	11	and	and	CCONJ
fnp-2613	175	12	axonal	axonal	ADJ
fnp-2613	175	13	dysfunction	dysfunction	NOUN
fnp-2613	175	14	without	without	ADP
fnp-2613	175	15	providing	provide	VERB
fnp-2613	175	16	any	any	DET
fnp-2613	175	17	differential	differential	ADJ
fnp-2613	175	18	value	value	NOUN
fnp-2613	175	19	to	to	PART
fnp-2613	175	20	separate	separate	VERB
fnp-2613	175	21	dlb	dlb	NOUN
fnp-2613	175	22	from	from	ADP
fnp-2613	175	23	other	other	ADJ
fnp-2613	175	24	disorders	disorder	NOUN
fnp-2613	175	25	.	.	PUNCT
fnp-2613	176	1	on	on	ADP
fnp-2613	176	2	the	the	DET
fnp-2613	176	3	other	other	ADJ
fnp-2613	176	4	hand	hand	NOUN
fnp-2613	176	5	,	,	PUNCT
fnp-2613	176	6	other	other	ADJ
fnp-2613	176	7	isoforms	isoform	NOUN
fnp-2613	176	8	of	of	ADP
fnp-2613	176	9	nfs112	nfs112	PROPN
fnp-2613	176	10	do	do	AUX
fnp-2613	176	11	exist	exist	VERB
fnp-2613	176	12	and	and	CCONJ
fnp-2613	176	13	would	would	AUX
fnp-2613	176	14	have	have	VERB
fnp-2613	176	15	to	to	PART
fnp-2613	176	16	be	be	AUX
fnp-2613	176	17	further	far	ADV
fnp-2613	176	18	investigated	investigate	VERB
fnp-2613	176	19	in	in	ADP
fnp-2613	176	20	dlb	dlb	PROPN
fnp-2613	176	21	.	.	PUNCT
fnp-2613	177	1	since	since	SCONJ
fnp-2613	177	2	there	there	PRON
fnp-2613	177	3	is	be	VERB
fnp-2613	177	4	greater	great	ADJ
fnp-2613	177	5	involvement	involvement	NOUN
fnp-2613	177	6	of	of	ADP
fnp-2613	177	7	the	the	DET
fnp-2613	177	8	dopaminergic	dopaminergic	ADJ
fnp-2613	177	9	and	and	CCONJ
fnp-2613	177	10	serotonergic	serotonergic	ADJ
fnp-2613	177	11	neurotransmitters	neurotransmitter	NOUN
fnp-2613	177	12	in	in	ADP
fnp-2613	177	13	dlb	dlb	NOUN
fnp-2613	177	14	compared	compare	VERB
fnp-2613	177	15	to	to	ADP
fnp-2613	177	16	ad	ad	NOUN
fnp-2613	177	17	,	,	PUNCT
fnp-2613	177	18	several	several	ADJ
fnp-2613	177	19	groups	group	NOUN
fnp-2613	177	20	have	have	AUX
fnp-2613	177	21	investigated	investigate	VERB
fnp-2613	177	22	metabolites	metabolite	NOUN
fnp-2613	177	23	from	from	ADP
fnp-2613	177	24	these	these	DET
fnp-2613	177	25	pathways	pathway	NOUN
fnp-2613	177	26	.	.	PUNCT
fnp-2613	178	1	in	in	ADP
fnp-2613	178	2	combination	combination	NOUN
fnp-2613	178	3	with	with	ADP
fnp-2613	178	4	csf	csf	ADJ
fnp-2613	178	5	aβ1	aβ1	NOUN
fnp-2613	178	6	-	-	PUNCT
fnp-2613	178	7	42	42	NUM
fnp-2613	178	8	,	,	PUNCT
fnp-2613	178	9	reduced	reduce	VERB
fnp-2613	178	10	levels	level	NOUN
fnp-2613	178	11	of	of	ADP
fnp-2613	178	12	5hydroxyindolacetic	5hydroxyindolacetic	NUM
fnp-2613	178	13	acid	acid	NOUN
fnp-2613	178	14	and	and	CCONJ
fnp-2613	178	15	3methoxy-4	3methoxy-4	NUM
fnp-2613	178	16	-	-	NUM
fnp-2613	178	17	hydroxyphenylethyleneglycol	hydroxyphenylethyleneglycol	PROPN
fnp-2613	178	18	have	have	AUX
fnp-2613	178	19	been	be	AUX
fnp-2613	178	20	found	find	VERB
fnp-2613	178	21	in	in	ADP
fnp-2613	178	22	dlb	dlb	NOUN
fnp-2613	178	23	compared	compare	VERB
fnp-2613	178	24	with	with	ADP
fnp-2613	178	25	ad104,113	ad104,113	PROPN
fnp-2613	178	26	.	.	PUNCT
fnp-2613	179	1	in	in	ADP
fnp-2613	179	2	summary	summary	NOUN
fnp-2613	179	3	,	,	PUNCT
fnp-2613	179	4	current	current	ADJ
fnp-2613	179	5	studies	study	NOUN
fnp-2613	179	6	suggest	suggest	VERB
fnp-2613	179	7	that	that	SCONJ
fnp-2613	179	8	dlb	dlb	NOUN
fnp-2613	179	9	is	be	AUX
fnp-2613	179	10	intermediate	intermediate	ADJ
fnp-2613	179	11	to	to	ADP
fnp-2613	179	12	ad	ad	NOUN
fnp-2613	179	13	and	and	CCONJ
fnp-2613	179	14	pd	pd	PROPN
fnp-2613	179	15	,	,	PUNCT
fnp-2613	179	16	such	such	ADJ
fnp-2613	179	17	that	that	SCONJ
fnp-2613	179	18	biomarkers	biomarker	NOUN
fnp-2613	179	19	from	from	ADP
fnp-2613	179	20	ad	ad	NOUN
fnp-2613	179	21	and	and	CCONJ
fnp-2613	179	22	pd	pd	PROPN
fnp-2613	179	23	have	have	AUX
fnp-2613	179	24	been	be	AUX
fnp-2613	179	25	tested	test	VERB
fnp-2613	179	26	in	in	ADP
fnp-2613	179	27	dlb	dlb	NOUN
fnp-2613	179	28	with	with	ADP
fnp-2613	179	29	moderate	moderate	ADJ
fnp-2613	179	30	success114	success114	PROPN
fnp-2613	179	31	.	.	PUNCT
fnp-2613	180	1	likewise	likewise	ADV
fnp-2613	180	2	,	,	PUNCT
fnp-2613	180	3	new	new	ADJ
fnp-2613	180	4	diagnostic	diagnostic	ADJ
fnp-2613	180	5	proteins	protein	NOUN
fnp-2613	180	6	may	may	AUX
fnp-2613	180	7	be	be	AUX
fnp-2613	180	8	discovered	discover	VERB
fnp-2613	180	9	in	in	ADP
fnp-2613	180	10	the	the	DET
fnp-2613	180	11	future	future	NOUN
fnp-2613	180	12	with	with	ADP
fnp-2613	180	13	further	further	ADJ
fnp-2613	180	14	proteomic	proteomic	ADJ
fnp-2613	180	15	studies	study	NOUN
fnp-2613	180	16	which	which	PRON
fnp-2613	180	17	could	could	AUX
fnp-2613	180	18	provide	provide	VERB
fnp-2613	180	19	a	a	DET
fnp-2613	180	20	better	well	ADJ
fnp-2613	180	21	differentiation	differentiation	NOUN
fnp-2613	180	22	of	of	ADP
fnp-2613	180	23	dlb	dlb	NOUN
fnp-2613	180	24	from	from	ADP
fnp-2613	180	25	other	other	ADJ
fnp-2613	180	26	closely	closely	ADV
fnp-2613	180	27	related	relate	VERB
fnp-2613	180	28	neurodegenerative	neurodegenerative	ADJ
fnp-2613	180	29	disorders115–117	disorders115–117	NOUN
fnp-2613	180	30	.	.	PUNCT
fnp-2613	181	1	diagnostic	diagnostic	ADJ
fnp-2613	181	2	criteria	criterion	NOUN
fnp-2613	181	3	considering	consider	VERB
fnp-2613	181	4	the	the	DET
fnp-2613	181	5	heterogeneous	heterogeneous	ADJ
fnp-2613	181	6	phenotype	phenotype	NOUN
fnp-2613	181	7	and	and	CCONJ
fnp-2613	181	8	the	the	DET
fnp-2613	181	9	frequently	frequently	ADV
fnp-2613	181	10	associated	associate	VERB
fnp-2613	181	11	ad	ad	NOUN
fnp-2613	181	12	pathology	pathology	NOUN
fnp-2613	181	13	,	,	PUNCT
fnp-2613	181	14	the	the	DET
fnp-2613	181	15	clinical	clinical	ADJ
fnp-2613	181	16	symptom	symptom	NOUN
fnp-2613	181	17	-	-	PUNCT
fnp-2613	181	18	based	base	VERB
fnp-2613	181	19	diagnosis	diagnosis	NOUN
fnp-2613	181	20	of	of	ADP
fnp-2613	181	21	dlb	dlb	NOUN
fnp-2613	181	22	is	be	AUX
fnp-2613	181	23	rather	rather	ADV
fnp-2613	181	24	difficult	difficult	ADJ
fnp-2613	181	25	.	.	PUNCT
fnp-2613	182	1	to	to	ADP
fnp-2613	182	2	date	date	NOUN
fnp-2613	182	3	,	,	PUNCT
fnp-2613	182	4	there	there	PRON
fnp-2613	182	5	is	be	VERB
fnp-2613	182	6	no	no	DET
fnp-2613	182	7	consensus	consensus	NOUN
fnp-2613	182	8	on	on	ADP
fnp-2613	182	9	the	the	DET
fnp-2613	182	10	guidelines	guideline	NOUN
fnp-2613	182	11	for	for	ADP
fnp-2613	182	12	assessing	assess	VERB
fnp-2613	182	13	clinical	clinical	ADJ
fnp-2613	182	14	symptoms	symptom	NOUN
fnp-2613	182	15	of	of	ADP
fnp-2613	182	16	dlb	dlb	NOUN
fnp-2613	182	17	.	.	PUNCT
fnp-2613	183	1	a	a	DET
fnp-2613	183	2	recent	recent	ADJ
fnp-2613	183	3	paper58	paper58	NOUN
fnp-2613	183	4	recommends	recommend	VERB
fnp-2613	183	5	the	the	DET
fnp-2613	183	6	following	follow	VERB
fnp-2613	183	7	rating	rating	NOUN
fnp-2613	183	8	strategies	strategy	NOUN
fnp-2613	183	9	:	:	PUNCT
fnp-2613	183	10	for	for	ADP
fnp-2613	183	11	evaluating	evaluate	VERB
fnp-2613	183	12	cognitive	cognitive	ADJ
fnp-2613	183	13	decline	decline	NOUN
fnp-2613	183	14	–	–	PUNCT
fnp-2613	183	15	clinical	clinical	ADJ
fnp-2613	183	16	dementia	dementia	NOUN
fnp-2613	183	17	rating	rating	NOUN
fnp-2613	183	18	scale118	scale118	PROPN
fnp-2613	183	19	;	;	PUNCT
fnp-2613	183	20	for	for	ADP
fnp-2613	183	21	estimating	estimate	VERB
fnp-2613	183	22	fluctuating	fluctuate	VERB
fnp-2613	183	23	cognition	cognition	NOUN
fnp-2613	183	24	–	–	PUNCT
fnp-2613	183	25	clinician	clinician	ADJ
fnp-2613	183	26	assessment	assessment	NOUN
fnp-2613	183	27	of	of	ADP
fnp-2613	183	28	cognitive	cognitive	ADJ
fnp-2613	183	29	fluctuations119	fluctuations119	PROPN
fnp-2613	183	30	or	or	CCONJ
fnp-2613	183	31	mayo	mayo	NOUN
fnp-2613	183	32	fluctuation	fluctuation	PROPN
fnp-2613	183	33	questionnaire120	questionnaire120	PROPN
fnp-2613	183	34	;	;	PUNCT
fnp-2613	183	35	for	for	ADP
fnp-2613	183	36	investigating	investigate	VERB
fnp-2613	183	37	rem	rem	PUNCT
fnp-2613	183	38	parasomnia	parasomnia	NOUN
fnp-2613	183	39	mayo	mayo	NOUN
fnp-2613	183	40	sleep	sleep	PROPN
fnp-2613	183	41	questionnaire121	questionnaire121	PROPN
fnp-2613	183	42	;	;	PUNCT
fnp-2613	183	43	for	for	ADP
fnp-2613	183	44	rating	rating	NOUN
fnp-2613	183	45	parkinsonism	parkinsonism	NOUN
fnp-2613	183	46	–	–	PUNCT
fnp-2613	183	47	unified	unify	VERB
fnp-2613	183	48	parkinson	parkinson	NOUN
fnp-2613	183	49	’s	’s	PART
fnp-2613	183	50	rating	rating	NOUN
fnp-2613	183	51	scale122	scale122	PROPN
fnp-2613	183	52	;	;	PUNCT
fnp-2613	183	53	for	for	ADP
fnp-2613	183	54	testing	testing	NOUN
fnp-2613	183	55	disability	disability	NOUN
fnp-2613	183	56	rapid	rapid	ADJ
fnp-2613	183	57	disability	disability	NOUN
fnp-2613	183	58	rating	rating	NOUN
fnp-2613	183	59	scale-2123	scale-2123	NOUN
fnp-2613	183	60	;	;	PUNCT
fnp-2613	183	61	for	for	ADP
fnp-2613	183	62	diagnosing	diagnose	VERB
fnp-2613	183	63	visual	visual	ADJ
fnp-2613	183	64	hallucinations	hallucination	NOUN
fnp-2613	183	65	or	or	CCONJ
fnp-2613	183	66	other	other	ADJ
fnp-2613	183	67	psychiatric	psychiatric	ADJ
fnp-2613	183	68	disorders	disorder	NOUN
fnp-2613	183	69	–	–	PUNCT
fnp-2613	183	70	neuropsychiatric	neuropsychiatric	ADJ
fnp-2613	183	71	inventory124	inventory124	PROPN
fnp-2613	183	72	;	;	PUNCT
fnp-2613	183	73	for	for	ADP
fnp-2613	183	74	measuring	measure	VERB
fnp-2613	183	75	effects	effect	NOUN
fnp-2613	183	76	of	of	ADP
fnp-2613	183	77	comorbidities	comorbiditie	NOUN
fnp-2613	183	78	–	–	PUNCT
fnp-2613	183	79	cumulative	cumulative	ADJ
fnp-2613	183	80	illness	illness	NOUN
fnp-2613	183	81	rating	rating	NOUN
fnp-2613	183	82	scale118	scale118	PROPN
fnp-2613	183	83	.	.	PUNCT
fnp-2613	184	1	additional	additional	ADJ
fnp-2613	184	2	difficulty	difficulty	NOUN
fnp-2613	184	3	is	be	AUX
fnp-2613	184	4	to	to	PART
fnp-2613	184	5	make	make	VERB
fnp-2613	184	6	a	a	DET
fnp-2613	184	7	distinction	distinction	NOUN
fnp-2613	184	8	,	,	PUNCT
fnp-2613	184	9	if	if	SCONJ
fnp-2613	184	10	it	it	PRON
fnp-2613	184	11	exists	exist	VERB
fnp-2613	184	12	,	,	PUNCT
fnp-2613	184	13	between	between	ADP
fnp-2613	184	14	dlb	dlb	NOUN
fnp-2613	184	15	and	and	CCONJ
fnp-2613	184	16	parkinson	parkinson	NOUN
fnp-2613	184	17	’s	’s	PART
fnp-2613	184	18	disease	disease	NOUN
fnp-2613	184	19	dementia	dementia	NOUN
fnp-2613	184	20	.	.	PUNCT
fnp-2613	185	1	the	the	DET
fnp-2613	185	2	question	question	NOUN
fnp-2613	185	3	,	,	PUNCT
fnp-2613	185	4	whether	whether	SCONJ
fnp-2613	185	5	dlb	dlb	NOUN
fnp-2613	185	6	and	and	CCONJ
fnp-2613	185	7	pdd	pdd	NOUN
fnp-2613	185	8	are	be	AUX
fnp-2613	185	9	different	different	ADJ
fnp-2613	185	10	entities	entity	NOUN
fnp-2613	185	11	or	or	CCONJ
fnp-2613	185	12	the	the	DET
fnp-2613	185	13	same	same	ADJ
fnp-2613	185	14	one	one	NUM
fnp-2613	185	15	,	,	PUNCT
fnp-2613	185	16	is	be	AUX
fnp-2613	185	17	still	still	ADV
fnp-2613	185	18	debated	debate	VERB
fnp-2613	185	19	.	.	PUNCT
fnp-2613	186	1	although	although	SCONJ
fnp-2613	186	2	there	there	PRON
fnp-2613	186	3	are	be	VERB
fnp-2613	186	4	a	a	DET
fnp-2613	186	5	few	few	ADJ
fnp-2613	186	6	morphologic	morphologic	ADJ
fnp-2613	186	7	differences	difference	NOUN
fnp-2613	186	8	between	between	ADP
fnp-2613	186	9	them	they	PRON
fnp-2613	186	10	(	(	PUNCT
fnp-2613	186	11	e.g.	e.g.	ADV
fnp-2613	186	12	cortical	cortical	ADJ
fnp-2613	186	13	spreading	spreading	NOUN
fnp-2613	186	14	of	of	ADP
fnp-2613	186	15	lbs	lbs	NOUN
fnp-2613	186	16	or	or	CCONJ
fnp-2613	186	17	rate	rate	NOUN
fnp-2613	186	18	of	of	ADP
fnp-2613	186	19	neuronal	neuronal	ADJ
fnp-2613	186	20	loss	loss	NOUN
fnp-2613	186	21	in	in	ADP
fnp-2613	186	22	sn)125	sn)125	ADJ
fnp-2613	186	23	,	,	PUNCT
fnp-2613	186	24	differential	differential	ADJ
fnp-2613	186	25	diagnosis	diagnosis	NOUN
fnp-2613	186	26	is	be	AUX
fnp-2613	186	27	rather	rather	ADV
fnp-2613	186	28	based	base	VERB
fnp-2613	186	29	on	on	ADP
fnp-2613	186	30	the	the	DET
fnp-2613	186	31	temporal	temporal	ADJ
fnp-2613	186	32	sequence	sequence	NOUN
fnp-2613	186	33	of	of	ADP
fnp-2613	186	34	symptoms	symptom	NOUN
fnp-2613	186	35	.	.	PUNCT
fnp-2613	187	1	if	if	SCONJ
fnp-2613	187	2	dementia	dementia	NOUN
fnp-2613	187	3	occurs	occur	VERB
fnp-2613	187	4	1	1	NUM
fnp-2613	187	5	year	year	NOUN
fnp-2613	187	6	after	after	ADP
fnp-2613	187	7	the	the	DET
fnp-2613	187	8	onset	onset	NOUN
fnp-2613	187	9	of	of	ADP
fnp-2613	187	10	extrapyramidal	extrapyramidal	ADJ
fnp-2613	187	11	motor	motor	NOUN
fnp-2613	187	12	signs	sign	NOUN
fnp-2613	187	13	,	,	PUNCT
fnp-2613	187	14	it	it	PRON
fnp-2613	187	15	is	be	AUX
fnp-2613	187	16	considered	consider	VERB
fnp-2613	187	17	as	as	ADP
fnp-2613	187	18	pdd	pdd	NOUN
fnp-2613	187	19	,	,	PUNCT
fnp-2613	187	20	otherwise	otherwise	ADV
fnp-2613	187	21	if	if	SCONJ
fnp-2613	187	22	dementia	dementia	NOUN
fnp-2613	187	23	has	have	AUX
fnp-2613	187	24	proceeded	proceed	VERB
fnp-2613	187	25	or	or	CCONJ
fnp-2613	187	26	presented	present	VERB
fnp-2613	187	27	within	within	ADP
fnp-2613	187	28	1	1	NUM
fnp-2613	187	29	year	year	NOUN
fnp-2613	187	30	after	after	ADP
fnp-2613	187	31	movement	movement	NOUN
fnp-2613	187	32	disorder	disorder	NOUN
fnp-2613	187	33	,	,	PUNCT
fnp-2613	187	34	the	the	DET
fnp-2613	187	35	diagnosis	diagnosis	NOUN
fnp-2613	187	36	should	should	AUX
fnp-2613	187	37	be	be	AUX
fnp-2613	187	38	dlb126	dlb126	NOUN
fnp-2613	187	39	.	.	PUNCT
fnp-2613	188	1	the	the	DET
fnp-2613	188	2	latest	late	ADJ
fnp-2613	188	3	mckeith	mckeith	NOUN
fnp-2613	188	4	diagnostic	diagnostic	ADJ
fnp-2613	188	5	criteria	criterion	NOUN
fnp-2613	188	6	define	define	VERB
fnp-2613	188	7	probable	probable	ADJ
fnp-2613	188	8	and	and	CCONJ
fnp-2613	188	9	possible	possible	ADJ
fnp-2613	188	10	dlb	dlb	NOUN
fnp-2613	188	11	based	base	VERB
fnp-2613	188	12	on	on	ADP
fnp-2613	188	13	the	the	DET
fnp-2613	188	14	clinical	clinical	ADJ
fnp-2613	188	15	symptoms	symptom	NOUN
fnp-2613	188	16	and	and	CCONJ
fnp-2613	188	17	biomarkers	biomarker	NOUN
fnp-2613	188	18	(	(	PUNCT
fnp-2613	188	19	figure	figure	NOUN
fnp-2613	188	20	2)20	2)20	VERB
fnp-2613	188	21	.	.	PUNCT
fnp-2613	189	1	the	the	DET
fnp-2613	189	2	presence	presence	NOUN
fnp-2613	189	3	of	of	ADP
fnp-2613	189	4	dementia	dementia	NOUN
fnp-2613	189	5	,	,	PUNCT
fnp-2613	189	6	memory	memory	NOUN
fnp-2613	189	7	impairment	impairment	NOUN
fnp-2613	189	8	and	and	CCONJ
fnp-2613	189	9	deficit	deficit	NOUN
fnp-2613	189	10	of	of	ADP
fnp-2613	189	11	attention	attention	NOUN
fnp-2613	189	12	,	,	PUNCT
fnp-2613	189	13	executive	executive	NOUN
fnp-2613	189	14	functions	function	NOUN
fnp-2613	189	15	and	and	CCONJ
fnp-2613	189	16	visuospatial	visuospatial	ADJ
fnp-2613	189	17	orientation	orientation	NOUN
fnp-2613	189	18	is	be	AUX
fnp-2613	189	19	essential	essential	ADJ
fnp-2613	189	20	for	for	ADP
fnp-2613	189	21	diagnosis	diagnosis	NOUN
fnp-2613	189	22	.	.	PUNCT
fnp-2613	190	1	core	core	NOUN
fnp-2613	190	2	symptoms	symptom	NOUN
fnp-2613	190	3	are	be	AUX
fnp-2613	190	4	frequently	frequently	ADV
fnp-2613	190	5	observed	observe	VERB
fnp-2613	190	6	in	in	ADP
fnp-2613	190	7	dlb	dlb	PROPN
fnp-2613	190	8	clinical	clinical	ADJ
fnp-2613	190	9	syndrome	syndrome	NOUN
fnp-2613	190	10	;	;	PUNCT
fnp-2613	190	11	in	in	ADP
fnp-2613	190	12	the	the	DET
fnp-2613	190	13	lack	lack	NOUN
fnp-2613	190	14	of	of	ADP
fnp-2613	190	15	at	at	ADV
fnp-2613	190	16	least	least	ADV
fnp-2613	190	17	one	one	NUM
fnp-2613	190	18	core	core	NOUN
fnp-2613	190	19	feature	feature	NOUN
fnp-2613	190	20	,	,	PUNCT
fnp-2613	190	21	the	the	DET
fnp-2613	190	22	probable	probable	ADJ
fnp-2613	190	23	dlb	dlb	NOUN
fnp-2613	190	24	diagnosis	diagnosis	NOUN
fnp-2613	190	25	can	can	AUX
fnp-2613	190	26	not	not	PART
fnp-2613	190	27	be	be	AUX
fnp-2613	190	28	established	establish	VERB
fnp-2613	190	29	.	.	PUNCT
fnp-2613	191	1	the	the	DET
fnp-2613	191	2	development	development	NOUN
fnp-2613	191	3	of	of	ADP
fnp-2613	191	4	diagnostic	diagnostic	ADJ
fnp-2613	191	5	techniques	technique	NOUN
fnp-2613	191	6	revealed	reveal	VERB
fnp-2613	191	7	that	that	SCONJ
fnp-2613	191	8	rem	rem	VERB
fnp-2613	191	9	sleep	sleep	NOUN
fnp-2613	191	10	behaviour	behaviour	NOUN
fnp-2613	191	11	disorder	disorder	NOUN
fnp-2613	191	12	is	be	AUX
fnp-2613	191	13	more	more	ADV
fnp-2613	191	14	characteristic	characteristic	ADJ
fnp-2613	191	15	of	of	ADP
fnp-2613	191	16	lbd	lbd	PROPN
fnp-2613	191	17	than	than	SCONJ
fnp-2613	191	18	it	it	PRON
fnp-2613	191	19	was	be	AUX
fnp-2613	191	20	previously	previously	ADV
fnp-2613	191	21	thought	think	VERB
fnp-2613	191	22	.	.	PUNCT
fnp-2613	192	1	therefore	therefore	ADV
fnp-2613	192	2	,	,	PUNCT
fnp-2613	192	3	mckeith	mckeith	PROPN
fnp-2613	192	4	et	et	PROPN
fnp-2613	192	5	al	al	PROPN
fnp-2613	192	6	.	.	PROPN
fnp-2613	192	7	recategorized	recategorize	VERB
fnp-2613	192	8	rbd	rbd	NOUN
fnp-2613	192	9	from	from	ADP
fnp-2613	192	10	supportive	supportive	ADJ
fnp-2613	192	11	to	to	ADP
fnp-2613	192	12	core	core	NOUN
fnp-2613	192	13	features20	features20	NOUN
fnp-2613	192	14	.	.	PUNCT
fnp-2613	193	1	supportive	supportive	ADJ
fnp-2613	193	2	features	feature	NOUN
fnp-2613	193	3	may	may	AUX
fnp-2613	193	4	help	help	VERB
fnp-2613	193	5	the	the	DET
fnp-2613	193	6	clinicians	clinician	NOUN
fnp-2613	193	7	;	;	PUNCT
fnp-2613	193	8	however	however	ADV
fnp-2613	193	9	,	,	PUNCT
fnp-2613	193	10	these	these	DET
fnp-2613	193	11	symptoms	symptom	NOUN
fnp-2613	193	12	are	be	AUX
fnp-2613	193	13	not	not	PART
fnp-2613	193	14	specific	specific	ADJ
fnp-2613	193	15	to	to	ADP
fnp-2613	193	16	dlb	dlb	NOUN
fnp-2613	193	17	and	and	CCONJ
fnp-2613	193	18	their	their	PRON
fnp-2613	193	19	presence	presence	NOUN
fnp-2613	193	20	is	be	AUX
fnp-2613	193	21	not	not	PART
fnp-2613	193	22	required	require	VERB
fnp-2613	193	23	for	for	ADP
fnp-2613	193	24	the	the	DET
fnp-2613	193	25	diagnosis	diagnosis	NOUN
fnp-2613	193	26	of	of	ADP
fnp-2613	193	27	neither	neither	CCONJ
fnp-2613	193	28	probable	probable	ADJ
fnp-2613	193	29	nor	nor	CCONJ
fnp-2613	193	30	possible	possible	ADJ
fnp-2613	193	31	dlb	dlb	NOUN
fnp-2613	193	32	.	.	PUNCT
fnp-2613	194	1	the	the	DET
fnp-2613	194	2	refreshed	refresh	VERB
fnp-2613	194	3	criteria	criterion	NOUN
fnp-2613	194	4	emphasize	emphasize	VERB
fnp-2613	194	5	the	the	DET
fnp-2613	194	6	importance	importance	NOUN
fnp-2613	194	7	of	of	ADP
fnp-2613	194	8	disease	disease	NOUN
fnp-2613	194	9	-	-	PUNCT
fnp-2613	194	10	specific	specific	ADJ
fnp-2613	194	11	biomarkers	biomarker	NOUN
fnp-2613	194	12	.	.	PUNCT
fnp-2613	195	1	one	one	NUM
fnp-2613	195	2	indicative	indicative	ADJ
fnp-2613	195	3	biomarker	biomarker	NOUN
fnp-2613	195	4	itself	itself	PRON
fnp-2613	195	5	is	be	AUX
fnp-2613	195	6	sufficient	sufficient	ADJ
fnp-2613	195	7	for	for	ADP
fnp-2613	195	8	possible	possible	ADJ
fnp-2613	195	9	dlb	dlb	NOUN
fnp-2613	195	10	diagnosis	diagnosis	NOUN
fnp-2613	195	11	.	.	PUNCT
fnp-2613	196	1	if	if	SCONJ
fnp-2613	196	2	one	one	NUM
fnp-2613	196	3	indicative	indicative	ADJ
fnp-2613	196	4	biomarker	biomarker	NOUN
fnp-2613	196	5	associates	associate	NOUN
fnp-2613	196	6	with	with	ADP
fnp-2613	196	7	one	one	NUM
fnp-2613	196	8	core	core	NOUN
fnp-2613	196	9	symptom	symptom	NOUN
fnp-2613	196	10	,	,	PUNCT
fnp-2613	196	11	the	the	DET
fnp-2613	196	12	diagnosis	diagnosis	NOUN
fnp-2613	196	13	is	be	AUX
fnp-2613	196	14	probable	probable	ADJ
fnp-2613	196	15	dlb	dlb	NOUN
fnp-2613	196	16	.	.	PUNCT
fnp-2613	197	1	figure	figure	NOUN
fnp-2613	197	2	2	2	NUM
fnp-2613	197	3	:	:	PUNCT
fnp-2613	197	4	symptoms	symptom	NOUN
fnp-2613	197	5	and	and	CCONJ
fnp-2613	197	6	biomarkers	biomarker	NOUN
fnp-2613	197	7	contribute	contribute	VERB
fnp-2613	197	8	to	to	ADP
fnp-2613	197	9	the	the	DET
fnp-2613	197	10	diagnosis	diagnosis	NOUN
fnp-2613	197	11	of	of	ADP
fnp-2613	197	12	probable	probable	ADJ
fnp-2613	197	13	or	or	CCONJ
fnp-2613	197	14	possible	possible	ADJ
fnp-2613	197	15	dementia	dementia	NOUN
fnp-2613	197	16	with	with	ADP
fnp-2613	197	17	lewy	lewy	ADJ
fnp-2613	197	18	bodies	body	NOUN
fnp-2613	197	19	(	(	PUNCT
fnp-2613	197	20	dlb	dlb	PROPN
fnp-2613	197	21	)	)	PUNCT
fnp-2613	197	22	.	.	PUNCT
fnp-2613	198	1	essential	essential	ADJ
fnp-2613	198	2	symptoms	symptom	NOUN
fnp-2613	198	3	are	be	AUX
fnp-2613	198	4	mandatory	mandatory	ADJ
fnp-2613	198	5	for	for	ADP
fnp-2613	198	6	diagnosis	diagnosis	NOUN
fnp-2613	198	7	of	of	ADP
fnp-2613	198	8	dlb	dlb	PROPN
fnp-2613	198	9	.	.	PUNCT
fnp-2613	199	1	core	core	ADJ
fnp-2613	199	2	clinical	clinical	ADJ
fnp-2613	199	3	symptoms	symptom	NOUN
fnp-2613	199	4	are	be	AUX
fnp-2613	199	5	characteristic	characteristic	ADJ
fnp-2613	199	6	to	to	ADP
fnp-2613	199	7	dlb	dlb	VERB
fnp-2613	199	8	,	,	PUNCT
fnp-2613	199	9	while	while	SCONJ
fnp-2613	199	10	supportive	supportive	ADJ
fnp-2613	199	11	symptoms	symptom	NOUN
fnp-2613	199	12	can	can	AUX
fnp-2613	199	13	confirm	confirm	VERB
fnp-2613	199	14	the	the	DET
fnp-2613	199	15	decision	decision	NOUN
fnp-2613	199	16	by	by	ADP
fnp-2613	199	17	clinicians	clinician	NOUN
fnp-2613	199	18	.	.	PUNCT
fnp-2613	200	1	indicative	indicative	ADJ
fnp-2613	200	2	biomarkers	biomarker	NOUN
fnp-2613	200	3	are	be	AUX
fnp-2613	200	4	frequently	frequently	ADV
fnp-2613	200	5	observed	observe	VERB
fnp-2613	200	6	in	in	ADP
fnp-2613	200	7	dlb	dlb	PROPN
fnp-2613	200	8	,	,	PUNCT
fnp-2613	200	9	while	while	SCONJ
fnp-2613	200	10	supportive	supportive	ADJ
fnp-2613	200	11	biomarkers	biomarker	NOUN
fnp-2613	200	12	can	can	AUX
fnp-2613	200	13	facilitate	facilitate	VERB
fnp-2613	200	14	the	the	DET
fnp-2613	200	15	decision	decision	NOUN
fnp-2613	200	16	-	-	PUNCT
fnp-2613	200	17	making	make	VERB
fnp-2613	200	18	procedure	procedure	NOUN
fnp-2613	200	19	.	.	PUNCT
fnp-2613	201	1	important	important	ADJ
fnp-2613	201	2	to	to	PART
fnp-2613	201	3	note	note	VERB
fnp-2613	201	4	that	that	SCONJ
fnp-2613	201	5	clinicians	clinician	NOUN
fnp-2613	201	6	can	can	AUX
fnp-2613	201	7	not	not	PART
fnp-2613	201	8	establish	establish	VERB
fnp-2613	201	9	the	the	DET
fnp-2613	201	10	diagnosis	diagnosis	NOUN
fnp-2613	201	11	of	of	ADP
fnp-2613	201	12	probable	probable	ADJ
fnp-2613	201	13	dlb	dlb	NOUN
fnp-2613	201	14	based	base	VERB
fnp-2613	201	15	on	on	ADP
fnp-2613	201	16	the	the	DET
fnp-2613	201	17	biomarkers	biomarker	NOUN
fnp-2613	201	18	.	.	PUNCT
fnp-2613	202	1	(	(	PUNCT
fnp-2613	202	2	recategorized	recategorize	VERB
fnp-2613	202	3	or	or	CCONJ
fnp-2613	202	4	newly	newly	ADV
fnp-2613	202	5	added	add	VERB
fnp-2613	202	6	features	feature	NOUN
fnp-2613	202	7	are	be	AUX
fnp-2613	202	8	highlighted	highlight	VERB
fnp-2613	202	9	in	in	ADP
fnp-2613	202	10	blue	blue	ADJ
fnp-2613	202	11	colour	colour	NOUN
fnp-2613	202	12	;	;	PUNCT
fnp-2613	202	13	rem	rem	X
fnp-2613	202	14	=	=	SYM
fnp-2613	202	15	rapid	rapid	ADJ
fnp-2613	202	16	eye	eye	NOUN
fnp-2613	202	17	movement	movement	NOUN
fnp-2613	202	18	;	;	PUNCT
fnp-2613	202	19	dat	dat	ADJ
fnp-2613	202	20	=	=	PUNCT
fnp-2613	202	21	dopamine	dopamine	NOUN
fnp-2613	202	22	transporter	transporter	NOUN
fnp-2613	202	23	;	;	PUNCT
fnp-2613	202	24	mibg	mibg	NOUN
fnp-2613	202	25	=	=	SYM
fnp-2613	202	26	metaiodobenzylguanidine	metaiodobenzylguanidine	NOUN
fnp-2613	202	27	;	;	PUNCT
fnp-2613	202	28	psg	psg	PROPN
fnp-2613	202	29	=	=	SYM
fnp-2613	202	30	polysomnography	polysomnography	NOUN
fnp-2613	202	31	;	;	PUNCT
fnp-2613	202	32	rbd	rbd	NOUN
fnp-2613	202	33	=	=	PUNCT
fnp-2613	202	34	rem	rem	PROPN
fnp-2613	202	35	sleep	sleep	NOUN
fnp-2613	202	36	behavior	behavior	NOUN
fnp-2613	202	37	disorder	disorder	NOUN
fnp-2613	202	38	;	;	PUNCT
fnp-2613	202	39	spect	spect	NOUN
fnp-2613	202	40	=	=	SYM
fnp-2613	202	41	single	single	ADJ
fnp-2613	202	42	-	-	PUNCT
fnp-2613	202	43	photon	photon	NOUN
fnp-2613	202	44	emission	emission	NOUN
fnp-2613	202	45	computed	compute	VERB
fnp-2613	202	46	tomography	tomography	NOUN
fnp-2613	202	47	;	;	PUNCT
fnp-2613	202	48	pet	pet	ADJ
fnp-2613	202	49	=	=	NOUN
fnp-2613	202	50	positron	positron	NOUN
fnp-2613	202	51	-	-	PUNCT
fnp-2613	202	52	emission	emission	NOUN
fnp-2613	202	53	tomography	tomography	NOUN
fnp-2613	202	54	;	;	PUNCT
fnp-2613	202	55	eeg	eeg	PROPN
fnp-2613	202	56	=	=	SYM
fnp-2613	202	57	electroencephalography	electroencephalography	NOUN
fnp-2613	202	58	;	;	PUNCT
fnp-2613	202	59	↓	↓	NOUN
fnp-2613	202	60	=	=	SYM
fnp-2613	202	61	decrease	decrease	NOUN
fnp-2613	202	62	)	)	PUNCT
fnp-2613	202	63	.	.	PUNCT
fnp-2613	203	1	[	[	X
fnp-2613	203	2	adapted	adapt	VERB
fnp-2613	203	3	from	from	ADP
fnp-2613	203	4	mckeith	mckeith	PROPN
fnp-2613	203	5	et	et	PROPN
fnp-2613	203	6	al.20	al.20	PROPN
fnp-2613	203	7	]	]	PUNCT
fnp-2613	203	8	therapy	therapy	NOUN
fnp-2613	203	9	there	there	PRON
fnp-2613	203	10	are	be	VERB
fnp-2613	203	11	two	two	NUM
fnp-2613	203	12	different	different	ADJ
fnp-2613	203	13	therapeutic	therapeutic	ADJ
fnp-2613	203	14	approaches	approach	NOUN
fnp-2613	203	15	:	:	PUNCT
fnp-2613	203	16	pharmacologic	pharmacologic	ADJ
fnp-2613	203	17	and	and	CCONJ
fnp-2613	203	18	non	non	ADJ
fnp-2613	203	19	-	-	ADJ
fnp-2613	203	20	pharmacologic	pharmacologic	ADJ
fnp-2613	203	21	.	.	PUNCT
fnp-2613	204	1	although	although	SCONJ
fnp-2613	204	2	there	there	PRON
fnp-2613	204	3	is	be	VERB
fnp-2613	204	4	no	no	DET
fnp-2613	204	5	curative	curative	ADJ
fnp-2613	204	6	treatment	treatment	NOUN
fnp-2613	204	7	strategy	strategy	NOUN
fnp-2613	204	8	,	,	PUNCT
fnp-2613	204	9	the	the	DET
fnp-2613	204	10	adequate	adequate	ADJ
fnp-2613	204	11	therapy	therapy	NOUN
fnp-2613	204	12	may	may	AUX
fnp-2613	204	13	slow	slow	VERB
fnp-2613	204	14	the	the	DET
fnp-2613	204	15	disease	disease	NOUN
fnp-2613	204	16	progression	progression	NOUN
fnp-2613	204	17	with	with	ADP
fnp-2613	204	18	the	the	DET
fnp-2613	204	19	chance	chance	NOUN
fnp-2613	204	20	of	of	ADP
fnp-2613	204	21	a	a	DET
fnp-2613	204	22	better	well	ADJ
fnp-2613	204	23	quality	quality	NOUN
fnp-2613	204	24	of	of	ADP
fnp-2613	204	25	life	life	NOUN
fnp-2613	204	26	.	.	PUNCT
fnp-2613	205	1	non	non	ADJ
fnp-2613	205	2	-	-	ADJ
fnp-2613	205	3	pharmacologic	pharmacologic	ADJ
fnp-2613	205	4	interventions	intervention	NOUN
fnp-2613	205	5	at	at	ADP
fnp-2613	205	6	the	the	DET
fnp-2613	205	7	first	first	ADJ
fnp-2613	205	8	signs	sign	NOUN
fnp-2613	205	9	of	of	ADP
fnp-2613	205	10	dlb	dlb	NOUN
fnp-2613	205	11	or	or	CCONJ
fnp-2613	205	12	mild	mild	ADJ
fnp-2613	205	13	ncd	ncd	NOUN
fnp-2613	205	14	,	,	PUNCT
fnp-2613	205	15	installation	installation	NOUN
fnp-2613	205	16	of	of	ADP
fnp-2613	205	17	the	the	DET
fnp-2613	205	18	below	below	NOUN
fnp-2613	205	19	mentioned	mention	VERB
fnp-2613	205	20	interventions	intervention	NOUN
fnp-2613	205	21	are	be	AUX
fnp-2613	205	22	recommended	recommend	VERB
fnp-2613	205	23	.	.	PUNCT
fnp-2613	206	1	changes	change	NOUN
fnp-2613	206	2	in	in	ADP
fnp-2613	206	3	the	the	DET
fnp-2613	206	4	dietary	dietary	ADJ
fnp-2613	206	5	habit	habit	NOUN
fnp-2613	206	6	,	,	PUNCT
fnp-2613	206	7	mediterranean	mediterranean	PROPN
fnp-2613	206	8	diet	diet	PROPN
fnp-2613	206	9	,	,	PUNCT
fnp-2613	206	10	and	and	CCONJ
fnp-2613	206	11	regularly	regularly	ADV
fnp-2613	206	12	performed	perform	VERB
fnp-2613	206	13	social	social	ADJ
fnp-2613	206	14	and	and	CCONJ
fnp-2613	206	15	mental	mental	ADJ
fnp-2613	206	16	tasks	task	NOUN
fnp-2613	206	17	as	as	ADV
fnp-2613	206	18	well	well	ADV
fnp-2613	206	19	as	as	ADP
fnp-2613	206	20	physical	physical	ADJ
fnp-2613	206	21	activities	activity	NOUN
fnp-2613	206	22	could	could	AUX
fnp-2613	206	23	reduce	reduce	VERB
fnp-2613	206	24	the	the	DET
fnp-2613	206	25	rate	rate	NOUN
fnp-2613	206	26	of	of	ADP
fnp-2613	206	27	progression127	progression127	PROPN
fnp-2613	206	28	.	.	PUNCT
fnp-2613	207	1	personalized	personalize	VERB
fnp-2613	207	2	cognitive	cognitive	ADJ
fnp-2613	207	3	rehabilitation	rehabilitation	NOUN
fnp-2613	207	4	trainings	training	NOUN
fnp-2613	207	5	with	with	ADP
fnp-2613	207	6	focus	focus	NOUN
fnp-2613	207	7	on	on	ADP
fnp-2613	207	8	the	the	DET
fnp-2613	207	9	declined	decline	VERB
fnp-2613	207	10	field	field	NOUN
fnp-2613	207	11	,	,	PUNCT
fnp-2613	207	12	improve	improve	VERB
fnp-2613	207	13	both	both	DET
fnp-2613	207	14	quality	quality	NOUN
fnp-2613	207	15	of	of	ADP
fnp-2613	207	16	life	life	NOUN
fnp-2613	207	17	and	and	CCONJ
fnp-2613	207	18	memory128	memory128	PROPN
fnp-2613	207	19	.	.	PUNCT
fnp-2613	208	1	pharmacologic	pharmacologic	ADJ
fnp-2613	208	2	treatments	treatment	NOUN
fnp-2613	208	3	the	the	DET
fnp-2613	208	4	frequently	frequently	ADV
fnp-2613	208	5	noted	note	VERB
fnp-2613	208	6	extrapyramidal	extrapyramidal	ADJ
fnp-2613	208	7	signs	sign	NOUN
fnp-2613	208	8	should	should	AUX
fnp-2613	208	9	be	be	AUX
fnp-2613	208	10	treated	treat	VERB
fnp-2613	208	11	with	with	ADP
fnp-2613	208	12	the	the	DET
fnp-2613	208	13	smallest	small	ADJ
fnp-2613	208	14	effective	effective	ADJ
fnp-2613	208	15	dose	dose	NOUN
fnp-2613	208	16	of	of	ADP
fnp-2613	208	17	levodopa	levodopa	NOUN
fnp-2613	208	18	,	,	PUNCT
fnp-2613	208	19	to	to	PART
fnp-2613	208	20	avoid	avoid	VERB
fnp-2613	208	21	the	the	DET
fnp-2613	208	22	worsening	worsening	NOUN
fnp-2613	208	23	of	of	ADP
fnp-2613	208	24	psychiatric	psychiatric	ADJ
fnp-2613	208	25	symptoms129	symptoms129	PROPN
fnp-2613	208	26	.	.	PUNCT
fnp-2613	209	1	selective	selective	ADJ
fnp-2613	209	2	serotonin	serotonin	NOUN
fnp-2613	209	3	reuptake	reuptake	NOUN
fnp-2613	209	4	inhibitors	inhibitor	NOUN
fnp-2613	209	5	(	(	PUNCT
fnp-2613	209	6	ssris	ssris	NOUN
fnp-2613	209	7	)	)	PUNCT
fnp-2613	209	8	are	be	AUX
fnp-2613	209	9	widely	widely	ADV
fnp-2613	209	10	-	-	PUNCT
fnp-2613	209	11	used	use	VERB
fnp-2613	209	12	and	and	CCONJ
fnp-2613	209	13	considered	consider	VERB
fnp-2613	209	14	as	as	ADP
fnp-2613	209	15	effective	effective	ADJ
fnp-2613	209	16	medications	medication	NOUN
fnp-2613	209	17	for	for	ADP
fnp-2613	209	18	depression130	depression130	PROPN
fnp-2613	209	19	.	.	PUNCT
fnp-2613	210	1	in	in	ADP
fnp-2613	210	2	the	the	DET
fnp-2613	210	3	case	case	NOUN
fnp-2613	210	4	of	of	ADP
fnp-2613	210	5	rem	rem	NOUN
fnp-2613	210	6	sleep	sleep	NOUN
fnp-2613	210	7	behaviour	behaviour	NOUN
fnp-2613	210	8	disorder	disorder	NOUN
fnp-2613	210	9	,	,	PUNCT
fnp-2613	210	10	clonazepam	clonazepam	NOUN
fnp-2613	210	11	and	and	CCONJ
fnp-2613	210	12	melatonin	melatonin	NOUN
fnp-2613	210	13	also	also	ADV
fnp-2613	210	14	have	have	VERB
fnp-2613	210	15	beneficial	beneficial	ADJ
fnp-2613	210	16	effect131	effect131	PROPN
fnp-2613	210	17	acetyl	acetyl	NOUN
fnp-2613	210	18	-	-	PUNCT
fnp-2613	210	19	cholinesterase	cholinesterase	NOUN
fnp-2613	210	20	inhibitors	inhibitor	NOUN
fnp-2613	210	21	(	(	PUNCT
fnp-2613	210	22	chat	chat	VERB
fnp-2613	210	23	-	-	PUNCT
fnp-2613	210	24	i	i	NOUN
fnp-2613	210	25	)	)	PUNCT
fnp-2613	210	26	have	have	VERB
fnp-2613	210	27	benefits	benefit	NOUN
fnp-2613	210	28	in	in	ADP
fnp-2613	210	29	the	the	DET
fnp-2613	210	30	treatment	treatment	NOUN
fnp-2613	210	31	of	of	ADP
fnp-2613	210	32	psychiatric	psychiatric	ADJ
fnp-2613	210	33	disturbances	disturbance	NOUN
fnp-2613	210	34	such	such	ADJ
fnp-2613	210	35	as	as	ADP
fnp-2613	210	36	visual	visual	ADJ
fnp-2613	210	37	hallucination	hallucination	NOUN
fnp-2613	210	38	,	,	PUNCT
fnp-2613	210	39	delusions	delusion	NOUN
fnp-2613	210	40	,	,	PUNCT
fnp-2613	210	41	behaviour	behaviour	NOUN
fnp-2613	210	42	disorders	disorder	NOUN
fnp-2613	210	43	or	or	CCONJ
fnp-2613	210	44	apathy	apathy	NOUN
fnp-2613	210	45	.	.	PUNCT
fnp-2613	211	1	despite	despite	SCONJ
fnp-2613	211	2	gastrointestinal	gastrointestinal	ADJ
fnp-2613	211	3	side	side	NOUN
fnp-2613	211	4	effects	effect	NOUN
fnp-2613	211	5	(	(	PUNCT
fnp-2613	211	6	i.e.	i.e.	X
fnp-2613	211	7	vomiting	vomiting	NOUN
fnp-2613	211	8	,	,	PUNCT
fnp-2613	211	9	diarrhoea	diarrhoea	NOUN
fnp-2613	211	10	)	)	PUNCT
fnp-2613	211	11	these	these	DET
fnp-2613	211	12	drugs	drug	NOUN
fnp-2613	211	13	are	be	AUX
fnp-2613	211	14	usually	usually	ADV
fnp-2613	211	15	well	well	ADV
fnp-2613	211	16	tolerated20	tolerated20	ADJ
fnp-2613	211	17	.	.	PUNCT
fnp-2613	212	1	if	if	SCONJ
fnp-2613	212	2	chat	chat	NOUN
fnp-2613	212	3	-	-	PUNCT
fnp-2613	212	4	is	be	AUX
fnp-2613	212	5	(	(	PUNCT
fnp-2613	212	6	rivastigmine	rivastigmine	ADJ
fnp-2613	212	7	,	,	PUNCT
fnp-2613	212	8	donepezil	donepezil	PROPN
fnp-2613	212	9	)	)	PUNCT
fnp-2613	212	10	are	be	AUX
fnp-2613	212	11	not	not	PART
fnp-2613	212	12	effective	effective	ADJ
fnp-2613	212	13	,	,	PUNCT
fnp-2613	212	14	the	the	DET
fnp-2613	212	15	use	use	NOUN
fnp-2613	212	16	of	of	ADP
fnp-2613	212	17	atypical	atypical	ADJ
fnp-2613	212	18	neuroleptic	neuroleptic	ADJ
fnp-2613	212	19	drugs	drug	NOUN
fnp-2613	212	20	(	(	PUNCT
fnp-2613	212	21	i.e.	i.e.	X
fnp-2613	212	22	clozapine	clozapine	NOUN
fnp-2613	212	23	)	)	PUNCT
fnp-2613	212	24	might	might	AUX
fnp-2613	212	25	be	be	AUX
fnp-2613	212	26	inevitable	inevitable	ADJ
fnp-2613	212	27	,	,	PUNCT
fnp-2613	212	28	but	but	CCONJ
fnp-2613	212	29	typical	typical	ADJ
fnp-2613	212	30	neuroleptics	neuroleptic	NOUN
fnp-2613	212	31	should	should	AUX
fnp-2613	212	32	be	be	AUX
fnp-2613	212	33	avoided	avoid	VERB
fnp-2613	212	34	to	to	PART
fnp-2613	212	35	minimize	minimize	VERB
fnp-2613	212	36	the	the	DET
fnp-2613	212	37	possibility	possibility	NOUN
fnp-2613	212	38	of	of	ADP
fnp-2613	212	39	severe	severe	ADJ
fnp-2613	212	40	neuroleptic	neuroleptic	ADJ
fnp-2613	212	41	hypersensitivity	hypersensitivity	NOUN
fnp-2613	212	42	reaction132	reaction132	PROPN
fnp-2613	212	43	.	.	PUNCT
fnp-2613	213	1	chat	chat	PROPN
fnp-2613	213	2	-	-	PUNCT
fnp-2613	213	3	is	be	AUX
fnp-2613	213	4	are	be	AUX
fnp-2613	213	5	more	more	ADV
fnp-2613	213	6	effective	effective	ADJ
fnp-2613	213	7	in	in	ADP
fnp-2613	213	8	patients	patient	NOUN
fnp-2613	213	9	with	with	ADP
fnp-2613	213	10	dlb	dlb	NOUN
fnp-2613	213	11	compared	compare	VERB
fnp-2613	213	12	to	to	ADP
fnp-2613	213	13	patients	patient	NOUN
fnp-2613	213	14	with	with	ADP
fnp-2613	213	15	ad	ad	NOUN
fnp-2613	213	16	.	.	PUNCT
fnp-2613	214	1	these	these	DET
fnp-2613	214	2	drugs	drug	NOUN
fnp-2613	214	3	improve	improve	VERB
fnp-2613	214	4	the	the	DET
fnp-2613	214	5	cognitive	cognitive	ADJ
fnp-2613	214	6	functions	function	NOUN
fnp-2613	214	7	,	,	PUNCT
fnp-2613	214	8	reduce	reduce	VERB
fnp-2613	214	9	fluctuation	fluctuation	NOUN
fnp-2613	214	10	,	,	PUNCT
fnp-2613	214	11	decrease	decrease	VERB
fnp-2613	214	12	the	the	DET
fnp-2613	214	13	progression	progression	NOUN
fnp-2613	214	14	and	and	CCONJ
fnp-2613	214	15	in	in	ADP
fnp-2613	214	16	addition	addition	NOUN
fnp-2613	214	17	patients	patient	NOUN
fnp-2613	214	18	score	score	VERB
fnp-2613	214	19	better	well	ADV
fnp-2613	214	20	on	on	ADP
fnp-2613	214	21	neuropsychological	neuropsychological	ADJ
fnp-2613	214	22	tests133	tests133	PROPN
fnp-2613	214	23	.	.	PROPN
fnp-2613	214	24	n	n	CCONJ
fnp-2613	214	25	-	-	PUNCT
fnp-2613	214	26	methyl	methyl	NOUN
fnp-2613	214	27	-	-	PUNCT
fnp-2613	214	28	d	d	NOUN
fnp-2613	214	29	-	-	PUNCT
fnp-2613	214	30	aspartate	aspartate	ADJ
fnp-2613	214	31	receptor	receptor	NOUN
fnp-2613	214	32	(	(	PUNCT
fnp-2613	214	33	nmda	nmda	NOUN
fnp-2613	214	34	-	-	PUNCT
fnp-2613	214	35	r	r	NOUN
fnp-2613	214	36	)	)	PUNCT
fnp-2613	214	37	antagonist	antagonist	NOUN
fnp-2613	214	38	memantine	memantine	NOUN
fnp-2613	214	39	is	be	AUX
fnp-2613	214	40	also	also	ADV
fnp-2613	214	41	useful	useful	ADJ
fnp-2613	214	42	in	in	ADP
fnp-2613	214	43	the	the	DET
fnp-2613	214	44	treatment	treatment	NOUN
fnp-2613	214	45	of	of	ADP
fnp-2613	214	46	cognitive	cognitive	ADJ
fnp-2613	214	47	decline134	decline134	PROPN
fnp-2613	214	48	.	.	PROPN
fnp-2613	214	49	lucza	lucza	PROPN
fnp-2613	214	50	et	et	PROPN
fnp-2613	214	51	al	al	PROPN
fnp-2613	214	52	.	.	PROPN
fnp-2613	214	53	have	have	AUX
fnp-2613	214	54	suggested	suggest	VERB
fnp-2613	214	55	treatment	treatment	NOUN
fnp-2613	214	56	with	with	ADP
fnp-2613	214	57	chat	chat	NOUN
fnp-2613	214	58	-	-	PUNCT
fnp-2613	214	59	is	be	AUX
fnp-2613	214	60	in	in	ADP
fnp-2613	214	61	mild	mild	ADJ
fnp-2613	214	62	or	or	CCONJ
fnp-2613	214	63	mid	mid	ADJ
fnp-2613	214	64	-	-	ADJ
fnp-2613	214	65	severe	severe	ADJ
fnp-2613	214	66	dementia	dementia	NOUN
fnp-2613	214	67	and	and	CCONJ
fnp-2613	214	68	memantine	memantine	NOUN
fnp-2613	214	69	combined	combine	VERB
fnp-2613	214	70	with	with	ADP
fnp-2613	214	71	high	high	ADJ
fnp-2613	214	72	dose	dose	NOUN
fnp-2613	214	73	of	of	ADP
fnp-2613	214	74	rivastigmine	rivastigmine	NOUN
fnp-2613	214	75	(	(	PUNCT
fnp-2613	214	76	13.5	13.5	NUM
fnp-2613	214	77	mg	mg	NOUN
fnp-2613	214	78	)	)	PUNCT
fnp-2613	214	79	in	in	ADP
fnp-2613	214	80	severe	severe	ADJ
fnp-2613	214	81	dementia135	dementia135	PROPN
fnp-2613	214	82	.	.	PUNCT
fnp-2613	215	1	summary	summary	NOUN
fnp-2613	215	2	despite	despite	SCONJ
fnp-2613	215	3	the	the	DET
fnp-2613	215	4	continuously	continuously	ADV
fnp-2613	215	5	growing	grow	VERB
fnp-2613	215	6	incidence	incidence	NOUN
fnp-2613	215	7	of	of	ADP
fnp-2613	215	8	dementia	dementia	NOUN
fnp-2613	215	9	,	,	PUNCT
fnp-2613	215	10	which	which	PRON
fnp-2613	215	11	could	could	AUX
fnp-2613	215	12	be	be	AUX
fnp-2613	215	13	the	the	DET
fnp-2613	215	14	most	most	ADV
fnp-2613	215	15	prevalent	prevalent	ADJ
fnp-2613	215	16	disease	disease	NOUN
fnp-2613	215	17	within	within	ADP
fnp-2613	215	18	20	20	NUM
fnp-2613	215	19	years	year	NOUN
fnp-2613	215	20	in	in	ADP
fnp-2613	215	21	the	the	DET
fnp-2613	215	22	industrialized	industrialized	ADJ
fnp-2613	215	23	world	world	NOUN
fnp-2613	215	24	,	,	PUNCT
fnp-2613	215	25	our	our	PRON
fnp-2613	215	26	present	present	ADJ
fnp-2613	215	27	knowledge	knowledge	NOUN
fnp-2613	215	28	is	be	AUX
fnp-2613	215	29	still	still	ADV
fnp-2613	215	30	insufficient	insufficient	ADJ
fnp-2613	215	31	to	to	PART
fnp-2613	215	32	fully	fully	ADV
fnp-2613	215	33	comprehend	comprehend	VERB
fnp-2613	215	34	the	the	DET
fnp-2613	215	35	underlying	underlie	VERB
fnp-2613	215	36	pathomechanism	pathomechanism	NOUN
fnp-2613	215	37	.	.	PUNCT
fnp-2613	216	1	this	this	PRON
fnp-2613	216	2	is	be	AUX
fnp-2613	216	3	particularly	particularly	ADV
fnp-2613	216	4	true	true	ADJ
fnp-2613	216	5	for	for	ADP
fnp-2613	216	6	dlb	dlb	NOUN
fnp-2613	216	7	,	,	PUNCT
fnp-2613	216	8	which	which	PRON
fnp-2613	216	9	is	be	AUX
fnp-2613	216	10	the	the	DET
fnp-2613	216	11	second	second	ADJ
fnp-2613	216	12	most	most	ADV
fnp-2613	216	13	common	common	ADJ
fnp-2613	216	14	neurodegenerative	neurodegenerative	ADJ
fnp-2613	216	15	dementia	dementia	NOUN
fnp-2613	216	16	.	.	PUNCT
fnp-2613	217	1	etiology	etiology	NOUN
fnp-2613	217	2	of	of	ADP
fnp-2613	217	3	the	the	DET
fnp-2613	217	4	disorder	disorder	NOUN
fnp-2613	217	5	,	,	PUNCT
fnp-2613	217	6	its	its	PRON
fnp-2613	217	7	connection	connection	NOUN
fnp-2613	217	8	with	with	ADP
fnp-2613	217	9	aging	age	VERB
fnp-2613	217	10	,	,	PUNCT
fnp-2613	217	11	underlying	underlying	ADJ
fnp-2613	217	12	pathomechanisms	pathomechanism	NOUN
fnp-2613	217	13	of	of	ADP
fnp-2613	217	14	clinical	clinical	ADJ
fnp-2613	217	15	signs	sign	NOUN
fnp-2613	217	16	and	and	CCONJ
fnp-2613	217	17	imaging	imaging	NOUN
fnp-2613	217	18	findings	finding	NOUN
fnp-2613	217	19	are	be	AUX
fnp-2613	217	20	still	still	ADV
fnp-2613	217	21	in	in	ADP
fnp-2613	217	22	need	need	NOUN
fnp-2613	217	23	for	for	ADP
fnp-2613	217	24	further	further	ADJ
fnp-2613	217	25	elucidation	elucidation	NOUN
fnp-2613	217	26	.	.	PUNCT
fnp-2613	218	1	unfortunately	unfortunately	ADV
fnp-2613	218	2	,	,	PUNCT
fnp-2613	218	3	the	the	DET
fnp-2613	218	4	definitive	definitive	ADJ
fnp-2613	218	5	diagnosis	diagnosis	NOUN
fnp-2613	218	6	is	be	AUX
fnp-2613	218	7	possible	possible	ADJ
fnp-2613	218	8	only	only	ADV
fnp-2613	218	9	by	by	ADP
fnp-2613	218	10	post	post	ADJ
fnp-2613	218	11	-	-	ADJ
fnp-2613	218	12	mortem	mortem	ADJ
fnp-2613	218	13	histopathological	histopathological	ADJ
fnp-2613	218	14	examination	examination	NOUN
fnp-2613	218	15	and	and	CCONJ
fnp-2613	218	16	not	not	PART
fnp-2613	218	17	by	by	ADP
fnp-2613	218	18	in	in	ADP
fnp-2613	218	19	vivo	vivo	ADJ
fnp-2613	218	20	techniques	technique	NOUN
fnp-2613	218	21	(	(	PUNCT
fnp-2613	218	22	apart	apart	ADV
fnp-2613	218	23	from	from	ADP
fnp-2613	218	24	a	a	DET
fnp-2613	218	25	low	low	ADJ
fnp-2613	218	26	percentage	percentage	NOUN
fnp-2613	218	27	of	of	ADP
fnp-2613	218	28	cases	case	NOUN
fnp-2613	218	29	)	)	PUNCT
fnp-2613	218	30	.	.	PUNCT
fnp-2613	219	1	the	the	DET
fnp-2613	219	2	concomitant	concomitant	ADJ
fnp-2613	219	3	alzheimer’s	alzheimer’s	NOUN
fnp-2613	219	4	-	-	PUNCT
fnp-2613	219	5	type	type	NOUN
fnp-2613	219	6	and	and	CCONJ
fnp-2613	219	7	vascular	vascular	ADJ
fnp-2613	219	8	pathology	pathology	NOUN
fnp-2613	219	9	raises	raise	VERB
fnp-2613	219	10	issues	issue	NOUN
fnp-2613	219	11	regarding	regard	VERB
fnp-2613	219	12	diagnostic	diagnostic	ADJ
fnp-2613	219	13	clarity	clarity	NOUN
fnp-2613	219	14	and	and	CCONJ
fnp-2613	219	15	accuracy136	accuracy136	PROPN
fnp-2613	219	16	.	.	PUNCT
fnp-2613	220	1	future	future	ADJ
fnp-2613	220	2	research	research	NOUN
fnp-2613	220	3	should	should	AUX
fnp-2613	220	4	be	be	AUX
fnp-2613	220	5	multidisciplinary	multidisciplinary	ADJ
fnp-2613	220	6	and	and	CCONJ
fnp-2613	220	7	should	should	AUX
fnp-2613	220	8	include	include	VERB
fnp-2613	220	9	pathological	pathological	ADJ
fnp-2613	220	10	,	,	PUNCT
fnp-2613	220	11	proteomic	proteomic	ADJ
fnp-2613	220	12	,	,	PUNCT
fnp-2613	220	13	genetic	genetic	ADJ
fnp-2613	220	14	and	and	CCONJ
fnp-2613	220	15	epigenetic	epigenetic	ADJ
fnp-2613	220	16	approaches	approach	NOUN
fnp-2613	220	17	to	to	PART
fnp-2613	220	18	identify	identify	VERB
fnp-2613	220	19	the	the	DET
fnp-2613	220	20	key	key	ADJ
fnp-2613	220	21	factors	factor	NOUN
fnp-2613	220	22	of	of	ADP
fnp-2613	220	23	the	the	DET
fnp-2613	220	24	disease	disease	NOUN
fnp-2613	220	25	and	and	CCONJ
fnp-2613	220	26	reveal	reveal	VERB
fnp-2613	220	27	the	the	DET
fnp-2613	220	28	correlation	correlation	NOUN
fnp-2613	220	29	between	between	ADP
fnp-2613	220	30	clinical	clinical	ADJ
fnp-2613	220	31	symptoms	symptom	NOUN
fnp-2613	220	32	,	,	PUNCT
fnp-2613	220	33	radiological	radiological	ADJ
fnp-2613	220	34	alterations	alteration	NOUN
fnp-2613	220	35	and	and	CCONJ
fnp-2613	220	36	pathological	pathological	ADJ
fnp-2613	220	37	findings	finding	NOUN
fnp-2613	220	38	.	.	PUNCT
fnp-2613	221	1	development	development	NOUN
fnp-2613	221	2	of	of	ADP
fnp-2613	221	3	imaging	imaging	NOUN
fnp-2613	221	4	techniques	technique	NOUN
fnp-2613	221	5	brings	bring	VERB
fnp-2613	221	6	the	the	DET
fnp-2613	221	7	possibility	possibility	NOUN
fnp-2613	221	8	of	of	ADP
fnp-2613	221	9	in	in	ADP
fnp-2613	221	10	vivo	vivo	ADJ
fnp-2613	221	11	diagnosis	diagnosis	NOUN
fnp-2613	221	12	,	,	PUNCT
fnp-2613	221	13	which	which	PRON
fnp-2613	221	14	implies	imply	VERB
fnp-2613	221	15	adequate	adequate	ADJ
fnp-2613	221	16	treatments	treatment	NOUN
fnp-2613	221	17	in	in	ADP
fnp-2613	221	18	early	early	ADJ
fnp-2613	221	19	stages	stage	NOUN
fnp-2613	221	20	,	,	PUNCT
fnp-2613	221	21	a	a	DET
fnp-2613	221	22	crucial	crucial	ADJ
fnp-2613	221	23	advancement	advancement	NOUN
fnp-2613	221	24	to	to	PART
fnp-2613	221	25	ensure	ensure	VERB
fnp-2613	221	26	better	well	ADJ
fnp-2613	221	27	quality	quality	NOUN
fnp-2613	221	28	of	of	ADP
fnp-2613	221	29	life	life	NOUN
fnp-2613	221	30	.	.	PUNCT
fnp-2613	222	1	longitudinal	longitudinal	ADJ
fnp-2613	222	2	cohort	cohort	NOUN
fnp-2613	222	3	studies	study	NOUN
fnp-2613	222	4	are	be	AUX
fnp-2613	222	5	also	also	ADV
fnp-2613	222	6	required	require	VERB
fnp-2613	222	7	to	to	PART
fnp-2613	222	8	provide	provide	VERB
fnp-2613	222	9	detailed	detailed	ADJ
fnp-2613	222	10	prognostic	prognostic	ADJ
fnp-2613	222	11	information	information	NOUN
fnp-2613	222	12	that	that	PRON
fnp-2613	222	13	are	be	AUX
fnp-2613	222	14	essential	essential	ADJ
fnp-2613	222	15	for	for	ADP
fnp-2613	222	16	planning	plan	VERB
fnp-2613	222	17	a	a	DET
fnp-2613	222	18	more	more	ADV
fnp-2613	222	19	effective	effective	ADJ
fnp-2613	222	20	and	and	CCONJ
fnp-2613	222	21	cost	cost	NOUN
fnp-2613	222	22	-	-	PUNCT
fnp-2613	222	23	efficient	efficient	ADJ
fnp-2613	222	24	treatment	treatment	NOUN
fnp-2613	222	25	protocol	protocol	NOUN
fnp-2613	222	26	.	.	PUNCT
fnp-2613	223	1	author	author	NOUN
fnp-2613	223	2	’s	’s	PART
fnp-2613	223	3	contribution	contribution	NOUN
fnp-2613	223	4	authors	author	NOUN
fnp-2613	223	5	contributed	contribute	VERB
fnp-2613	223	6	equally	equally	ADV
fnp-2613	223	7	to	to	ADP
fnp-2613	223	8	the	the	DET
fnp-2613	223	9	work	work	NOUN
fnp-2613	223	10	.	.	PUNCT
fnp-2613	224	1	funding	funding	NOUN
fnp-2613	224	2	supported	support	VERB
fnp-2613	224	3	by	by	ADP
fnp-2613	224	4	the	the	DET
fnp-2613	224	5	únkp-19	únkp-19	PROPN
fnp-2613	224	6	-	-	PUNCT
fnp-2613	224	7	3	3	NUM
fnp-2613	224	8	new	new	ADJ
fnp-2613	224	9	national	national	PROPN
fnp-2613	224	10	excellence	excellence	PROPN
fnp-2613	224	11	program	program	NOUN
fnp-2613	224	12	of	of	ADP
fnp-2613	224	13	the	the	DET
fnp-2613	224	14	ministry	ministry	PROPN
fnp-2613	224	15	of	of	ADP
fnp-2613	224	16	innovation	innovation	NOUN
fnp-2613	224	17	and	and	CCONJ
fnp-2613	224	18	technology	technology	NOUN
fnp-2613	224	19	and	and	CCONJ
fnp-2613	224	20	efop-3.6.3	efop-3.6.3	NUM
fnp-2613	224	21	-	-	PUNCT
fnp-2613	224	22	vekop-16	vekop-16	PROPN
fnp-2613	224	23	-	-	PUNCT
fnp-2613	224	24	2017	2017	NUM
fnp-2613	224	25	-	-	PUNCT
fnp-2613	224	26	00009	00009	NUM
fnp-2613	224	27	(	(	PUNCT
fnp-2613	224	28	j.b	j.b	PROPN
fnp-2613	224	29	.	.	PROPN
fnp-2613	224	30	)	)	PUNCT
fnp-2613	224	31	;	;	PUNCT
fnp-2613	224	32	ginop-2.3.2	ginop-2.3.2	PROPN
fnp-2613	224	33	-	-	SYM
fnp-2613	224	34	15	15	NUM
fnp-2613	224	35	-	-	PUNCT
fnp-2613	224	36	2016	2016	NUM
fnp-2613	224	37	-	-	PUNCT
fnp-2613	224	38	00043	00043	NUM
fnp-2613	224	39	,	,	PUNCT
fnp-2613	224	40	hungarian	hungarian	ADJ
fnp-2613	224	41	brain	brain	NOUN
fnp-2613	224	42	research	research	NOUN
fnp-2613	224	43	program	program	NOUN
fnp-2613	224	44	(	(	PUNCT
fnp-2613	224	45	2017	2017	NUM
fnp-2613	224	46	-	-	PUNCT
fnp-2613	224	47	1.2.1	1.2.1	NUM
fnp-2613	224	48	-	-	PUNCT
fnp-2613	224	49	nkp-2017	nkp-2017	NOUN
fnp-2613	224	50	-	-	PUNCT
fnp-2613	224	51	00002	00002	NUM
fnp-2613	224	52	)	)	PUNCT
fnp-2613	224	53	,	,	PUNCT
fnp-2613	224	54	nkfih	nkfih	VERB
fnp-2613	224	55	snn	snn	PROPN
fnp-2613	224	56	132999	132999	NUM
fnp-2613	224	57	,	,	PUNCT
fnp-2613	224	58	szte	szte	ADJ
fnp-2613	224	59	áok	áok	PROPN
fnp-2613	224	60	-	-	PROPN
fnp-2613	224	61	kka	kka	PROPN
fnp-2613	224	62	no	no	INTJ
fnp-2613	224	63	.	.	PUNCT
fnp-2613	225	1	5s	5s	NUM
fnp-2613	225	2	567	567	NUM
fnp-2613	225	3	(	(	PUNCT
fnp-2613	225	4	a202	a202	PROPN
fnp-2613	225	5	)	)	PUNCT
fnp-2613	225	6	and	and	CCONJ
fnp-2613	225	7	de	de	X
fnp-2613	225	8	áok	áok	PROPN
fnp-2613	225	9	research	research	NOUN
fnp-2613	225	10	fund	fund	NOUN
fnp-2613	225	11	(	(	PUNCT
fnp-2613	225	12	t.h	t.h	PROPN
fnp-2613	225	13	.	.	PUNCT
fnp-2613	225	14	)	)	PUNCT
fnp-2613	225	15	.	.	PUNCT
fnp-2613	226	1	this	this	DET
fnp-2613	226	2	paper	paper	NOUN
fnp-2613	226	3	represents	represent	VERB
fnp-2613	226	4	independent	independent	ADJ
fnp-2613	226	5	study	study	NOUN
fnp-2613	226	6	partly	partly	ADV
fnp-2613	226	7	funded	fund	VERB
fnp-2613	226	8	by	by	ADP
fnp-2613	226	9	the	the	DET
fnp-2613	226	10	national	national	PROPN
fnp-2613	226	11	institute	institute	PROPN
fnp-2613	226	12	for	for	ADP
fnp-2613	226	13	health	health	NOUN
fnp-2613	226	14	research	research	NOUN
fnp-2613	226	15	(	(	PUNCT
fnp-2613	226	16	nihr	nihr	ADJ
fnp-2613	226	17	)	)	PUNCT
fnp-2613	226	18	biomedical	biomedical	ADJ
fnp-2613	226	19	research	research	NOUN
fnp-2613	226	20	centre	centre	NOUN
fnp-2613	226	21	at	at	ADP
fnp-2613	226	22	south	south	PROPN
fnp-2613	226	23	london	london	PROPN
fnp-2613	226	24	and	and	CCONJ
fnp-2613	226	25	maudsley	maudsley	PROPN
fnp-2613	226	26	nhs	nhs	PROPN
fnp-2613	226	27	foundation	foundation	PROPN
fnp-2613	226	28	trust	trust	PROPN
fnp-2613	226	29	and	and	CCONJ
fnp-2613	226	30	king	king	NOUN
fnp-2613	226	31	’s	’s	PART
fnp-2613	226	32	college	college	PROPN
fnp-2613	226	33	london	london	PROPN
fnp-2613	226	34	.	.	PUNCT
fnp-2613	227	1	the	the	DET
fnp-2613	227	2	views	view	NOUN
fnp-2613	227	3	expressed	express	VERB
fnp-2613	227	4	are	be	AUX
fnp-2613	227	5	those	those	PRON
fnp-2613	227	6	of	of	ADP
fnp-2613	227	7	the	the	DET
fnp-2613	227	8	author(s	author(s	NOUN
fnp-2613	227	9	)	)	PUNCT
fnp-2613	227	10	and	and	CCONJ
fnp-2613	227	11	not	not	PART
fnp-2613	227	12	necessarily	necessarily	ADV
fnp-2613	227	13	those	those	PRON
fnp-2613	227	14	of	of	ADP
fnp-2613	227	15	the	the	DET
fnp-2613	227	16	nhs	nhs	NOUN
fnp-2613	227	17	,	,	PUNCT
fnp-2613	227	18	the	the	DET
fnp-2613	227	19	nihr	nihr	ADJ
fnp-2613	227	20	or	or	CCONJ
fnp-2613	227	21	the	the	DET
fnp-2613	227	22	department	department	NOUN
fnp-2613	227	23	of	of	ADP
fnp-2613	227	24	health	health	PROPN
fnp-2613	227	25	and	and	CCONJ
fnp-2613	227	26	social	social	ADJ
fnp-2613	227	27	care	care	NOUN
fnp-2613	227	28	.	.	PUNCT
fnp-2613	228	1	references	reference	NOUN
fnp-2613	228	2	1	1	NUM
fnp-2613	228	3	.	.	PUNCT
fnp-2613	229	1	tsuang	tsuang	PROPN
fnp-2613	229	2	,	,	PUNCT
fnp-2613	229	3	d.	d.	PROPN
fnp-2613	229	4	w.	w.	PROPN
fnp-2613	229	5	et	et	PROPN
fnp-2613	229	6	al	al	PROPN
fnp-2613	229	7	.	.	PROPN
fnp-2613	229	8	familial	familial	ADJ
fnp-2613	229	9	dementia	dementia	NOUN
fnp-2613	229	10	with	with	ADP
fnp-2613	229	11	lewy	lewy	PROPN
fnp-2613	229	12	bodies	body	NOUN
fnp-2613	229	13	:	:	PUNCT
fnp-2613	229	14	a	a	DET
fnp-2613	229	15	clinical	clinical	ADJ
fnp-2613	229	16	and	and	CCONJ
fnp-2613	229	17	neuropathological	neuropathological	ADJ
fnp-2613	229	18	study	study	NOUN
fnp-2613	229	19	of	of	ADP
fnp-2613	229	20	2	2	NUM
fnp-2613	229	21	families	family	NOUN
fnp-2613	229	22	.	.	PUNCT
fnp-2613	230	1	arch	arch	NOUN
fnp-2613	230	2	.	.	PUNCT
fnp-2613	231	1	neurol	neurol	NOUN
fnp-2613	231	2	.	.	PUNCT
fnp-2613	232	1	59	59	NUM
fnp-2613	232	2	,	,	PUNCT
fnp-2613	232	3	1622–30	1622–30	NUM
fnp-2613	232	4	(	(	PUNCT
fnp-2613	232	5	2002	2002	NUM
fnp-2613	232	6	)	)	PUNCT
fnp-2613	232	7	.	.	PUNCT
fnp-2613	233	1	2	2	X
fnp-2613	233	2	.	.	X
fnp-2613	233	3	zarranz	zarranz	PROPN
fnp-2613	233	4	,	,	PUNCT
fnp-2613	233	5	j.	j.	PROPN
fnp-2613	233	6	j.	j.	PROPN
fnp-2613	233	7	et	et	PROPN
fnp-2613	233	8	al	al	PROPN
fnp-2613	233	9	.	.	PUNCT
fnp-2613	234	1	the	the	DET
fnp-2613	234	2	new	new	ADJ
fnp-2613	234	3	mutation	mutation	NOUN
fnp-2613	234	4	,	,	PUNCT
fnp-2613	234	5	e46k	e46k	PROPN
fnp-2613	234	6	,	,	PUNCT
fnp-2613	234	7	of	of	ADP
fnp-2613	234	8	alpha	alpha	NOUN
fnp-2613	234	9	-	-	PUNCT
fnp-2613	234	10	synuclein	synuclein	NOUN
fnp-2613	234	11	causes	cause	VERB
fnp-2613	234	12	parkinson	parkinson	NOUN
fnp-2613	234	13	and	and	CCONJ
fnp-2613	234	14	lewy	lewy	PROPN
fnp-2613	234	15	body	body	NOUN
fnp-2613	234	16	dementia	dementia	NOUN
fnp-2613	234	17	.	.	PUNCT
fnp-2613	235	1	ann	ann	PROPN
fnp-2613	235	2	.	.	PUNCT
fnp-2613	236	1	neurol	neurol	PROPN
fnp-2613	236	2	.	.	PUNCT
fnp-2613	237	1	55	55	NUM
fnp-2613	237	2	,	,	PUNCT
fnp-2613	237	3	164–73	164–73	NUM
fnp-2613	237	4	(	(	PUNCT
fnp-2613	237	5	2004	2004	NUM
fnp-2613	237	6	)	)	PUNCT
fnp-2613	237	7	.	.	PUNCT
fnp-2613	238	1	3	3	X
fnp-2613	238	2	.	.	X
fnp-2613	238	3	bras	bras	NOUN
fnp-2613	238	4	,	,	PUNCT
fnp-2613	238	5	j.	j.	PROPN
fnp-2613	238	6	et	et	PROPN
fnp-2613	238	7	al	al	PROPN
fnp-2613	238	8	.	.	PUNCT
fnp-2613	239	1	genetic	genetic	ADJ
fnp-2613	239	2	analysis	analysis	NOUN
fnp-2613	239	3	implicates	implicate	VERB
fnp-2613	239	4	apoe	apoe	ADV
fnp-2613	239	5	,	,	PUNCT
fnp-2613	239	6	snca	snca	NOUN
fnp-2613	239	7	and	and	CCONJ
fnp-2613	239	8	suggests	suggest	VERB
fnp-2613	239	9	lysosomal	lysosomal	ADJ
fnp-2613	239	10	dysfunction	dysfunction	NOUN
fnp-2613	239	11	in	in	ADP
fnp-2613	239	12	the	the	DET
fnp-2613	239	13	etiology	etiology	NOUN
fnp-2613	239	14	of	of	ADP
fnp-2613	239	15	dementia	dementia	NOUN
fnp-2613	239	16	with	with	ADP
fnp-2613	239	17	lewy	lewy	PROPN
fnp-2613	239	18	bodies	body	NOUN
fnp-2613	239	19	.	.	PUNCT
fnp-2613	240	1	hum	hum	ADJ
fnp-2613	240	2	.	.	PUNCT
fnp-2613	241	1	mol	mol	PROPN
fnp-2613	241	2	.	.	PUNCT
fnp-2613	242	1	genet	genet	NOUN
fnp-2613	242	2	.	.	PUNCT
fnp-2613	243	1	23	23	NUM
fnp-2613	243	2	,	,	PUNCT
fnp-2613	243	3	6139–46	6139–46	NUM
fnp-2613	243	4	(	(	PUNCT
fnp-2613	243	5	2014	2014	NUM
fnp-2613	243	6	)	)	PUNCT
fnp-2613	243	7	.	.	PUNCT
fnp-2613	244	1	4	4	X
fnp-2613	244	2	.	.	X
fnp-2613	244	3	takao	takao	NOUN
fnp-2613	244	4	,	,	PUNCT
fnp-2613	244	5	m.	m.	NOUN
fnp-2613	244	6	et	et	PROPN
fnp-2613	244	7	al	al	PROPN
fnp-2613	244	8	.	.	PUNCT
fnp-2613	245	1	early	early	ADJ
fnp-2613	245	2	-	-	PUNCT
fnp-2613	245	3	onset	onset	NOUN
fnp-2613	245	4	dementia	dementia	NOUN
fnp-2613	245	5	with	with	ADP
fnp-2613	245	6	lewy	lewy	PROPN
fnp-2613	245	7	bodies	body	NOUN
fnp-2613	245	8	.	.	PUNCT
fnp-2613	246	1	brain	brain	NOUN
fnp-2613	246	2	pathol	pathol	NOUN
fnp-2613	246	3	.	.	PUNCT
fnp-2613	247	1	14	14	NUM
fnp-2613	247	2	,	,	PUNCT
fnp-2613	247	3	137–147	137–147	NUM
fnp-2613	247	4	(	(	PUNCT
fnp-2613	247	5	2004	2004	NUM
fnp-2613	247	6	)	)	PUNCT
fnp-2613	247	7	.	.	PUNCT
fnp-2613	248	1	5	5	X
fnp-2613	248	2	.	.	X
fnp-2613	248	3	hogan	hogan	PROPN
fnp-2613	248	4	,	,	PUNCT
fnp-2613	248	5	d.	d.	PROPN
fnp-2613	248	6	b.	b.	PROPN
fnp-2613	248	7	et	et	PROPN
fnp-2613	248	8	al	al	PROPN
fnp-2613	248	9	.	.	PUNCT
fnp-2613	249	1	the	the	DET
fnp-2613	249	2	prevalence	prevalence	NOUN
fnp-2613	249	3	and	and	CCONJ
fnp-2613	249	4	incidence	incidence	NOUN
fnp-2613	249	5	of	of	ADP
fnp-2613	249	6	dementia	dementia	NOUN
fnp-2613	249	7	with	with	ADP
fnp-2613	249	8	lewy	lewy	PROPN
fnp-2613	249	9	bodies	body	NOUN
fnp-2613	249	10	:	:	PUNCT
fnp-2613	249	11	a	a	DET
fnp-2613	249	12	systematic	systematic	ADJ
fnp-2613	249	13	review	review	NOUN
fnp-2613	249	14	.	.	PUNCT
fnp-2613	250	1	can	can	AUX
fnp-2613	250	2	.	.	PUNCT
fnp-2613	251	1	j.	j.	PROPN
fnp-2613	251	2	neurol	neurol	PROPN
fnp-2613	251	3	.	.	PUNCT
fnp-2613	252	1	sci	sci	PROPN
fnp-2613	252	2	.	.	PROPN
fnp-2613	252	3	43	43	NUM
fnp-2613	252	4	,	,	PUNCT
fnp-2613	252	5	s83	s83	NOUN
fnp-2613	252	6	–	–	PUNCT
fnp-2613	252	7	s95	s95	NOUN
fnp-2613	252	8	(	(	PUNCT
fnp-2613	252	9	2016	2016	NUM
fnp-2613	252	10	)	)	PUNCT
fnp-2613	252	11	.	.	PUNCT
fnp-2613	253	1	6	6	X
fnp-2613	253	2	.	.	X
fnp-2613	253	3	aarsland	aarsland	PROPN
fnp-2613	253	4	,	,	PUNCT
fnp-2613	253	5	d.	d.	PROPN
fnp-2613	253	6	cognitive	cognitive	PROPN
fnp-2613	253	7	impairment	impairment	NOUN
fnp-2613	253	8	in	in	ADP
fnp-2613	253	9	parkinson	parkinson	NOUN
fnp-2613	253	10	’s	’s	PART
fnp-2613	253	11	disease	disease	NOUN
fnp-2613	253	12	and	and	CCONJ
fnp-2613	253	13	dementia	dementia	NOUN
fnp-2613	253	14	with	with	ADP
fnp-2613	253	15	lewy	lewy	PROPN
fnp-2613	253	16	bodies	body	NOUN
fnp-2613	253	17	.	.	PUNCT
fnp-2613	254	1	park	park	NOUN
fnp-2613	254	2	.	.	PUNCT
fnp-2613	255	1	relat	relat	PROPN
fnp-2613	255	2	.	.	PUNCT
fnp-2613	256	1	disord	disord	PROPN
fnp-2613	256	2	.	.	PUNCT
fnp-2613	257	1	22	22	NUM
fnp-2613	257	2	,	,	PUNCT
fnp-2613	257	3	s144	s144	PROPN
fnp-2613	257	4	–	–	PUNCT
fnp-2613	257	5	s148	s148	PROPN
fnp-2613	257	6	(	(	PUNCT
fnp-2613	257	7	2016	2016	NUM
fnp-2613	257	8	)	)	PUNCT
fnp-2613	257	9	.	.	PUNCT
fnp-2613	258	1	7	7	X
fnp-2613	258	2	.	.	X
fnp-2613	258	3	love	love	NOUN
fnp-2613	258	4	,	,	PUNCT
fnp-2613	258	5	j.	j.	PROPN
fnp-2613	258	6	,	,	PUNCT
fnp-2613	258	7	kalaria	kalaria	PROPN
fnp-2613	258	8	r.	r.	PROPN
fnp-2613	258	9	dementia	dementia	PROPN
fnp-2613	258	10	.	.	PUNCT
fnp-2613	259	1	in	in	ADP
fnp-2613	259	2	:	:	PUNCT
fnp-2613	259	3	love	love	NOUN
fnp-2613	259	4	,	,	PUNCT
fnp-2613	259	5	s.	s.	PROPN
fnp-2613	259	6	et	et	PROPN
fnp-2613	259	7	al	al	PROPN
fnp-2613	259	8	.	.	PROPN
fnp-2613	259	9	greenfield	greenfield	PROPN
fnp-2613	259	10	’s	’s	PART
fnp-2613	259	11	neuropathology	neuropathology	NOUN
fnp-2613	259	12	.	.	PUNCT
fnp-2613	260	1	9th	9th	ADJ
fnp-2613	260	2	ed	ed	NOUN
fnp-2613	260	3	.	.	PROPN
fnp-2613	260	4	,	,	PUNCT
fnp-2613	260	5	pp	pp	ADJ
fnp-2613	260	6	.	.	PUNCT
fnp-2613	261	1	858	858	NUM
fnp-2613	261	2	-	-	SYM
fnp-2613	261	3	973	973	NUM
fnp-2613	261	4	,	,	PUNCT
fnp-2613	261	5	crc	crc	NOUN
fnp-2613	261	6	press	press	NOUN
fnp-2613	261	7	(	(	PUNCT
fnp-2613	261	8	2015	2015	NUM
fnp-2613	261	9	)	)	PUNCT
fnp-2613	261	10	.	.	PUNCT
fnp-2613	262	1	8	8	X
fnp-2613	262	2	.	.	X
fnp-2613	262	3	lewy	lewy	PROPN
fnp-2613	262	4	,	,	PUNCT
fnp-2613	262	5	f.	f.	PROPN
fnp-2613	262	6	h.	h.	PROPN
fnp-2613	262	7	paralysis	paralysis	NOUN
fnp-2613	262	8	agitans	agitan	NOUN
fnp-2613	262	9	.	.	PUNCT
fnp-2613	263	1	i.	i.	PROPN
fnp-2613	263	2	pathologische	pathologische	PROPN
fnp-2613	263	3	anatomie	anatomie	PROPN
fnp-2613	263	4	.	.	PROPN
fnp-2613	264	1	in	in	ADP
fnp-2613	264	2	:	:	PUNCT
fnp-2613	264	3	handb	handb	NOUN
fnp-2613	264	4	.	.	PUNCT
fnp-2613	265	1	der	der	ADJ
fnp-2613	265	2	neurol	neurol	NOUN
fnp-2613	265	3	.	.	PUNCT
fnp-2613	266	1	920–958	920–958	NUM
fnp-2613	266	2	,	,	PUNCT
fnp-2613	266	3	springer	springer	NOUN
fnp-2613	266	4	,	,	PUNCT
fnp-2613	266	5	berlin	berlin	PROPN
fnp-2613	266	6	(	(	PUNCT
fnp-2613	266	7	1912	1912	NUM
fnp-2613	266	8	)	)	PUNCT
fnp-2613	266	9	.	.	PUNCT
fnp-2613	267	1	9	9	X
fnp-2613	267	2	.	.	X
fnp-2613	267	3	wakabayashi	wakabayashi	PROPN
fnp-2613	267	4	,	,	PUNCT
fnp-2613	267	5	k.	k.	PROPN
fnp-2613	267	6	et	et	PROPN
fnp-2613	267	7	al	al	PROPN
fnp-2613	267	8	.	.	PUNCT
fnp-2613	268	1	the	the	DET
fnp-2613	268	2	lewy	lewy	PROPN
fnp-2613	268	3	body	body	NOUN
fnp-2613	268	4	in	in	ADP
fnp-2613	268	5	parkinson	parkinson	NOUN
fnp-2613	268	6	’s	’s	PART
fnp-2613	268	7	disease	disease	NOUN
fnp-2613	268	8	:	:	PUNCT
fnp-2613	268	9	molecules	molecule	NOUN
fnp-2613	268	10	implicated	implicate	VERB
fnp-2613	268	11	in	in	ADP
fnp-2613	268	12	the	the	DET
fnp-2613	268	13	formation	formation	NOUN
fnp-2613	268	14	and	and	CCONJ
fnp-2613	268	15	degradation	degradation	NOUN
fnp-2613	268	16	of	of	ADP
fnp-2613	268	17	alpha	alpha	NOUN
fnp-2613	268	18	-	-	PUNCT
fnp-2613	268	19	synuclein	synuclein	NOUN
fnp-2613	268	20	aggregates	aggregate	NOUN
fnp-2613	268	21	.	.	PUNCT
fnp-2613	269	1	neuropathology	neuropathology	NOUN
fnp-2613	269	2	27	27	NUM
fnp-2613	269	3	,	,	PUNCT
fnp-2613	269	4	494–506	494–506	NUM
fnp-2613	269	5	(	(	PUNCT
fnp-2613	269	6	2007	2007	NUM
fnp-2613	269	7	)	)	PUNCT
fnp-2613	269	8	.	.	PUNCT
fnp-2613	270	1	10	10	NUM
fnp-2613	270	2	.	.	X
fnp-2613	270	3	spillantini	spillantini	PROPN
fnp-2613	270	4	,	,	PUNCT
fnp-2613	270	5	m.	m.	NOUN
fnp-2613	271	1	g.	g.	PROPN
fnp-2613	271	2	et	et	PROPN
fnp-2613	271	3	al	al	PROPN
fnp-2613	271	4	.	.	PROPN
fnp-2613	271	5	alpha	alpha	PROPN
fnp-2613	271	6	-	-	PUNCT
fnp-2613	271	7	synuclein	synuclein	NOUN
fnp-2613	271	8	in	in	ADP
fnp-2613	271	9	filamentous	filamentous	ADJ
fnp-2613	271	10	inclusions	inclusion	NOUN
fnp-2613	271	11	of	of	ADP
fnp-2613	271	12	lewy	lewy	ADJ
fnp-2613	271	13	bodies	body	NOUN
fnp-2613	271	14	from	from	ADP
fnp-2613	271	15	parkinson	parkinson	NOUN
fnp-2613	271	16	’s	’s	PART
fnp-2613	271	17	disease	disease	NOUN
fnp-2613	271	18	and	and	CCONJ
fnp-2613	271	19	dementia	dementia	NOUN
fnp-2613	271	20	with	with	ADP
fnp-2613	271	21	lewy	lewy	PROPN
fnp-2613	271	22	bodies	body	NOUN
fnp-2613	271	23	.	.	PUNCT
fnp-2613	272	1	proc	proc	NOUN
fnp-2613	272	2	.	.	PUNCT
fnp-2613	273	1	natl	natl	PROPN
fnp-2613	273	2	.	.	PUNCT
fnp-2613	274	1	acad	acad	PROPN
fnp-2613	274	2	.	.	PUNCT
fnp-2613	275	1	sci	sci	PROPN
fnp-2613	275	2	.	.	PUNCT
fnp-2613	275	3	u.	u.	PROPN
fnp-2613	275	4	s.	s.	PROPN
fnp-2613	275	5	a.	a.	PROPN
fnp-2613	275	6	95	95	NUM
fnp-2613	275	7	,	,	PUNCT
fnp-2613	275	8	6469–73	6469–73	X
fnp-2613	275	9	(	(	PUNCT
fnp-2613	275	10	1998	1998	NUM
fnp-2613	275	11	)	)	PUNCT
fnp-2613	275	12	.	.	PUNCT
fnp-2613	276	1	11	11	NUM
fnp-2613	276	2	.	.	X
fnp-2613	277	1	luk	luk	PROPN
fnp-2613	277	2	,	,	PUNCT
fnp-2613	277	3	k.	k.	PROPN
fnp-2613	277	4	c.	c.	PROPN
fnp-2613	277	5	et	et	PROPN
fnp-2613	277	6	al	al	PROPN
fnp-2613	277	7	.	.	PROPN
fnp-2613	277	8	modeling	model	VERB
fnp-2613	277	9	lewy	lewy	PROPN
fnp-2613	277	10	pathology	pathology	PROPN
fnp-2613	277	11	propagation	propagation	NOUN
fnp-2613	277	12	in	in	ADP
fnp-2613	277	13	parkinson	parkinson	NOUN
fnp-2613	277	14	’s	’s	PART
fnp-2613	277	15	disease	disease	NOUN
fnp-2613	277	16	.	.	PUNCT
fnp-2613	278	1	park	park	NOUN
fnp-2613	278	2	.	.	PUNCT
fnp-2613	279	1	relat	relat	PROPN
fnp-2613	279	2	.	.	PUNCT
fnp-2613	280	1	disord	disord	NOUN
fnp-2613	280	2	.	.	PUNCT
fnp-2613	281	1	20	20	NUM
fnp-2613	281	2	,	,	PUNCT
fnp-2613	281	3	s85	s85	NOUN
fnp-2613	281	4	-	-	PUNCT
fnp-2613	281	5	7	7	NUM
fnp-2613	281	6	(	(	PUNCT
fnp-2613	281	7	2014	2014	NUM
fnp-2613	281	8	)	)	PUNCT
fnp-2613	281	9	.	.	PUNCT
fnp-2613	282	1	12	12	NUM
fnp-2613	282	2	.	.	PUNCT
fnp-2613	283	1	olanow	olanow	PROPN
fnp-2613	283	2	,	,	PUNCT
fnp-2613	283	3	c.	c.	PROPN
fnp-2613	283	4	w.	w.	PROPN
fnp-2613	283	5	et	et	PROPN
fnp-2613	283	6	al	al	PROPN
fnp-2613	283	7	.	.	PROPN
fnp-2613	283	8	lewy	lewy	PROPN
fnp-2613	283	9	-	-	PUNCT
fnp-2613	283	10	body	body	NOUN
fnp-2613	283	11	formation	formation	NOUN
fnp-2613	283	12	is	be	AUX
fnp-2613	283	13	an	an	DET
fnp-2613	283	14	aggresome	aggresome	ADV
fnp-2613	283	15	-	-	PUNCT
fnp-2613	283	16	related	relate	VERB
fnp-2613	283	17	process	process	NOUN
fnp-2613	283	18	:	:	PUNCT
fnp-2613	283	19	a	a	DET
fnp-2613	283	20	hypothesis	hypothesis	NOUN
fnp-2613	283	21	.	.	PUNCT
fnp-2613	284	1	lancet	lancet	PROPN
fnp-2613	284	2	neurol	neurol	PROPN
fnp-2613	284	3	.	.	PUNCT
fnp-2613	285	1	3	3	NUM
fnp-2613	285	2	,	,	PUNCT
fnp-2613	285	3	496–503	496–503	NUM
fnp-2613	285	4	(	(	PUNCT
fnp-2613	285	5	2004	2004	NUM
fnp-2613	285	6	)	)	PUNCT
fnp-2613	285	7	.	.	PUNCT
fnp-2613	286	1	13	13	NUM
fnp-2613	286	2	.	.	X
fnp-2613	286	3	alghamdi	alghamdi	NOUN
fnp-2613	286	4	,	,	PUNCT
fnp-2613	286	5	a.	a.	PROPN
fnp-2613	286	6	et	et	PROPN
fnp-2613	286	7	al	al	PROPN
fnp-2613	286	8	.	.	PROPN
fnp-2613	286	9	reduction	reduction	NOUN
fnp-2613	286	10	of	of	ADP
fnp-2613	286	11	rpt6	rpt6	PROPN
fnp-2613	286	12	/	/	SYM
fnp-2613	286	13	s8	s8	PROPN
fnp-2613	286	14	(	(	PUNCT
fnp-2613	286	15	a	a	DET
fnp-2613	286	16	proteasome	proteasome	NOUN
fnp-2613	286	17	component	component	NOUN
fnp-2613	286	18	)	)	PUNCT
fnp-2613	286	19	and	and	CCONJ
fnp-2613	286	20	proteasome	proteasome	NOUN
fnp-2613	286	21	activity	activity	NOUN
fnp-2613	286	22	in	in	ADP
fnp-2613	286	23	the	the	DET
fnp-2613	286	24	cortex	cortex	NOUN
fnp-2613	286	25	is	be	AUX
fnp-2613	286	26	associated	associate	VERB
fnp-2613	286	27	with	with	ADP
fnp-2613	286	28	cognitive	cognitive	ADJ
fnp-2613	286	29	impairment	impairment	NOUN
fnp-2613	286	30	in	in	ADP
fnp-2613	286	31	lewy	lewy	PROPN
fnp-2613	286	32	body	body	NOUN
fnp-2613	286	33	dementia	dementia	NOUN
fnp-2613	286	34	.	.	PUNCT
fnp-2613	287	1	j.	j.	PROPN
fnp-2613	287	2	alzheimers	alzheimers	PROPN
fnp-2613	287	3	dis	dis	PROPN
fnp-2613	287	4	.	.	PUNCT
fnp-2613	288	1	57	57	NUM
fnp-2613	288	2	,	,	PUNCT
fnp-2613	288	3	373–386	373–386	NUM
fnp-2613	288	4	(	(	PUNCT
fnp-2613	288	5	2017	2017	NUM
fnp-2613	288	6	)	)	PUNCT
fnp-2613	288	7	.	.	PUNCT
fnp-2613	289	1	14	14	NUM
fnp-2613	289	2	.	.	PUNCT
fnp-2613	290	1	cuervo	cuervo	PROPN
fnp-2613	290	2	,	,	PUNCT
fnp-2613	290	3	a.	a.	NOUN
fnp-2613	290	4	m.	m.	NOUN
fnp-2613	290	5	et	et	PROPN
fnp-2613	290	6	al	al	PROPN
fnp-2613	290	7	.	.	PROPN
fnp-2613	290	8	impaired	impair	VERB
fnp-2613	290	9	degradation	degradation	NOUN
fnp-2613	290	10	of	of	ADP
fnp-2613	290	11	mutant	mutant	ADJ
fnp-2613	290	12	alpha	alpha	NOUN
fnp-2613	290	13	-	-	PUNCT
fnp-2613	290	14	synuclein	synuclein	NOUN
fnp-2613	290	15	by	by	ADP
fnp-2613	290	16	chaperone	chaperone	NOUN
fnp-2613	290	17	-	-	PUNCT
fnp-2613	290	18	mediated	mediate	VERB
fnp-2613	290	19	autophagy	autophagy	NOUN
fnp-2613	290	20	.	.	PUNCT
fnp-2613	291	1	science	science	NOUN
fnp-2613	291	2	305	305	NUM
fnp-2613	291	3	,	,	PUNCT
fnp-2613	291	4	1292–5	1292–5	NUM
fnp-2613	291	5	(	(	PUNCT
fnp-2613	291	6	2004	2004	NUM
fnp-2613	291	7	)	)	PUNCT
fnp-2613	291	8	.	.	PUNCT
fnp-2613	292	1	15	15	X
fnp-2613	292	2	.	.	X
fnp-2613	292	3	baek	baek	NOUN
fnp-2613	292	4	,	,	PUNCT
fnp-2613	292	5	j.	j.	PROPN
fnp-2613	292	6	h.	h.	PROPN
fnp-2613	292	7	et	et	PROPN
fnp-2613	292	8	al	al	PROPN
fnp-2613	292	9	.	.	PROPN
fnp-2613	292	10	unfolded	unfold	VERB
fnp-2613	292	11	protein	protein	NOUN
fnp-2613	292	12	response	response	NOUN
fnp-2613	292	13	is	be	AUX
fnp-2613	292	14	activated	activate	VERB
fnp-2613	292	15	in	in	ADP
fnp-2613	292	16	lewy	lewy	ADJ
fnp-2613	292	17	body	body	NOUN
fnp-2613	292	18	dementias	dementia	NOUN
fnp-2613	292	19	.	.	PUNCT
fnp-2613	293	1	neuropathol	neuropathol	NOUN
fnp-2613	293	2	.	.	PUNCT
fnp-2613	294	1	appl	appl	PROPN
fnp-2613	294	2	.	.	PUNCT
fnp-2613	295	1	neurobiol	neurobiol	PROPN
fnp-2613	295	2	.	.	PUNCT
fnp-2613	296	1	42	42	NUM
fnp-2613	296	2	,	,	PUNCT
fnp-2613	296	3	352–365	352–365	NUM
fnp-2613	296	4	(	(	PUNCT
fnp-2613	296	5	2016	2016	NUM
fnp-2613	296	6	)	)	PUNCT
fnp-2613	296	7	.	.	PUNCT
fnp-2613	297	1	16	16	NUM
fnp-2613	297	2	.	.	PUNCT
fnp-2613	297	3	tompkins	tompkins	PROPN
fnp-2613	297	4	,	,	PUNCT
fnp-2613	297	5	m.	m.	NOUN
fnp-2613	297	6	m.	m.	NOUN
fnp-2613	297	7	et	et	PROPN
fnp-2613	297	8	al	al	PROPN
fnp-2613	297	9	.	.	PROPN
fnp-2613	297	10	contribution	contribution	NOUN
fnp-2613	297	11	of	of	ADP
fnp-2613	297	12	somal	somal	NOUN
fnp-2613	297	13	lewy	lewy	ADJ
fnp-2613	297	14	bodies	body	NOUN
fnp-2613	297	15	to	to	ADP
fnp-2613	297	16	neuronal	neuronal	ADJ
fnp-2613	297	17	death	death	NOUN
fnp-2613	297	18	.	.	PUNCT
fnp-2613	298	1	brain	brain	NOUN
fnp-2613	298	2	res	re	NOUN
fnp-2613	298	3	.	.	PUNCT
fnp-2613	299	1	775	775	NUM
fnp-2613	299	2	,	,	PUNCT
fnp-2613	299	3	24–9	24–9	NUM
fnp-2613	299	4	(	(	PUNCT
fnp-2613	299	5	1997	1997	NUM
fnp-2613	299	6	)	)	PUNCT
fnp-2613	299	7	.	.	PUNCT
fnp-2613	300	1	17	17	NUM
fnp-2613	300	2	.	.	X
fnp-2613	300	3	mori	mori	PROPN
fnp-2613	300	4	,	,	PUNCT
fnp-2613	300	5	f.	f.	PROPN
fnp-2613	300	6	et	et	PROPN
fnp-2613	300	7	al	al	PROPN
fnp-2613	300	8	.	.	PROPN
fnp-2613	300	9	relationship	relationship	NOUN
fnp-2613	300	10	among	among	ADP
fnp-2613	300	11	alpha	alpha	NOUN
fnp-2613	300	12	-	-	PUNCT
fnp-2613	300	13	synuclein	synuclein	NOUN
fnp-2613	300	14	accumulation	accumulation	NOUN
fnp-2613	300	15	,	,	PUNCT
fnp-2613	300	16	dopamine	dopamine	NOUN
fnp-2613	300	17	synthesis	synthesis	NOUN
fnp-2613	300	18	,	,	PUNCT
fnp-2613	300	19	and	and	CCONJ
fnp-2613	300	20	neurodegeneration	neurodegeneration	NOUN
fnp-2613	300	21	in	in	ADP
fnp-2613	300	22	parkinson	parkinson	NOUN
fnp-2613	300	23	disease	disease	NOUN
fnp-2613	300	24	substantia	substantia	NOUN
fnp-2613	300	25	nigra	nigra	PROPN
fnp-2613	300	26	.	.	PUNCT
fnp-2613	301	1	j.	j.	PROPN
fnp-2613	301	2	neuropathol	neuropathol	PROPN
fnp-2613	301	3	.	.	PUNCT
fnp-2613	302	1	exp	exp	PROPN
fnp-2613	302	2	.	.	PUNCT
fnp-2613	303	1	neurol	neurol	PROPN
fnp-2613	303	2	.	.	PUNCT
fnp-2613	304	1	65	65	NUM
fnp-2613	304	2	,	,	PUNCT
fnp-2613	304	3	808–15	808–15	NUM
fnp-2613	304	4	(	(	PUNCT
fnp-2613	304	5	2006	2006	NUM
fnp-2613	304	6	)	)	PUNCT
fnp-2613	304	7	.	.	PUNCT
fnp-2613	305	1	18	18	NUM
fnp-2613	305	2	.	.	PUNCT
fnp-2613	306	1	kosaka	kosaka	PROPN
fnp-2613	306	2	,	,	PUNCT
fnp-2613	306	3	k.	k.	PROPN
fnp-2613	306	4	et	et	PROPN
fnp-2613	306	5	al	al	PROPN
fnp-2613	306	6	.	.	PUNCT
fnp-2613	307	1	diffuse	diffuse	PROPN
fnp-2613	307	2	type	type	NOUN
fnp-2613	307	3	of	of	ADP
fnp-2613	307	4	lewy	lewy	ADJ
fnp-2613	307	5	body	body	NOUN
fnp-2613	307	6	disease	disease	NOUN
fnp-2613	307	7	:	:	PUNCT
fnp-2613	307	8	progressive	progressive	ADJ
fnp-2613	307	9	dementia	dementia	NOUN
fnp-2613	307	10	with	with	ADP
fnp-2613	307	11	abundant	abundant	ADJ
fnp-2613	307	12	cortical	cortical	ADJ
fnp-2613	307	13	lewy	lewy	ADJ
fnp-2613	307	14	bodies	body	NOUN
fnp-2613	307	15	and	and	CCONJ
fnp-2613	307	16	senile	senile	ADJ
fnp-2613	307	17	changes	change	NOUN
fnp-2613	307	18	of	of	ADP
fnp-2613	307	19	varying	vary	VERB
fnp-2613	307	20	degree	degree	NOUN
fnp-2613	307	21	--	--	PUNCT
fnp-2613	307	22	a	a	DET
fnp-2613	307	23	new	new	ADJ
fnp-2613	307	24	disease	disease	NOUN
fnp-2613	307	25	?	?	PUNCT
fnp-2613	308	1	clin	clin	PROPN
fnp-2613	308	2	.	.	PUNCT
fnp-2613	309	1	neuropathol	neuropathol	PROPN
fnp-2613	309	2	.	.	PUNCT
fnp-2613	310	1	3	3	NUM
fnp-2613	310	2	,	,	PUNCT
fnp-2613	310	3	185–92	185–92	NUM
fnp-2613	310	4	(	(	PUNCT
fnp-2613	310	5	1984	1984	NUM
fnp-2613	310	6	)	)	PUNCT
fnp-2613	310	7	.	.	PUNCT
fnp-2613	311	1	19	19	NUM
fnp-2613	311	2	.	.	X
fnp-2613	311	3	kuusisto	kuusisto	PROPN
fnp-2613	311	4	,	,	PUNCT
fnp-2613	311	5	e.	e.	PROPN
fnp-2613	311	6	et	et	PROPN
fnp-2613	311	7	al	al	PROPN
fnp-2613	311	8	.	.	PROPN
fnp-2613	311	9	morphogenesis	morphogenesis	NOUN
fnp-2613	311	10	of	of	ADP
fnp-2613	311	11	lewy	lewy	ADJ
fnp-2613	311	12	bodies	body	NOUN
fnp-2613	311	13	:	:	PUNCT
fnp-2613	311	14	dissimilar	dissimilar	ADJ
fnp-2613	311	15	incorporation	incorporation	NOUN
fnp-2613	311	16	of	of	ADP
fnp-2613	311	17	alpha	alpha	NOUN
fnp-2613	311	18	-	-	PUNCT
fnp-2613	311	19	synuclein	synuclein	NOUN
fnp-2613	311	20	,	,	PUNCT
fnp-2613	311	21	ubiquitin	ubiquitin	ADJ
fnp-2613	311	22	,	,	PUNCT
fnp-2613	311	23	and	and	CCONJ
fnp-2613	311	24	p62	p62	NOUN
fnp-2613	311	25	.	.	PUNCT
fnp-2613	312	1	j.	j.	PROPN
fnp-2613	312	2	neuropathol	neuropathol	PROPN
fnp-2613	312	3	.	.	PUNCT
fnp-2613	313	1	exp	exp	PROPN
fnp-2613	313	2	.	.	PUNCT
fnp-2613	314	1	neurol	neurol	PROPN
fnp-2613	314	2	.	.	PUNCT
fnp-2613	315	1	62	62	NUM
fnp-2613	315	2	,	,	PUNCT
fnp-2613	315	3	1241–53	1241–53	NUM
fnp-2613	315	4	(	(	PUNCT
fnp-2613	315	5	2003	2003	NUM
fnp-2613	315	6	)	)	PUNCT
fnp-2613	315	7	.	.	PUNCT
fnp-2613	316	1	20	20	NUM
fnp-2613	316	2	.	.	X
fnp-2613	317	1	mckeith	mckeith	PROPN
fnp-2613	317	2	,	,	PUNCT
fnp-2613	317	3	i.	i.	PROPN
fnp-2613	317	4	g.	g.	PROPN
fnp-2613	317	5	et	et	PROPN
fnp-2613	317	6	al	al	PROPN
fnp-2613	317	7	.	.	PUNCT
fnp-2613	317	8	diagnosis	diagnosis	NOUN
fnp-2613	317	9	and	and	CCONJ
fnp-2613	317	10	management	management	NOUN
fnp-2613	317	11	of	of	ADP
fnp-2613	317	12	dementia	dementia	NOUN
fnp-2613	317	13	with	with	ADP
fnp-2613	317	14	lewy	lewy	PROPN
fnp-2613	317	15	bodies	body	NOUN
fnp-2613	317	16	.	.	PUNCT
fnp-2613	318	1	neurology	neurology	NOUN
fnp-2613	318	2	89	89	NUM
fnp-2613	318	3	,	,	PUNCT
fnp-2613	318	4	88–100	88–100	NUM
fnp-2613	318	5	(	(	PUNCT
fnp-2613	318	6	2017	2017	NUM
fnp-2613	318	7	)	)	PUNCT
fnp-2613	318	8	.	.	PUNCT
fnp-2613	319	1	21	21	NUM
fnp-2613	319	2	.	.	PUNCT
fnp-2613	319	3	braak	braak	PROPN
fnp-2613	319	4	,	,	PUNCT
fnp-2613	319	5	h.	h.	PROPN
fnp-2613	319	6	et	et	PROPN
fnp-2613	319	7	al	al	PROPN
fnp-2613	319	8	.	.	PROPN
fnp-2613	319	9	staging	staging	NOUN
fnp-2613	319	10	of	of	ADP
fnp-2613	319	11	brain	brain	NOUN
fnp-2613	319	12	pathology	pathology	NOUN
fnp-2613	319	13	related	relate	VERB
fnp-2613	319	14	to	to	ADP
fnp-2613	319	15	sporadic	sporadic	ADJ
fnp-2613	319	16	parkinson	parkinson	NOUN
fnp-2613	319	17	’s	’s	PART
fnp-2613	319	18	disease	disease	NOUN
fnp-2613	319	19	.	.	PUNCT
fnp-2613	320	1	neurobiol	neurobiol	NOUN
fnp-2613	320	2	.	.	PUNCT
fnp-2613	321	1	aging	age	VERB
fnp-2613	321	2	24	24	NUM
fnp-2613	321	3	,	,	PUNCT
fnp-2613	321	4	197–211	197–211	NUM
fnp-2613	321	5	(	(	PUNCT
fnp-2613	321	6	2003	2003	NUM
fnp-2613	321	7	)	)	PUNCT
fnp-2613	321	8	.	.	PUNCT
fnp-2613	322	1	22	22	NUM
fnp-2613	322	2	.	.	PUNCT
fnp-2613	322	3	leverenz	leverenz	PROPN
fnp-2613	322	4	,	,	PUNCT
fnp-2613	322	5	j.	j.	PROPN
fnp-2613	322	6	b.	b.	PROPN
fnp-2613	322	7	et	et	PROPN
fnp-2613	322	8	al	al	PROPN
fnp-2613	322	9	.	.	PROPN
fnp-2613	322	10	empiric	empiric	ADJ
fnp-2613	322	11	refinement	refinement	NOUN
fnp-2613	322	12	of	of	ADP
fnp-2613	322	13	the	the	DET
fnp-2613	322	14	pathologic	pathologic	ADJ
fnp-2613	322	15	assessment	assessment	NOUN
fnp-2613	322	16	of	of	ADP
fnp-2613	322	17	lewy	lewy	PROPN
fnp-2613	322	18	-	-	PUNCT
fnp-2613	322	19	related	relate	VERB
fnp-2613	322	20	pathology	pathology	NOUN
fnp-2613	322	21	in	in	ADP
fnp-2613	322	22	the	the	DET
fnp-2613	322	23	dementia	dementia	NOUN
fnp-2613	322	24	patient	patient	NOUN
fnp-2613	322	25	.	.	PUNCT
fnp-2613	323	1	brain	brain	NOUN
fnp-2613	323	2	pathol	pathol	NOUN
fnp-2613	323	3	.	.	PUNCT
fnp-2613	324	1	18	18	NUM
fnp-2613	324	2	,	,	PUNCT
fnp-2613	324	3	220–4	220–4	NUM
fnp-2613	324	4	(	(	PUNCT
fnp-2613	324	5	2008	2008	NUM
fnp-2613	324	6	)	)	PUNCT
fnp-2613	324	7	.	.	PUNCT
fnp-2613	325	1	23	23	NUM
fnp-2613	325	2	.	.	X
fnp-2613	326	1	müller	müller	PROPN
fnp-2613	326	2	,	,	PUNCT
fnp-2613	326	3	c.	c.	PROPN
fnp-2613	326	4	m.	m.	PROPN
fnp-2613	326	5	et	et	PROPN
fnp-2613	326	6	al	al	PROPN
fnp-2613	326	7	.	.	PROPN
fnp-2613	326	8	staging	staging	NOUN
fnp-2613	326	9	of	of	ADP
fnp-2613	326	10	sporadic	sporadic	ADJ
fnp-2613	326	11	parkinson	parkinson	NOUN
fnp-2613	326	12	disease	disease	NOUN
fnp-2613	326	13	-	-	PUNCT
fnp-2613	326	14	related	relate	VERB
fnp-2613	326	15	alpha	alpha	NOUN
fnp-2613	326	16	-	-	PUNCT
fnp-2613	326	17	synuclein	synuclein	NOUN
fnp-2613	326	18	pathology	pathology	NOUN
fnp-2613	326	19	:	:	PUNCT
fnp-2613	326	20	interand	interand	VERB
fnp-2613	326	21	intra	intra	ADJ
fnp-2613	326	22	-	-	ADJ
fnp-2613	326	23	rater	rater	ADJ
fnp-2613	326	24	reliability	reliability	NOUN
fnp-2613	326	25	.	.	PUNCT
fnp-2613	327	1	j.	j.	PROPN
fnp-2613	327	2	neuropathol	neuropathol	PROPN
fnp-2613	327	3	.	.	PUNCT
fnp-2613	328	1	exp	exp	PROPN
fnp-2613	328	2	.	.	PUNCT
fnp-2613	329	1	neurol	neurol	PROPN
fnp-2613	329	2	.	.	PUNCT
fnp-2613	330	1	64	64	NUM
fnp-2613	330	2	,	,	PUNCT
fnp-2613	330	3	623–8	623–8	NUM
fnp-2613	330	4	(	(	PUNCT
fnp-2613	330	5	2005	2005	NUM
fnp-2613	330	6	)	)	PUNCT
fnp-2613	330	7	.	.	PUNCT
fnp-2613	331	1	24	24	NUM
fnp-2613	331	2	.	.	NOUN
fnp-2613	331	3	alafuzoff	alafuzoff	PROPN
fnp-2613	331	4	,	,	PUNCT
fnp-2613	331	5	i.	i.	PROPN
fnp-2613	331	6	et	et	PROPN
fnp-2613	331	7	al	al	PROPN
fnp-2613	331	8	.	.	PROPN
fnp-2613	331	9	staging	staging	NOUN
fnp-2613	331	10	/	/	SYM
fnp-2613	331	11	typing	typing	NOUN
fnp-2613	331	12	of	of	ADP
fnp-2613	331	13	lewy	lewy	PROPN
fnp-2613	331	14	body	body	NOUN
fnp-2613	331	15	related	relate	VERB
fnp-2613	331	16	α	α	PRON
fnp-2613	331	17	-	-	PUNCT
fnp-2613	331	18	synuclein	synuclein	NOUN
fnp-2613	331	19	pathology	pathology	NOUN
fnp-2613	331	20	:	:	PUNCT
fnp-2613	331	21	a	a	DET
fnp-2613	331	22	study	study	NOUN
fnp-2613	331	23	of	of	ADP
fnp-2613	331	24	the	the	DET
fnp-2613	331	25	brainnet	brainnet	PROPN
fnp-2613	331	26	europe	europe	PROPN
fnp-2613	331	27	consortium	consortium	PROPN
fnp-2613	331	28	.	.	PUNCT
fnp-2613	332	1	acta	acta	PROPN
fnp-2613	332	2	neuropathol	neuropathol	PROPN
fnp-2613	332	3	.	.	PUNCT
fnp-2613	333	1	117	117	NUM
fnp-2613	333	2	,	,	PUNCT
fnp-2613	333	3	635–652	635–652	NUM
fnp-2613	333	4	(	(	PUNCT
fnp-2613	333	5	2009	2009	NUM
fnp-2613	333	6	)	)	PUNCT
fnp-2613	333	7	.	.	PUNCT
fnp-2613	334	1	25	25	NUM
fnp-2613	334	2	.	.	X
fnp-2613	334	3	beach	beach	PROPN
fnp-2613	334	4	,	,	PUNCT
fnp-2613	334	5	t.	t.	PROPN
fnp-2613	334	6	g.	g.	PROPN
fnp-2613	334	7	et	et	PROPN
fnp-2613	334	8	al	al	PROPN
fnp-2613	334	9	.	.	PROPN
fnp-2613	334	10	unified	unify	VERB
fnp-2613	334	11	staging	staging	NOUN
fnp-2613	334	12	system	system	NOUN
fnp-2613	334	13	for	for	ADP
fnp-2613	334	14	lewy	lewy	ADJ
fnp-2613	334	15	body	body	NOUN
fnp-2613	334	16	disorders	disorder	NOUN
fnp-2613	334	17	:	:	PUNCT
fnp-2613	334	18	correlation	correlation	NOUN
fnp-2613	334	19	with	with	ADP
fnp-2613	334	20	nigrostriatal	nigrostriatal	ADJ
fnp-2613	334	21	degeneration	degeneration	NOUN
fnp-2613	334	22	,	,	PUNCT
fnp-2613	334	23	cognitive	cognitive	ADJ
fnp-2613	334	24	impairment	impairment	NOUN
fnp-2613	334	25	and	and	CCONJ
fnp-2613	334	26	motor	motor	NOUN
fnp-2613	334	27	dysfunction	dysfunction	NOUN
fnp-2613	334	28	.	.	PUNCT
fnp-2613	335	1	acta	acta	PROPN
fnp-2613	335	2	neuropathol	neuropathol	PROPN
fnp-2613	335	3	.	.	PUNCT
fnp-2613	336	1	117	117	NUM
fnp-2613	336	2	,	,	PUNCT
fnp-2613	336	3	613–634	613–634	NUM
fnp-2613	336	4	(	(	PUNCT
fnp-2613	336	5	2009	2009	NUM
fnp-2613	336	6	)	)	PUNCT
fnp-2613	336	7	.	.	PUNCT
fnp-2613	337	1	26	26	NUM
fnp-2613	337	2	.	.	X
fnp-2613	338	1	mckeith	mckeith	PROPN
fnp-2613	338	2	,	,	PUNCT
fnp-2613	338	3	i.	i.	PROPN
fnp-2613	338	4	g.	g.	PROPN
fnp-2613	338	5	et	et	PROPN
fnp-2613	338	6	al	al	PROPN
fnp-2613	338	7	.	.	PUNCT
fnp-2613	338	8	diagnosis	diagnosis	NOUN
fnp-2613	338	9	and	and	CCONJ
fnp-2613	338	10	management	management	NOUN
fnp-2613	338	11	of	of	ADP
fnp-2613	338	12	dementia	dementia	NOUN
fnp-2613	338	13	with	with	ADP
fnp-2613	338	14	lewy	lewy	PROPN
fnp-2613	338	15	bodies	body	NOUN
fnp-2613	338	16	:	:	PUNCT
fnp-2613	338	17	third	third	ADJ
fnp-2613	338	18	report	report	NOUN
fnp-2613	338	19	of	of	ADP
fnp-2613	338	20	the	the	DET
fnp-2613	338	21	dlb	dlb	PROPN
fnp-2613	338	22	consortium	consortium	PROPN
fnp-2613	338	23	.	.	PUNCT
fnp-2613	339	1	neurology	neurology	NOUN
fnp-2613	339	2	65	65	NUM
fnp-2613	339	3	,	,	PUNCT
fnp-2613	339	4	1863–1872	1863–1872	NUM
fnp-2613	339	5	(	(	PUNCT
fnp-2613	339	6	2005	2005	NUM
fnp-2613	339	7	)	)	PUNCT
fnp-2613	339	8	.	.	PUNCT
fnp-2613	340	1	27	27	NUM
fnp-2613	340	2	.	.	PUNCT
fnp-2613	341	1	jellinger	jellinger	PROPN
fnp-2613	341	2	,	,	PUNCT
fnp-2613	341	3	k.	k.	PROPN
fnp-2613	341	4	a.	a.	PROPN
fnp-2613	341	5	et	et	PROPN
fnp-2613	341	6	al	al	PROPN
fnp-2613	341	7	.	.	PROPN
fnp-2613	341	8	impact	impact	NOUN
fnp-2613	341	9	of	of	ADP
fnp-2613	341	10	coexistent	coexistent	ADJ
fnp-2613	341	11	alzheimer	alzheimer	PROPN
fnp-2613	341	12	pathology	pathology	NOUN
fnp-2613	341	13	on	on	ADP
fnp-2613	341	14	the	the	DET
fnp-2613	341	15	natural	natural	ADJ
fnp-2613	341	16	history	history	NOUN
fnp-2613	341	17	of	of	ADP
fnp-2613	341	18	parkinson	parkinson	NOUN
fnp-2613	341	19	’s	’s	PART
fnp-2613	341	20	disease	disease	NOUN
fnp-2613	341	21	.	.	PUNCT
fnp-2613	342	1	j.	j.	PROPN
fnp-2613	342	2	neural	neural	PROPN
fnp-2613	342	3	transm	transm	PROPN
fnp-2613	342	4	.	.	PUNCT
fnp-2613	343	1	109	109	NUM
fnp-2613	343	2	,	,	PUNCT
fnp-2613	343	3	329–39	329–39	NUM
fnp-2613	343	4	(	(	PUNCT
fnp-2613	343	5	2002	2002	NUM
fnp-2613	343	6	)	)	PUNCT
fnp-2613	343	7	.	.	PUNCT
fnp-2613	344	1	28	28	NUM
fnp-2613	344	2	.	.	PUNCT
fnp-2613	344	3	barker	barker	PROPN
fnp-2613	344	4	,	,	PUNCT
fnp-2613	344	5	w.	w.	PROPN
fnp-2613	344	6	w.	w.	PROPN
fnp-2613	344	7	et	et	PROPN
fnp-2613	344	8	al	al	PROPN
fnp-2613	344	9	.	.	PROPN
fnp-2613	344	10	relative	relative	ADJ
fnp-2613	344	11	frequencies	frequency	NOUN
fnp-2613	344	12	of	of	ADP
fnp-2613	344	13	alzheimer	alzheimer	PROPN
fnp-2613	344	14	disease	disease	PROPN
fnp-2613	344	15	,	,	PUNCT
fnp-2613	344	16	lewy	lewy	PROPN
fnp-2613	344	17	body	body	NOUN
fnp-2613	344	18	,	,	PUNCT
fnp-2613	344	19	vascular	vascular	ADJ
fnp-2613	344	20	and	and	CCONJ
fnp-2613	344	21	frontotemporal	frontotemporal	ADJ
fnp-2613	344	22	dementia	dementia	NOUN
fnp-2613	344	23	,	,	PUNCT
fnp-2613	344	24	and	and	CCONJ
fnp-2613	344	25	hippocampal	hippocampal	ADJ
fnp-2613	344	26	sclerosis	sclerosis	NOUN
fnp-2613	344	27	in	in	ADP
fnp-2613	344	28	the	the	DET
fnp-2613	344	29	state	state	NOUN
fnp-2613	344	30	of	of	ADP
fnp-2613	344	31	florida	florida	PROPN
fnp-2613	344	32	brain	brain	PROPN
fnp-2613	344	33	bank	bank	PROPN
fnp-2613	344	34	.	.	PUNCT
fnp-2613	345	1	alzheimer	alzheimer	PROPN
fnp-2613	345	2	dis	dis	PROPN
fnp-2613	345	3	.	.	PUNCT
fnp-2613	346	1	assoc	assoc	PROPN
fnp-2613	346	2	.	.	PUNCT
fnp-2613	347	1	disord	disord	PROPN
fnp-2613	347	2	.	.	PUNCT
fnp-2613	348	1	16	16	NUM
fnp-2613	348	2	,	,	PUNCT
fnp-2613	348	3	203–212	203–212	NUM
fnp-2613	348	4	(	(	PUNCT
fnp-2613	348	5	2002	2002	NUM
fnp-2613	348	6	)	)	PUNCT
fnp-2613	348	7	.	.	PUNCT
fnp-2613	349	1	29	29	NUM
fnp-2613	349	2	.	.	PUNCT
fnp-2613	350	1	kosaka	kosaka	PROPN
fnp-2613	350	2	,	,	PUNCT
fnp-2613	350	3	k.	k.	PROPN
fnp-2613	350	4	diffuse	diffuse	PROPN
fnp-2613	350	5	lewy	lewy	PROPN
fnp-2613	350	6	body	body	NOUN
fnp-2613	350	7	disease	disease	NOUN
fnp-2613	350	8	in	in	ADP
fnp-2613	350	9	japan	japan	PROPN
fnp-2613	350	10	.	.	PUNCT
fnp-2613	351	1	j.	j.	PROPN
fnp-2613	351	2	neurol	neurol	PROPN
fnp-2613	351	3	.	.	PUNCT
fnp-2613	352	1	237	237	NUM
fnp-2613	352	2	,	,	PUNCT
fnp-2613	352	3	197–204	197–204	NUM
fnp-2613	352	4	(	(	PUNCT
fnp-2613	352	5	1990	1990	NUM
fnp-2613	352	6	)	)	PUNCT
fnp-2613	352	7	.	.	PUNCT
fnp-2613	353	1	30	30	NUM
fnp-2613	353	2	.	.	PUNCT
fnp-2613	353	3	hyman	hyman	PROPN
fnp-2613	353	4	,	,	PUNCT
fnp-2613	353	5	b.	b.	PROPN
fnp-2613	353	6	t.	t.	PROPN
fnp-2613	353	7	et	et	PROPN
fnp-2613	353	8	al	al	PROPN
fnp-2613	353	9	.	.	PUNCT
fnp-2613	353	10	longitudinal	longitudinal	ADJ
fnp-2613	353	11	assessment	assessment	NOUN
fnp-2613	353	12	of	of	ADP
fnp-2613	353	13	ab	ab	PROPN
fnp-2613	353	14	and	and	CCONJ
fnp-2613	353	15	cognition	cognition	NOUN
fnp-2613	353	16	in	in	ADP
fnp-2613	353	17	aging	aging	NOUN
fnp-2613	353	18	and	and	CCONJ
fnp-2613	353	19	alzheimer	alzheimer	NOUN
fnp-2613	353	20	disease	disease	NOUN
fnp-2613	353	21	.	.	PUNCT
fnp-2613	354	1	ann	ann	PROPN
fnp-2613	354	2	.	.	PUNCT
fnp-2613	355	1	neurol	neurol	PROPN
fnp-2613	355	2	.	.	PUNCT
fnp-2613	356	1	69	69	NUM
fnp-2613	356	2	,	,	PUNCT
fnp-2613	356	3	181–192	181–192	NUM
fnp-2613	356	4	(	(	PUNCT
fnp-2613	356	5	2011	2011	NUM
fnp-2613	356	6	)	)	PUNCT
fnp-2613	356	7	.	.	PUNCT
fnp-2613	357	1	31	31	NUM
fnp-2613	357	2	.	.	PUNCT
fnp-2613	358	1	howlett	howlett	PROPN
fnp-2613	358	2	,	,	PUNCT
fnp-2613	358	3	d.	d.	PROPN
fnp-2613	358	4	r.	r.	PROPN
fnp-2613	358	5	et	et	PROPN
fnp-2613	359	1	al	al	PROPN
fnp-2613	359	2	.	.	PROPN
fnp-2613	360	1	regional	regional	ADJ
fnp-2613	360	2	multiple	multiple	ADJ
fnp-2613	360	3	pathology	pathology	NOUN
fnp-2613	360	4	scores	score	NOUN
fnp-2613	360	5	are	be	AUX
fnp-2613	360	6	associated	associate	VERB
fnp-2613	360	7	with	with	ADP
fnp-2613	360	8	cognitive	cognitive	ADJ
fnp-2613	360	9	decline	decline	NOUN
fnp-2613	360	10	in	in	ADP
fnp-2613	360	11	lewy	lewy	ADJ
fnp-2613	360	12	body	body	NOUN
fnp-2613	360	13	dementias	dementia	NOUN
fnp-2613	360	14	.	.	PUNCT
fnp-2613	361	1	brain	brain	NOUN
fnp-2613	361	2	pathol	pathol	NOUN
fnp-2613	361	3	.	.	PUNCT
fnp-2613	362	1	25	25	NUM
fnp-2613	362	2	,	,	PUNCT
fnp-2613	362	3	401–408	401–408	NUM
fnp-2613	362	4	(	(	PUNCT
fnp-2613	362	5	2015	2015	NUM
fnp-2613	362	6	)	)	PUNCT
fnp-2613	362	7	.	.	PUNCT
fnp-2613	363	1	32	32	NUM
fnp-2613	363	2	.	.	PUNCT
fnp-2613	364	1	jellinger	jellinger	PROPN
fnp-2613	364	2	,	,	PUNCT
fnp-2613	364	3	k.	k.	PROPN
fnp-2613	364	4	a.	a.	PROPN
fnp-2613	364	5	et	et	PROPN
fnp-2613	364	6	al	al	PROPN
fnp-2613	364	7	.	.	PROPN
fnp-2613	364	8	are	be	AUX
fnp-2613	364	9	dementia	dementia	NOUN
fnp-2613	364	10	with	with	ADP
fnp-2613	364	11	lewy	lewy	PROPN
fnp-2613	364	12	bodies	body	NOUN
fnp-2613	364	13	and	and	CCONJ
fnp-2613	364	14	parkinson	parkinson	NOUN
fnp-2613	364	15	’s	’s	PART
fnp-2613	364	16	disease	disease	NOUN
fnp-2613	364	17	dementia	dementia	NOUN
fnp-2613	364	18	the	the	DET
fnp-2613	364	19	same	same	ADJ
fnp-2613	364	20	disease	disease	NOUN
fnp-2613	364	21	?	?	PUNCT
fnp-2613	365	1	bmc	bmc	PROPN
fnp-2613	365	2	med	med	PROPN
fnp-2613	365	3	.	.	PROPN
fnp-2613	366	1	16	16	NUM
fnp-2613	366	2	,	,	PUNCT
fnp-2613	366	3	(	(	PUNCT
fnp-2613	366	4	2018	2018	NUM
fnp-2613	366	5	)	)	PUNCT
fnp-2613	366	6	.	.	PUNCT
fnp-2613	367	1	33	33	NUM
fnp-2613	367	2	.	.	PUNCT
fnp-2613	368	1	skogseth	skogseth	PROPN
fnp-2613	368	2	,	,	PUNCT
fnp-2613	368	3	r.	r.	PROPN
fnp-2613	368	4	et	et	PROPN
fnp-2613	368	5	al	al	PROPN
fnp-2613	368	6	.	.	PROPN
fnp-2613	368	7	accuracy	accuracy	NOUN
fnp-2613	368	8	of	of	ADP
fnp-2613	368	9	clinical	clinical	ADJ
fnp-2613	368	10	diagnosis	diagnosis	NOUN
fnp-2613	368	11	of	of	ADP
fnp-2613	368	12	dementia	dementia	NOUN
fnp-2613	368	13	with	with	ADP
fnp-2613	368	14	lewy	lewy	ADJ
fnp-2613	368	15	bodies	body	NOUN
fnp-2613	368	16	versus	versus	ADP
fnp-2613	368	17	neuropathology	neuropathology	NOUN
fnp-2613	368	18	.	.	PUNCT
fnp-2613	369	1	j.	j.	PROPN
fnp-2613	369	2	alzheimer	alzheimer	PROPN
fnp-2613	369	3	’s	’s	PART
fnp-2613	369	4	dis	dis	PROPN
fnp-2613	369	5	.	.	PROPN
fnp-2613	370	1	59	59	NUM
fnp-2613	370	2	,	,	PUNCT
fnp-2613	370	3	1139–1152	1139–1152	NUM
fnp-2613	370	4	(	(	PUNCT
fnp-2613	370	5	2017	2017	NUM
fnp-2613	370	6	)	)	PUNCT
fnp-2613	370	7	.	.	PUNCT
fnp-2613	371	1	34	34	NUM
fnp-2613	371	2	.	.	PUNCT
fnp-2613	372	1	piggott	piggott	PROPN
fnp-2613	372	2	,	,	PUNCT
fnp-2613	372	3	m.	m.	NOUN
fnp-2613	372	4	a.	a.	PROPN
fnp-2613	372	5	et	et	PROPN
fnp-2613	372	6	al	al	PROPN
fnp-2613	372	7	.	.	PROPN
fnp-2613	372	8	striatal	striatal	ADJ
fnp-2613	372	9	dopaminergic	dopaminergic	ADJ
fnp-2613	372	10	markers	marker	NOUN
fnp-2613	372	11	in	in	ADP
fnp-2613	372	12	dementia	dementia	NOUN
fnp-2613	372	13	with	with	ADP
fnp-2613	372	14	lewy	lewy	PROPN
fnp-2613	372	15	bodies	body	NOUN
fnp-2613	372	16	,	,	PUNCT
fnp-2613	372	17	alzheimer	alzheimer	PROPN
fnp-2613	372	18	’s	’s	PART
fnp-2613	372	19	and	and	CCONJ
fnp-2613	372	20	parkinson	parkinson	NOUN
fnp-2613	372	21	’s	’s	PART
fnp-2613	372	22	diseases	disease	NOUN
fnp-2613	372	23	:	:	PUNCT
fnp-2613	372	24	rostrocaudal	rostrocaudal	ADJ
fnp-2613	372	25	distribution	distribution	NOUN
fnp-2613	372	26	.	.	PUNCT
fnp-2613	373	1	brain	brain	NOUN
fnp-2613	373	2	122	122	NUM
fnp-2613	373	3	,	,	PUNCT
fnp-2613	373	4	1449–1468	1449–1468	NUM
fnp-2613	373	5	(	(	PUNCT
fnp-2613	373	6	1999	1999	NUM
fnp-2613	373	7	)	)	PUNCT
fnp-2613	373	8	.	.	PUNCT
fnp-2613	374	1	35	35	NUM
fnp-2613	374	2	.	.	X
fnp-2613	374	3	perry	perry	PROPN
fnp-2613	374	4	,	,	PUNCT
fnp-2613	374	5	e.	e.	PROPN
fnp-2613	374	6	k.	k.	PROPN
fnp-2613	374	7	et	et	PROPN
fnp-2613	374	8	al	al	PROPN
fnp-2613	374	9	.	.	PROPN
fnp-2613	374	10	cholinergic	cholinergic	PROPN
fnp-2613	374	11	correlates	correlate	VERB
fnp-2613	374	12	of	of	ADP
fnp-2613	374	13	cognitive	cognitive	ADJ
fnp-2613	374	14	impairment	impairment	NOUN
fnp-2613	374	15	in	in	ADP
fnp-2613	374	16	parkinson	parkinson	NOUN
fnp-2613	374	17	’s	’s	PART
fnp-2613	374	18	disease	disease	NOUN
fnp-2613	374	19	:	:	PUNCT
fnp-2613	374	20	comparisons	comparison	NOUN
fnp-2613	374	21	with	with	ADP
fnp-2613	374	22	alzheimer	alzheimer	PROPN
fnp-2613	374	23	’s	’s	PART
fnp-2613	374	24	disease	disease	NOUN
fnp-2613	374	25	.	.	PUNCT
fnp-2613	375	1	j.	j.	PROPN
fnp-2613	375	2	neurol	neurol	PROPN
fnp-2613	375	3	.	.	PUNCT
fnp-2613	376	1	neurosurg	neurosurg	PROPN
fnp-2613	376	2	.	.	PUNCT
fnp-2613	377	1	psychiatry	psychiatry	NOUN
fnp-2613	377	2	48	48	NUM
fnp-2613	377	3	,	,	PUNCT
fnp-2613	377	4	413–21	413–21	PROPN
fnp-2613	377	5	(	(	PUNCT
fnp-2613	377	6	1985	1985	NUM
fnp-2613	377	7	)	)	PUNCT
fnp-2613	377	8	.	.	PUNCT
fnp-2613	378	1	36	36	NUM
fnp-2613	378	2	.	.	X
fnp-2613	379	1	tiraboschi	tiraboschi	ADV
fnp-2613	379	2	,	,	PUNCT
fnp-2613	379	3	p.	p.	NOUN
fnp-2613	379	4	et	et	NOUN
fnp-2613	380	1	al	al	PROPN
fnp-2613	380	2	.	.	PUNCT
fnp-2613	381	1	cholinergic	cholinergic	ADJ
fnp-2613	381	2	dysfunction	dysfunction	NOUN
fnp-2613	381	3	in	in	ADP
fnp-2613	381	4	diseases	disease	NOUN
fnp-2613	381	5	with	with	ADP
fnp-2613	381	6	lewy	lewy	PROPN
fnp-2613	381	7	bodies	body	NOUN
fnp-2613	381	8	.	.	PUNCT
fnp-2613	382	1	neurology	neurology	NOUN
fnp-2613	382	2	54	54	NUM
fnp-2613	382	3	,	,	PUNCT
fnp-2613	382	4	407–411	407–411	NUM
fnp-2613	382	5	(	(	PUNCT
fnp-2613	382	6	2000	2000	NUM
fnp-2613	382	7	)	)	PUNCT
fnp-2613	382	8	.	.	PUNCT
fnp-2613	383	1	37	37	NUM
fnp-2613	383	2	.	.	PUNCT
fnp-2613	384	1	vallortigara	vallortigara	PROPN
fnp-2613	384	2	,	,	PUNCT
fnp-2613	384	3	j.	j.	PROPN
fnp-2613	384	4	et	et	PROPN
fnp-2613	384	5	al	al	PROPN
fnp-2613	384	6	.	.	PUNCT
fnp-2613	384	7	dynamin1	dynamin1	ADJ
fnp-2613	384	8	concentration	concentration	NOUN
fnp-2613	384	9	in	in	ADP
fnp-2613	384	10	the	the	DET
fnp-2613	384	11	prefrontal	prefrontal	ADJ
fnp-2613	384	12	cortex	cortex	NOUN
fnp-2613	384	13	is	be	AUX
fnp-2613	384	14	associated	associate	VERB
fnp-2613	384	15	with	with	ADP
fnp-2613	384	16	cognitive	cognitive	ADJ
fnp-2613	384	17	impairment	impairment	NOUN
fnp-2613	384	18	in	in	ADP
fnp-2613	384	19	lewy	lewy	PROPN
fnp-2613	384	20	body	body	NOUN
fnp-2613	384	21	dementia	dementia	PROPN
fnp-2613	384	22	.	.	PUNCT
fnp-2613	385	1	f1000research	f1000research	PROPN
fnp-2613	385	2	3	3	NUM
fnp-2613	385	3	,	,	PUNCT
fnp-2613	385	4	108	108	NUM
fnp-2613	385	5	(	(	PUNCT
fnp-2613	385	6	2014	2014	NUM
fnp-2613	385	7	)	)	PUNCT
fnp-2613	385	8	.	.	PUNCT
fnp-2613	386	1	38	38	NUM
fnp-2613	386	2	.	.	PUNCT
fnp-2613	386	3	whitfield	whitfield	PROPN
fnp-2613	386	4	,	,	PUNCT
fnp-2613	386	5	d.	d.	PROPN
fnp-2613	386	6	r.	r.	PROPN
fnp-2613	386	7	et	et	PROPN
fnp-2613	386	8	al	al	PROPN
fnp-2613	386	9	.	.	PROPN
fnp-2613	386	10	assessment	assessment	NOUN
fnp-2613	386	11	of	of	ADP
fnp-2613	386	12	znt3	znt3	PROPN
fnp-2613	386	13	and	and	CCONJ
fnp-2613	386	14	psd95	psd95	VERB
fnp-2613	386	15	protein	protein	NOUN
fnp-2613	386	16	levels	level	NOUN
fnp-2613	386	17	in	in	ADP
fnp-2613	386	18	lewy	lewy	PROPN
fnp-2613	386	19	body	body	NOUN
fnp-2613	386	20	dementias	dementia	NOUN
fnp-2613	386	21	and	and	CCONJ
fnp-2613	386	22	alzheimer	alzheimer	PROPN
fnp-2613	386	23	’s	’s	PART
fnp-2613	386	24	disease	disease	NOUN
fnp-2613	386	25	:	:	PUNCT
fnp-2613	386	26	association	association	NOUN
fnp-2613	386	27	with	with	ADP
fnp-2613	386	28	cognitive	cognitive	ADJ
fnp-2613	386	29	impairment	impairment	NOUN
fnp-2613	386	30	.	.	PUNCT
fnp-2613	387	1	neurobiol	neurobiol	NOUN
fnp-2613	387	2	.	.	PUNCT
fnp-2613	388	1	aging	age	VERB
fnp-2613	388	2	35	35	NUM
fnp-2613	388	3	,	,	PUNCT
fnp-2613	388	4	2836–2844	2836–2844	NUM
fnp-2613	388	5	(	(	PUNCT
fnp-2613	388	6	2014	2014	NUM
fnp-2613	388	7	)	)	PUNCT
fnp-2613	388	8	.	.	PUNCT
fnp-2613	389	1	39	39	NUM
fnp-2613	389	2	.	.	PUNCT
fnp-2613	390	1	bereczki	bereczki	PROPN
fnp-2613	390	2	,	,	PUNCT
fnp-2613	390	3	e.	e.	PROPN
fnp-2613	390	4	et	et	PROPN
fnp-2613	390	5	al	al	PROPN
fnp-2613	390	6	.	.	PUNCT
fnp-2613	391	1	synaptic	synaptic	ADJ
fnp-2613	391	2	proteins	protein	NOUN
fnp-2613	391	3	predict	predict	VERB
fnp-2613	391	4	cognitive	cognitive	ADJ
fnp-2613	391	5	decline	decline	NOUN
fnp-2613	391	6	in	in	ADP
fnp-2613	391	7	alzheimer	alzheimer	PROPN
fnp-2613	391	8	’s	’s	PART
fnp-2613	391	9	disease	disease	NOUN
fnp-2613	391	10	and	and	CCONJ
fnp-2613	391	11	lewy	lewy	ADJ
fnp-2613	391	12	body	body	NOUN
fnp-2613	391	13	dementia	dementia	NOUN
fnp-2613	391	14	.	.	PUNCT
fnp-2613	392	1	alzheimer	alzheimer	PROPN
fnp-2613	392	2	’s	’s	PART
fnp-2613	392	3	dement	dement	PROPN
fnp-2613	392	4	.	.	PUNCT
fnp-2613	393	1	12	12	NUM
fnp-2613	393	2	,	,	PUNCT
fnp-2613	393	3	1149–1158	1149–1158	NUM
fnp-2613	393	4	(	(	PUNCT
fnp-2613	393	5	2016	2016	NUM
fnp-2613	393	6	)	)	PUNCT
fnp-2613	393	7	.	.	PUNCT
fnp-2613	394	1	40	40	NUM
fnp-2613	394	2	.	.	PUNCT
fnp-2613	395	1	vallortigara	vallortigara	PROPN
fnp-2613	395	2	,	,	PUNCT
fnp-2613	395	3	j.	j.	PROPN
fnp-2613	395	4	et	et	PROPN
fnp-2613	395	5	al	al	PROPN
fnp-2613	395	6	.	.	PROPN
fnp-2613	395	7	decreased	decrease	VERB
fnp-2613	395	8	levels	level	NOUN
fnp-2613	395	9	of	of	ADP
fnp-2613	395	10	vamp2	vamp2	NOUN
fnp-2613	395	11	and	and	CCONJ
fnp-2613	395	12	monomeric	monomeric	ADJ
fnp-2613	395	13	alpha	alpha	NOUN
fnp-2613	395	14	-	-	PUNCT
fnp-2613	395	15	synuclein	synuclein	NOUN
fnp-2613	395	16	correlate	correlate	VERB
fnp-2613	395	17	with	with	ADP
fnp-2613	395	18	duration	duration	NOUN
fnp-2613	395	19	of	of	ADP
fnp-2613	395	20	dementia	dementia	NOUN
fnp-2613	395	21	.	.	PUNCT
fnp-2613	396	1	j.	j.	PROPN
fnp-2613	396	2	alzheimer	alzheimer	PROPN
fnp-2613	396	3	’s	’s	PART
fnp-2613	396	4	dis	dis	PROPN
fnp-2613	396	5	.	.	PUNCT
fnp-2613	397	1	50	50	NUM
fnp-2613	397	2	,	,	PUNCT
fnp-2613	397	3	101–110	101–110	NUM
fnp-2613	397	4	(	(	PUNCT
fnp-2613	397	5	2015	2015	NUM
fnp-2613	397	6	)	)	PUNCT
fnp-2613	397	7	.	.	PUNCT
fnp-2613	398	1	41	41	NUM
fnp-2613	398	2	.	.	PUNCT
fnp-2613	399	1	bereczki	bereczki	PROPN
fnp-2613	399	2	,	,	PUNCT
fnp-2613	399	3	e.	e.	PROPN
fnp-2613	399	4	et	et	PROPN
fnp-2613	399	5	al	al	PROPN
fnp-2613	399	6	.	.	PUNCT
fnp-2613	400	1	synaptic	synaptic	ADJ
fnp-2613	400	2	markers	marker	NOUN
fnp-2613	400	3	of	of	ADP
fnp-2613	400	4	cognitive	cognitive	ADJ
fnp-2613	400	5	decline	decline	NOUN
fnp-2613	400	6	in	in	ADP
fnp-2613	400	7	neurodegenerative	neurodegenerative	ADJ
fnp-2613	400	8	diseases	disease	NOUN
fnp-2613	400	9	:	:	PUNCT
fnp-2613	400	10	a	a	DET
fnp-2613	400	11	proteomic	proteomic	ADJ
fnp-2613	400	12	approach	approach	NOUN
fnp-2613	400	13	.	.	PUNCT
fnp-2613	401	1	brain	brain	NOUN
fnp-2613	401	2	141	141	NUM
fnp-2613	401	3	,	,	PUNCT
fnp-2613	401	4	582–595	582–595	NUM
fnp-2613	401	5	(	(	PUNCT
fnp-2613	401	6	2018	2018	NUM
fnp-2613	401	7	)	)	PUNCT
fnp-2613	401	8	.	.	PUNCT
fnp-2613	402	1	42	42	NUM
fnp-2613	402	2	.	.	PUNCT
fnp-2613	403	1	schulz	schulz	NOUN
fnp-2613	403	2	-	-	PUNCT
fnp-2613	403	3	schaeffer	schaeffer	PROPN
fnp-2613	403	4	,	,	PUNCT
fnp-2613	403	5	w.	w.	PROPN
fnp-2613	403	6	j.	j.	PROPN
fnp-2613	403	7	the	the	DET
fnp-2613	403	8	synaptic	synaptic	ADJ
fnp-2613	403	9	pathology	pathology	NOUN
fnp-2613	403	10	of	of	ADP
fnp-2613	403	11	α	α	PROPN
fnp-2613	403	12	-	-	PUNCT
fnp-2613	403	13	synuclein	synuclein	NOUN
fnp-2613	403	14	aggregation	aggregation	NOUN
fnp-2613	403	15	in	in	ADP
fnp-2613	403	16	dementia	dementia	NOUN
fnp-2613	403	17	with	with	ADP
fnp-2613	403	18	lewy	lewy	PROPN
fnp-2613	403	19	bodies	body	NOUN
fnp-2613	403	20	,	,	PUNCT
fnp-2613	403	21	parkinson	parkinson	NOUN
fnp-2613	403	22	’s	’s	PART
fnp-2613	403	23	disease	disease	NOUN
fnp-2613	403	24	and	and	CCONJ
fnp-2613	403	25	parkinson	parkinson	NOUN
fnp-2613	403	26	’s	’s	PART
fnp-2613	403	27	disease	disease	NOUN
fnp-2613	403	28	dementia	dementia	NOUN
fnp-2613	403	29	.	.	PUNCT
fnp-2613	404	1	acta	acta	PROPN
fnp-2613	404	2	neuropathol	neuropathol	PROPN
fnp-2613	404	3	.	.	PUNCT
fnp-2613	405	1	120	120	NUM
fnp-2613	405	2	,	,	PUNCT
fnp-2613	405	3	131–143	131–143	NUM
fnp-2613	405	4	(	(	PUNCT
fnp-2613	405	5	2010	2010	NUM
fnp-2613	405	6	)	)	PUNCT
fnp-2613	405	7	.	.	PUNCT
fnp-2613	406	1	43	43	NUM
fnp-2613	406	2	.	.	PUNCT
fnp-2613	407	1	bridi	bridi	PROPN
fnp-2613	407	2	,	,	PUNCT
fnp-2613	407	3	j.	j.	PROPN
fnp-2613	407	4	c.	c.	PROPN
fnp-2613	407	5	et	et	PROPN
fnp-2613	407	6	al	al	PROPN
fnp-2613	407	7	.	.	PROPN
fnp-2613	407	8	mechanisms	mechanism	NOUN
fnp-2613	407	9	of	of	ADP
fnp-2613	407	10	α	α	NOUN
fnp-2613	407	11	-	-	PUNCT
fnp-2613	407	12	synuclein	synuclein	NOUN
fnp-2613	407	13	induced	induce	VERB
fnp-2613	407	14	synaptopathy	synaptopathy	NOUN
fnp-2613	407	15	in	in	ADP
fnp-2613	407	16	parkinson	parkinson	NOUN
fnp-2613	407	17	’s	’s	PART
fnp-2613	407	18	disease	disease	NOUN
fnp-2613	407	19	.	.	PUNCT
fnp-2613	408	1	front	front	ADJ
fnp-2613	408	2	.	.	PUNCT
fnp-2613	409	1	neurosci	neurosci	PROPN
fnp-2613	409	2	.	.	PUNCT
fnp-2613	410	1	12	12	NUM
fnp-2613	410	2	,	,	PUNCT
fnp-2613	410	3	(	(	PUNCT
fnp-2613	410	4	2018	2018	NUM
fnp-2613	410	5	)	)	PUNCT
fnp-2613	410	6	.	.	PUNCT
fnp-2613	411	1	44	44	NUM
fnp-2613	411	2	.	.	PUNCT
fnp-2613	411	3	frigerio	frigerio	PROPN
fnp-2613	411	4	,	,	PUNCT
fnp-2613	411	5	r.	r.	PROPN
fnp-2613	411	6	et	et	PROPN
fnp-2613	411	7	al	al	PROPN
fnp-2613	411	8	.	.	PROPN
fnp-2613	412	1	incidental	incidental	PROPN
fnp-2613	412	2	lewy	lewy	PROPN
fnp-2613	412	3	body	body	NOUN
fnp-2613	412	4	disease	disease	NOUN
fnp-2613	412	5	:	:	PUNCT
fnp-2613	412	6	do	do	AUX
fnp-2613	412	7	some	some	DET
fnp-2613	412	8	cases	case	NOUN
fnp-2613	412	9	represent	represent	VERB
fnp-2613	412	10	a	a	DET
fnp-2613	412	11	preclinical	preclinical	ADJ
fnp-2613	412	12	stage	stage	NOUN
fnp-2613	412	13	of	of	ADP
fnp-2613	412	14	dementia	dementia	NOUN
fnp-2613	412	15	with	with	ADP
fnp-2613	412	16	lewy	lewy	PROPN
fnp-2613	412	17	bodies	body	NOUN
fnp-2613	412	18	?	?	PUNCT
fnp-2613	413	1	neurobiol	neurobiol	NOUN
fnp-2613	413	2	.	.	PUNCT
fnp-2613	414	1	aging	age	VERB
fnp-2613	414	2	32	32	NUM
fnp-2613	414	3	,	,	PUNCT
fnp-2613	414	4	857–63	857–63	NUM
fnp-2613	414	5	(	(	PUNCT
fnp-2613	414	6	2011	2011	NUM
fnp-2613	414	7	)	)	PUNCT
fnp-2613	414	8	.	.	PUNCT
fnp-2613	415	1	45	45	NUM
fnp-2613	415	2	.	.	X
fnp-2613	415	3	auning	auning	PROPN
fnp-2613	415	4	,	,	PUNCT
fnp-2613	415	5	e.	e.	PROPN
fnp-2613	415	6	et	et	PROPN
fnp-2613	415	7	al	al	PROPN
fnp-2613	415	8	.	.	PROPN
fnp-2613	416	1	early	early	ADV
fnp-2613	416	2	and	and	CCONJ
fnp-2613	416	3	presenting	present	VERB
fnp-2613	416	4	symptoms	symptom	NOUN
fnp-2613	416	5	of	of	ADP
fnp-2613	416	6	dementia	dementia	NOUN
fnp-2613	416	7	with	with	ADP
fnp-2613	416	8	lewy	lewy	PROPN
fnp-2613	416	9	bodies	body	NOUN
fnp-2613	416	10	.	.	PUNCT
fnp-2613	417	1	dement	dement	NOUN
fnp-2613	417	2	.	.	PUNCT
fnp-2613	418	1	geriatr	geriatr	PROPN
fnp-2613	418	2	.	.	PUNCT
fnp-2613	419	1	cogn	cogn	PROPN
fnp-2613	419	2	.	.	PUNCT
fnp-2613	420	1	disord	disord	PROPN
fnp-2613	420	2	.	.	PUNCT
fnp-2613	421	1	32	32	NUM
fnp-2613	421	2	,	,	PUNCT
fnp-2613	421	3	202–208	202–208	NUM
fnp-2613	421	4	(	(	PUNCT
fnp-2613	421	5	2011	2011	NUM
fnp-2613	421	6	)	)	PUNCT
fnp-2613	421	7	.	.	PUNCT
fnp-2613	422	1	46	46	NUM
fnp-2613	422	2	.	.	X
fnp-2613	422	3	ross	ross	PROPN
fnp-2613	422	4	,	,	PUNCT
fnp-2613	422	5	g.	g.	PROPN
fnp-2613	422	6	w.	w.	PROPN
fnp-2613	422	7	et	et	PROPN
fnp-2613	422	8	al	al	PROPN
fnp-2613	422	9	.	.	PROPN
fnp-2613	422	10	association	association	PROPN
fnp-2613	422	11	of	of	ADP
fnp-2613	422	12	olfactory	olfactory	ADJ
fnp-2613	422	13	dysfunction	dysfunction	NOUN
fnp-2613	422	14	with	with	ADP
fnp-2613	422	15	incidental	incidental	ADJ
fnp-2613	422	16	lewy	lewy	ADJ
fnp-2613	422	17	bodies	body	NOUN
fnp-2613	422	18	.	.	PUNCT
fnp-2613	423	1	mov	mov	NOUN
fnp-2613	423	2	.	.	PUNCT
fnp-2613	423	3	disord	disord	PROPN
fnp-2613	423	4	.	.	PUNCT
fnp-2613	424	1	21	21	NUM
fnp-2613	424	2	,	,	PUNCT
fnp-2613	424	3	2062–2067	2062–2067	NUM
fnp-2613	424	4	(	(	PUNCT
fnp-2613	424	5	2006	2006	NUM
fnp-2613	424	6	)	)	PUNCT
fnp-2613	424	7	.	.	PUNCT
fnp-2613	425	1	47	47	NUM
fnp-2613	425	2	.	.	PUNCT
fnp-2613	426	1	abbott	abbott	PROPN
fnp-2613	426	2	,	,	PUNCT
fnp-2613	426	3	r.	r.	PROPN
fnp-2613	426	4	d.	d.	PROPN
fnp-2613	426	5	et	et	PROPN
fnp-2613	427	1	al	al	PROPN
fnp-2613	427	2	.	.	PROPN
fnp-2613	427	3	bowel	bowel	PROPN
fnp-2613	427	4	movement	movement	NOUN
fnp-2613	427	5	frequency	frequency	NOUN
fnp-2613	427	6	in	in	ADP
fnp-2613	427	7	late	late	ADJ
fnp-2613	427	8	-	-	PUNCT
fnp-2613	427	9	life	life	NOUN
fnp-2613	427	10	and	and	CCONJ
fnp-2613	427	11	incidental	incidental	ADJ
fnp-2613	427	12	lewy	lewy	ADJ
fnp-2613	427	13	bodies	body	NOUN
fnp-2613	427	14	.	.	PUNCT
fnp-2613	428	1	mov	mov	NOUN
fnp-2613	428	2	.	.	PUNCT
fnp-2613	428	3	disord	disord	PROPN
fnp-2613	428	4	.	.	PUNCT
fnp-2613	429	1	22	22	NUM
fnp-2613	429	2	,	,	PUNCT
fnp-2613	429	3	1581–6	1581–6	NUM
fnp-2613	429	4	(	(	PUNCT
fnp-2613	429	5	2007	2007	NUM
fnp-2613	429	6	)	)	PUNCT
fnp-2613	429	7	.	.	PUNCT
fnp-2613	430	1	48	48	NUM
fnp-2613	430	2	.	.	PUNCT
fnp-2613	431	1	delledonne	delledonne	NOUN
fnp-2613	431	2	,	,	PUNCT
fnp-2613	431	3	a.	a.	PROPN
fnp-2613	431	4	et	et	PROPN
fnp-2613	431	5	al	al	PROPN
fnp-2613	431	6	.	.	PROPN
fnp-2613	432	1	incidental	incidental	PROPN
fnp-2613	432	2	lewy	lewy	PROPN
fnp-2613	432	3	body	body	NOUN
fnp-2613	432	4	disease	disease	NOUN
fnp-2613	432	5	and	and	CCONJ
fnp-2613	432	6	preclinical	preclinical	ADJ
fnp-2613	432	7	parkinson	parkinson	NOUN
fnp-2613	432	8	disease	disease	NOUN
fnp-2613	432	9	.	.	PUNCT
fnp-2613	433	1	arch	arch	NOUN
fnp-2613	433	2	.	.	PUNCT
fnp-2613	434	1	neurol	neurol	NOUN
fnp-2613	434	2	.	.	PUNCT
fnp-2613	435	1	65	65	NUM
fnp-2613	435	2	,	,	PUNCT
fnp-2613	435	3	1074–80	1074–80	PROPN
fnp-2613	435	4	(	(	PUNCT
fnp-2613	435	5	2008	2008	NUM
fnp-2613	435	6	)	)	PUNCT
fnp-2613	435	7	.	.	PUNCT
fnp-2613	436	1	49	49	NUM
fnp-2613	436	2	.	.	PUNCT
fnp-2613	437	1	american	american	PROPN
fnp-2613	437	2	psychiatric	psychiatric	PROPN
fnp-2613	437	3	association	association	PROPN
fnp-2613	437	4	:	:	PUNCT
fnp-2613	437	5	diagnostic	diagnostic	ADJ
fnp-2613	437	6	and	and	CCONJ
fnp-2613	437	7	statistical	statistical	ADJ
fnp-2613	437	8	manual	manual	NOUN
fnp-2613	437	9	of	of	ADP
fnp-2613	437	10	mental	mental	ADJ
fnp-2613	437	11	disorders	disorder	NOUN
fnp-2613	437	12	.	.	PUNCT
fnp-2613	438	1	american	american	ADJ
fnp-2613	438	2	psychiatric	psychiatric	PROPN
fnp-2613	438	3	publishing	publishing	PROPN
fnp-2613	438	4	,	,	PUNCT
fnp-2613	438	5	arlington	arlington	PROPN
fnp-2613	438	6	,	,	PUNCT
fnp-2613	438	7	usa	usa	PROPN
fnp-2613	438	8	.	.	PROPN
fnp-2613	438	9	(	(	PUNCT
fnp-2613	438	10	2013	2013	NUM
fnp-2613	438	11	)	)	PUNCT
fnp-2613	438	12	.	.	PUNCT
fnp-2613	439	1	50	50	NUM
fnp-2613	439	2	.	.	X
fnp-2613	439	3	walker	walker	PROPN
fnp-2613	439	4	,	,	PUNCT
fnp-2613	439	5	z.	z.	PROPN
fnp-2613	439	6	et	et	PROPN
fnp-2613	439	7	al	al	PROPN
fnp-2613	439	8	.	.	PROPN
fnp-2613	439	9	lewy	lewy	PROPN
fnp-2613	439	10	body	body	NOUN
fnp-2613	439	11	dementias	dementia	NOUN
fnp-2613	439	12	.	.	PUNCT
fnp-2613	440	1	lancet	lancet	NOUN
fnp-2613	440	2	386	386	NUM
fnp-2613	440	3	,	,	PUNCT
fnp-2613	440	4	1683–1697	1683–1697	NUM
fnp-2613	440	5	(	(	PUNCT
fnp-2613	440	6	2015	2015	NUM
fnp-2613	440	7	)	)	PUNCT
fnp-2613	440	8	.	.	PUNCT
fnp-2613	441	1	51	51	NUM
fnp-2613	441	2	.	.	PUNCT
fnp-2613	441	3	majer	majer	PROPN
fnp-2613	441	4	,	,	PUNCT
fnp-2613	441	5	r.	r.	PROPN
fnp-2613	441	6	et	et	PROPN
fnp-2613	441	7	al	al	PROPN
fnp-2613	441	8	.	.	PROPN
fnp-2613	441	9	behavioural	behavioural	ADJ
fnp-2613	441	10	and	and	CCONJ
fnp-2613	441	11	psychological	psychological	ADJ
fnp-2613	441	12	symptoms	symptom	NOUN
fnp-2613	441	13	in	in	ADP
fnp-2613	441	14	neurocognitive	neurocognitive	ADJ
fnp-2613	441	15	disorders	disorder	NOUN
fnp-2613	441	16	:	:	PUNCT
fnp-2613	441	17	specific	specific	ADJ
fnp-2613	441	18	patterns	pattern	NOUN
fnp-2613	441	19	in	in	ADP
fnp-2613	441	20	dementia	dementia	NOUN
fnp-2613	441	21	subtypes	subtype	NOUN
fnp-2613	441	22	.	.	PUNCT
fnp-2613	442	1	open	open	ADJ
fnp-2613	442	2	med	med	PROPN
fnp-2613	442	3	.	.	PUNCT
fnp-2613	443	1	14	14	NUM
fnp-2613	443	2	,	,	PUNCT
fnp-2613	443	3	307–316	307–316	NUM
fnp-2613	443	4	(	(	PUNCT
fnp-2613	443	5	2019	2019	NUM
fnp-2613	443	6	)	)	PUNCT
fnp-2613	443	7	.	.	PUNCT
fnp-2613	444	1	52	52	NUM
fnp-2613	444	2	.	.	X
fnp-2613	445	1	vik	vik	PROPN
fnp-2613	445	2	-	-	PUNCT
fnp-2613	445	3	mo	mo	PROPN
fnp-2613	445	4	,	,	PUNCT
fnp-2613	445	5	a.	a.	NOUN
fnp-2613	445	6	o.	o.	NOUN
fnp-2613	445	7	et	et	PROPN
fnp-2613	446	1	al	al	PROPN
fnp-2613	446	2	.	.	PROPN
fnp-2613	447	1	advanced	advanced	ADJ
fnp-2613	447	2	cerebral	cerebral	ADJ
fnp-2613	447	3	amyloid	amyloid	NOUN
fnp-2613	447	4	angiopathy	angiopathy	ADJ
fnp-2613	447	5	and	and	CCONJ
fnp-2613	447	6	small	small	ADJ
fnp-2613	447	7	vessel	vessel	NOUN
fnp-2613	447	8	disease	disease	NOUN
fnp-2613	447	9	are	be	AUX
fnp-2613	447	10	associated	associate	VERB
fnp-2613	447	11	with	with	ADP
fnp-2613	447	12	psychosis	psychosis	NOUN
fnp-2613	447	13	in	in	ADP
fnp-2613	447	14	alzheimer	alzheimer	PROPN
fnp-2613	447	15	’s	’s	PART
fnp-2613	447	16	disease	disease	NOUN
fnp-2613	447	17	.	.	PUNCT
fnp-2613	448	1	j.	j.	PROPN
fnp-2613	448	2	neurol	neurol	PROPN
fnp-2613	448	3	.	.	PUNCT
fnp-2613	449	1	neurosurg	neurosurg	PROPN
fnp-2613	449	2	.	.	PUNCT
fnp-2613	450	1	psychiatry	psychiatry	NOUN
fnp-2613	450	2	90	90	NUM
fnp-2613	450	3	,	,	PUNCT
fnp-2613	450	4	728–730	728–730	NUM
fnp-2613	450	5	(	(	PUNCT
fnp-2613	450	6	2019	2019	NUM
fnp-2613	450	7	)	)	PUNCT
fnp-2613	450	8	.	.	PUNCT
fnp-2613	451	1	53	53	NUM
fnp-2613	451	2	.	.	PUNCT
fnp-2613	452	1	fritze	fritze	PROPN
fnp-2613	452	2	,	,	PUNCT
fnp-2613	452	3	f.	f.	PROPN
fnp-2613	452	4	et	et	PROPN
fnp-2613	452	5	al	al	PROPN
fnp-2613	452	6	.	.	PROPN
fnp-2613	452	7	depressive	depressive	ADJ
fnp-2613	452	8	symptoms	symptom	NOUN
fnp-2613	452	9	in	in	ADP
fnp-2613	452	10	alzheimer	alzheimer	PROPN
fnp-2613	452	11	’s	’s	PART
fnp-2613	452	12	disease	disease	NOUN
fnp-2613	452	13	and	and	CCONJ
fnp-2613	452	14	lewy	lewy	ADJ
fnp-2613	452	15	body	body	NOUN
fnp-2613	452	16	dementia	dementia	NOUN
fnp-2613	452	17	:	:	PUNCT
fnp-2613	452	18	a	a	DET
fnp-2613	452	19	one	one	NUM
fnp-2613	452	20	-	-	PUNCT
fnp-2613	452	21	year	year	NOUN
fnp-2613	452	22	follow	follow	NOUN
fnp-2613	452	23	-	-	PUNCT
fnp-2613	452	24	up	up	ADP
fnp-2613	452	25	study	study	NOUN
fnp-2613	452	26	.	.	PUNCT
fnp-2613	453	1	dement	dement	NOUN
fnp-2613	453	2	.	.	PUNCT
fnp-2613	454	1	geriatr	geriatr	PROPN
fnp-2613	454	2	.	.	PUNCT
fnp-2613	455	1	cogn	cogn	PROPN
fnp-2613	455	2	.	.	PUNCT
fnp-2613	456	1	disord	disord	PROPN
fnp-2613	456	2	.	.	PUNCT
fnp-2613	457	1	32	32	NUM
fnp-2613	457	2	,	,	PUNCT
fnp-2613	457	3	143–149	143–149	NUM
fnp-2613	457	4	(	(	PUNCT
fnp-2613	457	5	2011	2011	NUM
fnp-2613	457	6	)	)	PUNCT
fnp-2613	457	7	.	.	PUNCT
fnp-2613	458	1	54	54	NUM
fnp-2613	458	2	.	.	PUNCT
fnp-2613	459	1	fritze	fritze	PROPN
fnp-2613	459	2	,	,	PUNCT
fnp-2613	459	3	f.	f.	PROPN
fnp-2613	459	4	et	et	PROPN
fnp-2613	459	5	al	al	PROPN
fnp-2613	459	6	.	.	PROPN
fnp-2613	459	7	depression	depression	NOUN
fnp-2613	459	8	in	in	ADP
fnp-2613	459	9	mild	mild	ADJ
fnp-2613	459	10	dementia	dementia	NOUN
fnp-2613	459	11	:	:	PUNCT
fnp-2613	459	12	associations	association	NOUN
fnp-2613	459	13	with	with	ADP
fnp-2613	459	14	diagnosis	diagnosis	NOUN
fnp-2613	459	15	,	,	PUNCT
fnp-2613	459	16	apoe	apoe	ADJ
fnp-2613	459	17	genotype	genotype	NOUN
fnp-2613	459	18	and	and	CCONJ
fnp-2613	459	19	clinical	clinical	ADJ
fnp-2613	459	20	features	feature	NOUN
fnp-2613	459	21	.	.	PUNCT
fnp-2613	460	1	int	int	NOUN
fnp-2613	460	2	.	.	PUNCT
fnp-2613	461	1	j.	j.	PROPN
fnp-2613	461	2	geriatr	geriatr	PROPN
fnp-2613	461	3	.	.	PUNCT
fnp-2613	462	1	psychiatry	psychiatry	NOUN
fnp-2613	462	2	26	26	NUM
fnp-2613	462	3	,	,	PUNCT
fnp-2613	462	4	1054–1061	1054–1061	NUM
fnp-2613	462	5	(	(	PUNCT
fnp-2613	462	6	2011	2011	NUM
fnp-2613	462	7	)	)	PUNCT
fnp-2613	462	8	.	.	PUNCT
fnp-2613	463	1	55	55	NUM
fnp-2613	463	2	.	.	PUNCT
fnp-2613	464	1	aarsland	aarsland	PROPN
fnp-2613	464	2	,	,	PUNCT
fnp-2613	464	3	d.	d.	PROPN
fnp-2613	464	4	et	et	PROPN
fnp-2613	464	5	al	al	PROPN
fnp-2613	464	6	.	.	PROPN
fnp-2613	464	7	comparison	comparison	NOUN
fnp-2613	464	8	of	of	ADP
fnp-2613	464	9	extrapyramidal	extrapyramidal	ADJ
fnp-2613	464	10	signs	sign	NOUN
fnp-2613	464	11	in	in	ADP
fnp-2613	464	12	dementia	dementia	NOUN
fnp-2613	464	13	with	with	ADP
fnp-2613	464	14	lewy	lewy	PROPN
fnp-2613	464	15	bodies	body	NOUN
fnp-2613	464	16	and	and	CCONJ
fnp-2613	464	17	parkinson	parkinson	NOUN
fnp-2613	464	18	’s	’s	PART
fnp-2613	464	19	disease	disease	NOUN
fnp-2613	464	20	.	.	PUNCT
fnp-2613	465	1	j.	j.	PROPN
fnp-2613	465	2	neuropsychiatry	neuropsychiatry	PROPN
fnp-2613	465	3	clin	clin	PROPN
fnp-2613	465	4	.	.	PUNCT
fnp-2613	466	1	neurosci	neurosci	PROPN
fnp-2613	466	2	.	.	PUNCT
fnp-2613	467	1	13	13	NUM
fnp-2613	467	2	,	,	PUNCT
fnp-2613	467	3	374–379	374–379	NUM
fnp-2613	467	4	(	(	PUNCT
fnp-2613	467	5	2001	2001	NUM
fnp-2613	467	6	)	)	PUNCT
fnp-2613	467	7	.	.	PUNCT
fnp-2613	468	1	56	56	NUM
fnp-2613	468	2	.	.	PUNCT
fnp-2613	469	1	ferini	ferini	PROPN
fnp-2613	469	2	-	-	PUNCT
fnp-2613	469	3	strambi	strambi	PROPN
fnp-2613	469	4	,	,	PUNCT
fnp-2613	469	5	l.	l.	PROPN
fnp-2613	469	6	et	et	PROPN
fnp-2613	469	7	al	al	PROPN
fnp-2613	469	8	.	.	PROPN
fnp-2613	470	1	rem	rem	VERB
fnp-2613	470	2	sleep	sleep	NOUN
fnp-2613	470	3	behavior	behavior	NOUN
fnp-2613	470	4	disorder	disorder	NOUN
fnp-2613	470	5	(	(	PUNCT
fnp-2613	470	6	rbd	rbd	NOUN
fnp-2613	470	7	)	)	PUNCT
fnp-2613	470	8	as	as	ADP
fnp-2613	470	9	a	a	DET
fnp-2613	470	10	marker	marker	NOUN
fnp-2613	470	11	of	of	ADP
fnp-2613	470	12	neurodegenerative	neurodegenerative	ADJ
fnp-2613	470	13	disorders	disorder	NOUN
fnp-2613	470	14	.	.	PUNCT
fnp-2613	471	1	arch	arch	NOUN
fnp-2613	471	2	.	.	PUNCT
fnp-2613	472	1	ital	ital	PROPN
fnp-2613	472	2	.	.	PUNCT
fnp-2613	473	1	biol	biol	PROPN
fnp-2613	473	2	.	.	PUNCT
fnp-2613	474	1	152	152	NUM
fnp-2613	474	2	,	,	PUNCT
fnp-2613	474	3	129–146	129–146	NUM
fnp-2613	474	4	(	(	PUNCT
fnp-2613	474	5	2014	2014	NUM
fnp-2613	474	6	)	)	PUNCT
fnp-2613	474	7	.	.	PUNCT
fnp-2613	475	1	57	57	NUM
fnp-2613	475	2	.	.	X
fnp-2613	476	1	ballard	ballard	PROPN
fnp-2613	476	2	,	,	PUNCT
fnp-2613	476	3	c.	c.	PROPN
fnp-2613	476	4	et	et	PROPN
fnp-2613	476	5	al	al	PROPN
fnp-2613	476	6	.	.	PROPN
fnp-2613	476	7	high	high	ADJ
fnp-2613	476	8	prevalence	prevalence	NOUN
fnp-2613	476	9	of	of	ADP
fnp-2613	476	10	neurovascular	neurovascular	ADJ
fnp-2613	476	11	instability	instability	NOUN
fnp-2613	476	12	in	in	ADP
fnp-2613	476	13	neurodegenerative	neurodegenerative	ADJ
fnp-2613	476	14	dementias	dementia	NOUN
fnp-2613	476	15	.	.	PUNCT
fnp-2613	477	1	neurology	neurology	NOUN
fnp-2613	477	2	51	51	NUM
fnp-2613	477	3	,	,	PUNCT
fnp-2613	477	4	1760–2	1760–2	NUM
fnp-2613	477	5	(	(	PUNCT
fnp-2613	477	6	1998	1998	NUM
fnp-2613	477	7	)	)	PUNCT
fnp-2613	477	8	.	.	PUNCT
fnp-2613	478	1	58	58	NUM
fnp-2613	478	2	.	.	PUNCT
fnp-2613	479	1	rongve	rongve	PROPN
fnp-2613	479	2	,	,	PUNCT
fnp-2613	479	3	a.	a.	NOUN
fnp-2613	479	4	et	et	PROPN
fnp-2613	479	5	al	al	PROPN
fnp-2613	479	6	.	.	PROPN
fnp-2613	479	7	cognitive	cognitive	ADJ
fnp-2613	479	8	decline	decline	NOUN
fnp-2613	479	9	in	in	ADP
fnp-2613	479	10	dementia	dementia	NOUN
fnp-2613	479	11	with	with	ADP
fnp-2613	479	12	lewy	lewy	PROPN
fnp-2613	479	13	bodies	body	NOUN
fnp-2613	479	14	:	:	PUNCT
fnp-2613	479	15	a	a	DET
fnp-2613	479	16	5	5	NUM
fnp-2613	479	17	-	-	PUNCT
fnp-2613	479	18	year	year	NOUN
fnp-2613	479	19	prospective	prospective	ADJ
fnp-2613	479	20	cohort	cohort	NOUN
fnp-2613	479	21	study	study	NOUN
fnp-2613	479	22	.	.	PUNCT
fnp-2613	480	1	bmj	bmj	PROPN
fnp-2613	480	2	open	open	VERB
fnp-2613	480	3	6	6	NUM
fnp-2613	480	4	,	,	PUNCT
fnp-2613	480	5	e010357	e010357	ADV
fnp-2613	480	6	(	(	PUNCT
fnp-2613	480	7	2016	2016	NUM
fnp-2613	480	8	)	)	PUNCT
fnp-2613	480	9	.	.	PUNCT
fnp-2613	481	1	59	59	NUM
fnp-2613	481	2	.	.	X
fnp-2613	481	3	perry	perry	PROPN
fnp-2613	481	4	,	,	PUNCT
fnp-2613	481	5	e.	e.	PROPN
fnp-2613	481	6	k.	k.	PROPN
fnp-2613	481	7	et	et	PROPN
fnp-2613	482	1	al	al	PROPN
fnp-2613	482	2	.	.	PROPN
fnp-2613	482	3	neocortical	neocortical	ADJ
fnp-2613	482	4	cholinergic	cholinergic	ADJ
fnp-2613	482	5	activities	activity	NOUN
fnp-2613	482	6	differentiate	differentiate	VERB
fnp-2613	482	7	lewy	lewy	ADJ
fnp-2613	482	8	body	body	NOUN
fnp-2613	482	9	dementia	dementia	NOUN
fnp-2613	482	10	from	from	ADP
fnp-2613	482	11	classical	classical	ADJ
fnp-2613	482	12	alzheimer	alzheimer	PROPN
fnp-2613	482	13	’s	’s	PART
fnp-2613	482	14	disease	disease	NOUN
fnp-2613	482	15	.	.	PUNCT
fnp-2613	483	1	neuroreport	neuroreport	NOUN
fnp-2613	483	2	5	5	NUM
fnp-2613	483	3	,	,	PUNCT
fnp-2613	483	4	747–749	747–749	NUM
fnp-2613	483	5	(	(	PUNCT
fnp-2613	483	6	1994	1994	NUM
fnp-2613	483	7	)	)	PUNCT
fnp-2613	483	8	.	.	PUNCT
fnp-2613	484	1	60	60	NUM
fnp-2613	484	2	.	.	PUNCT
fnp-2613	485	1	bereczki	bereczki	PROPN
fnp-2613	485	2	,	,	PUNCT
fnp-2613	485	3	e.	e.	PROPN
fnp-2613	485	4	et	et	PROPN
fnp-2613	485	5	al	al	PROPN
fnp-2613	485	6	.	.	PUNCT
fnp-2613	486	1	synaptic	synaptic	ADJ
fnp-2613	486	2	markers	marker	NOUN
fnp-2613	486	3	of	of	ADP
fnp-2613	486	4	cognitive	cognitive	ADJ
fnp-2613	486	5	decline	decline	NOUN
fnp-2613	486	6	in	in	ADP
fnp-2613	486	7	neurodegenerative	neurodegenerative	ADJ
fnp-2613	486	8	diseases	disease	NOUN
fnp-2613	486	9	:	:	PUNCT
fnp-2613	486	10	a	a	DET
fnp-2613	486	11	proteomic	proteomic	ADJ
fnp-2613	486	12	approach	approach	NOUN
fnp-2613	486	13	.	.	PUNCT
fnp-2613	487	1	brain	brain	NOUN
fnp-2613	487	2	141	141	NUM
fnp-2613	487	3	,	,	PUNCT
fnp-2613	487	4	582–595	582–595	NUM
fnp-2613	487	5	(	(	PUNCT
fnp-2613	487	6	2018	2018	NUM
fnp-2613	487	7	)	)	PUNCT
fnp-2613	487	8	.	.	PUNCT
fnp-2613	488	1	61	61	NUM
fnp-2613	488	2	.	.	X
fnp-2613	488	3	giil	giil	PROPN
fnp-2613	488	4	,	,	PUNCT
fnp-2613	488	5	l.	l.	PROPN
fnp-2613	488	6	m.	m.	PROPN
fnp-2613	488	7	et	et	PROPN
fnp-2613	488	8	al	al	PROPN
fnp-2613	488	9	.	.	PROPN
fnp-2613	488	10	serum	serum	PROPN
fnp-2613	488	11	potassium	potassium	NOUN
fnp-2613	488	12	is	be	AUX
fnp-2613	488	13	associated	associate	VERB
fnp-2613	488	14	with	with	ADP
fnp-2613	488	15	cognitive	cognitive	ADJ
fnp-2613	488	16	decline	decline	NOUN
fnp-2613	488	17	in	in	ADP
fnp-2613	488	18	patients	patient	NOUN
fnp-2613	488	19	with	with	ADP
fnp-2613	488	20	lewy	lewy	PROPN
fnp-2613	488	21	body	body	NOUN
fnp-2613	488	22	dementia	dementia	NOUN
fnp-2613	488	23	.	.	PUNCT
fnp-2613	489	1	j.	j.	PROPN
fnp-2613	489	2	alzheimer	alzheimer	PROPN
fnp-2613	489	3	’s	’s	PART
fnp-2613	489	4	dis	dis	PROPN
fnp-2613	489	5	.	.	PUNCT
fnp-2613	490	1	68	68	NUM
fnp-2613	490	2	,	,	PUNCT
fnp-2613	490	3	239–253	239–253	NUM
fnp-2613	490	4	(	(	PUNCT
fnp-2613	490	5	2019	2019	NUM
fnp-2613	490	6	)	)	PUNCT
fnp-2613	490	7	.	.	PUNCT
fnp-2613	491	1	62	62	NUM
fnp-2613	491	2	.	.	PUNCT
fnp-2613	491	3	ishii	ishii	PROPN
fnp-2613	491	4	,	,	PUNCT
fnp-2613	491	5	k.	k.	PROPN
fnp-2613	491	6	et	et	PROPN
fnp-2613	492	1	al	al	PROPN
fnp-2613	492	2	.	.	PROPN
fnp-2613	493	1	regional	regional	ADJ
fnp-2613	493	2	cerebral	cerebral	ADJ
fnp-2613	493	3	blood	blood	NOUN
fnp-2613	493	4	flow	flow	NOUN
fnp-2613	493	5	difference	difference	NOUN
fnp-2613	493	6	between	between	ADP
fnp-2613	493	7	dementia	dementia	NOUN
fnp-2613	493	8	with	with	ADP
fnp-2613	493	9	lewy	lewy	PROPN
fnp-2613	493	10	bodies	body	NOUN
fnp-2613	493	11	and	and	CCONJ
fnp-2613	493	12	ad	ad	NOUN
fnp-2613	493	13	.	.	PUNCT
fnp-2613	493	14	neurology	neurology	NOUN
fnp-2613	493	15	53	53	NUM
fnp-2613	493	16	,	,	PUNCT
fnp-2613	493	17	413–6	413–6	NUM
fnp-2613	493	18	(	(	PUNCT
fnp-2613	493	19	1999	1999	NUM
fnp-2613	493	20	)	)	PUNCT
fnp-2613	493	21	.	.	PUNCT
fnp-2613	494	1	63	63	NUM
fnp-2613	494	2	.	.	PUNCT
fnp-2613	494	3	mak	mak	PROPN
fnp-2613	494	4	,	,	PUNCT
fnp-2613	494	5	e.	e.	PROPN
fnp-2613	494	6	et	et	PROPN
fnp-2613	494	7	al	al	PROPN
fnp-2613	494	8	.	.	PUNCT
fnp-2613	495	1	neuroimaging	neuroimage	VERB
fnp-2613	495	2	characteristics	characteristic	NOUN
fnp-2613	495	3	of	of	ADP
fnp-2613	495	4	dementia	dementia	NOUN
fnp-2613	495	5	with	with	ADP
fnp-2613	495	6	lewy	lewy	PROPN
fnp-2613	495	7	bodies	body	NOUN
fnp-2613	495	8	.	.	PUNCT
fnp-2613	496	1	alzheimers	alzheimer	NOUN
fnp-2613	496	2	.	.	PUNCT
fnp-2613	497	1	res	re	NOUN
fnp-2613	497	2	.	.	PUNCT
fnp-2613	498	1	ther	ther	PROPN
fnp-2613	498	2	.	.	PUNCT
fnp-2613	499	1	6	6	NUM
fnp-2613	499	2	,	,	PUNCT
fnp-2613	499	3	18	18	NUM
fnp-2613	499	4	(	(	PUNCT
fnp-2613	499	5	2014	2014	NUM
fnp-2613	499	6	)	)	PUNCT
fnp-2613	499	7	.	.	PUNCT
fnp-2613	500	1	64	64	NUM
fnp-2613	500	2	.	.	PUNCT
fnp-2613	500	3	eisensehr	eisensehr	NOUN
fnp-2613	500	4	,	,	PUNCT
fnp-2613	500	5	i.	i.	PROPN
fnp-2613	500	6	et	et	PROPN
fnp-2613	500	7	al	al	PROPN
fnp-2613	500	8	.	.	PROPN
fnp-2613	500	9	reduced	reduce	VERB
fnp-2613	500	10	striatal	striatal	ADJ
fnp-2613	500	11	dopamine	dopamine	NOUN
fnp-2613	500	12	transporters	transporter	NOUN
fnp-2613	500	13	in	in	ADP
fnp-2613	500	14	idiopathic	idiopathic	ADJ
fnp-2613	500	15	rapid	rapid	ADJ
fnp-2613	500	16	eye	eye	NOUN
fnp-2613	500	17	movement	movement	NOUN
fnp-2613	500	18	sleep	sleep	NOUN
fnp-2613	500	19	behaviour	behaviour	NOUN
fnp-2613	500	20	disorder	disorder	NOUN
fnp-2613	500	21	.	.	PUNCT
fnp-2613	501	1	comparison	comparison	NOUN
fnp-2613	501	2	with	with	ADP
fnp-2613	501	3	parkinson	parkinson	NOUN
fnp-2613	501	4	’s	’s	PART
fnp-2613	501	5	disease	disease	NOUN
fnp-2613	501	6	and	and	CCONJ
fnp-2613	501	7	controls	control	NOUN
fnp-2613	501	8	.	.	PUNCT
fnp-2613	502	1	brain	brain	NOUN
fnp-2613	502	2	123	123	NUM
fnp-2613	502	3	,	,	PUNCT
fnp-2613	502	4	1155–1160	1155–1160	NUM
fnp-2613	502	5	(	(	PUNCT
fnp-2613	502	6	2000	2000	NUM
fnp-2613	502	7	)	)	PUNCT
fnp-2613	502	8	.	.	PUNCT
fnp-2613	503	1	65	65	NUM
fnp-2613	503	2	.	.	PUNCT
fnp-2613	503	3	gelpi	gelpi	NOUN
fnp-2613	503	4	,	,	PUNCT
fnp-2613	503	5	e.	e.	PROPN
fnp-2613	503	6	et	et	PROPN
fnp-2613	503	7	al	al	PROPN
fnp-2613	503	8	.	.	PROPN
fnp-2613	503	9	multiple	multiple	ADJ
fnp-2613	503	10	organ	organ	NOUN
fnp-2613	503	11	involvement	involvement	NOUN
fnp-2613	503	12	by	by	ADP
fnp-2613	503	13	alpha	alpha	NOUN
fnp-2613	503	14	-	-	PUNCT
fnp-2613	503	15	synuclein	synuclein	NOUN
fnp-2613	503	16	pathology	pathology	NOUN
fnp-2613	503	17	in	in	ADP
fnp-2613	503	18	lewy	lewy	PROPN
fnp-2613	503	19	body	body	NOUN
fnp-2613	503	20	disorders	disorder	NOUN
fnp-2613	503	21	.	.	PUNCT
fnp-2613	504	1	mov	mov	NOUN
fnp-2613	504	2	.	.	PUNCT
fnp-2613	504	3	disord	disord	PROPN
fnp-2613	504	4	.	.	PUNCT
fnp-2613	505	1	29	29	NUM
fnp-2613	505	2	,	,	PUNCT
fnp-2613	505	3	1010–1018	1010–1018	NUM
fnp-2613	505	4	(	(	PUNCT
fnp-2613	505	5	2014	2014	NUM
fnp-2613	505	6	)	)	PUNCT
fnp-2613	505	7	.	.	PUNCT
fnp-2613	506	1	66	66	NUM
fnp-2613	506	2	.	.	PUNCT
fnp-2613	506	3	whitfield	whitfield	PROPN
fnp-2613	506	4	,	,	PUNCT
fnp-2613	506	5	d.	d.	PROPN
fnp-2613	506	6	r.	r.	PROPN
fnp-2613	506	7	et	et	PROPN
fnp-2613	506	8	al	al	PROPN
fnp-2613	506	9	.	.	PROPN
fnp-2613	506	10	depression	depression	NOUN
fnp-2613	506	11	and	and	CCONJ
fnp-2613	506	12	synaptic	synaptic	ADJ
fnp-2613	506	13	zinc	zinc	NOUN
fnp-2613	506	14	regulation	regulation	NOUN
fnp-2613	506	15	in	in	ADP
fnp-2613	506	16	alzheimer	alzheimer	PROPN
fnp-2613	506	17	’s	’s	PART
fnp-2613	506	18	disease	disease	NOUN
fnp-2613	506	19	,	,	PUNCT
fnp-2613	506	20	dementia	dementia	NOUN
fnp-2613	506	21	with	with	ADP
fnp-2613	506	22	lewy	lewy	PROPN
fnp-2613	506	23	bodies	body	NOUN
fnp-2613	506	24	and	and	CCONJ
fnp-2613	506	25	parkinson	parkinson	NOUN
fnp-2613	506	26	’s	’s	PART
fnp-2613	506	27	disease	disease	NOUN
fnp-2613	506	28	dementia	dementia	NOUN
fnp-2613	506	29	.	.	PUNCT
fnp-2613	507	1	am	be	AUX
fnp-2613	507	2	.	.	PUNCT
fnp-2613	508	1	j.	j.	PROPN
fnp-2613	508	2	geriatr	geriatr	PROPN
fnp-2613	508	3	.	.	PUNCT
fnp-2613	509	1	psychiatry	psychiatry	NOUN
fnp-2613	509	2	23	23	NUM
fnp-2613	509	3	,	,	PUNCT
fnp-2613	509	4	1–8	1–8	NUM
fnp-2613	509	5	(	(	PUNCT
fnp-2613	509	6	2014	2014	NUM
fnp-2613	509	7	)	)	PUNCT
fnp-2613	509	8	.	.	PUNCT
fnp-2613	510	1	67	67	NUM
fnp-2613	510	2	.	.	PUNCT
fnp-2613	511	1	huber	huber	PROPN
fnp-2613	511	2	,	,	PUNCT
fnp-2613	511	3	m.	m.	NOUN
fnp-2613	511	4	et	et	PROPN
fnp-2613	511	5	al	al	PROPN
fnp-2613	511	6	.	.	PROPN
fnp-2613	511	7	metabolic	metabolic	PROPN
fnp-2613	511	8	correlates	correlate	VERB
fnp-2613	511	9	of	of	ADP
fnp-2613	511	10	dopaminergic	dopaminergic	ADJ
fnp-2613	511	11	loss	loss	NOUN
fnp-2613	511	12	in	in	ADP
fnp-2613	511	13	dementia	dementia	NOUN
fnp-2613	511	14	with	with	ADP
fnp-2613	511	15	lewy	lewy	PROPN
fnp-2613	511	16	bodies	body	NOUN
fnp-2613	511	17	.	.	PUNCT
fnp-2613	512	1	mov	mov	NOUN
fnp-2613	512	2	.	.	PUNCT
fnp-2613	512	3	disord	disord	PROPN
fnp-2613	512	4	.	.	PUNCT
fnp-2613	513	1	mds.27945	mds.27945	CCONJ
fnp-2613	513	2	(	(	PUNCT
fnp-2613	513	3	2019	2019	NUM
fnp-2613	513	4	)	)	PUNCT
fnp-2613	513	5	doi:10.1002	doi:10.1002	NOUN
fnp-2613	513	6	/	/	SYM
fnp-2613	513	7	mds.27945	mds.27945	NOUN
fnp-2613	513	8	.	.	PROPN
fnp-2613	513	9	68	68	NUM
fnp-2613	513	10	.	.	PUNCT
fnp-2613	514	1	lessig	lessig	PROPN
fnp-2613	514	2	,	,	PUNCT
fnp-2613	514	3	s.	s.	PROPN
fnp-2613	514	4	et	et	PROPN
fnp-2613	514	5	al	al	PROPN
fnp-2613	514	6	.	.	PROPN
fnp-2613	515	1	reduced	reduce	VERB
fnp-2613	515	2	hypocretin	hypocretin	NOUN
fnp-2613	515	3	(	(	PUNCT
fnp-2613	515	4	orexin	orexin	NOUN
fnp-2613	515	5	)	)	PUNCT
fnp-2613	515	6	levels	level	NOUN
fnp-2613	515	7	in	in	ADP
fnp-2613	515	8	dementia	dementia	NOUN
fnp-2613	515	9	with	with	ADP
fnp-2613	515	10	lewy	lewy	PROPN
fnp-2613	515	11	bodies	body	NOUN
fnp-2613	515	12	.	.	PUNCT
fnp-2613	516	1	neuroreport	neuroreport	NOUN
fnp-2613	516	2	21	21	NUM
fnp-2613	516	3	,	,	PUNCT
fnp-2613	516	4	756–760	756–760	NUM
fnp-2613	516	5	(	(	PUNCT
fnp-2613	516	6	2010	2010	NUM
fnp-2613	516	7	)	)	PUNCT
fnp-2613	516	8	.	.	PUNCT
fnp-2613	517	1	69	69	NUM
fnp-2613	517	2	.	.	PUNCT
fnp-2613	518	1	ferman	ferman	NOUN
fnp-2613	518	2	,	,	PUNCT
fnp-2613	518	3	t.	t.	PROPN
fnp-2613	518	4	j.	j.	PROPN
fnp-2613	518	5	et	et	PROPN
fnp-2613	518	6	al	al	PROPN
fnp-2613	518	7	.	.	PROPN
fnp-2613	519	1	sleep	sleep	NOUN
fnp-2613	519	2	in	in	ADP
fnp-2613	519	3	parkinson	parkinson	NOUN
fnp-2613	519	4	’s	’s	PART
fnp-2613	519	5	disease	disease	NOUN
fnp-2613	519	6	and	and	CCONJ
fnp-2613	519	7	dementia	dementia	NOUN
fnp-2613	519	8	with	with	ADP
fnp-2613	519	9	lewy	lewy	PROPN
fnp-2613	519	10	bodies	body	NOUN
fnp-2613	519	11	.	.	PUNCT
fnp-2613	520	1	psychiatry	psychiatry	NOUN
fnp-2613	520	2	park	park	PROPN
fnp-2613	520	3	.	.	PUNCT
fnp-2613	521	1	dis	dis	PROPN
fnp-2613	521	2	.	.	PUNCT
fnp-2613	522	1	27	27	NUM
fnp-2613	522	2	,	,	PUNCT
fnp-2613	522	3	61–70	61–70	NUM
fnp-2613	522	4	(	(	PUNCT
fnp-2613	522	5	2012	2012	NUM
fnp-2613	522	6	)	)	PUNCT
fnp-2613	522	7	.	.	PUNCT
fnp-2613	523	1	70	70	NUM
fnp-2613	523	2	.	.	X
fnp-2613	524	1	borda	borda	PROPN
fnp-2613	524	2	,	,	PUNCT
fnp-2613	524	3	m.	m.	NOUN
fnp-2613	524	4	g.	g.	PROPN
fnp-2613	524	5	et	et	PROPN
fnp-2613	524	6	al	al	PROPN
fnp-2613	524	7	.	.	PROPN
fnp-2613	524	8	association	association	PROPN
fnp-2613	524	9	of	of	ADP
fnp-2613	524	10	depressive	depressive	ADJ
fnp-2613	524	11	symptoms	symptom	NOUN
fnp-2613	524	12	and	and	CCONJ
fnp-2613	524	13	subjective	subjective	ADJ
fnp-2613	524	14	memory	memory	NOUN
fnp-2613	524	15	complaints	complaint	NOUN
fnp-2613	524	16	with	with	ADP
fnp-2613	524	17	the	the	DET
fnp-2613	524	18	incidence	incidence	NOUN
fnp-2613	524	19	of	of	ADP
fnp-2613	524	20	cognitive	cognitive	ADJ
fnp-2613	524	21	impairment	impairment	NOUN
fnp-2613	524	22	in	in	ADP
fnp-2613	524	23	older	old	ADJ
fnp-2613	524	24	adults	adult	NOUN
fnp-2613	524	25	with	with	ADP
fnp-2613	524	26	high	high	ADJ
fnp-2613	524	27	blood	blood	NOUN
fnp-2613	524	28	pressure	pressure	NOUN
fnp-2613	524	29	.	.	PUNCT
fnp-2613	525	1	eur	eur	ADJ
fnp-2613	525	2	.	.	PUNCT
fnp-2613	526	1	geriatr	geriatr	PROPN
fnp-2613	526	2	.	.	PUNCT
fnp-2613	527	1	med	med	PROPN
fnp-2613	527	2	.	.	PROPN
fnp-2613	528	1	10	10	NUM
fnp-2613	528	2	,	,	PUNCT
fnp-2613	528	3	413–420	413–420	NUM
fnp-2613	528	4	(	(	PUNCT
fnp-2613	528	5	2019	2019	NUM
fnp-2613	528	6	)	)	PUNCT
fnp-2613	528	7	.	.	PUNCT
fnp-2613	529	1	71	71	NUM
fnp-2613	529	2	.	.	X
fnp-2613	530	1	beyer	beyer	PROPN
fnp-2613	530	2	,	,	PUNCT
fnp-2613	530	3	m.	m.	PROPN
fnp-2613	530	4	k.	k.	PROPN
fnp-2613	530	5	et	et	PROPN
fnp-2613	530	6	al	al	PROPN
fnp-2613	530	7	.	.	PROPN
fnp-2613	530	8	gray	gray	ADJ
fnp-2613	530	9	matter	matter	NOUN
fnp-2613	530	10	atrophy	atrophy	NOUN
fnp-2613	530	11	in	in	ADP
fnp-2613	530	12	parkinson	parkinson	NOUN
fnp-2613	530	13	disease	disease	NOUN
fnp-2613	530	14	with	with	ADP
fnp-2613	530	15	dementia	dementia	NOUN
fnp-2613	530	16	and	and	CCONJ
fnp-2613	530	17	dementia	dementia	NOUN
fnp-2613	530	18	with	with	ADP
fnp-2613	530	19	lewy	lewy	PROPN
fnp-2613	530	20	bodies	body	NOUN
fnp-2613	530	21	.	.	PUNCT
fnp-2613	531	1	neurology	neurology	NOUN
fnp-2613	531	2	69	69	NUM
fnp-2613	531	3	,	,	PUNCT
fnp-2613	531	4	747–54	747–54	NOUN
fnp-2613	531	5	(	(	PUNCT
fnp-2613	531	6	2007	2007	NUM
fnp-2613	531	7	)	)	PUNCT
fnp-2613	531	8	.	.	PUNCT
fnp-2613	532	1	72	72	NUM
fnp-2613	532	2	.	.	PUNCT
fnp-2613	533	1	whitwell	whitwell	PROPN
fnp-2613	533	2	,	,	PUNCT
fnp-2613	533	3	j.	j.	PROPN
fnp-2613	533	4	l.	l.	PROPN
fnp-2613	533	5	et	et	PROPN
fnp-2613	533	6	al	al	PROPN
fnp-2613	533	7	.	.	PROPN
fnp-2613	533	8	focal	focal	ADJ
fnp-2613	533	9	atrophy	atrophy	NOUN
fnp-2613	533	10	in	in	ADP
fnp-2613	533	11	dementia	dementia	NOUN
fnp-2613	533	12	with	with	ADP
fnp-2613	533	13	lewy	lewy	ADJ
fnp-2613	533	14	bodies	body	NOUN
fnp-2613	533	15	on	on	ADP
fnp-2613	533	16	mri	mri	NOUN
fnp-2613	533	17	:	:	PUNCT
fnp-2613	533	18	a	a	DET
fnp-2613	533	19	distinct	distinct	ADJ
fnp-2613	533	20	pattern	pattern	NOUN
fnp-2613	533	21	from	from	ADP
fnp-2613	533	22	alzheimer	alzheimer	PROPN
fnp-2613	533	23	’s	’s	PART
fnp-2613	533	24	disease	disease	NOUN
fnp-2613	533	25	.	.	PUNCT
fnp-2613	534	1	brain	brain	NOUN
fnp-2613	534	2	130	130	NUM
fnp-2613	534	3	,	,	PUNCT
fnp-2613	534	4	708–19	708–19	NOUN
fnp-2613	534	5	(	(	PUNCT
fnp-2613	534	6	2007	2007	NUM
fnp-2613	534	7	)	)	PUNCT
fnp-2613	534	8	.	.	PUNCT
fnp-2613	535	1	73	73	NUM
fnp-2613	535	2	.	.	PUNCT
fnp-2613	536	1	barkhof	barkhof	PROPN
fnp-2613	536	2	,	,	PUNCT
fnp-2613	536	3	f.	f.	PROPN
fnp-2613	536	4	et	et	PROPN
fnp-2613	536	5	al	al	PROPN
fnp-2613	536	6	.	.	PUNCT
fnp-2613	537	1	the	the	DET
fnp-2613	537	2	significance	significance	NOUN
fnp-2613	537	3	of	of	ADP
fnp-2613	537	4	medial	medial	ADJ
fnp-2613	537	5	temporal	temporal	ADJ
fnp-2613	537	6	lobe	lobe	ADJ
fnp-2613	537	7	atrophy	atrophy	NOUN
fnp-2613	537	8	:	:	PUNCT
fnp-2613	537	9	a	a	DET
fnp-2613	537	10	postmortem	postmortem	NOUN
fnp-2613	537	11	mri	mri	NOUN
fnp-2613	537	12	study	study	NOUN
fnp-2613	537	13	in	in	ADP
fnp-2613	537	14	the	the	DET
fnp-2613	537	15	very	very	ADV
fnp-2613	537	16	old	old	ADJ
fnp-2613	537	17	.	.	PUNCT
fnp-2613	538	1	neurology	neurology	NOUN
fnp-2613	538	2	69	69	NUM
fnp-2613	538	3	,	,	PUNCT
fnp-2613	538	4	1521–7	1521–7	NUM
fnp-2613	538	5	(	(	PUNCT
fnp-2613	538	6	2007	2007	NUM
fnp-2613	538	7	)	)	PUNCT
fnp-2613	538	8	.	.	PUNCT
fnp-2613	539	1	74	74	NUM
fnp-2613	539	2	.	.	PUNCT
fnp-2613	540	1	sabattoli	sabattoli	PROPN
fnp-2613	540	2	,	,	PUNCT
fnp-2613	540	3	f.	f.	PROPN
fnp-2613	540	4	et	et	PROPN
fnp-2613	540	5	al	al	PROPN
fnp-2613	540	6	.	.	PROPN
fnp-2613	540	7	hippocampal	hippocampal	PROPN
fnp-2613	540	8	shape	shape	NOUN
fnp-2613	540	9	differences	difference	NOUN
fnp-2613	540	10	in	in	ADP
fnp-2613	540	11	dementia	dementia	NOUN
fnp-2613	540	12	with	with	ADP
fnp-2613	540	13	lewy	lewy	PROPN
fnp-2613	540	14	bodies	body	NOUN
fnp-2613	540	15	.	.	PUNCT
fnp-2613	541	1	neuroimage	neuroimage	NOUN
fnp-2613	541	2	41	41	NUM
fnp-2613	541	3	,	,	PUNCT
fnp-2613	541	4	699–705	699–705	NUM
fnp-2613	541	5	(	(	PUNCT
fnp-2613	541	6	2008	2008	NUM
fnp-2613	541	7	)	)	PUNCT
fnp-2613	541	8	.	.	PUNCT
fnp-2613	542	1	75	75	NUM
fnp-2613	542	2	.	.	X
fnp-2613	542	3	mcaleese	mcaleese	PROPN
fnp-2613	542	4	,	,	PUNCT
fnp-2613	542	5	k.	k.	PROPN
fnp-2613	543	1	e.	e.	PROPN
fnp-2613	543	2	et	et	PROPN
fnp-2613	544	1	al	al	PROPN
fnp-2613	544	2	.	.	PUNCT
fnp-2613	545	1	post	post	ADJ
fnp-2613	545	2	-	-	ADJ
fnp-2613	545	3	mortem	mortem	ADJ
fnp-2613	545	4	assessment	assessment	NOUN
fnp-2613	545	5	in	in	ADP
fnp-2613	545	6	vascular	vascular	ADJ
fnp-2613	545	7	dementia	dementia	NOUN
fnp-2613	545	8	:	:	PUNCT
fnp-2613	545	9	advances	advance	NOUN
fnp-2613	545	10	and	and	CCONJ
fnp-2613	545	11	aspirations	aspiration	NOUN
fnp-2613	545	12	.	.	PUNCT
fnp-2613	546	1	bmc	bmc	PROPN
fnp-2613	546	2	med	med	PROPN
fnp-2613	546	3	.	.	PUNCT
fnp-2613	547	1	14	14	NUM
fnp-2613	547	2	,	,	PUNCT
fnp-2613	547	3	129	129	NUM
fnp-2613	547	4	(	(	PUNCT
fnp-2613	547	5	2016	2016	NUM
fnp-2613	547	6	)	)	PUNCT
fnp-2613	547	7	.	.	PUNCT
fnp-2613	548	1	76	76	NUM
fnp-2613	548	2	.	.	PUNCT
fnp-2613	548	3	watson	watson	PROPN
fnp-2613	548	4	,	,	PUNCT
fnp-2613	548	5	r.	r.	PROPN
fnp-2613	548	6	et	et	PROPN
fnp-2613	548	7	al	al	PROPN
fnp-2613	548	8	.	.	PROPN
fnp-2613	549	1	magnetic	magnetic	ADJ
fnp-2613	549	2	resonance	resonance	NOUN
fnp-2613	549	3	imaging	imaging	NOUN
fnp-2613	549	4	in	in	ADP
fnp-2613	549	5	lewy	lewy	PROPN
fnp-2613	549	6	body	body	NOUN
fnp-2613	549	7	dementias	dementia	NOUN
fnp-2613	549	8	.	.	PUNCT
fnp-2613	550	1	dement	dement	NOUN
fnp-2613	550	2	.	.	PUNCT
fnp-2613	551	1	geriatr	geriatr	PROPN
fnp-2613	551	2	.	.	PUNCT
fnp-2613	552	1	cogn	cogn	PROPN
fnp-2613	552	2	.	.	PUNCT
fnp-2613	553	1	disord	disord	PROPN
fnp-2613	553	2	.	.	PUNCT
fnp-2613	554	1	28	28	NUM
fnp-2613	554	2	,	,	PUNCT
fnp-2613	554	3	493–506	493–506	NUM
fnp-2613	554	4	(	(	PUNCT
fnp-2613	554	5	2009	2009	NUM
fnp-2613	554	6	)	)	PUNCT
fnp-2613	554	7	.	.	PUNCT
fnp-2613	555	1	77	77	NUM
fnp-2613	555	2	.	.	PUNCT
fnp-2613	555	3	sauer	sauer	PROPN
fnp-2613	555	4	,	,	PUNCT
fnp-2613	555	5	j.	j.	PROPN
fnp-2613	555	6	et	et	PROPN
fnp-2613	555	7	al	al	PROPN
fnp-2613	555	8	.	.	PROPN
fnp-2613	555	9	differences	difference	NOUN
fnp-2613	555	10	between	between	ADP
fnp-2613	555	11	alzheimer	alzheimer	PROPN
fnp-2613	555	12	’s	’s	PART
fnp-2613	555	13	disease	disease	NOUN
fnp-2613	555	14	and	and	CCONJ
fnp-2613	555	15	dementia	dementia	NOUN
fnp-2613	555	16	with	with	ADP
fnp-2613	555	17	lewy	lewy	PROPN
fnp-2613	555	18	bodies	body	NOUN
fnp-2613	555	19	:	:	PUNCT
fnp-2613	555	20	an	an	DET
fnp-2613	555	21	fmri	fmri	ADJ
fnp-2613	555	22	study	study	NOUN
fnp-2613	555	23	of	of	ADP
fnp-2613	555	24	task	task	NOUN
fnp-2613	555	25	-	-	PUNCT
fnp-2613	555	26	related	relate	VERB
fnp-2613	555	27	brain	brain	NOUN
fnp-2613	555	28	activity	activity	NOUN
fnp-2613	555	29	.	.	PUNCT
fnp-2613	556	1	brain	brain	NOUN
fnp-2613	556	2	129	129	NUM
fnp-2613	556	3	,	,	PUNCT
fnp-2613	556	4	1780–1788	1780–1788	NUM
fnp-2613	556	5	(	(	PUNCT
fnp-2613	556	6	2006	2006	NUM
fnp-2613	556	7	)	)	PUNCT
fnp-2613	556	8	.	.	PUNCT
fnp-2613	557	1	78	78	NUM
fnp-2613	557	2	.	.	PUNCT
fnp-2613	558	1	stebbins	stebbins	PROPN
fnp-2613	558	2	,	,	PUNCT
fnp-2613	558	3	g.	g.	PROPN
fnp-2613	558	4	t.	t.	PROPN
fnp-2613	558	5	et	et	PROPN
fnp-2613	558	6	al	al	PROPN
fnp-2613	558	7	.	.	PROPN
fnp-2613	558	8	altered	alter	VERB
fnp-2613	558	9	cortical	cortical	ADJ
fnp-2613	558	10	visual	visual	ADJ
fnp-2613	558	11	processing	processing	NOUN
fnp-2613	558	12	in	in	ADP
fnp-2613	558	13	pd	pd	PROPN
fnp-2613	558	14	with	with	ADP
fnp-2613	558	15	hallucinations	hallucination	NOUN
fnp-2613	558	16	:	:	PUNCT
fnp-2613	558	17	an	an	DET
fnp-2613	558	18	fmri	fmri	PROPN
fnp-2613	558	19	study	study	NOUN
fnp-2613	558	20	.	.	PUNCT
fnp-2613	559	1	neurology	neurology	NOUN
fnp-2613	559	2	63	63	NUM
fnp-2613	559	3	,	,	PUNCT
fnp-2613	559	4	1409–16	1409–16	NUM
fnp-2613	559	5	(	(	PUNCT
fnp-2613	559	6	2004	2004	NUM
fnp-2613	559	7	)	)	PUNCT
fnp-2613	559	8	.	.	PUNCT
fnp-2613	560	1	79	79	NUM
fnp-2613	560	2	.	.	PUNCT
fnp-2613	561	1	galvin	galvin	PROPN
fnp-2613	561	2	,	,	PUNCT
fnp-2613	561	3	j.	j.	PROPN
fnp-2613	561	4	e.	e.	PROPN
fnp-2613	561	5	et	et	PROPN
fnp-2613	561	6	al	al	PROPN
fnp-2613	561	7	.	.	PROPN
fnp-2613	561	8	resting	rest	VERB
fnp-2613	561	9	bold	bold	ADJ
fnp-2613	561	10	fmri	fmri	PROPN
fnp-2613	561	11	differentiates	differentiate	NOUN
fnp-2613	561	12	dementia	dementia	NOUN
fnp-2613	561	13	with	with	ADP
fnp-2613	561	14	lewy	lewy	PROPN
fnp-2613	561	15	bodies	body	NOUN
fnp-2613	561	16	vs	vs	ADP
fnp-2613	561	17	alzheimer	alzheimer	PROPN
fnp-2613	561	18	disease	disease	PROPN
fnp-2613	561	19	.	.	PUNCT
fnp-2613	562	1	neurology	neurology	NOUN
fnp-2613	562	2	76	76	NUM
fnp-2613	562	3	,	,	PUNCT
fnp-2613	562	4	1797–803	1797–803	NOUN
fnp-2613	562	5	(	(	PUNCT
fnp-2613	562	6	2011	2011	NUM
fnp-2613	562	7	)	)	PUNCT
fnp-2613	562	8	.	.	PUNCT
fnp-2613	563	1	80	80	NUM
fnp-2613	563	2	.	.	PUNCT
fnp-2613	564	1	taylor	taylor	PROPN
fnp-2613	564	2	,	,	PUNCT
fnp-2613	564	3	j.	j.	PROPN
fnp-2613	565	1	p.	p.	PROPN
fnp-2613	565	2	et	et	PROPN
fnp-2613	566	1	al	al	PROPN
fnp-2613	566	2	.	.	PUNCT
fnp-2613	567	1	neuroimaging	neuroimage	VERB
fnp-2613	567	2	of	of	ADP
fnp-2613	567	3	dementia	dementia	NOUN
fnp-2613	567	4	with	with	ADP
fnp-2613	567	5	lewy	lewy	PROPN
fnp-2613	567	6	bodies	body	NOUN
fnp-2613	567	7	.	.	PUNCT
fnp-2613	568	1	neuroimaging	neuroimage	VERB
fnp-2613	568	2	clin	clin	PROPN
fnp-2613	568	3	.	.	PUNCT
fnp-2613	569	1	n.	n.	PROPN
fnp-2613	569	2	am	am	PROPN
fnp-2613	569	3	.	.	PUNCT
fnp-2613	570	1	22	22	NUM
fnp-2613	570	2	,	,	PUNCT
fnp-2613	570	3	67–81	67–81	NUM
fnp-2613	570	4	(	(	PUNCT
fnp-2613	570	5	2012	2012	NUM
fnp-2613	570	6	)	)	PUNCT
fnp-2613	570	7	.	.	PUNCT
fnp-2613	571	1	81	81	NUM
fnp-2613	571	2	.	.	PUNCT
fnp-2613	571	3	siepel	siepel	PROPN
fnp-2613	571	4	,	,	PUNCT
fnp-2613	571	5	f.	f.	PROPN
fnp-2613	571	6	j.	j.	PROPN
fnp-2613	571	7	et	et	PROPN
fnp-2613	571	8	al	al	PROPN
fnp-2613	571	9	.	.	PROPN
fnp-2613	572	1	(	(	PUNCT
fnp-2613	572	2	123i)fp	123i)fp	NUM
fnp-2613	572	3	-	-	PUNCT
fnp-2613	572	4	cit	cit	ADJ
fnp-2613	572	5	spect	spect	NOUN
fnp-2613	572	6	in	in	ADP
fnp-2613	572	7	suspected	suspect	VERB
fnp-2613	572	8	dementia	dementia	NOUN
fnp-2613	572	9	with	with	ADP
fnp-2613	572	10	lewy	lewy	PROPN
fnp-2613	572	11	bodies	body	NOUN
fnp-2613	572	12	:	:	PUNCT
fnp-2613	572	13	a	a	DET
fnp-2613	572	14	longitudinal	longitudinal	ADJ
fnp-2613	572	15	case	case	NOUN
fnp-2613	572	16	study	study	NOUN
fnp-2613	572	17	.	.	PUNCT
fnp-2613	573	1	bmj	bmj	PROPN
fnp-2613	573	2	open	open	ADJ
fnp-2613	573	3	3	3	NUM
fnp-2613	573	4	,	,	PUNCT
fnp-2613	573	5	e002642	e002642	PROPN
fnp-2613	573	6	(	(	PUNCT
fnp-2613	573	7	2013	2013	NUM
fnp-2613	573	8	)	)	PUNCT
fnp-2613	573	9	.	.	PUNCT
fnp-2613	574	1	82	82	NUM
fnp-2613	574	2	.	.	PUNCT
fnp-2613	574	3	murai	murai	PROPN
fnp-2613	574	4	,	,	PUNCT
fnp-2613	574	5	t.	t.	PROPN
fnp-2613	574	6	et	et	PROPN
fnp-2613	574	7	al	al	PROPN
fnp-2613	574	8	.	.	PROPN
fnp-2613	575	1	in	in	ADP
fnp-2613	575	2	vivo	vivo	ADJ
fnp-2613	575	3	evidence	evidence	NOUN
fnp-2613	575	4	for	for	ADP
fnp-2613	575	5	differential	differential	ADJ
fnp-2613	575	6	association	association	NOUN
fnp-2613	575	7	of	of	ADP
fnp-2613	575	8	striatal	striatal	ADJ
fnp-2613	575	9	dopamine	dopamine	NOUN
fnp-2613	575	10	and	and	CCONJ
fnp-2613	575	11	midbrain	midbrain	NOUN
fnp-2613	575	12	serotonin	serotonin	NOUN
fnp-2613	575	13	systems	system	NOUN
fnp-2613	575	14	with	with	ADP
fnp-2613	575	15	neuropsychiatric	neuropsychiatric	ADJ
fnp-2613	575	16	symptoms	symptom	NOUN
fnp-2613	575	17	in	in	ADP
fnp-2613	575	18	parkinson	parkinson	NOUN
fnp-2613	575	19	’s	’s	PART
fnp-2613	575	20	disease	disease	NOUN
fnp-2613	575	21	.	.	PUNCT
fnp-2613	576	1	j.	j.	PROPN
fnp-2613	576	2	neuropsychiatry	neuropsychiatry	PROPN
fnp-2613	576	3	clin	clin	PROPN
fnp-2613	576	4	.	.	PUNCT
fnp-2613	577	1	neurosci	neurosci	PROPN
fnp-2613	577	2	.	.	PUNCT
fnp-2613	578	1	13	13	NUM
fnp-2613	578	2	,	,	PUNCT
fnp-2613	578	3	222–8	222–8	NUM
fnp-2613	578	4	(	(	PUNCT
fnp-2613	578	5	2001	2001	NUM
fnp-2613	578	6	)	)	PUNCT
fnp-2613	578	7	.	.	PUNCT
fnp-2613	579	1	83	83	NUM
fnp-2613	579	2	.	.	PUNCT
fnp-2613	579	3	ishii	ishii	PROPN
fnp-2613	579	4	,	,	PUNCT
fnp-2613	579	5	k.	k.	PROPN
fnp-2613	579	6	et	et	PROPN
fnp-2613	579	7	al	al	PROPN
fnp-2613	579	8	.	.	PROPN
fnp-2613	579	9	comparison	comparison	NOUN
fnp-2613	579	10	of	of	ADP
fnp-2613	579	11	fdg	fdg	PROPN
fnp-2613	579	12	-	-	ADJ
fnp-2613	579	13	pet	pet	ADJ
fnp-2613	579	14	and	and	CCONJ
fnp-2613	579	15	imp	imp	NOUN
fnp-2613	579	16	-	-	PUNCT
fnp-2613	579	17	spect	spect	NOUN
fnp-2613	579	18	in	in	ADP
fnp-2613	579	19	patients	patient	NOUN
fnp-2613	579	20	with	with	ADP
fnp-2613	579	21	dementia	dementia	NOUN
fnp-2613	579	22	with	with	ADP
fnp-2613	579	23	lewy	lewy	PROPN
fnp-2613	579	24	bodies	body	NOUN
fnp-2613	579	25	.	.	PUNCT
fnp-2613	580	1	ann	ann	PROPN
fnp-2613	580	2	.	.	PUNCT
fnp-2613	580	3	nucl	nucl	PROPN
fnp-2613	580	4	.	.	PUNCT
fnp-2613	581	1	med	med	PROPN
fnp-2613	581	2	.	.	PROPN
fnp-2613	581	3	18	18	NUM
fnp-2613	581	4	,	,	PUNCT
fnp-2613	581	5	447–451	447–451	NUM
fnp-2613	581	6	(	(	PUNCT
fnp-2613	581	7	2004	2004	NUM
fnp-2613	581	8	)	)	PUNCT
fnp-2613	581	9	.	.	PUNCT
fnp-2613	582	1	84	84	NUM
fnp-2613	582	2	.	.	PUNCT
fnp-2613	583	1	shimada	shimada	PROPN
fnp-2613	583	2	,	,	PUNCT
fnp-2613	583	3	h.	h.	PROPN
fnp-2613	583	4	et	et	PROPN
fnp-2613	583	5	al	al	PROPN
fnp-2613	583	6	.	.	PUNCT
fnp-2613	584	1	mapping	mapping	NOUN
fnp-2613	584	2	of	of	ADP
fnp-2613	584	3	brain	brain	NOUN
fnp-2613	584	4	acetylcholinesterase	acetylcholinesterase	NOUN
fnp-2613	584	5	alterations	alteration	NOUN
fnp-2613	584	6	in	in	ADP
fnp-2613	584	7	lewy	lewy	PROPN
fnp-2613	584	8	body	body	NOUN
fnp-2613	584	9	disease	disease	NOUN
fnp-2613	584	10	by	by	ADP
fnp-2613	584	11	pet	pet	PROPN
fnp-2613	584	12	.	.	PUNCT
fnp-2613	584	13	neurology	neurology	NOUN
fnp-2613	584	14	73	73	NUM
fnp-2613	584	15	,	,	PUNCT
fnp-2613	584	16	273–8	273–8	NUM
fnp-2613	584	17	(	(	PUNCT
fnp-2613	584	18	2009	2009	NUM
fnp-2613	584	19	)	)	PUNCT
fnp-2613	584	20	.	.	PUNCT
fnp-2613	585	1	85	85	NUM
fnp-2613	585	2	.	.	PUNCT
fnp-2613	586	1	roks	roks	PROPN
fnp-2613	586	2	,	,	PUNCT
fnp-2613	586	3	g.	g.	PROPN
fnp-2613	586	4	et	et	PROPN
fnp-2613	586	5	al	al	PROPN
fnp-2613	586	6	.	.	PUNCT
fnp-2613	587	1	the	the	DET
fnp-2613	587	2	use	use	NOUN
fnp-2613	587	3	of	of	ADP
fnp-2613	587	4	eeg	eeg	NOUN
fnp-2613	587	5	in	in	ADP
fnp-2613	587	6	the	the	DET
fnp-2613	587	7	diagnosis	diagnosis	NOUN
fnp-2613	587	8	of	of	ADP
fnp-2613	587	9	dementia	dementia	NOUN
fnp-2613	587	10	with	with	ADP
fnp-2613	587	11	lewy	lewy	PROPN
fnp-2613	587	12	bodies	body	NOUN
fnp-2613	587	13	.	.	PUNCT
fnp-2613	588	1	j.	j.	PROPN
fnp-2613	588	2	neurol	neurol	PROPN
fnp-2613	588	3	.	.	PUNCT
fnp-2613	589	1	neurosurg	neurosurg	PROPN
fnp-2613	589	2	.	.	PUNCT
fnp-2613	590	1	psychiatry	psychiatry	NOUN
fnp-2613	590	2	79	79	NUM
fnp-2613	590	3	,	,	PUNCT
fnp-2613	590	4	377–380	377–380	NUM
fnp-2613	590	5	(	(	PUNCT
fnp-2613	590	6	2008	2008	NUM
fnp-2613	590	7	)	)	PUNCT
fnp-2613	590	8	.	.	PUNCT
fnp-2613	591	1	86	86	NUM
fnp-2613	591	2	.	.	PUNCT
fnp-2613	592	1	dickson	dickson	PROPN
fnp-2613	592	2	,	,	PUNCT
fnp-2613	592	3	d.	d.	PROPN
fnp-2613	592	4	w.	w.	PROPN
fnp-2613	592	5	introduction	introduction	NOUN
fnp-2613	592	6	to	to	ADP
fnp-2613	592	7	neurodegeneration	neurodegeneration	NOUN
fnp-2613	592	8	:	:	PUNCT
fnp-2613	592	9	the	the	DET
fnp-2613	592	10	molecular	molecular	ADJ
fnp-2613	592	11	pathology	pathology	NOUN
fnp-2613	592	12	of	of	ADP
fnp-2613	592	13	dementia	dementia	NOUN
fnp-2613	592	14	and	and	CCONJ
fnp-2613	592	15	movement	movement	NOUN
fnp-2613	592	16	disorders	disorder	NOUN
fnp-2613	592	17	.	.	PUNCT
fnp-2613	593	1	in	in	ADP
fnp-2613	593	2	:	:	PUNCT
fnp-2613	593	3	neurodegeneration	neurodegeneration	NOUN
fnp-2613	593	4	:	:	PUNCT
fnp-2613	593	5	the	the	DET
fnp-2613	593	6	molecular	molecular	ADJ
fnp-2613	593	7	pathology	pathology	NOUN
fnp-2613	593	8	of	of	ADP
fnp-2613	593	9	dementia	dementia	NOUN
fnp-2613	593	10	and	and	CCONJ
fnp-2613	593	11	movement	movement	NOUN
fnp-2613	593	12	disorders	disorder	NOUN
fnp-2613	593	13	:	:	PUNCT
fnp-2613	593	14	2nd	2nd	ADJ
fnp-2613	593	15	ed	ed	NOUN
fnp-2613	593	16	.	.	PUNCT
fnp-2613	594	1	pp	pp	ADJ
fnp-2613	594	2	.	.	PUNCT
fnp-2613	595	1	1–5	1–5	NUM
fnp-2613	595	2	,	,	PUNCT
fnp-2613	595	3	wiley	wiley	NOUN
fnp-2613	595	4	-	-	PUNCT
fnp-2613	595	5	blackwell	blackwell	PROPN
fnp-2613	595	6	(	(	PUNCT
fnp-2613	595	7	2011	2011	NUM
fnp-2613	595	8	)	)	PUNCT
fnp-2613	595	9	.	.	PUNCT
fnp-2613	596	1	87	87	NUM
fnp-2613	596	2	.	.	PUNCT
fnp-2613	596	3	schade	schade	PROPN
fnp-2613	596	4	,	,	PUNCT
fnp-2613	596	5	s.	s.	PROPN
fnp-2613	596	6	et	et	PROPN
fnp-2613	596	7	al	al	PROPN
fnp-2613	596	8	.	.	PUNCT
fnp-2613	596	9	biomarkers	biomarker	NOUN
fnp-2613	596	10	in	in	ADP
fnp-2613	596	11	biological	biological	ADJ
fnp-2613	596	12	fluids	fluid	NOUN
fnp-2613	596	13	for	for	ADP
fnp-2613	596	14	dementia	dementia	NOUN
fnp-2613	596	15	with	with	ADP
fnp-2613	596	16	lewy	lewy	PROPN
fnp-2613	596	17	bodies	body	NOUN
fnp-2613	596	18	.	.	PUNCT
fnp-2613	597	1	alzheimers	alzheimer	NOUN
fnp-2613	597	2	.	.	PUNCT
fnp-2613	598	1	res	re	NOUN
fnp-2613	598	2	.	.	PUNCT
fnp-2613	599	1	ther	ther	PROPN
fnp-2613	599	2	.	.	PUNCT
fnp-2613	600	1	6	6	NUM
fnp-2613	600	2	,	,	PUNCT
fnp-2613	600	3	72	72	NUM
fnp-2613	600	4	(	(	PUNCT
fnp-2613	600	5	2014	2014	NUM
fnp-2613	600	6	)	)	PUNCT
fnp-2613	600	7	.	.	PUNCT
fnp-2613	601	1	88	88	NUM
fnp-2613	601	2	.	.	PUNCT
fnp-2613	602	1	jendroska	jendroska	PROPN
fnp-2613	602	2	,	,	PUNCT
fnp-2613	602	3	k.	k.	PROPN
fnp-2613	602	4	et	et	PROPN
fnp-2613	603	1	al	al	PROPN
fnp-2613	603	2	.	.	PUNCT
fnp-2613	603	3	amyloid	amyloid	PROPN
fnp-2613	603	4	β	β	X
fnp-2613	603	5	peptide	peptide	NOUN
fnp-2613	603	6	and	and	CCONJ
fnp-2613	603	7	precursor	precursor	NOUN
fnp-2613	603	8	protein	protein	NOUN
fnp-2613	603	9	(	(	PUNCT
fnp-2613	603	10	app	app	NOUN
fnp-2613	603	11	)	)	PUNCT
fnp-2613	603	12	in	in	ADP
fnp-2613	603	13	mild	mild	ADJ
fnp-2613	603	14	and	and	CCONJ
fnp-2613	603	15	severe	severe	ADJ
fnp-2613	603	16	brain	brain	NOUN
fnp-2613	603	17	ischemia	ischemia	NOUN
fnp-2613	603	18	.	.	PUNCT
fnp-2613	604	1	ann	ann	PROPN
fnp-2613	604	2	.	.	PUNCT
fnp-2613	604	3	n.	n.	PROPN
fnp-2613	604	4	y.	y.	PROPN
fnp-2613	604	5	acad	acad	PROPN
fnp-2613	604	6	.	.	PUNCT
fnp-2613	605	1	sci	sci	PROPN
fnp-2613	605	2	.	.	PROPN
fnp-2613	605	3	826	826	NUM
fnp-2613	605	4	,	,	PUNCT
fnp-2613	605	5	401–405	401–405	NUM
fnp-2613	605	6	(	(	PUNCT
fnp-2613	605	7	1997	1997	NUM
fnp-2613	605	8	)	)	PUNCT
fnp-2613	605	9	.	.	PUNCT
fnp-2613	606	1	89	89	NUM
fnp-2613	606	2	.	.	PUNCT
fnp-2613	607	1	bonanni	bonanni	PROPN
fnp-2613	607	2	,	,	PUNCT
fnp-2613	607	3	l.	l.	PROPN
fnp-2613	607	4	et	et	PROPN
fnp-2613	607	5	al	al	PROPN
fnp-2613	607	6	.	.	PROPN
fnp-2613	607	7	quantitative	quantitative	ADJ
fnp-2613	607	8	electroencephalogram	electroencephalogram	NOUN
fnp-2613	607	9	utility	utility	NOUN
fnp-2613	607	10	in	in	ADP
fnp-2613	607	11	predicting	predict	VERB
fnp-2613	607	12	conversion	conversion	NOUN
fnp-2613	607	13	of	of	ADP
fnp-2613	607	14	mild	mild	ADJ
fnp-2613	607	15	cognitive	cognitive	ADJ
fnp-2613	607	16	impairment	impairment	NOUN
fnp-2613	607	17	to	to	ADP
fnp-2613	607	18	dementia	dementia	NOUN
fnp-2613	607	19	with	with	ADP
fnp-2613	607	20	lewy	lewy	PROPN
fnp-2613	607	21	bodies	body	NOUN
fnp-2613	607	22	.	.	PUNCT
fnp-2613	608	1	neurobiol	neurobiol	NOUN
fnp-2613	608	2	.	.	PUNCT
fnp-2613	609	1	aging	age	VERB
fnp-2613	609	2	36	36	NUM
fnp-2613	609	3	,	,	PUNCT
fnp-2613	609	4	434–445	434–445	NUM
fnp-2613	609	5	(	(	PUNCT
fnp-2613	609	6	2015	2015	NUM
fnp-2613	609	7	)	)	PUNCT
fnp-2613	609	8	.	.	PUNCT
fnp-2613	610	1	90	90	NUM
fnp-2613	610	2	.	.	X
fnp-2613	610	3	terzaghi	terzaghi	PROPN
fnp-2613	610	4	,	,	PUNCT
fnp-2613	610	5	m.	m.	NOUN
fnp-2613	610	6	et	et	PROPN
fnp-2613	610	7	al	al	PROPN
fnp-2613	610	8	.	.	PUNCT
fnp-2613	611	1	analysis	analysis	NOUN
fnp-2613	611	2	of	of	ADP
fnp-2613	611	3	video	video	NOUN
fnp-2613	611	4	-	-	PUNCT
fnp-2613	611	5	polysomnographic	polysomnographic	ADJ
fnp-2613	611	6	sleep	sleep	NOUN
fnp-2613	611	7	findings	finding	NOUN
fnp-2613	611	8	in	in	ADP
fnp-2613	611	9	dementia	dementia	NOUN
fnp-2613	611	10	with	with	ADP
fnp-2613	611	11	lewy	lewy	PROPN
fnp-2613	611	12	bodies	body	NOUN
fnp-2613	611	13	.	.	PUNCT
fnp-2613	612	1	mov	mov	NOUN
fnp-2613	612	2	.	.	PUNCT
fnp-2613	612	3	disord	disord	PROPN
fnp-2613	612	4	.	.	PUNCT
fnp-2613	613	1	28	28	NUM
fnp-2613	613	2	,	,	PUNCT
fnp-2613	613	3	1416–1423	1416–1423	NUM
fnp-2613	613	4	(	(	PUNCT
fnp-2613	613	5	2013	2013	NUM
fnp-2613	613	6	)	)	PUNCT
fnp-2613	613	7	.	.	PUNCT
fnp-2613	614	1	91	91	NUM
fnp-2613	614	2	.	.	PUNCT
fnp-2613	614	3	kanemaru	kanemaru	PROPN
fnp-2613	614	4	,	,	PUNCT
fnp-2613	614	5	k.	k.	PROPN
fnp-2613	614	6	et	et	PROPN
fnp-2613	614	7	al	al	PROPN
fnp-2613	614	8	.	.	PROPN
fnp-2613	614	9	decreased	decrease	VERB
fnp-2613	614	10	csf	csf	ADJ
fnp-2613	614	11	amyloid	amyloid	NOUN
fnp-2613	614	12	beta42	beta42	NOUN
fnp-2613	614	13	and	and	CCONJ
fnp-2613	614	14	normal	normal	ADJ
fnp-2613	614	15	tau	tau	PROPN
fnp-2613	614	16	levels	level	NOUN
fnp-2613	614	17	in	in	ADP
fnp-2613	614	18	dementia	dementia	NOUN
fnp-2613	614	19	with	with	ADP
fnp-2613	614	20	lewy	lewy	PROPN
fnp-2613	614	21	bodies	body	NOUN
fnp-2613	614	22	.	.	PUNCT
fnp-2613	615	1	neurology	neurology	NOUN
fnp-2613	615	2	54	54	NUM
fnp-2613	615	3	,	,	PUNCT
fnp-2613	615	4	1875–1876	1875–1876	NUM
fnp-2613	615	5	(	(	PUNCT
fnp-2613	615	6	2000	2000	NUM
fnp-2613	615	7	)	)	PUNCT
fnp-2613	615	8	.	.	PUNCT
fnp-2613	616	1	92	92	NUM
fnp-2613	616	2	.	.	PUNCT
fnp-2613	616	3	clark	clark	PROPN
fnp-2613	616	4	,	,	PUNCT
fnp-2613	616	5	c.	c.	PROPN
fnp-2613	616	6	m.	m.	PROPN
fnp-2613	616	7	et	et	PROPN
fnp-2613	616	8	al	al	PROPN
fnp-2613	616	9	.	.	PUNCT
fnp-2613	616	10	cerebrospinal	cerebrospinal	ADJ
fnp-2613	616	11	fluid	fluid	NOUN
fnp-2613	616	12	tau	tau	NOUN
fnp-2613	616	13	and	and	CCONJ
fnp-2613	616	14	betaamyloid	betaamyloid	NOUN
fnp-2613	616	15	.	.	PUNCT
fnp-2613	617	1	arch	arch	ADJ
fnp-2613	617	2	neurol	neurol	PROPN
fnp-2613	617	3	60	60	NUM
fnp-2613	617	4	,	,	PUNCT
fnp-2613	617	5	1696–1702	1696–1702	NUM
fnp-2613	617	6	(	(	PUNCT
fnp-2613	617	7	2003	2003	NUM
fnp-2613	617	8	)	)	PUNCT
fnp-2613	617	9	.	.	PUNCT
fnp-2613	618	1	93	93	NUM
fnp-2613	618	2	.	.	PUNCT
fnp-2613	619	1	mollenhauer	mollenhauer	PROPN
fnp-2613	619	2	,	,	PUNCT
fnp-2613	619	3	b.	b.	PROPN
fnp-2613	619	4	et	et	PROPN
fnp-2613	619	5	al	al	PROPN
fnp-2613	619	6	.	.	PUNCT
fnp-2613	620	1	tau	tau	PROPN
fnp-2613	620	2	protein	protein	NOUN
fnp-2613	620	3	,	,	PUNCT
fnp-2613	620	4	abeta42	abeta42	NOUN
fnp-2613	620	5	and	and	CCONJ
fnp-2613	620	6	s-100b	s-100b	NOUN
fnp-2613	620	7	protein	protein	NOUN
fnp-2613	620	8	in	in	ADP
fnp-2613	620	9	cerebrospinal	cerebrospinal	ADJ
fnp-2613	620	10	fluid	fluid	NOUN
fnp-2613	620	11	of	of	ADP
fnp-2613	620	12	patients	patient	NOUN
fnp-2613	620	13	with	with	ADP
fnp-2613	620	14	dementia	dementia	NOUN
fnp-2613	620	15	with	with	ADP
fnp-2613	620	16	lewy	lewy	PROPN
fnp-2613	620	17	bodies	body	NOUN
fnp-2613	620	18	.	.	PUNCT
fnp-2613	621	1	dement	dement	NOUN
fnp-2613	621	2	.	.	PUNCT
fnp-2613	622	1	geriatr	geriatr	PROPN
fnp-2613	622	2	.	.	PUNCT
fnp-2613	623	1	cogn	cogn	PROPN
fnp-2613	623	2	.	.	PUNCT
fnp-2613	624	1	disord	disord	PROPN
fnp-2613	624	2	.	.	PUNCT
fnp-2613	625	1	19	19	NUM
fnp-2613	625	2	,	,	PUNCT
fnp-2613	625	3	164–170	164–170	NUM
fnp-2613	625	4	(	(	PUNCT
fnp-2613	625	5	2005	2005	NUM
fnp-2613	625	6	)	)	PUNCT
fnp-2613	625	7	.	.	PUNCT
fnp-2613	626	1	94	94	NUM
fnp-2613	626	2	.	.	PUNCT
fnp-2613	626	3	llorens	llorens	PROPN
fnp-2613	626	4	,	,	PUNCT
fnp-2613	626	5	f.	f.	PROPN
fnp-2613	626	6	et	et	PROPN
fnp-2613	626	7	al	al	PROPN
fnp-2613	626	8	.	.	PUNCT
fnp-2613	627	1	cerebrospinal	cerebrospinal	ADJ
fnp-2613	627	2	α	α	NOUN
fnp-2613	627	3	-	-	PUNCT
fnp-2613	627	4	synuclein	synuclein	NOUN
fnp-2613	627	5	in	in	ADP
fnp-2613	627	6	α	α	NOUN
fnp-2613	627	7	-	-	PUNCT
fnp-2613	627	8	synuclein	synuclein	NOUN
fnp-2613	627	9	aggregation	aggregation	NOUN
fnp-2613	627	10	disorders	disorder	NOUN
fnp-2613	627	11	:	:	PUNCT
fnp-2613	627	12	tau	tau	NOUN
fnp-2613	627	13	/	/	SYM
fnp-2613	627	14	α	α	PROPN
fnp-2613	627	15	-	-	PUNCT
fnp-2613	627	16	synuclein	synuclein	NOUN
fnp-2613	627	17	ratio	ratio	NOUN
fnp-2613	627	18	as	as	ADP
fnp-2613	627	19	potential	potential	ADJ
fnp-2613	627	20	biomarker	biomarker	NOUN
fnp-2613	627	21	for	for	ADP
fnp-2613	627	22	dementia	dementia	NOUN
fnp-2613	627	23	with	with	ADP
fnp-2613	627	24	lewy	lewy	PROPN
fnp-2613	627	25	bodies	body	NOUN
fnp-2613	627	26	.	.	PUNCT
fnp-2613	628	1	j.	j.	PROPN
fnp-2613	628	2	neurol	neurol	PROPN
fnp-2613	628	3	.	.	PUNCT
fnp-2613	629	1	263	263	NUM
fnp-2613	629	2	,	,	PUNCT
fnp-2613	629	3	2271–2277	2271–2277	NUM
fnp-2613	629	4	(	(	PUNCT
fnp-2613	629	5	2016	2016	NUM
fnp-2613	629	6	)	)	PUNCT
fnp-2613	629	7	.	.	PUNCT
fnp-2613	630	1	95	95	NUM
fnp-2613	630	2	.	.	PUNCT
fnp-2613	631	1	tredici	tredici	PROPN
fnp-2613	631	2	,	,	PUNCT
fnp-2613	631	3	k.	k.	PROPN
fnp-2613	631	4	del	del	PROPN
fnp-2613	631	5	et	et	PROPN
fnp-2613	631	6	al	al	PROPN
fnp-2613	631	7	.	.	PROPN
fnp-2613	632	1	lewy	lewy	PROPN
fnp-2613	632	2	pathology	pathology	PROPN
fnp-2613	632	3	in	in	ADP
fnp-2613	632	4	the	the	DET
fnp-2613	632	5	submandibular	submandibular	ADJ
fnp-2613	632	6	gland	gland	NOUN
fnp-2613	632	7	of	of	ADP
fnp-2613	632	8	individuals	individual	NOUN
fnp-2613	632	9	with	with	ADP
fnp-2613	632	10	incidental	incidental	ADJ
fnp-2613	632	11	lewy	lewy	ADJ
fnp-2613	632	12	body	body	NOUN
fnp-2613	632	13	disease	disease	NOUN
fnp-2613	632	14	and	and	CCONJ
fnp-2613	632	15	sporadic	sporadic	ADJ
fnp-2613	632	16	parkinson	parkinson	NOUN
fnp-2613	632	17	’s	’s	PART
fnp-2613	632	18	disease	disease	NOUN
fnp-2613	632	19	.	.	PUNCT
fnp-2613	633	1	acta	acta	PROPN
fnp-2613	633	2	neuropathol	neuropathol	PROPN
fnp-2613	633	3	.	.	PUNCT
fnp-2613	634	1	119	119	NUM
fnp-2613	634	2	,	,	PUNCT
fnp-2613	634	3	703–713	703–713	NUM
fnp-2613	634	4	(	(	PUNCT
fnp-2613	634	5	2010	2010	NUM
fnp-2613	634	6	)	)	PUNCT
fnp-2613	634	7	.	.	PUNCT
fnp-2613	635	1	96	96	NUM
fnp-2613	635	2	.	.	X
fnp-2613	635	3	spillantini	spillantini	PROPN
fnp-2613	635	4	,	,	PUNCT
fnp-2613	635	5	m.	m.	NOUN
fnp-2613	636	1	g.	g.	PROPN
fnp-2613	636	2	et	et	PROPN
fnp-2613	636	3	al	al	PROPN
fnp-2613	636	4	.	.	PROPN
fnp-2613	636	5	alpha	alpha	PROPN
fnp-2613	636	6	-	-	PUNCT
fnp-2613	636	7	synuclein	synuclein	NOUN
fnp-2613	636	8	in	in	ADP
fnp-2613	636	9	filamentous	filamentous	ADJ
fnp-2613	636	10	inclusions	inclusion	NOUN
fnp-2613	636	11	of	of	ADP
fnp-2613	636	12	lewy	lewy	ADJ
fnp-2613	636	13	bodies	body	NOUN
fnp-2613	636	14	from	from	ADP
fnp-2613	636	15	parkinson	parkinson	NOUN
fnp-2613	636	16	’s	’s	PART
fnp-2613	636	17	disease	disease	NOUN
fnp-2613	636	18	and	and	CCONJ
fnp-2613	636	19	dementia	dementia	NOUN
fnp-2613	636	20	with	with	ADP
fnp-2613	636	21	lewy	lewy	PROPN
fnp-2613	636	22	bodies	body	NOUN
fnp-2613	636	23	.	.	PUNCT
fnp-2613	637	1	proc	proc	NOUN
fnp-2613	637	2	.	.	PUNCT
fnp-2613	638	1	natl	natl	PROPN
fnp-2613	638	2	.	.	PUNCT
fnp-2613	639	1	acad	acad	PROPN
fnp-2613	639	2	.	.	PUNCT
fnp-2613	640	1	sci	sci	PROPN
fnp-2613	640	2	.	.	PUNCT
fnp-2613	640	3	u.	u.	PROPN
fnp-2613	640	4	s.	s.	PROPN
fnp-2613	640	5	a.	a.	PROPN
fnp-2613	640	6	95	95	NUM
fnp-2613	640	7	,	,	PUNCT
fnp-2613	640	8	6469–73	6469–73	X
fnp-2613	640	9	(	(	PUNCT
fnp-2613	640	10	1998	1998	NUM
fnp-2613	640	11	)	)	PUNCT
fnp-2613	640	12	.	.	PUNCT
fnp-2613	641	1	97	97	NUM
fnp-2613	641	2	.	.	PUNCT
fnp-2613	642	1	lim	lim	PROPN
fnp-2613	642	2	,	,	PUNCT
fnp-2613	642	3	x.	x.	NOUN
fnp-2613	642	4	et	et	PROPN
fnp-2613	642	5	al	al	PROPN
fnp-2613	642	6	.	.	PUNCT
fnp-2613	643	1	the	the	DET
fnp-2613	643	2	diagnostic	diagnostic	ADJ
fnp-2613	643	3	utility	utility	NOUN
fnp-2613	643	4	of	of	ADP
fnp-2613	643	5	cerebrospinal	cerebrospinal	ADJ
fnp-2613	643	6	fluid	fluid	ADJ
fnp-2613	643	7	alpha	alpha	NOUN
fnp-2613	643	8	-	-	PUNCT
fnp-2613	643	9	synuclein	synuclein	NOUN
fnp-2613	643	10	analysis	analysis	NOUN
fnp-2613	643	11	in	in	ADP
fnp-2613	643	12	dementia	dementia	NOUN
fnp-2613	643	13	with	with	ADP
fnp-2613	643	14	lewy	lewy	PROPN
fnp-2613	643	15	bodies	body	NOUN
fnp-2613	643	16	a	a	DET
fnp-2613	643	17	systematic	systematic	ADJ
fnp-2613	643	18	review	review	NOUN
fnp-2613	643	19	and	and	CCONJ
fnp-2613	643	20	meta	meta	ADJ
fnp-2613	643	21	-	-	PUNCT
fnp-2613	643	22	analysis	analysis	NOUN
fnp-2613	643	23	.	.	PUNCT
fnp-2613	644	1	park	park	NOUN
fnp-2613	644	2	.	.	PUNCT
fnp-2613	645	1	relat	relat	PROPN
fnp-2613	645	2	.	.	PUNCT
fnp-2613	646	1	disord	disord	PROPN
fnp-2613	646	2	.	.	PUNCT
fnp-2613	647	1	19	19	NUM
fnp-2613	647	2	,	,	PUNCT
fnp-2613	647	3	851–858	851–858	NUM
fnp-2613	647	4	(	(	PUNCT
fnp-2613	647	5	2013	2013	NUM
fnp-2613	647	6	)	)	PUNCT
fnp-2613	647	7	.	.	PUNCT
fnp-2613	648	1	98	98	NUM
fnp-2613	648	2	.	.	X
fnp-2613	648	3	mollenhauer	mollenhauer	PROPN
fnp-2613	648	4	,	,	PUNCT
fnp-2613	648	5	b.	b.	PROPN
fnp-2613	648	6	et	et	PROPN
fnp-2613	648	7	al	al	PROPN
fnp-2613	648	8	.	.	PUNCT
fnp-2613	649	1	direct	direct	ADJ
fnp-2613	649	2	quantification	quantification	NOUN
fnp-2613	649	3	of	of	ADP
fnp-2613	649	4	csf	csf	ADJ
fnp-2613	649	5	α	α	NOUN
fnp-2613	649	6	-	-	NOUN
fnp-2613	649	7	synuclein	synuclein	NOUN
fnp-2613	649	8	by	by	ADP
fnp-2613	649	9	elisa	elisa	NOUN
fnp-2613	649	10	and	and	CCONJ
fnp-2613	649	11	first	first	ADJ
fnp-2613	649	12	cross	cross	ADJ
fnp-2613	649	13	-	-	ADJ
fnp-2613	649	14	sectional	sectional	ADJ
fnp-2613	649	15	study	study	NOUN
fnp-2613	649	16	in	in	ADP
fnp-2613	649	17	patients	patient	NOUN
fnp-2613	649	18	with	with	ADP
fnp-2613	649	19	neurodegeneration	neurodegeneration	NOUN
fnp-2613	649	20	.	.	PUNCT
fnp-2613	650	1	exp	exp	NOUN
fnp-2613	650	2	.	.	PUNCT
fnp-2613	651	1	neurol	neurol	PROPN
fnp-2613	651	2	.	.	PUNCT
fnp-2613	652	1	213	213	NUM
fnp-2613	652	2	,	,	PUNCT
fnp-2613	652	3	315–325	315–325	NUM
fnp-2613	652	4	(	(	PUNCT
fnp-2613	652	5	2008	2008	NUM
fnp-2613	652	6	)	)	PUNCT
fnp-2613	652	7	.	.	PUNCT
fnp-2613	653	1	99	99	NUM
fnp-2613	653	2	.	.	PUNCT
fnp-2613	654	1	noguchi	noguchi	PROPN
fnp-2613	654	2	-	-	PUNCT
fnp-2613	654	3	shinohara	shinohara	PROPN
fnp-2613	654	4	,	,	PUNCT
fnp-2613	654	5	m.	m.	NOUN
fnp-2613	654	6	et	et	PROPN
fnp-2613	654	7	al	al	PROPN
fnp-2613	654	8	.	.	PUNCT
fnp-2613	655	1	csf	csf	PROPN
fnp-2613	655	2	α	α	NOUN
fnp-2613	655	3	-	-	PUNCT
fnp-2613	655	4	synuclein	synuclein	NOUN
fnp-2613	655	5	levels	level	NOUN
fnp-2613	655	6	in	in	ADP
fnp-2613	655	7	dementia	dementia	NOUN
fnp-2613	655	8	with	with	ADP
fnp-2613	655	9	lewy	lewy	PROPN
fnp-2613	655	10	bodies	body	NOUN
fnp-2613	655	11	and	and	CCONJ
fnp-2613	655	12	alzheimer	alzheimer	PROPN
fnp-2613	655	13	’s	’s	PART
fnp-2613	655	14	disease	disease	NOUN
fnp-2613	655	15	.	.	PUNCT
fnp-2613	656	1	brain	brain	NOUN
fnp-2613	656	2	res	re	NOUN
fnp-2613	656	3	.	.	PUNCT
fnp-2613	656	4	1251	1251	NUM
fnp-2613	656	5	,	,	PUNCT
fnp-2613	656	6	1–6	1–6	NUM
fnp-2613	656	7	(	(	PUNCT
fnp-2613	656	8	2009	2009	NUM
fnp-2613	656	9	)	)	PUNCT
fnp-2613	656	10	.	.	PUNCT
fnp-2613	657	1	100	100	NUM
fnp-2613	657	2	.	.	PUNCT
fnp-2613	657	3	spies	spy	NOUN
fnp-2613	657	4	,	,	PUNCT
fnp-2613	657	5	p.	p.	PROPN
fnp-2613	657	6	e.	e.	PROPN
fnp-2613	657	7	et	et	PROPN
fnp-2613	658	1	al	al	PROPN
fnp-2613	658	2	.	.	PUNCT
fnp-2613	658	3	cerebrospinal	cerebrospinal	ADJ
fnp-2613	658	4	fluid	fluid	NOUN
fnp-2613	658	5	α	α	NOUN
fnp-2613	658	6	-	-	PUNCT
fnp-2613	658	7	synuclein	synuclein	NOUN
fnp-2613	658	8	does	do	AUX
fnp-2613	658	9	not	not	PART
fnp-2613	658	10	discriminate	discriminate	VERB
fnp-2613	658	11	between	between	ADP
fnp-2613	658	12	dementia	dementia	NOUN
fnp-2613	658	13	disorders	disorder	NOUN
fnp-2613	658	14	.	.	PUNCT
fnp-2613	659	1	j.	j.	PROPN
fnp-2613	659	2	alzheimer	alzheimer	PROPN
fnp-2613	659	3	’s	’s	PART
fnp-2613	659	4	dis	dis	PROPN
fnp-2613	659	5	.	.	PUNCT
fnp-2613	660	1	16	16	NUM
fnp-2613	660	2	,	,	PUNCT
fnp-2613	660	3	363–369	363–369	NUM
fnp-2613	660	4	(	(	PUNCT
fnp-2613	660	5	2009	2009	NUM
fnp-2613	660	6	)	)	PUNCT
fnp-2613	660	7	.	.	PUNCT
fnp-2613	661	1	101	101	NUM
fnp-2613	661	2	.	.	PUNCT
fnp-2613	662	1	campion	campion	NOUN
fnp-2613	662	2	,	,	PUNCT
fnp-2613	662	3	d.	d.	PROPN
fnp-2613	662	4	et	et	PROPN
fnp-2613	662	5	al	al	PROPN
fnp-2613	662	6	.	.	PUNCT
fnp-2613	663	1	mutations	mutation	NOUN
fnp-2613	663	2	of	of	ADP
fnp-2613	663	3	the	the	DET
fnp-2613	663	4	presenilin	presenilin	NOUN
fnp-2613	663	5	i	i	PRON
fnp-2613	663	6	gene	gene	VERB
fnp-2613	663	7	in	in	ADP
fnp-2613	663	8	families	family	NOUN
fnp-2613	663	9	with	with	ADP
fnp-2613	663	10	early	early	ADJ
fnp-2613	663	11	-	-	PUNCT
fnp-2613	663	12	onset	onset	NOUN
fnp-2613	663	13	alzheimer	alzheimer	PROPN
fnp-2613	663	14	’s	’s	PART
fnp-2613	663	15	disease	disease	NOUN
fnp-2613	663	16	.	.	PUNCT
fnp-2613	664	1	hum	hum	PROPN
fnp-2613	664	2	.	.	PUNCT
fnp-2613	665	1	mol	mol	PROPN
fnp-2613	665	2	.	.	PUNCT
fnp-2613	666	1	genet	genet	NOUN
fnp-2613	666	2	.	.	PUNCT
fnp-2613	667	1	4	4	NUM
fnp-2613	667	2	,	,	PUNCT
fnp-2613	667	3	2373–2377	2373–2377	NUM
fnp-2613	667	4	(	(	PUNCT
fnp-2613	667	5	1995	1995	NUM
fnp-2613	667	6	)	)	PUNCT
fnp-2613	667	7	.	.	PUNCT
fnp-2613	668	1	102	102	NUM
fnp-2613	668	2	.	.	PUNCT
fnp-2613	668	3	uéda	uéda	PROPN
fnp-2613	668	4	,	,	PUNCT
fnp-2613	668	5	k.	k.	PROPN
fnp-2613	668	6	et	et	PROPN
fnp-2613	668	7	al	al	PROPN
fnp-2613	668	8	.	.	PUNCT
fnp-2613	668	9	tissue	tissue	NOUN
fnp-2613	668	10	-	-	PUNCT
fnp-2613	668	11	dependent	dependent	ADJ
fnp-2613	668	12	alternative	alternative	ADJ
fnp-2613	668	13	splicing	splicing	NOUN
fnp-2613	668	14	of	of	ADP
fnp-2613	668	15	mrna	mrna	PROPN
fnp-2613	668	16	for	for	ADP
fnp-2613	668	17	nacp	nacp	PROPN
fnp-2613	668	18	,	,	PUNCT
fnp-2613	668	19	the	the	DET
fnp-2613	668	20	precursor	precursor	NOUN
fnp-2613	668	21	of	of	ADP
fnp-2613	668	22	non	non	ADJ
fnp-2613	668	23	-	-	ADJ
fnp-2613	668	24	a	a	DET
fnp-2613	668	25	beta	beta	ADJ
fnp-2613	668	26	component	component	NOUN
fnp-2613	668	27	of	of	ADP
fnp-2613	668	28	alzheimer	alzheimer	PROPN
fnp-2613	668	29	’s	’s	PART
fnp-2613	668	30	disease	disease	NOUN
fnp-2613	668	31	amyloid	amyloid	NOUN
fnp-2613	668	32	.	.	PUNCT
fnp-2613	669	1	biochem	biochem	PROPN
fnp-2613	669	2	.	.	PUNCT
fnp-2613	670	1	biophys	biophy	NOUN
fnp-2613	670	2	.	.	PUNCT
fnp-2613	671	1	res	re	NOUN
fnp-2613	671	2	.	.	PUNCT
fnp-2613	672	1	commun	commun	PROPN
fnp-2613	672	2	.	.	PUNCT
fnp-2613	673	1	205	205	NUM
fnp-2613	673	2	,	,	PUNCT
fnp-2613	673	3	1366–72	1366–72	NUM
fnp-2613	673	4	(	(	PUNCT
fnp-2613	673	5	1994	1994	NUM
fnp-2613	673	6	)	)	PUNCT
fnp-2613	673	7	.	.	PUNCT
fnp-2613	674	1	103	103	NUM
fnp-2613	674	2	.	.	PUNCT
fnp-2613	675	1	tokuda	tokuda	ADJ
fnp-2613	675	2	,	,	PUNCT
fnp-2613	675	3	t.	t.	PROPN
fnp-2613	675	4	et	et	PROPN
fnp-2613	675	5	al	al	PROPN
fnp-2613	675	6	.	.	PROPN
fnp-2613	675	7	decreased	decrease	VERB
fnp-2613	675	8	α	α	NOUN
fnp-2613	675	9	-	-	PUNCT
fnp-2613	675	10	synuclein	synuclein	NOUN
fnp-2613	675	11	in	in	ADP
fnp-2613	675	12	cerebrospinal	cerebrospinal	ADJ
fnp-2613	675	13	fluid	fluid	NOUN
fnp-2613	675	14	of	of	ADP
fnp-2613	675	15	aged	aged	ADJ
fnp-2613	675	16	individuals	individual	NOUN
fnp-2613	675	17	and	and	CCONJ
fnp-2613	675	18	subjects	subject	NOUN
fnp-2613	675	19	with	with	ADP
fnp-2613	675	20	parkinson	parkinson	NOUN
fnp-2613	675	21	’s	’s	PART
fnp-2613	675	22	disease	disease	NOUN
fnp-2613	675	23	.	.	PUNCT
fnp-2613	676	1	biochem	biochem	PROPN
fnp-2613	676	2	.	.	PUNCT
fnp-2613	677	1	biophys	biophy	NOUN
fnp-2613	677	2	.	.	PUNCT
fnp-2613	678	1	res	re	NOUN
fnp-2613	678	2	.	.	PUNCT
fnp-2613	679	1	commun	commun	PROPN
fnp-2613	679	2	.	.	PUNCT
fnp-2613	680	1	349	349	NUM
fnp-2613	680	2	,	,	PUNCT
fnp-2613	680	3	162–166	162–166	NUM
fnp-2613	680	4	(	(	PUNCT
fnp-2613	680	5	2006	2006	NUM
fnp-2613	680	6	)	)	PUNCT
fnp-2613	680	7	.	.	PUNCT
fnp-2613	681	1	104	104	NUM
fnp-2613	681	2	.	.	PUNCT
fnp-2613	682	1	el	el	NOUN
fnp-2613	682	2	-	-	NOUN
fnp-2613	682	3	agnaf	agnaf	NOUN
fnp-2613	682	4	,	,	PUNCT
fnp-2613	683	1	o.	o.	NOUN
fnp-2613	683	2	m.	m.	NOUN
fnp-2613	683	3	a.	a.	PROPN
fnp-2613	683	4	et	et	PROPN
fnp-2613	683	5	al	al	PROPN
fnp-2613	683	6	.	.	PUNCT
fnp-2613	684	1	α	α	X
fnp-2613	684	2	-	-	PUNCT
fnp-2613	684	3	synuclein	synuclein	NOUN
fnp-2613	684	4	implicated	implicate	VERB
fnp-2613	684	5	in	in	ADP
fnp-2613	684	6	parkinson	parkinson	NOUN
fnp-2613	684	7	’s	’s	PART
fnp-2613	684	8	disease	disease	NOUN
fnp-2613	684	9	is	be	AUX
fnp-2613	684	10	present	present	ADJ
fnp-2613	684	11	in	in	ADP
fnp-2613	684	12	extracellular	extracellular	ADJ
fnp-2613	684	13	biological	biological	ADJ
fnp-2613	684	14	fluids	fluid	NOUN
fnp-2613	684	15	,	,	PUNCT
fnp-2613	684	16	including	include	VERB
fnp-2613	684	17	human	human	ADJ
fnp-2613	684	18	plasma	plasma	NOUN
fnp-2613	684	19	.	.	PUNCT
fnp-2613	685	1	faseb	faseb	PROPN
fnp-2613	685	2	j.	j.	PROPN
fnp-2613	685	3	17	17	PROPN
fnp-2613	685	4	,	,	PUNCT
fnp-2613	685	5	1945–1947	1945–1947	NUM
fnp-2613	685	6	(	(	PUNCT
fnp-2613	685	7	2003	2003	NUM
fnp-2613	685	8	)	)	PUNCT
fnp-2613	685	9	.	.	PUNCT
fnp-2613	686	1	105	105	NUM
fnp-2613	686	2	.	.	PUNCT
fnp-2613	686	3	tokuda	tokuda	PROPN
fnp-2613	686	4	,	,	PUNCT
fnp-2613	686	5	t.	t.	PROPN
fnp-2613	686	6	et	et	PROPN
fnp-2613	686	7	al	al	PROPN
fnp-2613	686	8	.	.	PUNCT
fnp-2613	687	1	detection	detection	NOUN
fnp-2613	687	2	of	of	ADP
fnp-2613	687	3	elevated	elevated	ADJ
fnp-2613	687	4	levels	level	NOUN
fnp-2613	687	5	of	of	ADP
fnp-2613	687	6	α	α	NOUN
fnp-2613	687	7	-	-	PUNCT
fnp-2613	687	8	synuclein	synuclein	NOUN
fnp-2613	687	9	oligomers	oligomer	NOUN
fnp-2613	687	10	in	in	ADP
fnp-2613	687	11	csf	csf	ADJ
fnp-2613	687	12	from	from	ADP
fnp-2613	687	13	patients	patient	NOUN
fnp-2613	687	14	with	with	ADP
fnp-2613	687	15	parkinson	parkinson	NOUN
fnp-2613	687	16	disease	disease	NOUN
fnp-2613	687	17	.	.	PUNCT
fnp-2613	688	1	neurology	neurology	NOUN
fnp-2613	688	2	75	75	NUM
fnp-2613	688	3	,	,	PUNCT
fnp-2613	688	4	1766–1772	1766–1772	NUM
fnp-2613	688	5	(	(	PUNCT
fnp-2613	688	6	2010	2010	NUM
fnp-2613	688	7	)	)	PUNCT
fnp-2613	688	8	.	.	PUNCT
fnp-2613	689	1	106	106	NUM
fnp-2613	689	2	.	.	PUNCT
fnp-2613	690	1	el	el	NOUN
fnp-2613	690	2	-	-	NOUN
fnp-2613	690	3	agnaf	agnaf	NOUN
fnp-2613	690	4	,	,	PUNCT
fnp-2613	690	5	o.	o.	NOUN
fnp-2613	690	6	m.	m.	NOUN
fnp-2613	690	7	a.	a.	PROPN
fnp-2613	690	8	et	et	PROPN
fnp-2613	690	9	al	al	PROPN
fnp-2613	690	10	.	.	PUNCT
fnp-2613	690	11	detection	detection	NOUN
fnp-2613	690	12	of	of	ADP
fnp-2613	690	13	oligomeric	oligomeric	ADJ
fnp-2613	690	14	forms	form	NOUN
fnp-2613	690	15	of	of	ADP
fnp-2613	690	16	α	α	NOUN
fnp-2613	690	17	-	-	PUNCT
fnp-2613	690	18	synuclein	synuclein	NOUN
fnp-2613	690	19	protein	protein	NOUN
fnp-2613	690	20	in	in	ADP
fnp-2613	690	21	human	human	ADJ
fnp-2613	690	22	plasma	plasma	NOUN
fnp-2613	690	23	as	as	ADP
fnp-2613	690	24	a	a	DET
fnp-2613	690	25	potential	potential	ADJ
fnp-2613	690	26	biomarker	biomarker	NOUN
fnp-2613	690	27	for	for	ADP
fnp-2613	690	28	parkinson	parkinson	NOUN
fnp-2613	690	29	’s	’s	PART
fnp-2613	690	30	disease	disease	NOUN
fnp-2613	690	31	.	.	PUNCT
fnp-2613	691	1	faseb	faseb	PROPN
fnp-2613	691	2	j.	j.	PROPN
fnp-2613	691	3	20	20	PROPN
fnp-2613	691	4	,	,	PUNCT
fnp-2613	691	5	419–425	419–425	NUM
fnp-2613	691	6	(	(	PUNCT
fnp-2613	691	7	2006	2006	NUM
fnp-2613	691	8	)	)	PUNCT
fnp-2613	691	9	.	.	PUNCT
fnp-2613	692	1	107	107	NUM
fnp-2613	692	2	.	.	PUNCT
fnp-2613	693	1	simonsen	simonsen	PROPN
fnp-2613	693	2	,	,	PUNCT
fnp-2613	693	3	a.	a.	PROPN
fnp-2613	693	4	h.	h.	PROPN
fnp-2613	693	5	et	et	PROPN
fnp-2613	693	6	al	al	PROPN
fnp-2613	693	7	.	.	PUNCT
fnp-2613	694	1	the	the	DET
fnp-2613	694	2	utility	utility	NOUN
fnp-2613	694	3	of	of	ADP
fnp-2613	694	4	α	α	NOUN
fnp-2613	694	5	-	-	PUNCT
fnp-2613	694	6	synuclein	synuclein	NOUN
fnp-2613	694	7	as	as	ADP
fnp-2613	694	8	biofluid	biofluid	ADJ
fnp-2613	694	9	marker	marker	NOUN
fnp-2613	694	10	in	in	ADP
fnp-2613	694	11	neurodegenerative	neurodegenerative	ADJ
fnp-2613	694	12	diseases	disease	NOUN
fnp-2613	694	13	:	:	PUNCT
fnp-2613	694	14	a	a	DET
fnp-2613	694	15	systematic	systematic	ADJ
fnp-2613	694	16	review	review	NOUN
fnp-2613	694	17	of	of	ADP
fnp-2613	694	18	the	the	DET
fnp-2613	694	19	literature	literature	NOUN
fnp-2613	694	20	.	.	PUNCT
fnp-2613	695	1	biomark	biomark	PROPN
fnp-2613	695	2	.	.	PUNCT
fnp-2613	696	1	med	med	PROPN
fnp-2613	696	2	.	.	PROPN
fnp-2613	697	1	10	10	NUM
fnp-2613	697	2	,	,	PUNCT
fnp-2613	697	3	19–34	19–34	NUM
fnp-2613	697	4	(	(	PUNCT
fnp-2613	697	5	2016	2016	NUM
fnp-2613	697	6	)	)	PUNCT
fnp-2613	697	7	.	.	PUNCT
fnp-2613	698	1	108	108	NUM
fnp-2613	698	2	.	.	X
fnp-2613	698	3	ashton	ashton	PROPN
fnp-2613	698	4	,	,	PUNCT
fnp-2613	698	5	n.	n.	PROPN
fnp-2613	698	6	j.	j.	PROPN
fnp-2613	698	7	et	et	PROPN
fnp-2613	698	8	al	al	PROPN
fnp-2613	698	9	.	.	PROPN
fnp-2613	698	10	increased	increase	VERB
fnp-2613	698	11	plasma	plasma	NOUN
fnp-2613	698	12	neurofilament	neurofilament	NOUN
fnp-2613	698	13	light	light	ADJ
fnp-2613	698	14	chain	chain	NOUN
fnp-2613	698	15	concentration	concentration	NOUN
fnp-2613	698	16	correlates	correlate	VERB
fnp-2613	698	17	with	with	ADP
fnp-2613	698	18	severity	severity	NOUN
fnp-2613	698	19	of	of	ADP
fnp-2613	698	20	post	post	ADJ
fnp-2613	698	21	-	-	ADJ
fnp-2613	698	22	mortem	mortem	ADJ
fnp-2613	698	23	neurofibrillary	neurofibrillary	ADJ
fnp-2613	698	24	tangle	tangle	NOUN
fnp-2613	698	25	pathology	pathology	NOUN
fnp-2613	698	26	and	and	CCONJ
fnp-2613	698	27	neurodegeneration	neurodegeneration	NOUN
fnp-2613	698	28	.	.	PUNCT
fnp-2613	699	1	acta	acta	PROPN
fnp-2613	699	2	neuropathol	neuropathol	PROPN
fnp-2613	699	3	.	.	PUNCT
fnp-2613	700	1	commun	commun	PROPN
fnp-2613	700	2	.	.	PUNCT
fnp-2613	701	1	7	7	NUM
fnp-2613	701	2	,	,	PUNCT
fnp-2613	701	3	5	5	NUM
fnp-2613	701	4	(	(	PUNCT
fnp-2613	701	5	2019	2019	NUM
fnp-2613	701	6	)	)	PUNCT
fnp-2613	701	7	.	.	PUNCT
fnp-2613	702	1	109	109	NUM
fnp-2613	702	2	.	.	PUNCT
fnp-2613	703	1	zetterberg	zetterberg	PROPN
fnp-2613	703	2	,	,	PUNCT
fnp-2613	703	3	h.	h.	PROPN
fnp-2613	703	4	et	et	PROPN
fnp-2613	703	5	al	al	PROPN
fnp-2613	703	6	.	.	PROPN
fnp-2613	703	7	association	association	PROPN
fnp-2613	703	8	of	of	ADP
fnp-2613	703	9	cerebrospinal	cerebrospinal	ADJ
fnp-2613	703	10	fluid	fluid	ADJ
fnp-2613	703	11	neurofila	neurofila	NOUN
fnp-2613	703	12	-	-	PUNCT
fnp-2613	703	13	ment	ment	NOUN
fnp-2613	703	14	light	light	ADJ
fnp-2613	703	15	concentration	concentration	NOUN
fnp-2613	703	16	with	with	ADP
fnp-2613	703	17	alzheimer	alzheimer	PROPN
fnp-2613	703	18	disease	disease	NOUN
fnp-2613	703	19	progression	progression	NOUN
fnp-2613	703	20	.	.	PUNCT
fnp-2613	704	1	jama	jama	PROPN
fnp-2613	704	2	neurol	neurol	PROPN
fnp-2613	704	3	.	.	PUNCT
fnp-2613	705	1	73	73	NUM
fnp-2613	705	2	,	,	PUNCT
fnp-2613	705	3	60	60	NUM
fnp-2613	705	4	(	(	PUNCT
fnp-2613	705	5	2016	2016	NUM
fnp-2613	705	6	)	)	PUNCT
fnp-2613	705	7	.	.	PUNCT
fnp-2613	706	1	110	110	NUM
fnp-2613	706	2	.	.	PUNCT
fnp-2613	706	3	gaiottino	gaiottino	PROPN
fnp-2613	706	4	,	,	PUNCT
fnp-2613	706	5	j.	j.	PROPN
fnp-2613	706	6	et	et	PROPN
fnp-2613	706	7	al	al	PROPN
fnp-2613	706	8	.	.	PROPN
fnp-2613	706	9	increased	increase	VERB
fnp-2613	706	10	neurofilament	neurofilament	ADJ
fnp-2613	706	11	light	light	NOUN
fnp-2613	706	12	chain	chain	NOUN
fnp-2613	706	13	blood	blood	NOUN
fnp-2613	706	14	levels	level	NOUN
fnp-2613	706	15	in	in	ADP
fnp-2613	706	16	neurodegenerative	neurodegenerative	ADJ
fnp-2613	706	17	neurological	neurological	ADJ
fnp-2613	706	18	diseases	disease	NOUN
fnp-2613	706	19	.	.	PUNCT
fnp-2613	707	1	plos	plos	PROPN
fnp-2613	707	2	one	one	NUM
fnp-2613	707	3	8	8	NUM
fnp-2613	707	4	,	,	PUNCT
fnp-2613	707	5	e75091	e75091	ADP
fnp-2613	707	6	(	(	PUNCT
fnp-2613	707	7	2013	2013	NUM
fnp-2613	707	8	)	)	PUNCT
fnp-2613	707	9	.	.	PUNCT
fnp-2613	708	1	111	111	NUM
fnp-2613	708	2	.	.	PUNCT
fnp-2613	709	1	xu	xu	PROPN
fnp-2613	709	2	,	,	PUNCT
fnp-2613	709	3	z.	z.	PROPN
fnp-2613	709	4	et	et	PROPN
fnp-2613	709	5	al	al	PROPN
fnp-2613	709	6	.	.	PROPN
fnp-2613	709	7	neurofilaments	neurofilament	NOUN
fnp-2613	709	8	as	as	ADP
fnp-2613	709	9	biomarkers	biomarker	NOUN
fnp-2613	709	10	for	for	ADP
fnp-2613	709	11	amyotrophic	amyotrophic	ADJ
fnp-2613	709	12	lateral	lateral	ADJ
fnp-2613	709	13	sclerosis	sclerosis	NOUN
fnp-2613	709	14	:	:	PUNCT
fnp-2613	709	15	a	a	DET
fnp-2613	709	16	systematic	systematic	ADJ
fnp-2613	709	17	review	review	NOUN
fnp-2613	709	18	and	and	CCONJ
fnp-2613	709	19	meta	meta	ADJ
fnp-2613	709	20	-	-	PUNCT
fnp-2613	709	21	analysis	analysis	NOUN
fnp-2613	709	22	.	.	PUNCT
fnp-2613	710	1	plos	plos	PROPN
fnp-2613	710	2	one	one	NUM
fnp-2613	710	3	11	11	NUM
fnp-2613	710	4	,	,	PUNCT
fnp-2613	710	5	e0164625	e0164625	PROPN
fnp-2613	710	6	(	(	PUNCT
fnp-2613	710	7	2016	2016	NUM
fnp-2613	710	8	)	)	PUNCT
fnp-2613	710	9	.	.	PUNCT
fnp-2613	711	1	112	112	NUM
fnp-2613	711	2	.	.	PUNCT
fnp-2613	712	1	schmidt	schmidt	PROPN
fnp-2613	712	2	,	,	PUNCT
fnp-2613	712	3	m.	m.	NOUN
fnp-2613	712	4	l.	l.	PROPN
fnp-2613	712	5	et	et	PROPN
fnp-2613	712	6	al	al	PROPN
fnp-2613	712	7	.	.	PUNCT
fnp-2613	712	8	epitope	epitope	PROPN
fnp-2613	712	9	map	map	NOUN
fnp-2613	712	10	of	of	ADP
fnp-2613	712	11	neurofilament	neurofilament	ADJ
fnp-2613	712	12	protein	protein	NOUN
fnp-2613	712	13	domains	domain	NOUN
fnp-2613	712	14	in	in	ADP
fnp-2613	712	15	cortical	cortical	ADJ
fnp-2613	712	16	and	and	CCONJ
fnp-2613	712	17	peripheral	peripheral	ADJ
fnp-2613	712	18	nervous	nervous	ADJ
fnp-2613	712	19	system	system	NOUN
fnp-2613	712	20	lewy	lewy	PROPN
fnp-2613	712	21	bodies	body	NOUN
fnp-2613	712	22	.	.	PUNCT
fnp-2613	713	1	am	be	AUX
fnp-2613	713	2	.	.	PUNCT
fnp-2613	714	1	j.	j.	PROPN
fnp-2613	714	2	pathol	pathol	PROPN
fnp-2613	714	3	.	.	PUNCT
fnp-2613	715	1	139	139	NUM
fnp-2613	715	2	,	,	PUNCT
fnp-2613	715	3	53–65	53–65	NUM
fnp-2613	715	4	(	(	PUNCT
fnp-2613	715	5	1991	1991	NUM
fnp-2613	715	6	)	)	PUNCT
fnp-2613	715	7	.	.	PUNCT
fnp-2613	716	1	113	113	NUM
fnp-2613	716	2	.	.	PUNCT
fnp-2613	716	3	aerts	aert	NOUN
fnp-2613	716	4	,	,	PUNCT
fnp-2613	716	5	m.	m.	PROPN
fnp-2613	716	6	b.	b.	PROPN
fnp-2613	716	7	et	et	PROPN
fnp-2613	716	8	al	al	PROPN
fnp-2613	716	9	.	.	PROPN
fnp-2613	717	1	csf	csf	PROPN
fnp-2613	717	2	α	α	NOUN
fnp-2613	717	3	-	-	PUNCT
fnp-2613	717	4	synuclein	synuclein	NOUN
fnp-2613	717	5	does	do	AUX
fnp-2613	717	6	not	not	PART
fnp-2613	717	7	differentiate	differentiate	VERB
fnp-2613	717	8	between	between	ADP
fnp-2613	717	9	parkinsonian	parkinsonian	ADJ
fnp-2613	717	10	disorders	disorder	NOUN
fnp-2613	717	11	.	.	PUNCT
fnp-2613	718	1	neurobiol	neurobiol	NOUN
fnp-2613	718	2	.	.	PUNCT
fnp-2613	719	1	aging	age	VERB
fnp-2613	719	2	33	33	NUM
fnp-2613	719	3	,	,	PUNCT
fnp-2613	719	4	430.e1–3	430.e1–3	NUM
fnp-2613	719	5	(	(	PUNCT
fnp-2613	719	6	2012	2012	NUM
fnp-2613	719	7	)	)	PUNCT
fnp-2613	719	8	.	.	PUNCT
fnp-2613	720	1	114	114	NUM
fnp-2613	720	2	.	.	PUNCT
fnp-2613	720	3	ashton	ashton	PROPN
fnp-2613	720	4	,	,	PUNCT
fnp-2613	720	5	n.	n.	PROPN
fnp-2613	720	6	j.	j.	PROPN
fnp-2613	720	7	et	et	PROPN
fnp-2613	720	8	al	al	PROPN
fnp-2613	720	9	.	.	PUNCT
fnp-2613	721	1	an	an	DET
fnp-2613	721	2	update	update	NOUN
fnp-2613	721	3	on	on	ADP
fnp-2613	721	4	blood	blood	NOUN
fnp-2613	721	5	-	-	PUNCT
fnp-2613	721	6	based	base	VERB
fnp-2613	721	7	biomarkers	biomarker	NOUN
fnp-2613	721	8	for	for	ADP
fnp-2613	721	9	non	non	ADJ
fnp-2613	721	10	-	-	ADJ
fnp-2613	721	11	alzheimer	alzheimer	ADJ
fnp-2613	721	12	neurodegenerative	neurodegenerative	ADJ
fnp-2613	721	13	dementias	dementia	NOUN
fnp-2613	721	14	.	.	PUNCT
fnp-2613	722	1	nat	nat	PROPN
fnp-2613	722	2	.	.	PUNCT
fnp-2613	722	3	rev	rev	PROPN
fnp-2613	722	4	.	.	PUNCT
fnp-2613	723	1	neurol	neurol	PROPN
fnp-2613	723	2	.	.	PUNCT
fnp-2613	724	1	(	(	PUNCT
fnp-2613	724	2	in	in	ADP
fnp-2613	724	3	press	press	NOUN
fnp-2613	724	4	)	)	PUNCT
fnp-2613	724	5	.	.	PUNCT
fnp-2613	725	1	115	115	NUM
fnp-2613	725	2	.	.	PUNCT
fnp-2613	725	3	bencze	bencze	PROPN
fnp-2613	725	4	,	,	PUNCT
fnp-2613	725	5	j.	j.	PROPN
fnp-2613	725	6	et	et	PROPN
fnp-2613	725	7	al	al	PROPN
fnp-2613	725	8	.	.	PROPN
fnp-2613	725	9	biological	biological	ADJ
fnp-2613	725	10	function	function	NOUN
fnp-2613	725	11	of	of	ADP
fnp-2613	725	12	lemur	lemur	ADJ
fnp-2613	725	13	tyrosine	tyrosine	PROPN
fnp-2613	725	14	kinase	kinase	PROPN
fnp-2613	725	15	2	2	NUM
fnp-2613	725	16	(	(	PUNCT
fnp-2613	725	17	lmtk2	lmtk2	ADJ
fnp-2613	725	18	):	):	PUNCT
fnp-2613	725	19	implications	implication	NOUN
fnp-2613	725	20	in	in	ADP
fnp-2613	725	21	neurodegeneration	neurodegeneration	NOUN
fnp-2613	725	22	.	.	PUNCT
fnp-2613	726	1	mol	mol	PROPN
fnp-2613	726	2	.	.	PROPN
fnp-2613	726	3	brain	brain	PROPN
fnp-2613	726	4	11	11	NUM
fnp-2613	726	5	,	,	PUNCT
fnp-2613	726	6	20	20	NUM
fnp-2613	726	7	(	(	PUNCT
fnp-2613	726	8	2018	2018	NUM
fnp-2613	726	9	)	)	PUNCT
fnp-2613	726	10	.	.	PUNCT
fnp-2613	727	1	116	116	NUM
fnp-2613	727	2	.	.	PUNCT
fnp-2613	727	3	bencze	bencze	PROPN
fnp-2613	727	4	,	,	PUNCT
fnp-2613	727	5	j.	j.	PROPN
fnp-2613	727	6	et	et	PROPN
fnp-2613	727	7	al	al	PROPN
fnp-2613	727	8	.	.	PUNCT
fnp-2613	727	9	neuropathological	neuropathological	ADJ
fnp-2613	727	10	characterization	characterization	NOUN
fnp-2613	727	11	of	of	ADP
fnp-2613	727	12	lemur	lemur	ADJ
fnp-2613	727	13	tyrosine	tyrosine	PROPN
fnp-2613	727	14	kinase	kinase	PROPN
fnp-2613	727	15	2	2	NUM
fnp-2613	727	16	(	(	PUNCT
fnp-2613	727	17	lmtk2	lmtk2	NOUN
fnp-2613	727	18	)	)	PUNCT
fnp-2613	727	19	in	in	ADP
fnp-2613	727	20	alzheimer	alzheimer	PROPN
fnp-2613	727	21	’s	’s	PART
fnp-2613	727	22	disease	disease	NOUN
fnp-2613	727	23	and	and	CCONJ
fnp-2613	727	24	neocortical	neocortical	ADJ
fnp-2613	727	25	lewy	lewy	ADJ
fnp-2613	727	26	body	body	NOUN
fnp-2613	727	27	disease	disease	NOUN
fnp-2613	727	28	.	.	PUNCT
fnp-2613	728	1	sci	sci	PROPN
fnp-2613	728	2	.	.	PROPN
fnp-2613	728	3	rep	rep	PROPN
fnp-2613	728	4	.	.	PROPN
fnp-2613	728	5	9	9	NUM
fnp-2613	728	6	,	,	PUNCT
fnp-2613	728	7	17222	17222	NUM
fnp-2613	728	8	(	(	PUNCT
fnp-2613	728	9	2019	2019	NUM
fnp-2613	728	10	)	)	PUNCT
fnp-2613	728	11	.	.	PUNCT
fnp-2613	729	1	117	117	NUM
fnp-2613	729	2	.	.	PUNCT
fnp-2613	729	3	bencze	bencze	PROPN
fnp-2613	729	4	et	et	PROPN
fnp-2613	729	5	al	al	PROPN
fnp-2613	729	6	.	.	PROPN
fnp-2613	730	1	lemur	lemur	PROPN
fnp-2613	730	2	tyrosine	tyrosine	PROPN
fnp-2613	730	3	kinase	kinase	PROPN
fnp-2613	730	4	2	2	NUM
fnp-2613	730	5	(	(	PUNCT
fnp-2613	730	6	lmtk2	lmtk2	NOUN
fnp-2613	730	7	)	)	PUNCT
fnp-2613	730	8	level	level	NOUN
fnp-2613	730	9	inversely	inversely	ADV
fnp-2613	730	10	correlates	correlate	VERB
fnp-2613	730	11	with	with	ADP
fnp-2613	730	12	phospho	phospho	NOUN
fnp-2613	730	13	-	-	PUNCT
fnp-2613	730	14	tau	tau	NOUN
fnp-2613	730	15	in	in	ADP
fnp-2613	730	16	neuropathological	neuropathological	ADJ
fnp-2613	730	17	stages	stage	NOUN
fnp-2613	730	18	of	of	ADP
fnp-2613	730	19	alzheimer	alzheimer	PROPN
fnp-2613	730	20	’s	’s	PART
fnp-2613	730	21	disease	disease	NOUN
fnp-2613	730	22	.	.	PUNCT
fnp-2613	731	1	brain	brain	PROPN
fnp-2613	731	2	sci	sci	PROPN
fnp-2613	731	3	.	.	PROPN
fnp-2613	732	1	10	10	NUM
fnp-2613	732	2	,	,	PUNCT
fnp-2613	732	3	68	68	NUM
fnp-2613	732	4	(	(	PUNCT
fnp-2613	732	5	2020	2020	NUM
fnp-2613	732	6	)	)	PUNCT
fnp-2613	732	7	.	.	PUNCT
fnp-2613	733	1	118	118	NUM
fnp-2613	733	2	.	.	X
fnp-2613	733	3	morris	morris	PROPN
fnp-2613	733	4	,	,	PUNCT
fnp-2613	733	5	j.	j.	PROPN
fnp-2613	733	6	c.	c.	PROPN
fnp-2613	733	7	clinical	clinical	ADJ
fnp-2613	733	8	dementia	dementia	NOUN
fnp-2613	733	9	rating	rating	NOUN
fnp-2613	733	10	:	:	PUNCT
fnp-2613	733	11	a	a	DET
fnp-2613	733	12	reliable	reliable	ADJ
fnp-2613	733	13	and	and	CCONJ
fnp-2613	733	14	valid	valid	ADJ
fnp-2613	733	15	diagnostic	diagnostic	ADJ
fnp-2613	733	16	and	and	CCONJ
fnp-2613	733	17	staging	stage	VERB
fnp-2613	733	18	measure	measure	NOUN
fnp-2613	733	19	for	for	ADP
fnp-2613	733	20	dementia	dementia	NOUN
fnp-2613	733	21	of	of	ADP
fnp-2613	733	22	the	the	DET
fnp-2613	733	23	alzheimer	alzheimer	PROPN
fnp-2613	733	24	type	type	NOUN
fnp-2613	733	25	.	.	PUNCT
fnp-2613	734	1	int	int	NOUN
fnp-2613	734	2	.	.	PUNCT
fnp-2613	735	1	psychogeriatrics	psychogeriatrics	PROPN
fnp-2613	735	2	9	9	NUM
fnp-2613	735	3	,	,	PUNCT
fnp-2613	735	4	173–176	173–176	NUM
fnp-2613	735	5	(	(	PUNCT
fnp-2613	735	6	1997	1997	NUM
fnp-2613	735	7	)	)	PUNCT
fnp-2613	735	8	.	.	PUNCT
fnp-2613	736	1	119	119	NUM
fnp-2613	736	2	.	.	X
fnp-2613	736	3	walker	walker	PROPN
fnp-2613	736	4	,	,	PUNCT
fnp-2613	736	5	m.	m.	NOUN
fnp-2613	736	6	p.	p.	NOUN
fnp-2613	736	7	et	et	PROPN
fnp-2613	737	1	al	al	PROPN
fnp-2613	737	2	.	.	PUNCT
fnp-2613	738	1	the	the	DET
fnp-2613	738	2	clinician	clinician	ADJ
fnp-2613	738	3	assessment	assessment	NOUN
fnp-2613	738	4	of	of	ADP
fnp-2613	738	5	fluctuation	fluctuation	NOUN
fnp-2613	738	6	and	and	CCONJ
fnp-2613	738	7	the	the	DET
fnp-2613	738	8	one	one	NUM
fnp-2613	738	9	day	day	NOUN
fnp-2613	738	10	fluctuation	fluctuation	NOUN
fnp-2613	738	11	assessment	assessment	NOUN
fnp-2613	738	12	scale	scale	NOUN
fnp-2613	738	13	:	:	PUNCT
fnp-2613	738	14	two	two	NUM
fnp-2613	738	15	methods	method	NOUN
fnp-2613	738	16	to	to	PART
fnp-2613	738	17	assess	assess	VERB
fnp-2613	738	18	fluctuating	fluctuate	VERB
fnp-2613	738	19	confusion	confusion	NOUN
fnp-2613	738	20	in	in	ADP
fnp-2613	738	21	dementia	dementia	NOUN
fnp-2613	738	22	.	.	PUNCT
fnp-2613	739	1	br	br	PROPN
fnp-2613	739	2	.	.	PUNCT
fnp-2613	740	1	j.	j.	PROPN
fnp-2613	740	2	psychiatry	psychiatry	PROPN
fnp-2613	740	3	177	177	NUM
fnp-2613	740	4	,	,	PUNCT
fnp-2613	740	5	252–256	252–256	NUM
fnp-2613	740	6	(	(	PUNCT
fnp-2613	740	7	2000	2000	NUM
fnp-2613	740	8	)	)	PUNCT
fnp-2613	740	9	.	.	PUNCT
fnp-2613	741	1	120	120	NUM
fnp-2613	741	2	.	.	PUNCT
fnp-2613	741	3	ferman	ferman	PROPN
fnp-2613	741	4	,	,	PUNCT
fnp-2613	741	5	t.	t.	PROPN
fnp-2613	741	6	j.	j.	PROPN
fnp-2613	741	7	et	et	PROPN
fnp-2613	741	8	al	al	PROPN
fnp-2613	741	9	.	.	PROPN
fnp-2613	742	1	dlb	dlb	PROPN
fnp-2613	742	2	fluctuations	fluctuation	NOUN
fnp-2613	742	3	:	:	PUNCT
fnp-2613	742	4	specific	specific	ADJ
fnp-2613	742	5	features	feature	NOUN
fnp-2613	742	6	that	that	PRON
fnp-2613	742	7	reliably	reliably	ADV
fnp-2613	742	8	differentiate	differentiate	VERB
fnp-2613	742	9	dlb	dlb	NOUN
fnp-2613	742	10	from	from	ADP
fnp-2613	742	11	ad	ad	NOUN
fnp-2613	742	12	and	and	CCONJ
fnp-2613	742	13	normal	normal	ADJ
fnp-2613	742	14	aging	aging	NOUN
fnp-2613	742	15	.	.	PUNCT
fnp-2613	743	1	neurology	neurology	NOUN
fnp-2613	743	2	62	62	NUM
fnp-2613	743	3	,	,	PUNCT
fnp-2613	743	4	181–7	181–7	NUM
fnp-2613	743	5	(	(	PUNCT
fnp-2613	743	6	2004	2004	NUM
fnp-2613	743	7	)	)	PUNCT
fnp-2613	743	8	.	.	PUNCT
fnp-2613	744	1	121	121	NUM
fnp-2613	744	2	.	.	PUNCT
fnp-2613	744	3	boeve	boeve	PROPN
fnp-2613	744	4	,	,	PUNCT
fnp-2613	744	5	b.	b.	PROPN
fnp-2613	744	6	f.	f.	PROPN
fnp-2613	744	7	et	et	PROPN
fnp-2613	744	8	al	al	PROPN
fnp-2613	744	9	.	.	PUNCT
fnp-2613	744	10	validation	validation	NOUN
fnp-2613	744	11	of	of	ADP
fnp-2613	744	12	the	the	DET
fnp-2613	744	13	mayo	mayo	NOUN
fnp-2613	744	14	sleep	sleep	NOUN
fnp-2613	744	15	questionnaire	questionnaire	NOUN
fnp-2613	744	16	to	to	PART
fnp-2613	744	17	screen	screen	VERB
fnp-2613	744	18	for	for	ADP
fnp-2613	744	19	rem	rem	PUNCT
fnp-2613	744	20	sleep	sleep	NOUN
fnp-2613	744	21	behavior	behavior	NOUN
fnp-2613	744	22	disorder	disorder	NOUN
fnp-2613	744	23	in	in	ADP
fnp-2613	744	24	an	an	DET
fnp-2613	744	25	aging	age	VERB
fnp-2613	744	26	and	and	CCONJ
fnp-2613	744	27	dementia	dementia	NOUN
fnp-2613	744	28	cohort	cohort	NOUN
fnp-2613	744	29	.	.	PUNCT
fnp-2613	745	1	sleep	sleep	NOUN
fnp-2613	745	2	med	me	VERB
fnp-2613	745	3	.	.	PUNCT
fnp-2613	746	1	12	12	NUM
fnp-2613	746	2	,	,	PUNCT
fnp-2613	746	3	445–453	445–453	NUM
fnp-2613	746	4	(	(	PUNCT
fnp-2613	746	5	2011	2011	NUM
fnp-2613	746	6	)	)	PUNCT
fnp-2613	746	7	.	.	PUNCT
fnp-2613	747	1	122	122	NUM
fnp-2613	747	2	.	.	PUNCT
fnp-2613	748	1	goetz	goetz	PROPN
fnp-2613	748	2	,	,	PUNCT
fnp-2613	748	3	c.	c.	PROPN
fnp-2613	748	4	c.	c.	PROPN
fnp-2613	749	1	the	the	DET
fnp-2613	749	2	unified	unified	ADJ
fnp-2613	749	3	parkinson	parkinson	NOUN
fnp-2613	749	4	’s	’s	PART
fnp-2613	749	5	disease	disease	NOUN
fnp-2613	749	6	rating	rating	NOUN
fnp-2613	749	7	scale	scale	NOUN
fnp-2613	749	8	(	(	PUNCT
fnp-2613	749	9	updrs	updr	NOUN
fnp-2613	749	10	):	):	PUNCT
fnp-2613	749	11	status	status	NOUN
fnp-2613	749	12	and	and	CCONJ
fnp-2613	749	13	recommendations	recommendation	NOUN
fnp-2613	749	14	.	.	PUNCT
fnp-2613	750	1	mov	mov	NOUN
fnp-2613	750	2	.	.	PUNCT
fnp-2613	750	3	disord	disord	PROPN
fnp-2613	750	4	.	.	PUNCT
fnp-2613	751	1	18	18	NUM
fnp-2613	751	2	,	,	PUNCT
fnp-2613	751	3	738–750	738–750	NUM
fnp-2613	751	4	(	(	PUNCT
fnp-2613	751	5	2003	2003	NUM
fnp-2613	751	6	)	)	PUNCT
fnp-2613	751	7	.	.	PUNCT
fnp-2613	752	1	123	123	NUM
fnp-2613	752	2	.	.	PUNCT
fnp-2613	752	3	linn	linn	PROPN
fnp-2613	752	4	,	,	PUNCT
fnp-2613	752	5	m.	m.	PROPN
fnp-2613	752	6	w.	w.	PROPN
fnp-2613	752	7	et	et	PROPN
fnp-2613	752	8	al	al	PROPN
fnp-2613	752	9	.	.	PUNCT
fnp-2613	753	1	the	the	DET
fnp-2613	753	2	rapid	rapid	ADJ
fnp-2613	753	3	disability	disability	NOUN
fnp-2613	753	4	rating	rate	VERB
fnp-2613	753	5	scale—2	scale—2	PROPN
fnp-2613	753	6	.	.	PUNCT
fnp-2613	754	1	j.	j.	PROPN
fnp-2613	754	2	am	am	PROPN
fnp-2613	754	3	.	.	PUNCT
fnp-2613	755	1	geriatr	geriatr	PROPN
fnp-2613	755	2	.	.	PUNCT
fnp-2613	756	1	soc	soc	PROPN
fnp-2613	756	2	.	.	PUNCT
fnp-2613	757	1	30	30	NUM
fnp-2613	757	2	,	,	PUNCT
fnp-2613	757	3	378–382	378–382	NUM
fnp-2613	757	4	(	(	PUNCT
fnp-2613	757	5	1982	1982	NUM
fnp-2613	757	6	)	)	PUNCT
fnp-2613	757	7	.	.	PUNCT
fnp-2613	758	1	124	124	NUM
fnp-2613	758	2	.	.	PUNCT
fnp-2613	758	3	cummings	cummings	PROPN
fnp-2613	758	4	,	,	PUNCT
fnp-2613	758	5	j.	j.	PROPN
fnp-2613	758	6	l.	l.	PROPN
fnp-2613	758	7	et	et	PROPN
fnp-2613	758	8	al	al	PROPN
fnp-2613	758	9	.	.	PUNCT
fnp-2613	759	1	the	the	DET
fnp-2613	759	2	neuropsychiatric	neuropsychiatric	ADJ
fnp-2613	759	3	inventory	inventory	NOUN
fnp-2613	759	4	:	:	PUNCT
fnp-2613	759	5	comprehensive	comprehensive	ADJ
fnp-2613	759	6	assessment	assessment	NOUN
fnp-2613	759	7	of	of	ADP
fnp-2613	759	8	psychopathology	psychopathology	NOUN
fnp-2613	759	9	in	in	ADP
fnp-2613	759	10	dementia	dementia	NOUN
fnp-2613	759	11	.	.	PUNCT
fnp-2613	760	1	neurology	neurology	NOUN
fnp-2613	760	2	44	44	NUM
fnp-2613	760	3	,	,	PUNCT
fnp-2613	760	4	2308–14	2308–14	NUM
fnp-2613	760	5	(	(	PUNCT
fnp-2613	760	6	1994	1994	NUM
fnp-2613	760	7	)	)	PUNCT
fnp-2613	760	8	.	.	PUNCT
fnp-2613	761	1	125	125	NUM
fnp-2613	761	2	.	.	PUNCT
fnp-2613	761	3	tsuboi	tsuboi	NOUN
fnp-2613	761	4	,	,	PUNCT
fnp-2613	761	5	y.	y.	PROPN
fnp-2613	761	6	et	et	PROPN
fnp-2613	761	7	al	al	PROPN
fnp-2613	761	8	.	.	PROPN
fnp-2613	761	9	dementia	dementia	PROPN
fnp-2613	761	10	with	with	ADP
fnp-2613	761	11	lewy	lewy	PROPN
fnp-2613	761	12	bodies	body	NOUN
fnp-2613	761	13	and	and	CCONJ
fnp-2613	761	14	parkinson	parkinson	NOUN
fnp-2613	761	15	’s	’s	PART
fnp-2613	761	16	disease	disease	NOUN
fnp-2613	761	17	with	with	ADP
fnp-2613	761	18	dementia	dementia	PROPN
fnp-2613	761	19	:	:	PUNCT
fnp-2613	761	20	are	be	AUX
fnp-2613	761	21	they	they	PRON
fnp-2613	761	22	different	different	ADJ
fnp-2613	761	23	?	?	PUNCT
fnp-2613	762	1	park	park	NOUN
fnp-2613	762	2	.	.	PUNCT
fnp-2613	763	1	relat	relat	PROPN
fnp-2613	763	2	.	.	PUNCT
fnp-2613	764	1	disord	disord	NOUN
fnp-2613	764	2	.	.	PUNCT
fnp-2613	765	1	11	11	NUM
fnp-2613	765	2	,	,	PUNCT
fnp-2613	765	3	s47	s47	NOUN
fnp-2613	765	4	-	-	SYM
fnp-2613	765	5	51	51	NUM
fnp-2613	765	6	(	(	PUNCT
fnp-2613	765	7	2005	2005	NUM
fnp-2613	765	8	)	)	PUNCT
fnp-2613	765	9	.	.	PUNCT
fnp-2613	766	1	126	126	NUM
fnp-2613	766	2	.	.	PUNCT
fnp-2613	767	1	mckeith	mckeith	PROPN
fnp-2613	767	2	,	,	PUNCT
fnp-2613	767	3	i.	i.	PROPN
fnp-2613	767	4	commentary	commentary	PROPN
fnp-2613	767	5	:	:	PUNCT
fnp-2613	767	6	dlb	dlb	NOUN
fnp-2613	767	7	and	and	CCONJ
fnp-2613	767	8	pdd	pdd	NOUN
fnp-2613	767	9	:	:	PUNCT
fnp-2613	767	10	the	the	DET
fnp-2613	767	11	same	same	ADJ
fnp-2613	767	12	or	or	CCONJ
fnp-2613	767	13	different	different	ADJ
fnp-2613	767	14	?	?	PUNCT
fnp-2613	767	15	is	be	AUX
fnp-2613	767	16	there	there	PRON
fnp-2613	767	17	a	a	DET
fnp-2613	767	18	debate	debate	NOUN
fnp-2613	767	19	?	?	PUNCT
fnp-2613	768	1	int	int	NOUN
fnp-2613	768	2	.	.	PUNCT
fnp-2613	769	1	psychogeriatrics	psychogeriatrics	PROPN
fnp-2613	769	2	21	21	NUM
fnp-2613	769	3	,	,	PUNCT
fnp-2613	769	4	220	220	NUM
fnp-2613	769	5	(	(	PUNCT
fnp-2613	769	6	2009	2009	NUM
fnp-2613	769	7	)	)	PUNCT
fnp-2613	769	8	.	.	PUNCT
fnp-2613	770	1	127	127	NUM
fnp-2613	770	2	.	.	PUNCT
fnp-2613	771	1	grande	grande	PROPN
fnp-2613	771	2	,	,	PUNCT
fnp-2613	772	1	g.	g.	PROPN
fnp-2613	772	2	et	et	PROPN
fnp-2613	772	3	al	al	PROPN
fnp-2613	772	4	.	.	PROPN
fnp-2613	773	1	physical	physical	ADJ
fnp-2613	773	2	activity	activity	NOUN
fnp-2613	773	3	reduces	reduce	VERB
fnp-2613	773	4	the	the	DET
fnp-2613	773	5	risk	risk	NOUN
fnp-2613	773	6	of	of	ADP
fnp-2613	773	7	dementia	dementia	NOUN
fnp-2613	773	8	in	in	ADP
fnp-2613	773	9	mild	mild	ADJ
fnp-2613	773	10	cognitive	cognitive	ADJ
fnp-2613	773	11	impairment	impairment	NOUN
fnp-2613	773	12	subjects	subject	NOUN
fnp-2613	773	13	:	:	PUNCT
fnp-2613	773	14	a	a	DET
fnp-2613	773	15	cohort	cohort	NOUN
fnp-2613	773	16	study	study	NOUN
fnp-2613	773	17	.	.	PUNCT
fnp-2613	774	1	j.	j.	PROPN
fnp-2613	774	2	alzheimers	alzheimers	PROPN
fnp-2613	774	3	.	.	PUNCT
fnp-2613	775	1	dis	dis	PROPN
fnp-2613	775	2	.	.	PROPN
fnp-2613	776	1	39	39	NUM
fnp-2613	776	2	,	,	PUNCT
fnp-2613	776	3	833–9	833–9	PRON
fnp-2613	776	4	(	(	PUNCT
fnp-2613	776	5	2014	2014	NUM
fnp-2613	776	6	)	)	PUNCT
fnp-2613	776	7	.	.	PUNCT
fnp-2613	777	1	128	128	NUM
fnp-2613	777	2	.	.	PUNCT
fnp-2613	778	1	kalbe	kalbe	PROPN
fnp-2613	778	2	,	,	PUNCT
fnp-2613	778	3	e.	e.	PROPN
fnp-2613	778	4	et	et	PROPN
fnp-2613	778	5	al	al	PROPN
fnp-2613	778	6	.	.	PROPN
fnp-2613	778	7	task	task	PROPN
fnp-2613	778	8	force	force	PROPN
fnp-2613	778	9	wanted	want	VERB
fnp-2613	778	10	:	:	PUNCT
fnp-2613	778	11	many	many	ADJ
fnp-2613	778	12	reasons	reason	NOUN
fnp-2613	778	13	to	to	PART
fnp-2613	778	14	promote	promote	VERB
fnp-2613	778	15	research	research	NOUN
fnp-2613	778	16	on	on	ADP
fnp-2613	778	17	cognitive	cognitive	ADJ
fnp-2613	778	18	rehabilitation	rehabilitation	NOUN
fnp-2613	778	19	to	to	PART
fnp-2613	778	20	prevent	prevent	VERB
fnp-2613	778	21	,	,	PUNCT
fnp-2613	778	22	delay	delay	NOUN
fnp-2613	778	23	,	,	PUNCT
fnp-2613	778	24	and	and	CCONJ
fnp-2613	778	25	treat	treat	VERB
fnp-2613	778	26	cognitive	cognitive	ADJ
fnp-2613	778	27	dysfunctions	dysfunction	NOUN
fnp-2613	778	28	in	in	ADP
fnp-2613	778	29	patients	patient	NOUN
fnp-2613	778	30	with	with	ADP
fnp-2613	778	31	parkinson	parkinson	NOUN
fnp-2613	778	32	’s	’s	PART
fnp-2613	778	33	disease	disease	NOUN
fnp-2613	778	34	.	.	PUNCT
fnp-2613	779	1	parkinsonism	parkinsonism	PROPN
fnp-2613	779	2	relat	relat	PROPN
fnp-2613	779	3	.	.	PUNCT
fnp-2613	780	1	disord	disord	PROPN
fnp-2613	780	2	.	.	PUNCT
fnp-2613	781	1	21	21	NUM
fnp-2613	781	2	,	,	PUNCT
fnp-2613	781	3	166–167	166–167	NUM
fnp-2613	781	4	(	(	PUNCT
fnp-2613	781	5	2015	2015	NUM
fnp-2613	781	6	)	)	PUNCT
fnp-2613	781	7	.	.	PUNCT
fnp-2613	782	1	129	129	NUM
fnp-2613	782	2	.	.	PUNCT
fnp-2613	783	1	molloy	molloy	PROPN
fnp-2613	783	2	,	,	PUNCT
fnp-2613	783	3	s.	s.	PROPN
fnp-2613	783	4	et	et	PROPN
fnp-2613	783	5	al	al	PROPN
fnp-2613	783	6	.	.	PUNCT
fnp-2613	784	1	the	the	DET
fnp-2613	784	2	role	role	NOUN
fnp-2613	784	3	of	of	ADP
fnp-2613	784	4	levodopa	levodopa	NOUN
fnp-2613	784	5	in	in	ADP
fnp-2613	784	6	the	the	DET
fnp-2613	784	7	management	management	NOUN
fnp-2613	784	8	of	of	ADP
fnp-2613	784	9	dementia	dementia	NOUN
fnp-2613	784	10	with	with	ADP
fnp-2613	784	11	lewy	lewy	PROPN
fnp-2613	784	12	bodies	body	NOUN
fnp-2613	784	13	.	.	PUNCT
fnp-2613	785	1	j.	j.	PROPN
fnp-2613	785	2	neurol	neurol	PROPN
fnp-2613	785	3	.	.	PUNCT
fnp-2613	786	1	neurosurg	neurosurg	PROPN
fnp-2613	786	2	.	.	PUNCT
fnp-2613	787	1	psychiatry	psychiatry	NOUN
fnp-2613	787	2	76	76	NUM
fnp-2613	787	3	,	,	PUNCT
fnp-2613	787	4	1200–3	1200–3	NUM
fnp-2613	787	5	(	(	PUNCT
fnp-2613	787	6	2005	2005	NUM
fnp-2613	787	7	)	)	PUNCT
fnp-2613	787	8	.	.	PUNCT
fnp-2613	788	1	130	130	NUM
fnp-2613	788	2	.	.	PUNCT
fnp-2613	788	3	boot	boot	PROPN
fnp-2613	788	4	,	,	PUNCT
fnp-2613	788	5	b.	b.	PROPN
fnp-2613	789	1	p.	p.	NOUN
fnp-2613	789	2	et	et	PROPN
fnp-2613	790	1	al	al	PROPN
fnp-2613	790	2	.	.	PROPN
fnp-2613	790	3	treatment	treatment	NOUN
fnp-2613	790	4	of	of	ADP
fnp-2613	790	5	dementia	dementia	NOUN
fnp-2613	790	6	with	with	ADP
fnp-2613	790	7	lewy	lewy	PROPN
fnp-2613	790	8	bodies	body	NOUN
fnp-2613	790	9	.	.	PUNCT
fnp-2613	791	1	curr	curr	AUX
fnp-2613	791	2	.	.	PUNCT
fnp-2613	791	3	treat	treat	NOUN
fnp-2613	791	4	.	.	PUNCT
fnp-2613	792	1	options	option	NOUN
fnp-2613	792	2	neurol	neurol	NOUN
fnp-2613	792	3	.	.	PUNCT
fnp-2613	793	1	15	15	NUM
fnp-2613	793	2	,	,	PUNCT
fnp-2613	793	3	738–64	738–64	PROPN
fnp-2613	793	4	(	(	PUNCT
fnp-2613	793	5	2013	2013	NUM
fnp-2613	793	6	)	)	PUNCT
fnp-2613	793	7	.	.	PUNCT
fnp-2613	794	1	131	131	NUM
fnp-2613	794	2	.	.	PUNCT
fnp-2613	794	3	boeve	boeve	PROPN
fnp-2613	794	4	,	,	PUNCT
fnp-2613	794	5	b.	b.	PROPN
fnp-2613	795	1	f.	f.	PROPN
fnp-2613	795	2	et	et	PROPN
fnp-2613	795	3	al	al	PROPN
fnp-2613	795	4	.	.	PROPN
fnp-2613	796	1	rem	rem	VERB
fnp-2613	796	2	sleep	sleep	NOUN
fnp-2613	796	3	behavior	behavior	NOUN
fnp-2613	796	4	disorder	disorder	NOUN
fnp-2613	796	5	in	in	ADP
fnp-2613	796	6	parkinson	parkinson	NOUN
fnp-2613	796	7	’s	’s	PART
fnp-2613	796	8	disease	disease	NOUN
fnp-2613	796	9	and	and	CCONJ
fnp-2613	796	10	dementia	dementia	NOUN
fnp-2613	796	11	with	with	ADP
fnp-2613	796	12	lewy	lewy	PROPN
fnp-2613	796	13	bodies	body	NOUN
fnp-2613	796	14	.	.	PUNCT
fnp-2613	797	1	j.	j.	PROPN
fnp-2613	797	2	geriatr	geriatr	PROPN
fnp-2613	797	3	.	.	PUNCT
fnp-2613	798	1	psychiatry	psychiatry	NOUN
fnp-2613	798	2	neurol	neurol	PROPN
fnp-2613	798	3	.	.	PUNCT
fnp-2613	799	1	17	17	NUM
fnp-2613	799	2	,	,	PUNCT
fnp-2613	799	3	146–57	146–57	NUM
fnp-2613	799	4	(	(	PUNCT
fnp-2613	799	5	2004	2004	NUM
fnp-2613	799	6	)	)	PUNCT
fnp-2613	799	7	.	.	PUNCT
fnp-2613	800	1	132	132	NUM
fnp-2613	800	2	.	.	PUNCT
fnp-2613	801	1	aarsland	aarsland	PROPN
fnp-2613	801	2	,	,	PUNCT
fnp-2613	801	3	d.	d.	PROPN
fnp-2613	801	4	et	et	PROPN
fnp-2613	801	5	al	al	PROPN
fnp-2613	801	6	.	.	PROPN
fnp-2613	801	7	neuroleptic	neuroleptic	ADJ
fnp-2613	801	8	sensitivity	sensitivity	NOUN
fnp-2613	801	9	in	in	ADP
fnp-2613	801	10	parkinson	parkinson	NOUN
fnp-2613	801	11	’s	’s	PART
fnp-2613	801	12	disease	disease	NOUN
fnp-2613	801	13	and	and	CCONJ
fnp-2613	801	14	parkinsonian	parkinsonian	ADJ
fnp-2613	801	15	dementias	dementia	NOUN
fnp-2613	801	16	.	.	PUNCT
fnp-2613	802	1	j.	j.	PROPN
fnp-2613	802	2	clin	clin	PROPN
fnp-2613	802	3	.	.	PUNCT
fnp-2613	803	1	psychiatry	psychiatry	NOUN
fnp-2613	803	2	66	66	NUM
fnp-2613	803	3	,	,	PUNCT
fnp-2613	803	4	633–7	633–7	NUM
fnp-2613	803	5	(	(	PUNCT
fnp-2613	803	6	2005	2005	NUM
fnp-2613	803	7	)	)	PUNCT
fnp-2613	803	8	.	.	PUNCT
fnp-2613	804	1	133	133	NUM
fnp-2613	804	2	.	.	PUNCT
fnp-2613	805	1	aarsland	aarsland	PROPN
fnp-2613	805	2	,	,	PUNCT
fnp-2613	806	1	d.	d.	PROPN
fnp-2613	806	2	et	et	PROPN
fnp-2613	806	3	al	al	PROPN
fnp-2613	806	4	.	.	PROPN
fnp-2613	806	5	role	role	NOUN
fnp-2613	806	6	of	of	ADP
fnp-2613	806	7	cholinesterase	cholinesterase	NOUN
fnp-2613	806	8	inhibitors	inhibitor	NOUN
fnp-2613	806	9	in	in	ADP
fnp-2613	806	10	parkinson	parkinson	NOUN
fnp-2613	806	11	’s	’s	PART
fnp-2613	806	12	disease	disease	NOUN
fnp-2613	806	13	and	and	CCONJ
fnp-2613	806	14	dementia	dementia	NOUN
fnp-2613	806	15	with	with	ADP
fnp-2613	806	16	lewy	lewy	PROPN
fnp-2613	806	17	bodies	body	NOUN
fnp-2613	806	18	.	.	PUNCT
fnp-2613	807	1	j.	j.	PROPN
fnp-2613	807	2	geriatr	geriatr	PROPN
fnp-2613	807	3	.	.	PUNCT
fnp-2613	808	1	psychiatry	psychiatry	NOUN
fnp-2613	808	2	neurol	neurol	PROPN
fnp-2613	808	3	.	.	PUNCT
fnp-2613	809	1	17	17	NUM
fnp-2613	809	2	,	,	PUNCT
fnp-2613	809	3	164–71	164–71	PROPN
fnp-2613	809	4	(	(	PUNCT
fnp-2613	809	5	2004	2004	NUM
fnp-2613	809	6	)	)	PUNCT
fnp-2613	809	7	.	.	PUNCT
fnp-2613	810	1	134	134	NUM
fnp-2613	810	2	.	.	PUNCT
fnp-2613	810	3	stinton	stinton	PROPN
fnp-2613	810	4	,	,	PUNCT
fnp-2613	810	5	c.	c.	PROPN
fnp-2613	810	6	et	et	PROPN
fnp-2613	810	7	al	al	PROPN
fnp-2613	810	8	.	.	PROPN
fnp-2613	810	9	pharmacological	pharmacological	ADJ
fnp-2613	810	10	management	management	NOUN
fnp-2613	810	11	of	of	ADP
fnp-2613	810	12	lewy	lewy	PROPN
fnp-2613	810	13	body	body	NOUN
fnp-2613	810	14	dementia	dementia	NOUN
fnp-2613	810	15	:	:	PUNCT
fnp-2613	810	16	a	a	DET
fnp-2613	810	17	systematic	systematic	ADJ
fnp-2613	810	18	review	review	NOUN
fnp-2613	810	19	and	and	CCONJ
fnp-2613	810	20	meta	meta	ADJ
fnp-2613	810	21	-	-	PUNCT
fnp-2613	810	22	analysis	analysis	NOUN
fnp-2613	810	23	.	.	PUNCT
fnp-2613	811	1	am	be	AUX
fnp-2613	811	2	.	.	PUNCT
fnp-2613	812	1	j.	j.	PROPN
fnp-2613	812	2	psychiatry	psychiatry	PROPN
fnp-2613	812	3	172	172	NUM
fnp-2613	812	4	,	,	PUNCT
fnp-2613	812	5	731–742	731–742	NUM
fnp-2613	812	6	(	(	PUNCT
fnp-2613	812	7	2015	2015	NUM
fnp-2613	812	8	)	)	PUNCT
fnp-2613	812	9	.	.	PUNCT
fnp-2613	813	1	135	135	NUM
fnp-2613	813	2	.	.	X
fnp-2613	813	3	lucza	lucza	PROPN
fnp-2613	813	4	,	,	PUNCT
fnp-2613	813	5	t.	t.	PROPN
fnp-2613	813	6	et	et	PROPN
fnp-2613	813	7	al	al	PROPN
fnp-2613	813	8	.	.	PROPN
fnp-2613	814	1	neurocognitive	neurocognitive	ADJ
fnp-2613	814	2	disorders	disorder	NOUN
fnp-2613	814	3	in	in	ADP
fnp-2613	814	4	parkinson	parkinson	NOUN
fnp-2613	814	5	’s	’s	PART
fnp-2613	814	6	disease	disease	NOUN
fnp-2613	814	7	.	.	PUNCT
fnp-2613	815	1	orv	orv	PROPN
fnp-2613	815	2	.	.	PROPN
fnp-2613	815	3	hetil	hetil	PROPN
fnp-2613	815	4	.	.	PUNCT
fnp-2613	816	1	156	156	NUM
fnp-2613	816	2	,	,	PUNCT
fnp-2613	816	3	915–926	915–926	NUM
fnp-2613	816	4	(	(	PUNCT
fnp-2613	816	5	2015	2015	NUM
fnp-2613	816	6	)	)	PUNCT
fnp-2613	816	7	.	.	PUNCT
fnp-2613	817	1	136	136	NUM
fnp-2613	817	2	.	.	PUNCT
fnp-2613	818	1	skrobot	skrobot	PROPN
fnp-2613	818	2	,	,	PUNCT
fnp-2613	819	1	o.	o.	NOUN
fnp-2613	819	2	a.	a.	PROPN
fnp-2613	819	3	et	et	PROPN
fnp-2613	819	4	al	al	PROPN
fnp-2613	819	5	.	.	PROPN
fnp-2613	819	6	vascular	vascular	ADJ
fnp-2613	819	7	cognitive	cognitive	ADJ
fnp-2613	819	8	impairment	impairment	NOUN
fnp-2613	819	9	neuropathology	neuropathology	NOUN
fnp-2613	819	10	guidelines	guideline	NOUN
fnp-2613	819	11	(	(	PUNCT
fnp-2613	819	12	vcing	vcing	NOUN
fnp-2613	819	13	):	):	PUNCT
fnp-2613	819	14	the	the	DET
fnp-2613	819	15	contribution	contribution	NOUN
fnp-2613	819	16	of	of	ADP
fnp-2613	819	17	cerebrovascular	cerebrovascular	ADJ
fnp-2613	819	18	pathology	pathology	NOUN
fnp-2613	819	19	to	to	PART
fnp-2613	819	20	cognitive	cognitive	ADJ
fnp-2613	819	21	impairment	impairment	NOUN
fnp-2613	819	22	.	.	PUNCT
fnp-2613	820	1	brain	brain	NOUN
fnp-2613	820	2	139	139	NUM
fnp-2613	820	3	,	,	PUNCT
fnp-2613	820	4	2957–2969	2957–2969	NUM
fnp-2613	820	5	(	(	PUNCT
fnp-2613	820	6	2016	2016	NUM
fnp-2613	820	7	)	)	PUNCT
fnp-2613	820	8	.	.	PUNCT
fnp-2613	821	1	copyright	copyright	NOUN
fnp-2613	821	2	:	:	PUNCT
fnp-2613	821	3	©	©	PROPN
fnp-2613	821	4	2020	2020	NUM
fnp-2613	821	5	the	the	DET
fnp-2613	821	6	author(s	author(s	NOUN
fnp-2613	821	7	)	)	PUNCT
fnp-2613	821	8	.	.	PUNCT
fnp-2613	822	1	this	this	PRON
fnp-2613	822	2	is	be	AUX
fnp-2613	822	3	an	an	DET
fnp-2613	822	4	open	open	ADJ
fnp-2613	822	5	access	access	NOUN
fnp-2613	822	6	article	article	NOUN
fnp-2613	822	7	distributed	distribute	VERB
fnp-2613	822	8	under	under	ADP
fnp-2613	822	9	the	the	DET
fnp-2613	822	10	terms	term	NOUN
fnp-2613	822	11	of	of	ADP
fnp-2613	822	12	the	the	DET
fnp-2613	822	13	creative	creative	ADJ
fnp-2613	822	14	commons	common	NOUN
fnp-2613	822	15	attribution	attribution	NOUN
fnp-2613	822	16	4.0	4.0	NUM
fnp-2613	822	17	international	international	ADJ
fnp-2613	822	18	license	license	NOUN
fnp-2613	822	19	(	(	PUNCT
fnp-2613	822	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-2613	822	21	)	)	PUNCT
fnp-2613	822	22	,	,	PUNCT
fnp-2613	822	23	which	which	PRON
fnp-2613	822	24	permits	permit	VERB
fnp-2613	822	25	unrestricted	unrestricted	ADJ
fnp-2613	822	26	use	use	NOUN
fnp-2613	822	27	,	,	PUNCT
fnp-2613	822	28	distribution	distribution	NOUN
fnp-2613	822	29	,	,	PUNCT
fnp-2613	822	30	and	and	CCONJ
fnp-2613	822	31	reproduction	reproduction	NOUN
fnp-2613	822	32	in	in	ADP
fnp-2613	822	33	any	any	DET
fnp-2613	822	34	medium	medium	NOUN
fnp-2613	822	35	,	,	PUNCT
fnp-2613	822	36	provided	provide	VERB
fnp-2613	822	37	the	the	DET
fnp-2613	822	38	original	original	ADJ
fnp-2613	822	39	author	author	NOUN
fnp-2613	822	40	and	and	CCONJ
fnp-2613	822	41	source	source	NOUN
fnp-2613	822	42	are	be	AUX
fnp-2613	822	43	credited	credit	VERB
fnp-2613	822	44	,	,	PUNCT
fnp-2613	822	45	a	a	DET
fnp-2613	822	46	link	link	NOUN
fnp-2613	822	47	to	to	ADP
fnp-2613	822	48	the	the	DET
fnp-2613	822	49	creative	creative	ADJ
fnp-2613	822	50	commons	common	NOUN
fnp-2613	822	51	license	license	NOUN
fnp-2613	822	52	is	be	AUX
fnp-2613	822	53	provided	provide	VERB
fnp-2613	822	54	,	,	PUNCT
fnp-2613	822	55	and	and	CCONJ
fnp-2613	822	56	any	any	DET
fnp-2613	822	57	changes	change	NOUN
fnp-2613	822	58	are	be	AUX
fnp-2613	822	59	indicated	indicate	VERB
fnp-2613	822	60	.	.	PUNCT
fnp-2613	823	1	the	the	DET
fnp-2613	823	2	creative	creative	ADJ
fnp-2613	823	3	commons	common	NOUN
fnp-2613	823	4	public	public	ADJ
fnp-2613	823	5	domain	domain	NOUN
fnp-2613	823	6	dedication	dedication	NOUN
fnp-2613	823	7	waiver	waiver	NOUN
fnp-2613	823	8	(	(	PUNCT
fnp-2613	823	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-2613	823	10	)	)	PUNCT
fnp-2613	823	11	applies	apply	VERB
fnp-2613	823	12	to	to	ADP
fnp-2613	823	13	the	the	DET
fnp-2613	823	14	data	datum	NOUN
fnp-2613	823	15	made	make	VERB
fnp-2613	823	16	available	available	ADJ
fnp-2613	823	17	in	in	ADP
fnp-2613	823	18	this	this	DET
fnp-2613	823	19	article	article	NOUN
fnp-2613	823	20	,	,	PUNCT
fnp-2613	823	21	unless	unless	SCONJ
fnp-2613	823	22	otherwise	otherwise	ADV
fnp-2613	823	23	stated	state	VERB
fnp-2613	823	24	.	.	PUNCT